Latest peptide research

Browse dated
peptide records.

Filter selected PubMed metadata, ClinicalTrials.gov records, and official notices by peptide, record type, and source date. Each entry links to the cited public source.

This page shows
Selected records organized by the date carried by each cited source.
It does not establish
A record's date does not establish importance, safety, or effectiveness.
2,625dated records
1,425PubMed records
721trial records
August 20, 2026latest source date

Showing 2625 records

Regulatory · Exenatide

Federal Register notice 2026-16998

The Federal Register published notice 2026-16998, attributed to FDA and its parent HHS department, on 2026-08-20. Its official title is “Advisory Committee; Endocrinologic and Metabolic Drugs Advisory Committee; Renewal,” and PeptideScanner's exact reviewed identity mapping connects the document to Exenatide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Literature metadata · Semaglutide

Validation of a Pharmacist-Led Semaglutide Prescribing Algorithm for Type 2 Diabetes and Chronic Kidney Disease: Research Letter.

PubMed lists PMID 42602345 in Canadian journal of kidney health and disease as Journal Article, with publication-date metadata of 2026-08-13 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 16, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

Geographic Disparities in Glucagon Prescriptions Across North Carolina.

PubMed lists PMID 40513916 in American journal of preventive medicine as Journal Article, with publication-date metadata of 2025-06-11 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 16, 2026 · Source: PubMed ↗

Literature metadata · Liraglutide

Treatment of obesity with liraglutide in bipolar disorder: a case report.

PubMed lists PMID 42597211 in Frontiers in psychiatry as Case Reports, Journal Article, with publication-date metadata of 2026-07-30 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

Inflammation-mediated facial nodules to compounded tirzepatide.

PubMed lists PMID 42598502 in JAAD case reports as Letter, with publication-date metadata of 2026-06-17 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07087795

PeptideScanner retained ClinicalTrials.gov record NCT07087795 at 2026-08-13T16:32:13.881Z. Its registry update date was 2026-08-13, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 14, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Teriparatide

Letter to the Editor: "Comparison of Teriparatide and Denosumab in Patients Switching from Long-Term Bisphosphonate Use".

PubMed lists PMID 31408164 in The Journal of clinical endocrinology and metabolism as Comment, Letter, with publication-date metadata of 2019-12-01 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

A new C-peptide minimal model to assess β-cell responsiveness to glucagon in individuals with and without type 2 diabetes.

PubMed lists PMID 39925097 in American journal of physiology. Endocrinology and metabolism as Journal Article, with publication-date metadata of 2025-02-10 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

A Computational Glucoregulatory Model of Liver and Glucagon for the Evaluation of Therapeutics.

PubMed lists PMID 40969902 in ACS pharmacology & translational science as Journal Article, with publication-date metadata of 2025-08-12 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Octreotide

Real-World Indirect Treatment Comparison of Terlipressin vs Midodrine Plus Octreotide in Hepatorenal Syndrome-Acute Kidney Injury.

PubMed lists PMID 41472624 in Clinical and translational gastroenterology as Journal Article, Comparative Study, with publication-date metadata of 2026-02-01 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

Glucagon secretion by pancreatic alpha-cells requires an intact tubulin-cytoskeleton-primary cilium axis.

PubMed lists PMID 41667949 in Molecular medicine (Cambridge, Mass.) as Journal Article, with publication-date metadata of 2026-02-10 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Teriparatide

Targeted drug repurposing in medication-related osteonecrosis of the jaw: a review of teriparatide and pentoxifylline/α-tocopherol protocols.

PubMed lists PMID 41852535 in Frontiers in medicine as Journal Article, Review, with publication-date metadata of 2026-03-03 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

Semaglutide and Non-arteritic Anterior Ischemic Optic Neuropathy: A Systematic Review and Narrative Synthesis.

PubMed lists PMID 41938304 in AACE endocrinology and diabetes as Journal Article, Review, with publication-date metadata of 2026-01-17 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

Tirzepatide and Autonomic Dysfunction: Insights From Postural Orthostatic Tachycardia Syndrome.

PubMed lists PMID 41945548 in JACC. Case reports as Letter, with publication-date metadata of 2025-12-17 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Liraglutide

Application of the OBIMAP (One-Bead Interchain Multipeptide Assembly Platform) to Long Peptide Synthesis: Liraglutide as a Case Study.

PubMed lists PMID 41970854 in ACS omega as Journal Article, with publication-date metadata of 2026-03-25 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Teriparatide

Teriparatide in Two Patients With Mucopolysaccharidosis Type IVB.

PubMed lists PMID 41987916 in JIMD reports as Journal Article, with publication-date metadata of 2026-04-13 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

Glucose-dependent dynamics of glucagon, cortisol and adrenocorticotropic hormone before and after gastric bypass.

PubMed lists PMID 41994483 in Journal of the Endocrine Society as Journal Article, with publication-date metadata of 2026-04-02 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Teriparatide

Comparing Teriparatide and Bisphosphonates for Postmenopausal Osteoporosis: A Systematic Review and Meta-Analysis of RCTs.

PubMed lists PMID 42022682 in Health science reports as Journal Article, Review, with publication-date metadata of 2026-03-13 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Octreotide

Uptake of 18F-AlF-NOTA-octreotide PET/CT in gastrointestinal stromal tumors.

PubMed lists PMID 42026400 in EJNMMI reports as Journal Article, with publication-date metadata of 2026-04-24 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Teriparatide

Acute use of teriparatide and palopegteriparatide in the management of hungry bone syndrome following parathyroidectomy.

PubMed lists PMID 42058698 in JCEM case reports as Case Reports, Journal Article, with publication-date metadata of 2026-04-28 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

Quality by Design-Based Formulation Development of an Oral Semaglutide Tablet.

PubMed lists PMID 42076092 in Pharmaceutics as Journal Article, with publication-date metadata of 2026-04-01 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

Is Oral Semaglutide a Good Fit for Patients After Metabolic Bariatric Surgery? A Biopharmaceutical Mechanistic Perspective.

PubMed lists PMID 42076118 in Pharmaceutics as Journal Article, with publication-date metadata of 2026-04-10 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Teriparatide

A Comparison Between Bisphosphonates and Teriparatide in the Treatment of Postmenopausal Osteoporosis: A Systematic Review.

PubMed lists PMID 42083710 in Cureus as Journal Article, Review, with publication-date metadata of 2026-04-03 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

Facial nodules following filler injections after initiating compounded tirzepatide use.

PubMed lists PMID 42088720 in JAAD case reports as Case Reports, Journal Article, with publication-date metadata of 2026-03-27 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

Semaglutide use for hypothalamic obesity and type 2 diabetes mellitus after suprasellar germinoma treatment.

PubMed lists PMID 42158165 in JCEM case reports as Case Reports, Journal Article, with publication-date metadata of 2026-05-18 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Octreotide

Transarterial embolization combined with octreotide long-acting release in treating rectal neuroendocrine tumor liver metastases: a single-institutional experience.

PubMed lists PMID 42169939 in Journal of gastrointestinal oncology as Journal Article, with publication-date metadata of 2026-04-28 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

Optimization of nursing strategies for semaglutide treatment in overweight type 2 diabetes based on gene polymorphism.

PubMed lists PMID 42232304 in Frontiers in clinical diabetes and healthcare as Journal Article, with publication-date metadata of 2026-05-18 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Octreotide

Combined SSTR2-targeted Analogue with 177Lu-DOTATATE radionuclide and octreotide therapy for refractory meningioma: a case report.

PubMed lists PMID 42370133 in Frontiers in oncology as Case Reports, Journal Article, with publication-date metadata of 2026-06-11 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

Topic and Sentiment Trends in Semaglutide Discussions on X: Subpopulation-Based Longitudinal Analysis.

PubMed lists PMID 41734897 in Online journal of public health informatics as Journal Article, with publication-date metadata of 2026-02-24 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

Comment on Rossing et al. Nuances in Interpretation: Assessing the Interaction Between Semaglutide and MRAs in the FLOW Trial.

PubMed lists PMID 41771053 in Diabetes care as Letter, with publication-date metadata of 2026-06-01 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

Engineering a Glucose-Responsive Glucagon Prodrug Through Arginine-Phenylboronic Acid Pendant Modification.

PubMed lists PMID 41810046 in Small science as Journal Article, with publication-date metadata of 2026-03-06 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

Real-World Cohort Study of Semaglutide in Adults with Type 2 Diabetes Using an Electronic Health Records Database in Tianjin, China.

PubMed lists PMID 41848818 in Diabetes therapy : research, treatment and education of diabetes and related disorders as Journal Article, with publication-date metadata of 2026-03-18 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Maridebart cafraglutide

Design and therapeutic rationale of antibody-peptide conjugates: insights from maridebart cafraglutide (AMG133) and emerging applications.

PubMed lists PMID 42592044 in Antibody therapeutics as Journal Article, Review, with publication-date metadata of 2026-06-01 (day precision). PeptideScanner associated the retained record with the identity slug maridebart-cafraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

Real-world use of oral semaglutide in adults with type 2 diabetes.

PubMed lists PMID 42592768 in Danish medical journal as Journal Article, Multicenter Study, with publication-date metadata of 2026-06-16 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Teriparatide

Transient teriparatide for postoperative hypocalcaemia with hungry bone features.

PubMed lists PMID 42592840 in European journal of endocrinology as Journal Article, with publication-date metadata of 2026-08-13 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

Role of glucagon in metabolic diseases.

PubMed lists PMID 42593182 in Journal of diabetes investigation as Journal Article, Review, with publication-date metadata of 2026-08-13 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT03883412

PeptideScanner retained ClinicalTrials.gov record NCT03883412 at 2026-08-13T05:54:14.859Z. Its registry update date was 2026-08-12, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 14, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Dulaglutide

ClinicalTrials.gov record NCT05478707

PeptideScanner retained ClinicalTrials.gov record NCT05478707 at 2026-08-13T05:54:14.860Z. Its registry update date was 2026-08-12, and PeptideScanner's reviewed identity mapping was dulaglutide.

Added August 14, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07463846

PeptideScanner retained ClinicalTrials.gov record NCT07463846 at 2026-08-13T05:54:14.856Z. Its registry update date was 2026-08-12, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 14, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07046819

PeptideScanner retained ClinicalTrials.gov record NCT07046819 at 2026-08-13T05:54:14.859Z. Its registry update date was 2026-08-12, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07218354

PeptideScanner retained ClinicalTrials.gov record NCT07218354 at 2026-08-13T05:54:14.857Z. Its registry update date was 2026-08-12, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07734870

PeptideScanner retained ClinicalTrials.gov record NCT07734870 at 2026-08-13T05:54:14.859Z. Its registry update date was 2026-08-12, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · MOTS-c

PubMed record PMID 42243958

PeptideScanner retained PubMed bibliographic metadata for PMID 42243958 at 2026-08-12T11:06:05.213Z. PubMed recorded a metadata revision date of 2026-08-12 and an Entrez history date of 2026-06-05. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Survodutide

ClinicalTrials.gov record NCT06077864

PeptideScanner retained ClinicalTrials.gov record NCT06077864 at 2026-08-13T05:52:27.018Z. Its registry update date was 2026-08-11, and PeptideScanner's reviewed identity mapping was survodutide.

Added August 14, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT06965413

PeptideScanner retained ClinicalTrials.gov record NCT06965413 at 2026-08-13T05:52:27.007Z. Its registry update date was 2026-08-11, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 14, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT06651177

PeptideScanner retained ClinicalTrials.gov record NCT06651177 at 2026-08-13T05:52:27.017Z. Its registry update date was 2026-08-11, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT03884075

PeptideScanner retained ClinicalTrials.gov record NCT03884075 at 2026-08-13T05:52:27.026Z. Its registry update date was 2026-08-10, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 14, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Survodutide

ClinicalTrials.gov record NCT07754461

PeptideScanner retained ClinicalTrials.gov record NCT07754461 at 2026-08-13T05:52:27.026Z. Its registry update date was 2026-08-10, and PeptideScanner's reviewed identity mapping was survodutide.

Added August 14, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Survodutide

ClinicalTrials.gov record NCT06632444

PeptideScanner retained ClinicalTrials.gov record NCT06632444 at 2026-08-13T05:52:27.024Z. Its registry update date was 2026-08-10, and PeptideScanner's reviewed identity mapping was survodutide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Survodutide

ClinicalTrials.gov record NCT06632457

PeptideScanner retained ClinicalTrials.gov record NCT06632457 at 2026-08-13T05:52:27.009Z. Its registry update date was 2026-08-10, and PeptideScanner's reviewed identity mapping was survodutide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Octreotide

PubMed record PMID 39631560

PeptideScanner retained PubMed bibliographic metadata for PMID 39631560 at 2026-08-10T10:49:06.913Z. PubMed recorded a metadata revision date of 2026-08-09 and an Entrez history date of 2024-12-04. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42264960

PeptideScanner retained PubMed bibliographic metadata for PMID 42264960 at 2026-08-10T10:49:10.674Z. PubMed recorded a metadata revision date of 2026-08-09 and an Entrez history date of 2026-06-09. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42297751

PeptideScanner retained PubMed bibliographic metadata for PMID 42297751 at 2026-08-10T10:49:10.683Z. PubMed recorded a metadata revision date of 2026-08-09 and an Entrez history date of 2026-06-15. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42297754

PeptideScanner retained PubMed bibliographic metadata for PMID 42297754 at 2026-08-10T10:49:10.683Z. PubMed recorded a metadata revision date of 2026-08-09 and an Entrez history date of 2026-06-15. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42297758

PeptideScanner retained PubMed bibliographic metadata for PMID 42297758 at 2026-08-10T10:49:10.684Z. PubMed recorded a metadata revision date of 2026-08-09 and an Entrez history date of 2026-06-15. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42304199

PeptideScanner retained PubMed bibliographic metadata for PMID 42304199 at 2026-08-10T10:49:10.691Z. PubMed recorded a metadata revision date of 2026-08-09 and an Entrez history date of 2026-06-16. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 42315494

PeptideScanner retained PubMed bibliographic metadata for PMID 42315494 at 2026-08-10T10:49:10.699Z. PubMed recorded a metadata revision date of 2026-08-09 and an Entrez history date of 2026-06-18. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42348366

PeptideScanner retained PubMed bibliographic metadata for PMID 42348366 at 2026-08-10T10:49:10.723Z. PubMed recorded a metadata revision date of 2026-08-09 and an Entrez history date of 2026-06-25. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42365987

PeptideScanner retained PubMed bibliographic metadata for PMID 42365987 at 2026-08-10T10:49:10.730Z. PubMed recorded a metadata revision date of 2026-08-09 and an Entrez history date of 2026-06-28. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42387290

PeptideScanner retained PubMed bibliographic metadata for PMID 42387290 at 2026-08-10T10:49:10.738Z. PubMed recorded a metadata revision date of 2026-08-09 and an Entrez history date of 2026-07-02. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42403263

PeptideScanner retained PubMed bibliographic metadata for PMID 42403263 at 2026-08-10T10:49:10.745Z. PubMed recorded a metadata revision date of 2026-08-09 and an Entrez history date of 2026-07-06. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42420782

PeptideScanner retained PubMed bibliographic metadata for PMID 42420782 at 2026-08-10T10:49:10.753Z. PubMed recorded a metadata revision date of 2026-08-09 and an Entrez history date of 2026-07-08. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42443711

PeptideScanner retained PubMed bibliographic metadata for PMID 42443711 at 2026-08-10T10:49:10.765Z. PubMed recorded a metadata revision date of 2026-08-09 and an Entrez history date of 2026-07-13. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Exenatide

PubMed record PMID 30974038

PeptideScanner retained PubMed bibliographic metadata for PMID 30974038 at 2026-08-10T10:49:06.835Z. PubMed recorded a metadata revision date of 2026-08-08 and an Entrez history date of 2019-04-12. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 38149727

PeptideScanner retained PubMed bibliographic metadata for PMID 38149727 at 2026-08-10T10:49:06.860Z. PubMed recorded a metadata revision date of 2026-08-08 and an Entrez history date of 2023-12-27. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 38151966

PeptideScanner retained PubMed bibliographic metadata for PMID 38151966 at 2026-08-10T10:49:06.863Z. PubMed recorded a metadata revision date of 2026-08-08 and an Entrez history date of 2023-12-28. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 38253809

PeptideScanner retained PubMed bibliographic metadata for PMID 38253809 at 2026-08-10T10:49:06.874Z. PubMed recorded a metadata revision date of 2026-08-08 and an Entrez history date of 2024-01-22. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 38302718

PeptideScanner retained PubMed bibliographic metadata for PMID 38302718 at 2026-08-10T10:49:06.877Z. PubMed recorded a metadata revision date of 2026-08-08 and an Entrez history date of 2024-02-01. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 39776038

PeptideScanner retained PubMed bibliographic metadata for PMID 39776038 at 2026-08-10T10:49:06.923Z. PubMed recorded a metadata revision date of 2026-08-08 and an Entrez history date of 2025-01-08. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 41342185

PeptideScanner retained PubMed bibliographic metadata for PMID 41342185 at 2026-08-10T10:49:07.015Z. PubMed recorded a metadata revision date of 2026-08-08 and an Entrez history date of 2025-12-04. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 42557738

PeptideScanner retained PubMed bibliographic metadata for PMID 42557738 at 2026-08-10T10:49:13.006Z. PubMed recorded a metadata revision date of 2026-08-08 and an Entrez history date of 2026-08-06. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 42559671

PeptideScanner retained PubMed bibliographic metadata for PMID 42559671 at 2026-08-10T10:49:13.017Z. PubMed recorded a metadata revision date of 2026-08-08 and an Entrez history date of 2026-08-06. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 42568245

PeptideScanner retained PubMed bibliographic metadata for PMID 42568245 at 2026-08-10T10:49:13.603Z. PubMed recorded a metadata revision date of 2026-08-08 and an Entrez history date of 2026-08-08. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Teriparatide

PubMed record PMID 42568899

PeptideScanner retained PubMed bibliographic metadata for PMID 42568899 at 2026-08-10T10:49:13.608Z. PubMed recorded a metadata revision date of 2026-08-08 and an Entrez history date of 2026-08-08. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42569002

PeptideScanner retained PubMed bibliographic metadata for PMID 42569002 at 2026-08-10T10:49:13.608Z. PubMed recorded a metadata revision date of 2026-08-08 and an Entrez history date of 2026-08-08. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42569707

PeptideScanner retained PubMed bibliographic metadata for PMID 42569707 at 2026-08-10T10:49:13.615Z. PubMed recorded a metadata revision date of 2026-08-08 and an Entrez history date of 2026-08-08. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Teriparatide

PubMed record PMID 42570209

PeptideScanner retained PubMed bibliographic metadata for PMID 42570209 at 2026-08-10T10:49:13.625Z. PubMed recorded a metadata revision date of 2026-08-08 and an Entrez history date of 2026-08-08. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Clinical trials · Dulaglutide

ClinicalTrials.gov record NCT06739122

PeptideScanner retained ClinicalTrials.gov record NCT06739122 at 2026-08-13T05:52:27.010Z. Its registry update date was 2026-08-07, and PeptideScanner's reviewed identity mapping was dulaglutide.

Added August 14, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Maridebart cafraglutide

ClinicalTrials.gov record NCT07313761

PeptideScanner retained ClinicalTrials.gov record NCT07313761 at 2026-08-13T05:52:27.026Z. Its registry update date was 2026-08-07, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.

Added August 14, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Petrelintide

ClinicalTrials.gov record NCT07589686

PeptideScanner retained ClinicalTrials.gov record NCT07589686 at 2026-08-13T05:52:27.014Z. Its registry update date was 2026-08-07, and PeptideScanner's reviewed identity mapping was petrelintide.

Added August 14, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Glucagon

PubMed record PMID 33491091

PeptideScanner retained PubMed bibliographic metadata for PMID 33491091 at 2026-08-10T10:49:06.839Z. PubMed recorded a metadata revision date of 2026-08-07 and an Entrez history date of 2021-01-25. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Liraglutide

PubMed record PMID 38240127

PeptideScanner retained PubMed bibliographic metadata for PMID 38240127 at 2026-08-10T10:49:06.873Z. PubMed recorded a metadata revision date of 2026-08-07 and an Entrez history date of 2024-01-19. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 41290555

PeptideScanner retained PubMed bibliographic metadata for PMID 41290555 at 2026-08-10T10:49:07.005Z. PubMed recorded a metadata revision date of 2026-08-07 and an Entrez history date of 2025-11-25. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 41885866

PeptideScanner retained PubMed bibliographic metadata for PMID 41885866 at 2026-08-10T10:49:08.813Z. PubMed recorded a metadata revision date of 2026-08-07 and an Entrez history date of 2026-03-26. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42253285

PeptideScanner retained PubMed bibliographic metadata for PMID 42253285 at 2026-08-10T10:49:10.672Z. PubMed recorded a metadata revision date of 2026-08-07 and an Entrez history date of 2026-06-08. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Teriparatide

PubMed record PMID 42501079

PeptideScanner retained PubMed bibliographic metadata for PMID 42501079 at 2026-08-10T10:49:10.788Z. PubMed recorded a metadata revision date of 2026-08-07 and an Entrez history date of 2026-07-25. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42567173

PeptideScanner retained PubMed bibliographic metadata for PMID 42567173 at 2026-08-10T10:49:13.603Z. PubMed recorded a metadata revision date of 2026-08-07 and an Entrez history date of 2026-08-07. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Retatrutide

PubMed record PMID 42567543

PeptideScanner retained PubMed bibliographic metadata for PMID 42567543 at 2026-08-10T10:49:13.603Z. PubMed recorded a metadata revision date of 2026-08-07 and an Entrez history date of 2026-08-07. PeptideScanner associated this retained record with the identity slug retatrutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Clinical trials · Setmelanotide

ClinicalTrials.gov record NCT05093634

PeptideScanner retained ClinicalTrials.gov record NCT05093634 at 2026-08-13T05:52:27.024Z. Its registry update date was 2026-08-06, and PeptideScanner's reviewed identity mapping was setmelanotide.

Added August 14, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT05313529

PeptideScanner retained ClinicalTrials.gov record NCT05313529 at 2026-08-13T05:52:27.020Z. Its registry update date was 2026-08-06, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 14, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT07455903

PeptideScanner retained ClinicalTrials.gov record NCT07455903 at 2026-08-13T05:52:27.015Z. Its registry update date was 2026-08-06, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 14, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Glucagon

PubMed record PMID 37152965

PeptideScanner retained PubMed bibliographic metadata for PMID 37152965 at 2026-08-10T10:49:06.848Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2023-05-08. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 38082468

PeptideScanner retained PubMed bibliographic metadata for PMID 38082468 at 2026-08-10T10:49:06.856Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2023-12-12. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 38093674

PeptideScanner retained PubMed bibliographic metadata for PMID 38093674 at 2026-08-10T10:49:06.858Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2023-12-14. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 38195847

PeptideScanner retained PubMed bibliographic metadata for PMID 38195847 at 2026-08-10T10:49:06.868Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2024-01-10. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 39604050

PeptideScanner retained PubMed bibliographic metadata for PMID 39604050 at 2026-08-10T10:49:06.908Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2024-11-27. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Liraglutide

PubMed record PMID 40429612

PeptideScanner retained PubMed bibliographic metadata for PMID 40429612 at 2026-08-10T10:49:06.946Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2025-05-28. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Liraglutide

PubMed record PMID 40913889

PeptideScanner retained PubMed bibliographic metadata for PMID 40913889 at 2026-08-10T10:49:06.966Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2025-09-06. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 41766347

PeptideScanner retained PubMed bibliographic metadata for PMID 41766347 at 2026-08-10T10:49:08.779Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2026-03-02. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 41804540

PeptideScanner retained PubMed bibliographic metadata for PMID 41804540 at 2026-08-10T10:49:08.787Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2026-03-10. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Teriparatide

PubMed record PMID 41904726

PeptideScanner retained PubMed bibliographic metadata for PMID 41904726 at 2026-08-10T10:49:08.825Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2026-03-29. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42495930

PeptideScanner retained PubMed bibliographic metadata for PMID 42495930 at 2026-08-10T10:49:10.785Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2026-07-24. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42541373

PeptideScanner retained PubMed bibliographic metadata for PMID 42541373 at 2026-08-10T10:49:12.960Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2026-08-01. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Liraglutide

PubMed record PMID 41321175

PeptideScanner retained PubMed bibliographic metadata for PMID 41321175 at 2026-08-10T10:49:07.012Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2025-12-01. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Teriparatide

PubMed record PMID 41949681

PeptideScanner retained PubMed bibliographic metadata for PMID 41949681 at 2026-08-10T10:49:08.835Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2026-04-08. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Vosoritide

PubMed record PMID 42026358

PeptideScanner retained PubMed bibliographic metadata for PMID 42026358 at 2026-08-10T10:49:08.854Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2026-04-23. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42542232

PeptideScanner retained PubMed bibliographic metadata for PMID 42542232 at 2026-08-10T10:49:12.963Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2026-08-01. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Liraglutide

PubMed record PMID 42549609

PeptideScanner retained PubMed bibliographic metadata for PMID 42549609 at 2026-08-10T10:49:12.984Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2026-08-04. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42560020

PeptideScanner retained PubMed bibliographic metadata for PMID 42560020 at 2026-08-10T10:49:13.020Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2026-08-06. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42560442

PeptideScanner retained PubMed bibliographic metadata for PMID 42560442 at 2026-08-10T10:49:13.020Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2026-08-06. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 38016699

PeptideScanner retained PubMed bibliographic metadata for PMID 38016699 at 2026-08-10T10:49:06.852Z. PubMed recorded a metadata revision date of 2026-08-05 and an Entrez history date of 2023-11-28. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 38073422

PeptideScanner retained PubMed bibliographic metadata for PMID 38073422 at 2026-08-10T10:49:06.856Z. PubMed recorded a metadata revision date of 2026-08-05 and an Entrez history date of 2023-12-11. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Liraglutide

PubMed record PMID 38092710

PeptideScanner retained PubMed bibliographic metadata for PMID 38092710 at 2026-08-10T10:49:06.858Z. PubMed recorded a metadata revision date of 2026-08-05 and an Entrez history date of 2023-12-13. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 39618173

PeptideScanner retained PubMed bibliographic metadata for PMID 39618173 at 2026-08-10T10:49:06.912Z. PubMed recorded a metadata revision date of 2026-08-05 and an Entrez history date of 2024-12-02. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 40015592

PeptideScanner retained PubMed bibliographic metadata for PMID 40015592 at 2026-08-10T10:49:06.932Z. PubMed recorded a metadata revision date of 2026-08-05 and an Entrez history date of 2025-02-27. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 41532935

PeptideScanner retained PubMed bibliographic metadata for PMID 41532935 at 2026-08-10T10:49:08.747Z. PubMed recorded a metadata revision date of 2026-08-05 and an Entrez history date of 2026-01-14. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 41802735

PeptideScanner retained PubMed bibliographic metadata for PMID 41802735 at 2026-08-10T10:49:08.786Z. PubMed recorded a metadata revision date of 2026-08-05 and an Entrez history date of 2026-03-09. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42275945

PeptideScanner retained PubMed bibliographic metadata for PMID 42275945 at 2026-08-10T10:49:10.676Z. PubMed recorded a metadata revision date of 2026-08-05 and an Entrez history date of 2026-06-11. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42504064

PeptideScanner retained PubMed bibliographic metadata for PMID 42504064 at 2026-08-10T10:49:10.789Z. PubMed recorded a metadata revision date of 2026-08-05 and an Entrez history date of 2026-07-27. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42552573

PeptideScanner retained PubMed bibliographic metadata for PMID 42552573 at 2026-08-10T10:49:12.986Z. PubMed recorded a metadata revision date of 2026-08-05 and an Entrez history date of 2026-08-05. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42555072

PeptideScanner retained PubMed bibliographic metadata for PMID 42555072 at 2026-08-10T10:49:12.992Z. PubMed recorded a metadata revision date of 2026-08-05 and an Entrez history date of 2026-08-05. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42556854

PeptideScanner retained PubMed bibliographic metadata for PMID 42556854 at 2026-08-10T10:49:12.998Z. PubMed recorded a metadata revision date of 2026-08-05 and an Entrez history date of 2026-08-05. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42556867

PeptideScanner retained PubMed bibliographic metadata for PMID 42556867 at 2026-08-10T10:49:12.998Z. PubMed recorded a metadata revision date of 2026-08-05 and an Entrez history date of 2026-08-05. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · BPC-157

PubMed record PMID 42555375

PeptideScanner retained PubMed bibliographic metadata for PMID 42555375 at 2026-08-10T10:49:12.992Z. PubMed recorded a metadata revision date of 2026-08-05 and an Entrez history date of 2026-08-05. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Clinical trials · Exenatide

ClinicalTrials.gov record NCT05663515

PeptideScanner retained ClinicalTrials.gov record NCT05663515 at 2026-08-13T05:52:27.024Z. Its registry update date was 2026-08-04, and PeptideScanner's reviewed identity mapping was exenatide.

Added August 14, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Maridebart cafraglutide

ClinicalTrials.gov record NCT07684235

PeptideScanner retained ClinicalTrials.gov record NCT07684235 at 2026-08-13T05:52:27.017Z. Its registry update date was 2026-08-04, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.

Added August 14, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Cagrilintide

ClinicalTrials.gov record NCT07745504

PeptideScanner retained ClinicalTrials.gov record NCT07745504 at 2026-08-13T05:52:27.004Z. Its registry update date was 2026-08-04, and PeptideScanner's reviewed identity mapping was cagrilintide.

Added August 14, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Octreotide

PubMed record PMID 37951584

PeptideScanner retained PubMed bibliographic metadata for PMID 37951584 at 2026-08-10T10:49:06.851Z. PubMed recorded a metadata revision date of 2026-08-04 and an Entrez history date of 2023-11-11. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Octreotide

PubMed record PMID 38407358

PeptideScanner retained PubMed bibliographic metadata for PMID 38407358 at 2026-08-10T10:49:06.879Z. PubMed recorded a metadata revision date of 2026-08-04 and an Entrez history date of 2024-02-26. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Liraglutide

PubMed record PMID 41651380

PeptideScanner retained PubMed bibliographic metadata for PMID 41651380 at 2026-08-10T10:49:08.761Z. PubMed recorded a metadata revision date of 2026-08-04 and an Entrez history date of 2026-02-06. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 41944572

PeptideScanner retained PubMed bibliographic metadata for PMID 41944572 at 2026-08-10T10:49:08.831Z. PubMed recorded a metadata revision date of 2026-08-04 and an Entrez history date of 2026-04-07. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42549476

PeptideScanner retained PubMed bibliographic metadata for PMID 42549476 at 2026-08-10T10:49:12.984Z. PubMed recorded a metadata revision date of 2026-08-04 and an Entrez history date of 2026-08-04. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Leuprolide

PubMed record PMID 39177865

PeptideScanner retained PubMed bibliographic metadata for PMID 39177865 at 2026-08-10T10:49:06.892Z. PubMed recorded a metadata revision date of 2026-08-04 and an Entrez history date of 2024-08-23. PeptideScanner associated this retained record with the identity slug leuprolide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Mazdutide

PubMed record PMID 42251596

PeptideScanner retained PubMed bibliographic metadata for PMID 42251596 at 2026-08-10T10:49:10.669Z. PubMed recorded a metadata revision date of 2026-08-04 and an Entrez history date of 2026-06-07. PeptideScanner associated this retained record with the identity slug mazdutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Ziconotide

PubMed record PMID 42548796

PeptideScanner retained PubMed bibliographic metadata for PMID 42548796 at 2026-08-10T10:49:12.983Z. PubMed recorded a metadata revision date of 2026-08-04 and an Entrez history date of 2026-08-04. PeptideScanner associated this retained record with the identity slug ziconotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Clinical trials · Cagrilintide

ClinicalTrials.gov record NCT07220759

PeptideScanner retained ClinicalTrials.gov record NCT07220759 at 2026-08-13T05:52:27.019Z. Its registry update date was 2026-08-03, and PeptideScanner's reviewed identity mapping was cagrilintide.

Added August 14, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT06015893

PeptideScanner retained ClinicalTrials.gov record NCT06015893 at 2026-08-13T05:52:27.015Z. Its registry update date was 2026-08-03, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Teriparatide

PubMed record PMID 41272927

PeptideScanner retained PubMed bibliographic metadata for PMID 41272927 at 2026-08-10T10:49:06.999Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2025-11-22. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Liraglutide

PubMed record PMID 41736232

PeptideScanner retained PubMed bibliographic metadata for PMID 41736232 at 2026-08-10T10:49:08.773Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-02-25. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Teriparatide

PubMed record PMID 41748193

PeptideScanner retained PubMed bibliographic metadata for PMID 41748193 at 2026-08-10T10:49:08.774Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-02-26. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42012431

PeptideScanner retained PubMed bibliographic metadata for PMID 42012431 at 2026-08-10T10:49:08.852Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-04-21. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Octreotide

PubMed record PMID 42029102

PeptideScanner retained PubMed bibliographic metadata for PMID 42029102 at 2026-08-10T10:49:08.854Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-04-24. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42258199

PeptideScanner retained PubMed bibliographic metadata for PMID 42258199 at 2026-08-10T10:49:10.672Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-06-08. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42288971

PeptideScanner retained PubMed bibliographic metadata for PMID 42288971 at 2026-08-10T10:49:10.679Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-06-14. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42289805

PeptideScanner retained PubMed bibliographic metadata for PMID 42289805 at 2026-08-10T10:49:10.680Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-06-15. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Octreotide

PubMed record PMID 42333429

PeptideScanner retained PubMed bibliographic metadata for PMID 42333429 at 2026-08-10T10:49:10.713Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-06-23. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Teriparatide

PubMed record PMID 42532234

PeptideScanner retained PubMed bibliographic metadata for PMID 42532234 at 2026-08-10T10:49:12.924Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-07-30. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42535667

PeptideScanner retained PubMed bibliographic metadata for PMID 42535667 at 2026-08-10T10:49:12.941Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-07-31. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42538551

PeptideScanner retained PubMed bibliographic metadata for PMID 42538551 at 2026-08-10T10:49:12.951Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-07-31. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Liraglutide

PubMed record PMID 42538646

PeptideScanner retained PubMed bibliographic metadata for PMID 42538646 at 2026-08-10T10:49:12.953Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-08-01. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Liraglutide

PubMed record PMID 42545022

PeptideScanner retained PubMed bibliographic metadata for PMID 42545022 at 2026-08-10T10:49:12.969Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-08-03. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42546302

PeptideScanner retained PubMed bibliographic metadata for PMID 42546302 at 2026-08-10T10:49:12.978Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-08-03. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42547311

PeptideScanner retained PubMed bibliographic metadata for PMID 42547311 at 2026-08-10T10:49:12.979Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-08-03. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Linaclotide

PubMed record PMID 41692643

PeptideScanner retained PubMed bibliographic metadata for PMID 41692643 at 2026-08-10T10:49:08.765Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-02-15. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Abaloparatide

PubMed record PMID 41812602

PeptideScanner retained PubMed bibliographic metadata for PMID 41812602 at 2026-08-10T10:49:08.791Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-03-11. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Leuprolide

PubMed record PMID 41824265

PeptideScanner retained PubMed bibliographic metadata for PMID 41824265 at 2026-08-10T10:49:08.794Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-03-13. PeptideScanner associated this retained record with the identity slug leuprolide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Linaclotide

PubMed record PMID 42425925

PeptideScanner retained PubMed bibliographic metadata for PMID 42425925 at 2026-08-10T10:49:10.758Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-07-09. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 33595146

PeptideScanner retained PubMed bibliographic metadata for PMID 33595146 at 2026-08-10T10:49:06.839Z. PubMed recorded a metadata revision date of 2026-08-02 and an Entrez history date of 2021-02-17. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 40036855

PeptideScanner retained PubMed bibliographic metadata for PMID 40036855 at 2026-08-10T10:49:06.932Z. PubMed recorded a metadata revision date of 2026-08-02 and an Entrez history date of 2025-03-04. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 40510020

PeptideScanner retained PubMed bibliographic metadata for PMID 40510020 at 2026-08-10T10:49:06.950Z. PubMed recorded a metadata revision date of 2026-08-02 and an Entrez history date of 2025-06-13. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Teriparatide

PubMed record PMID 40978515

PeptideScanner retained PubMed bibliographic metadata for PMID 40978515 at 2026-08-10T10:49:06.968Z. PubMed recorded a metadata revision date of 2026-08-02 and an Entrez history date of 2025-09-22. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 41077767

PeptideScanner retained PubMed bibliographic metadata for PMID 41077767 at 2026-08-10T10:49:06.977Z. PubMed recorded a metadata revision date of 2026-08-02 and an Entrez history date of 2025-10-13. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 42322376

PeptideScanner retained PubMed bibliographic metadata for PMID 42322376 at 2026-08-10T10:49:10.708Z. PubMed recorded a metadata revision date of 2026-08-02 and an Entrez history date of 2026-06-20. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Liraglutide

PubMed record PMID 42446801

PeptideScanner retained PubMed bibliographic metadata for PMID 42446801 at 2026-08-10T10:49:10.767Z. PubMed recorded a metadata revision date of 2026-08-02 and an Entrez history date of 2026-07-14. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42532547

PeptideScanner retained PubMed bibliographic metadata for PMID 42532547 at 2026-08-10T10:49:12.924Z. PubMed recorded a metadata revision date of 2026-08-02 and an Entrez history date of 2026-07-30. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42533465

PeptideScanner retained PubMed bibliographic metadata for PMID 42533465 at 2026-08-10T10:49:12.933Z. PubMed recorded a metadata revision date of 2026-08-02 and an Entrez history date of 2026-07-31. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Tesamorelin

PubMed record PMID 41545261

PeptideScanner retained PubMed bibliographic metadata for PMID 41545261 at 2026-08-10T10:49:08.747Z. PubMed recorded a metadata revision date of 2026-08-02 and an Entrez history date of 2026-01-16. PeptideScanner associated this retained record with the identity slug tesamorelin. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 40383978

PeptideScanner retained PubMed bibliographic metadata for PMID 40383978 at 2026-08-10T10:49:06.944Z. PubMed recorded a metadata revision date of 2026-08-01 and an Entrez history date of 2025-05-19. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42273973

PeptideScanner retained PubMed bibliographic metadata for PMID 42273973 at 2026-08-10T10:49:10.675Z. PubMed recorded a metadata revision date of 2026-08-01 and an Entrez history date of 2026-06-11. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42437874

PeptideScanner retained PubMed bibliographic metadata for PMID 42437874 at 2026-08-10T10:49:10.764Z. PubMed recorded a metadata revision date of 2026-08-01 and an Entrez history date of 2026-07-12. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42540132

PeptideScanner retained PubMed bibliographic metadata for PMID 42540132 at 2026-08-10T10:49:12.959Z. PubMed recorded a metadata revision date of 2026-08-01 and an Entrez history date of 2026-08-01. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42542297

PeptideScanner retained PubMed bibliographic metadata for PMID 42542297 at 2026-08-10T10:49:12.964Z. PubMed recorded a metadata revision date of 2026-08-01 and an Entrez history date of 2026-08-01. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · BPC-157

PubMed record PMID 40756949

PeptideScanner retained PubMed bibliographic metadata for PMID 40756949 at 2026-08-10T10:49:06.956Z. PubMed recorded a metadata revision date of 2026-08-01 and an Entrez history date of 2025-08-04. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Setmelanotide

PubMed record PMID 42498078

PeptideScanner retained PubMed bibliographic metadata for PMID 42498078 at 2026-08-10T10:49:10.787Z. PubMed recorded a metadata revision date of 2026-08-01 and an Entrez history date of 2026-07-24. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Setmelanotide

PubMed record PMID 42538728

PeptideScanner retained PubMed bibliographic metadata for PMID 42538728 at 2026-08-10T10:49:12.953Z. PubMed recorded a metadata revision date of 2026-08-01 and an Entrez history date of 2026-08-01. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Clinical trials · Pemvidutide

ClinicalTrials.gov record NCT06987513

PeptideScanner retained ClinicalTrials.gov record NCT06987513 at 2026-08-10T18:10:03.928Z. Its registry update date was 2026-07-31, and PeptideScanner's reviewed identity mapping was pemvidutide.

Added August 14, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Semaglutide

PubMed record PMID 42210124

PeptideScanner retained PubMed bibliographic metadata for PMID 42210124 at 2026-08-10T10:49:10.656Z. PubMed recorded a metadata revision date of 2026-07-31 and an Entrez history date of 2026-05-28. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Octreotide

PubMed record PMID 42515664

PeptideScanner retained PubMed bibliographic metadata for PMID 42515664 at 2026-08-10T10:49:12.892Z. PubMed recorded a metadata revision date of 2026-07-31 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 42521859

PeptideScanner retained PubMed bibliographic metadata for PMID 42521859 at 2026-08-10T10:49:12.900Z. PubMed recorded a metadata revision date of 2026-07-31 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Retatrutide

PubMed record PMID 38323122

PeptideScanner retained PubMed bibliographic metadata for PMID 38323122 at 2026-08-10T10:49:06.879Z. PubMed recorded a metadata revision date of 2026-07-31 and an Entrez history date of 2024-02-07. PeptideScanner associated this retained record with the identity slug retatrutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Vosoritide

PubMed record PMID 41764752

PeptideScanner retained PubMed bibliographic metadata for PMID 41764752 at 2026-08-10T10:49:08.778Z. PubMed recorded a metadata revision date of 2026-07-31 and an Entrez history date of 2026-03-01. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Clinical trials · Retatrutide

ClinicalTrials.gov record NCT05882045

PeptideScanner retained ClinicalTrials.gov record NCT05882045 at 2026-08-10T18:10:03.944Z. Its registry update date was 2026-07-30, and PeptideScanner's reviewed identity mapping was retatrutide.

Added August 14, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Retatrutide

ClinicalTrials.gov record NCT05929079

PeptideScanner retained ClinicalTrials.gov record NCT05929079 at 2026-08-10T18:10:04.224Z. Its registry update date was 2026-07-30, and PeptideScanner's reviewed identity mapping was retatrutide.

Added August 14, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT05765500

PeptideScanner retained ClinicalTrials.gov record NCT05765500 at 2026-08-10T18:10:03.862Z. Its registry update date was 2026-07-30, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Tirzepatide

PubMed record PMID 37989596

PeptideScanner retained PubMed bibliographic metadata for PMID 37989596 at 2026-08-10T10:49:06.851Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2023-11-21. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 41032183

PeptideScanner retained PubMed bibliographic metadata for PMID 41032183 at 2026-08-10T10:49:06.970Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2025-10-01. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 41292908

PeptideScanner retained PubMed bibliographic metadata for PMID 41292908 at 2026-08-10T10:49:07.007Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2025-11-26. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 41419187

PeptideScanner retained PubMed bibliographic metadata for PMID 41419187 at 2026-08-10T10:49:08.723Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2025-12-19. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 41475544

PeptideScanner retained PubMed bibliographic metadata for PMID 41475544 at 2026-08-10T10:49:08.728Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2025-12-31. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 41483046

PeptideScanner retained PubMed bibliographic metadata for PMID 41483046 at 2026-08-10T10:49:08.730Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2026-01-03. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Liraglutide

PubMed record PMID 41508932

PeptideScanner retained PubMed bibliographic metadata for PMID 41508932 at 2026-08-10T10:49:08.740Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2026-01-09. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 41917519

PeptideScanner retained PubMed bibliographic metadata for PMID 41917519 at 2026-08-10T10:49:08.829Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2026-04-01. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Teriparatide

PubMed record PMID 41999058

PeptideScanner retained PubMed bibliographic metadata for PMID 41999058 at 2026-08-10T10:49:08.848Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2026-04-18. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42487213

PeptideScanner retained PubMed bibliographic metadata for PMID 42487213 at 2026-08-10T10:49:10.780Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2026-07-23. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42513491

PeptideScanner retained PubMed bibliographic metadata for PMID 42513491 at 2026-08-10T10:49:12.876Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Teriparatide

PubMed record PMID 42513596

PeptideScanner retained PubMed bibliographic metadata for PMID 42513596 at 2026-08-10T10:49:12.877Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42530904

PeptideScanner retained PubMed bibliographic metadata for PMID 42530904 at 2026-08-10T10:49:12.922Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2026-07-30. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42531456

PeptideScanner retained PubMed bibliographic metadata for PMID 42531456 at 2026-08-10T10:49:12.922Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2026-07-30. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Lixisenatide

PubMed record PMID 39604042

PeptideScanner retained PubMed bibliographic metadata for PMID 39604042 at 2026-07-30T16:31:16.748Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2024-11-27. PeptideScanner associated this retained record with the identity slug lixisenatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Vosoritide

PubMed record PMID 41424367

PeptideScanner retained PubMed bibliographic metadata for PMID 41424367 at 2026-08-10T10:49:08.725Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2025-12-22. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Setmelanotide

PubMed record PMID 42008191

PeptideScanner retained PubMed bibliographic metadata for PMID 42008191 at 2026-08-10T10:49:08.851Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2026-04-20. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · MOTS-c

PubMed record PMID 42321010

PeptideScanner retained PubMed bibliographic metadata for PMID 42321010 at 2026-08-10T10:49:10.706Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2026-06-19. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Tesamorelin

PubMed record PMID 42419889

PeptideScanner retained PubMed bibliographic metadata for PMID 42419889 at 2026-08-10T10:49:10.753Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2026-07-08. PeptideScanner associated this retained record with the identity slug tesamorelin. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · GHK-Cu

PubMed record PMID 42510549

PeptideScanner retained PubMed bibliographic metadata for PMID 42510549 at 2026-08-10T10:49:10.805Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug ghk-cu. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Setmelanotide

PubMed record PMID 42528856

PeptideScanner retained PubMed bibliographic metadata for PMID 42528856 at 2026-08-10T10:49:12.911Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2026-07-30. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Regulatory · Glucagon + 5 more

Federal Register notice 2026-15285

The Federal Register published notice 2026-15285, attributed to FDA and its parent HHS department, on 2026-07-29. Its official title is “Product-Specific Guidances; Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Glucagon, Liraglutide, Semaglutide, Teriparatide, Tirzepatide and Vosoritide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT00569127

PeptideScanner retained ClinicalTrials.gov record NCT00569127 at 2026-08-10T18:10:03.946Z. Its registry update date was 2026-07-29, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 14, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Linaclotide

ClinicalTrials.gov record NCT05796388

PeptideScanner retained ClinicalTrials.gov record NCT05796388 at 2026-08-10T18:10:03.859Z. Its registry update date was 2026-07-29, and PeptideScanner's reviewed identity mapping was linaclotide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07734792

PeptideScanner retained ClinicalTrials.gov record NCT07734792 at 2026-08-10T18:10:03.951Z. Its registry update date was 2026-07-29, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Glucagon

Intravenous Glucagon Infusion in the Management of Hypoglycemia in Infants of Diabetic Mothers.

PubMed lists PMID 41610862 in American journal of perinatology as Journal Article, with publication-date metadata of 2026-01-29 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

Glutamine Metabolism Supports α cell Mass and Glucagon Secretion.

PubMed lists PMID 42523345 in bioRxiv : the preprint server for biology as Journal Article, Preprint, with publication-date metadata of 2026-07-13 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 41627802

PeptideScanner retained PubMed bibliographic metadata for PMID 41627802 at 2026-08-10T18:13:40.591Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-02-02. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Octreotide

PubMed record PMID 41719493

PeptideScanner retained PubMed bibliographic metadata for PMID 41719493 at 2026-08-10T18:13:42.706Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-02-20. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42219226

PeptideScanner retained PubMed bibliographic metadata for PMID 42219226 at 2026-08-10T18:13:50.707Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-05-31. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42225300

PeptideScanner retained PubMed bibliographic metadata for PMID 42225300 at 2026-08-10T18:13:50.717Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-06-01. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42361988

PeptideScanner retained PubMed bibliographic metadata for PMID 42361988 at 2026-08-10T18:13:53.774Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-06-26. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Teriparatide

PubMed record PMID 42398904

PeptideScanner retained PubMed bibliographic metadata for PMID 42398904 at 2026-08-10T18:13:53.834Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-07-03. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42493207

PeptideScanner retained PubMed bibliographic metadata for PMID 42493207 at 2026-08-10T18:13:56.730Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-07-23. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Teriparatide

PubMed record PMID 42516799

PeptideScanner retained PubMed bibliographic metadata for PMID 42516799 at 2026-08-10T18:13:56.766Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42516860

PeptideScanner retained PubMed bibliographic metadata for PMID 42516860 at 2026-08-10T18:13:56.767Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42518363

PeptideScanner retained PubMed bibliographic metadata for PMID 42518363 at 2026-08-10T18:13:56.773Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42518535

PeptideScanner retained PubMed bibliographic metadata for PMID 42518535 at 2026-08-10T18:13:56.774Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42518971

PeptideScanner retained PubMed bibliographic metadata for PMID 42518971 at 2026-08-10T18:13:56.776Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42524366

PeptideScanner retained PubMed bibliographic metadata for PMID 42524366 at 2026-08-10T18:13:56.785Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-07-29. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42526426

PeptideScanner retained PubMed bibliographic metadata for PMID 42526426 at 2026-08-10T18:13:57.051Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-07-29. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42526939

PeptideScanner retained PubMed bibliographic metadata for PMID 42526939 at 2026-08-10T18:13:57.051Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-07-29. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Vosoritide

PubMed record PMID 42518139

PeptideScanner retained PubMed bibliographic metadata for PMID 42518139 at 2026-08-10T18:13:56.769Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Vosoritide

PubMed record PMID 42519733

PeptideScanner retained PubMed bibliographic metadata for PMID 42519733 at 2026-08-10T18:13:56.777Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Linaclotide

PubMed record PMID 42523615

PeptideScanner retained PubMed bibliographic metadata for PMID 42523615 at 2026-08-10T18:13:56.783Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-07-29. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Retatrutide

PubMed record PMID 42527705

PeptideScanner retained PubMed bibliographic metadata for PMID 42527705 at 2026-08-10T18:13:57.053Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-07-29. PeptideScanner associated this retained record with the identity slug retatrutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT04484818

PeptideScanner retained ClinicalTrials.gov record NCT04484818 at 2026-08-10T18:10:03.948Z. Its registry update date was 2026-07-28, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT06169124

PeptideScanner retained ClinicalTrials.gov record NCT06169124 at 2026-08-13T05:56:16.370Z. Its registry update date was 2026-07-28, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07191873

PeptideScanner retained ClinicalTrials.gov record NCT07191873 at 2026-08-10T18:10:04.225Z. Its registry update date was 2026-07-28, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07559500

PeptideScanner retained ClinicalTrials.gov record NCT07559500 at 2026-08-10T18:10:03.920Z. Its registry update date was 2026-07-28, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07732426

PeptideScanner retained ClinicalTrials.gov record NCT07732426 at 2026-08-10T18:10:03.951Z. Its registry update date was 2026-07-28, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Liraglutide

PubMed record PMID 35936066

PeptideScanner retained PubMed bibliographic metadata for PMID 35936066 at 2026-08-10T18:13:32.320Z. PubMed recorded a metadata revision date of 2026-07-28 and an Entrez history date of 2022-08-08. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 39655973

PeptideScanner retained PubMed bibliographic metadata for PMID 39655973 at 2026-08-10T18:13:36.057Z. PubMed recorded a metadata revision date of 2026-07-28 and an Entrez history date of 2024-12-10. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 41778920

PeptideScanner retained PubMed bibliographic metadata for PMID 41778920 at 2026-08-10T18:13:42.771Z. PubMed recorded a metadata revision date of 2026-07-28 and an Entrez history date of 2026-03-04. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42014432

PeptideScanner retained PubMed bibliographic metadata for PMID 42014432 at 2026-08-10T18:13:48.770Z. PubMed recorded a metadata revision date of 2026-07-28 and an Entrez history date of 2026-04-21. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42516042

PeptideScanner retained PubMed bibliographic metadata for PMID 42516042 at 2026-08-10T18:13:56.764Z. PubMed recorded a metadata revision date of 2026-07-28 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42520650

PeptideScanner retained PubMed bibliographic metadata for PMID 42520650 at 2026-08-10T18:13:56.780Z. PubMed recorded a metadata revision date of 2026-07-28 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Teriparatide

PubMed record PMID 42521191

PeptideScanner retained PubMed bibliographic metadata for PMID 42521191 at 2026-08-10T18:13:56.780Z. PubMed recorded a metadata revision date of 2026-07-28 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42521631

PeptideScanner retained PubMed bibliographic metadata for PMID 42521631 at 2026-08-10T18:13:56.781Z. PubMed recorded a metadata revision date of 2026-07-28 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Leuprolide

PubMed record PMID 41712259

PeptideScanner retained PubMed bibliographic metadata for PMID 41712259 at 2026-08-10T18:13:42.694Z. PubMed recorded a metadata revision date of 2026-07-28 and an Entrez history date of 2026-02-19. PeptideScanner associated this retained record with the identity slug leuprolide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Linaclotide

PubMed record PMID 41913506

PeptideScanner retained PubMed bibliographic metadata for PMID 41913506 at 2026-08-10T18:13:46.784Z. PubMed recorded a metadata revision date of 2026-07-28 and an Entrez history date of 2026-03-31. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT06072963

PeptideScanner retained ClinicalTrials.gov record NCT06072963 at 2026-08-10T18:10:03.864Z. Its registry update date was 2026-07-27, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Afamelanotide

ClinicalTrials.gov record NCT06388642

PeptideScanner retained ClinicalTrials.gov record NCT06388642 at 2026-08-10T18:10:03.859Z. Its registry update date was 2026-07-27, and PeptideScanner's reviewed identity mapping was afamelanotide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Glucagon

Fear of hypoglycemia in parents of children with type 1 diabetes trained for intranasal glucagon use.

PubMed lists PMID 38972099 in Journal of psychosomatic research as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2024-07-04 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 41540105

PeptideScanner retained PubMed bibliographic metadata for PMID 41540105 at 2026-08-10T18:13:40.558Z. PubMed recorded a metadata revision date of 2026-07-27 and an Entrez history date of 2026-01-15. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 41962807

PeptideScanner retained PubMed bibliographic metadata for PMID 41962807 at 2026-08-10T18:13:46.844Z. PubMed recorded a metadata revision date of 2026-07-27 and an Entrez history date of 2026-04-10. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42314683

PeptideScanner retained PubMed bibliographic metadata for PMID 42314683 at 2026-08-10T18:13:52.286Z. PubMed recorded a metadata revision date of 2026-07-27 and an Entrez history date of 2026-06-18. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Liraglutide

PubMed record PMID 42342869

PeptideScanner retained PubMed bibliographic metadata for PMID 42342869 at 2026-08-10T18:13:52.311Z. PubMed recorded a metadata revision date of 2026-07-27 and an Entrez history date of 2026-06-24. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Liraglutide

PubMed record PMID 42507607

PeptideScanner retained PubMed bibliographic metadata for PMID 42507607 at 2026-08-10T18:13:56.762Z. PubMed recorded a metadata revision date of 2026-07-27 and an Entrez history date of 2026-07-27. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42507846

PeptideScanner retained PubMed bibliographic metadata for PMID 42507846 at 2026-08-10T18:13:56.762Z. PubMed recorded a metadata revision date of 2026-07-27 and an Entrez history date of 2026-07-27. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Elamipretide

PubMed record PMID 42456009

PeptideScanner retained PubMed bibliographic metadata for PMID 42456009 at 2026-08-10T18:13:55.284Z. PubMed recorded a metadata revision date of 2026-07-27 and an Entrez history date of 2026-07-15. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

100 years of glucagon and 100 more.

PubMed lists PMID 37367959 in Diabetologia as Journal Article, Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2023-06-27 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

Interruption of glucagon signaling augments islet non-alpha cell proliferation in SLC7A2- and mTOR-dependent manners.

PubMed lists PMID 39149351 in bioRxiv : the preprint server for biology as Journal Article, Preprint, with publication-date metadata of 2024-08-07 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Octreotide

Octreotide therapy in patients with a left ventricular assist device and bleeding gastrointestinal angiodysplasias.

PubMed lists PMID 40086695 in The American journal of the medical sciences as Journal Article, with publication-date metadata of 2025-03-12 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

Titration and discontinuation of semaglutide for weight management in commercially insured US adults.

PubMed lists PMID 40464214 in Obesity (Silver Spring, Md.) as Journal Article, with publication-date metadata of 2025-06-04 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Octreotide

SSTR-Mediated Precision Delivery: Overcoming Triptolide's Limitations through Octreotide Conjugation in Pancreatic Cancer Treatment.

PubMed lists PMID 40529047 in ACS medicinal chemistry letters as Journal Article, with publication-date metadata of 2025-05-13 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

Oral absorption of semaglutide: pharmacokinetic modeling and molecular dynamics simulations.

PubMed lists PMID 40686549 in In silico pharmacology as Journal Article, with publication-date metadata of 2025-07-16 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

The use of semaglutide as an add-on therapy in patients with latent autoimmune diabetes in adults.

PubMed lists PMID 41729594 in The Journal of clinical endocrinology and metabolism as Journal Article, with publication-date metadata of 2026-06-17 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

Ozempic and Wegovy Meet Congress: Political Economy Without Critique and Sociology Without Society.

PubMed lists PMID 41744415 in International journal of social determinants of health and health services as Journal Article, with publication-date metadata of 2026-02-26 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

Semaglutide in peripheral artery disease and diabetes by baseline disease severity and age: the STRIDE trial.

PubMed lists PMID 41780559 in European heart journal as Journal Article, with publication-date metadata of 2026-07-01 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

Semaglutide Treatment in Young Adults Living With Type 2 Diabetes: A Post Hoc Analysis From the SUSTAIN and PIONEER Clinical Trials.

PubMed lists PMID 41994903 in Diabetes, obesity & metabolism as Journal Article, Randomized Controlled Trial, with publication-date metadata of 2026-04-17 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Octreotide

Optimization of automated radiosynthesis method for [18F]AlF-NOTA-Octreotide and PET/CT imaging in neuroendocrine neoplasms.

PubMed lists PMID 42014536 in EJNMMI radiopharmacy and chemistry as Journal Article, with publication-date metadata of 2026-04-21 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

Inflammatory Cytokines Impair Glucagon Expression and Secretion in Pancreatic α-Cells.

PubMed lists PMID 42219277 in Diabetes, obesity & metabolism as Journal Article, with publication-date metadata of 2026-05-31 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

Dysregulated glucagon signaling contributes to hypoglycemia after vertical sleeve gastrectomy in mice.

PubMed lists PMID 42270043 in Molecular metabolism as Journal Article, with publication-date metadata of 2026-06-10 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

What the Scale Does Not Show: A Patient's Reflection on Semaglutide, Strength, and the SMART Trial.

PubMed lists PMID 42308137 in Clinical journal of the American Society of Nephrology : CJASN as Journal Article, with publication-date metadata of 2026-06-18 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Exenatide

PubMed record PMID 41364402

PeptideScanner retained PubMed bibliographic metadata for PMID 41364402 at 2026-08-10T18:13:38.016Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2025-12-09. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Teriparatide

PubMed record PMID 41686215

PeptideScanner retained PubMed bibliographic metadata for PMID 41686215 at 2026-08-10T18:13:40.663Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-02-13. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Liraglutide

PubMed record PMID 42203210

PeptideScanner retained PubMed bibliographic metadata for PMID 42203210 at 2026-08-10T18:13:50.682Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-05-27. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Liraglutide

PubMed record PMID 42233323

PeptideScanner retained PubMed bibliographic metadata for PMID 42233323 at 2026-08-10T18:13:50.725Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-06-03. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42260100

PeptideScanner retained PubMed bibliographic metadata for PMID 42260100 at 2026-08-10T18:13:52.233Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-06-08. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Liraglutide

PubMed record PMID 42286095

PeptideScanner retained PubMed bibliographic metadata for PMID 42286095 at 2026-08-10T18:13:52.266Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-06-12. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Teriparatide

PubMed record PMID 42294947

PeptideScanner retained PubMed bibliographic metadata for PMID 42294947 at 2026-08-10T18:13:52.269Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-06-15. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42307617

PeptideScanner retained PubMed bibliographic metadata for PMID 42307617 at 2026-08-10T18:13:52.282Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-06-17. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Teriparatide

PubMed record PMID 42355862

PeptideScanner retained PubMed bibliographic metadata for PMID 42355862 at 2026-08-10T18:13:53.757Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-06-26. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Teriparatide

PubMed record PMID 42355866

PeptideScanner retained PubMed bibliographic metadata for PMID 42355866 at 2026-08-10T18:13:53.757Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-06-26. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Liraglutide

PubMed record PMID 42356253

PeptideScanner retained PubMed bibliographic metadata for PMID 42356253 at 2026-08-10T18:13:53.759Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-06-26. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Liraglutide

PubMed record PMID 42394413

PeptideScanner retained PubMed bibliographic metadata for PMID 42394413 at 2026-08-10T18:13:53.810Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-07-03. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

PubMed record PMID 42464179

PeptideScanner retained PubMed bibliographic metadata for PMID 42464179 at 2026-08-10T18:13:55.290Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-07-17. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Octreotide

PubMed record PMID 42503373

PeptideScanner retained PubMed bibliographic metadata for PMID 42503373 at 2026-08-10T18:13:56.753Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-07-26. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

PubMed record PMID 42503575

PeptideScanner retained PubMed bibliographic metadata for PMID 42503575 at 2026-08-10T18:13:56.757Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-07-26. PeptideScanner associated this retained record with the identity slug semaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Elamipretide

PubMed record PMID 35611788

PeptideScanner retained PubMed bibliographic metadata for PMID 35611788 at 2026-08-10T18:13:32.311Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2022-05-25. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Setmelanotide

PubMed record PMID 41894554

PeptideScanner retained PubMed bibliographic metadata for PMID 41894554 at 2026-08-10T18:13:44.905Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-03-27. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Linaclotide

PubMed record PMID 42009975

PeptideScanner retained PubMed bibliographic metadata for PMID 42009975 at 2026-08-10T18:13:48.763Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-04-20. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Exenatide

PubMed record PMID 42171611

PeptideScanner retained PubMed bibliographic metadata for PMID 42171611 at 2026-08-10T18:13:50.652Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-05-22. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Exenatide

PubMed record PMID 42290292

PeptideScanner retained PubMed bibliographic metadata for PMID 42290292 at 2026-08-10T18:13:52.268Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-06-15. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Tesamorelin

PubMed record PMID 22495074

PeptideScanner retained PubMed bibliographic metadata for PMID 22495074 at 2026-08-10T18:13:32.273Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2012-04-13. PeptideScanner associated this retained record with the identity slug tesamorelin. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Petrelintide

PubMed record PMID 42017294

PeptideScanner retained PubMed bibliographic metadata for PMID 42017294 at 2026-08-10T18:13:48.775Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-04-22. PeptideScanner associated this retained record with the identity slug petrelintide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · BPC-157

PubMed record PMID 42278509

PeptideScanner retained PubMed bibliographic metadata for PMID 42278509 at 2026-08-10T18:13:52.250Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-06-12. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · MOTS-c

PubMed record PMID 42278864

PeptideScanner retained PubMed bibliographic metadata for PMID 42278864 at 2026-08-10T18:13:52.251Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-06-12. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Abaloparatide

PubMed record PMID 42351259

PeptideScanner retained PubMed bibliographic metadata for PMID 42351259 at 2026-08-10T18:13:52.323Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-06-26. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · BPC-157

PubMed record PMID 42356491

PeptideScanner retained PubMed bibliographic metadata for PMID 42356491 at 2026-08-10T18:13:53.763Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-06-26. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Elamipretide

PubMed record PMID 42450582

PeptideScanner retained PubMed bibliographic metadata for PMID 42450582 at 2026-08-10T18:13:55.269Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-07-15. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Liraglutide

PubMed record PMID 42500463

PeptideScanner retained PubMed bibliographic metadata for PMID 42500463 at 2026-08-10T18:13:56.748Z. PubMed recorded a metadata revision date of 2026-07-25 and an Entrez history date of 2026-07-25. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Maridebart cafraglutide

ClinicalTrials.gov record NCT07037433

PeptideScanner retained ClinicalTrials.gov record NCT07037433 at 2026-08-10T18:10:03.862Z. Its registry update date was 2026-07-24, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Vosoritide

PubMed record PMID 42495828

PeptideScanner retained PubMed bibliographic metadata for PMID 42495828 at 2026-08-10T18:13:56.737Z. PubMed recorded a metadata revision date of 2026-07-24 and an Entrez history date of 2026-07-24. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Abaloparatide

PubMed record PMID 42498818

PeptideScanner retained PubMed bibliographic metadata for PMID 42498818 at 2026-08-10T18:13:56.743Z. PubMed recorded a metadata revision date of 2026-07-24 and an Entrez history date of 2026-07-24. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Clinical trials · Setmelanotide

ClinicalTrials.gov record NCT07496463

PeptideScanner retained ClinicalTrials.gov record NCT07496463 at 2026-08-10T18:10:04.219Z. Its registry update date was 2026-07-23, and PeptideScanner's reviewed identity mapping was setmelanotide.

Added August 14, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Plecanatide

ClinicalTrials.gov record NCT07723924

PeptideScanner retained ClinicalTrials.gov record NCT07723924 at 2026-08-10T18:10:03.859Z. Its registry update date was 2026-07-23, and PeptideScanner's reviewed identity mapping was plecanatide.

Added August 14, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Abaloparatide

ClinicalTrials.gov record NCT07587775

PeptideScanner retained ClinicalTrials.gov record NCT07587775 at 2026-08-10T18:10:03.948Z. Its registry update date was 2026-07-23, and PeptideScanner's reviewed identity mapping was abaloparatide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Semaglutide

The silent rise of self-prescribed semaglutide use among non-obese young adults in the Middle East.

PubMed lists PMID 42487380 in Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit as Letter, with publication-date metadata of 2026-06-28 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Liraglutide

PubMed record PMID 40521838

PeptideScanner retained PubMed bibliographic metadata for PMID 40521838 at 2026-08-10T18:13:37.865Z. PubMed recorded a metadata revision date of 2026-07-23 and an Entrez history date of 2025-06-16. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Liraglutide

PubMed record PMID 42491030

PeptideScanner retained PubMed bibliographic metadata for PMID 42491030 at 2026-08-10T18:13:56.726Z. PubMed recorded a metadata revision date of 2026-07-23 and an Entrez history date of 2026-07-23. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Linaclotide

PubMed record PMID 38962910

PeptideScanner retained PubMed bibliographic metadata for PMID 38962910 at 2026-08-10T18:13:32.376Z. PubMed recorded a metadata revision date of 2026-07-23 and an Entrez history date of 2024-07-04. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Vosoritide

PubMed record PMID 41810698

PeptideScanner retained PubMed bibliographic metadata for PMID 41810698 at 2026-08-10T18:13:44.816Z. PubMed recorded a metadata revision date of 2026-07-23 and an Entrez history date of 2026-03-11. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Retatrutide

PubMed record PMID 42493254

PeptideScanner retained PubMed bibliographic metadata for PMID 42493254 at 2026-08-10T18:13:56.730Z. PubMed recorded a metadata revision date of 2026-07-23 and an Entrez history date of 2026-07-23. PeptideScanner associated this retained record with the identity slug retatrutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Clinical trials · Linaclotide

ClinicalTrials.gov record NCT03796884

PeptideScanner retained ClinicalTrials.gov record NCT03796884 at 2026-08-10T18:10:04.224Z. Its registry update date was 2026-07-22, and PeptideScanner's reviewed identity mapping was linaclotide.

Added August 14, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT06164795

PeptideScanner retained ClinicalTrials.gov record NCT06164795 at 2026-08-10T18:10:03.919Z. Its registry update date was 2026-07-22, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07257484

PeptideScanner retained ClinicalTrials.gov record NCT07257484 at 2026-08-10T18:10:04.223Z. Its registry update date was 2026-07-22, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Glucagon

Differential Role of Phosphorylation in Glucagon Family Receptor Signaling Revealed by Mass Spectrometry.

PubMed lists PMID 40503712 in Journal of proteome research as Journal Article, with publication-date metadata of 2025-06-12 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Linaclotide

PubMed record PMID 42482900

PeptideScanner retained PubMed bibliographic metadata for PMID 42482900 at 2026-08-10T18:13:56.703Z. PubMed recorded a metadata revision date of 2026-07-22 and an Entrez history date of 2026-07-22. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Bremelanotide

PubMed record PMID 42485063

PeptideScanner retained PubMed bibliographic metadata for PMID 42485063 at 2026-08-10T18:13:56.710Z. PubMed recorded a metadata revision date of 2026-07-22 and an Entrez history date of 2026-07-22. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT06299098

PeptideScanner retained ClinicalTrials.gov record NCT06299098 at 2026-08-10T18:10:03.940Z. Its registry update date was 2026-07-21, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT06967389

PeptideScanner retained ClinicalTrials.gov record NCT06967389 at 2026-08-10T18:10:03.916Z. Its registry update date was 2026-07-21, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT06975111

PeptideScanner retained ClinicalTrials.gov record NCT06975111 at 2026-08-10T18:10:03.862Z. Its registry update date was 2026-07-21, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07715929

PeptideScanner retained ClinicalTrials.gov record NCT07715929 at 2026-08-10T18:10:04.226Z. Its registry update date was 2026-07-21, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Mazdutide

ClinicalTrials.gov record NCT07718126

PeptideScanner retained ClinicalTrials.gov record NCT07718126 at 2026-08-10T18:10:03.957Z. Its registry update date was 2026-07-21, and PeptideScanner's reviewed identity mapping was mazdutide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Glucagon

Tracking Insulin- and Glucagon-Expressing Cells In Vitro and In Vivo Using a Double-Reporter Human Embryonic Stem Cell Line.

PubMed lists PMID 39561351 in Diabetes as Journal Article, with publication-date metadata of 2025-02-01 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

Total Chemical Synthesis of Glucagon Glycoforms Reveals the Remarkable Influence of Natural Glycosylation.

PubMed lists PMID 40337851 in Journal of the American Chemical Society as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2025-05-08 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

Tirzepatide on physical function in adults with overweight or obesity: A systematic review and meta-analysis.

PubMed lists PMID 41705736 in Diabetes, obesity & metabolism as Systematic Review, Journal Article, Meta-Analysis, with publication-date metadata of 2026-02-18 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Octreotide

Octreotide in the Management of Chyle Leaks After Head and Neck Surgery: A Systematic Review of Cohort Studies.

PubMed lists PMID 42478204 in The Journal of laryngology and otology as Journal Article, Review, with publication-date metadata of 2026-07-21 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Liraglutide

PubMed record PMID 41160027

PeptideScanner retained PubMed bibliographic metadata for PMID 41160027 at 2026-08-10T18:13:37.970Z. PubMed recorded a metadata revision date of 2026-07-21 and an Entrez history date of 2025-10-29. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Liraglutide

PubMed record PMID 42392029

PeptideScanner retained PubMed bibliographic metadata for PMID 42392029 at 2026-08-10T18:13:53.799Z. PubMed recorded a metadata revision date of 2026-07-21 and an Entrez history date of 2026-07-02. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Vosoritide

PubMed record PMID 42479670

PeptideScanner retained PubMed bibliographic metadata for PMID 42479670 at 2026-08-10T18:13:56.698Z. PubMed recorded a metadata revision date of 2026-07-21 and an Entrez history date of 2026-07-21. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT06378866

PeptideScanner retained ClinicalTrials.gov record NCT06378866 at 2026-08-10T18:10:04.225Z. Its registry update date was 2026-07-20, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07707778

PeptideScanner retained ClinicalTrials.gov record NCT07707778 at 2026-08-10T18:10:03.948Z. Its registry update date was 2026-07-20, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Glucagon

Comparison between capillary electrophoresis and fluorescence anisotropy competitive immunoassay for glucagon.

PubMed lists PMID 38984929 in Electrophoresis as Journal Article, Comparative Study, with publication-date metadata of 2024-07-10 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

Affordable Semaglutide in India: Expanding Access and Unanswered Questions for Children and Special Populations.

PubMed lists PMID 42474946 in Indian pediatrics as Letter, with publication-date metadata of 2026-07-20 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Leuprolide

PubMed record PMID 42003759

PeptideScanner retained PubMed bibliographic metadata for PMID 42003759 at 2026-08-10T18:13:48.759Z. PubMed recorded a metadata revision date of 2026-07-20 and an Entrez history date of 2026-04-20. PeptideScanner associated this retained record with the identity slug leuprolide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · GHK-Cu

PubMed record PMID 39451062

PeptideScanner retained PubMed bibliographic metadata for PMID 39451062 at 2026-08-10T18:13:36.036Z. PubMed recorded a metadata revision date of 2026-07-20 and an Entrez history date of 2024-10-25. PeptideScanner associated this retained record with the identity slug ghk-cu. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

Readability and understandability of online patient education on semaglutide.

PubMed lists PMID 41877445 in Health informatics journal as Journal Article, with publication-date metadata of 2026-03-24 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

Incretin and Glucagon Signalling in MASLD and MASH: Integrating Metabolic Pathways With Disease Progression.

PubMed lists PMID 41816810 in Diabetes, obesity & metabolism as Journal Article, Review, with publication-date metadata of 2026-03-12 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Liraglutide

PubMed record PMID 42470452

PeptideScanner retained PubMed bibliographic metadata for PMID 42470452 at 2026-08-10T18:13:56.686Z. PubMed recorded a metadata revision date of 2026-07-18 and an Entrez history date of 2026-07-18. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07602699

PeptideScanner retained ClinicalTrials.gov record NCT07602699 at 2026-08-10T18:10:03.953Z. Its registry update date was 2026-07-17, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Semaglutide

Real-world use of semaglutide for obesity treatment: A cohort study in an integrated health care delivery system.

PubMed lists PMID 42166306 in Journal of managed care & specialty pharmacy as Journal Article, Observational Study, with publication-date metadata of 2026-06 (month precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

Influence of Social Media on Self-Medication Behavior: A Study on Ozempic Use Among Emirati University Students.

PubMed lists PMID 42196730 in International journal of environmental research and public health as Journal Article, with publication-date metadata of 2026-05-12 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

Management of patients with cardiovascular disease and overweight/obesity: expert opinion on semaglutide use.

PubMed lists PMID 42469146 in Nutrition, metabolism, and cardiovascular diseases : NMCD as Journal Article, with publication-date metadata of 2026-07-16 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Vosoritide

PubMed record PMID 42001280

PeptideScanner retained PubMed bibliographic metadata for PMID 42001280 at 2026-08-10T18:13:48.756Z. PubMed recorded a metadata revision date of 2026-07-17 and an Entrez history date of 2026-04-19. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Elamipretide

PubMed record PMID 42219795

PeptideScanner retained PubMed bibliographic metadata for PMID 42219795 at 2026-08-10T18:13:50.715Z. PubMed recorded a metadata revision date of 2026-07-17 and an Entrez history date of 2026-06-01. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Linaclotide

PubMed record PMID 42465095

PeptideScanner retained PubMed bibliographic metadata for PMID 42465095 at 2026-08-10T18:13:55.292Z. PubMed recorded a metadata revision date of 2026-07-17 and an Entrez history date of 2026-07-17. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT06814938

PeptideScanner retained ClinicalTrials.gov record NCT06814938 at 2026-08-10T18:10:03.940Z. Its registry update date was 2026-07-16, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Mazdutide

ClinicalTrials.gov record NCT06817356

PeptideScanner retained ClinicalTrials.gov record NCT06817356 at 2026-08-10T18:10:03.951Z. Its registry update date was 2026-07-16, and PeptideScanner's reviewed identity mapping was mazdutide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Semaglutide

Redefining peptide therapeutics with semaglutide.

PubMed lists PMID 38321235 in Nature chemistry as Journal Article, with publication-date metadata of 2024-02 (month precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

Real-Life Data of Tirzepatide Use to Support Lifestyle Modification in Patients with Metabolic Syndrome.

PubMed lists PMID 42075085 in Nutrients as Journal Article, with publication-date metadata of 2026-04-17 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

Shifts in waist-to-height ratio categories within tirzepatide groups: a post-hoc analysis of SURMOUNT-1.

PubMed lists PMID 42082865 in Journal of endocrinological investigation as Journal Article, Randomized Controlled Trial, Clinical Trial, Phase III, with publication-date metadata of 2026-05-04 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

Identification of insulin and glucagon genes in the finless porpoise and the developmental distribution of their producing endocrine cells.

PubMed lists PMID 42147104 in Frontiers in endocrinology as Journal Article, with publication-date metadata of 2026-04-30 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

The STRIDE Trial and Semaglutide: Implications for Clinical Vascular Practice.

PubMed lists PMID 42462869 in European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery as Editorial, with publication-date metadata of 2026-07-16 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Linaclotide

PubMed record PMID 42083746

PeptideScanner retained PubMed bibliographic metadata for PMID 42083746 at 2026-08-10T18:13:48.845Z. PubMed recorded a metadata revision date of 2026-07-16 and an Entrez history date of 2026-05-05. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · GHK-Cu

PubMed record PMID 42084774

PeptideScanner retained PubMed bibliographic metadata for PMID 42084774 at 2026-08-10T18:13:48.846Z. PubMed recorded a metadata revision date of 2026-07-16 and an Entrez history date of 2026-05-05. PeptideScanner associated this retained record with the identity slug ghk-cu. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · MOTS-c

PubMed record PMID 42128272

PeptideScanner retained PubMed bibliographic metadata for PMID 42128272 at 2026-08-10T18:13:50.589Z. PubMed recorded a metadata revision date of 2026-07-16 and an Entrez history date of 2026-05-13. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Clinical trials · Setmelanotide

ClinicalTrials.gov record NCT06596135

PeptideScanner retained ClinicalTrials.gov record NCT06596135 at 2026-08-10T18:10:03.859Z. Its registry update date was 2026-07-15, and PeptideScanner's reviewed identity mapping was setmelanotide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT06934642

PeptideScanner retained ClinicalTrials.gov record NCT06934642 at 2026-08-10T18:10:03.939Z. Its registry update date was 2026-07-15, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Liraglutide

Target-mediated drug disposition modeling of liraglutide in rats: Implications of target engagement for pharmacodynamic predictions.

PubMed lists PMID 41966799 in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie as Journal Article, with publication-date metadata of 2026-04-10 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

GLP-1, GIP, and Glucagon Excursions During a Mixed Meal Tolerance Test in Young and Lean South Asians Versus Europids.

PubMed lists PMID 41983366 in Diabetes, obesity & metabolism as Clinical Trial, Comparative Study, Journal Article, with publication-date metadata of 2026-04-15 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Teriparatide

Teriparatide Plus Zoledronic Acid for Osteogenesis Imperfecta: A Randomized Clinical Trial.

PubMed lists PMID 42133304 in JAMA as Journal Article, Randomized Controlled Trial, Multicenter Study, with publication-date metadata of 2026-07-14 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Liraglutide

Development of zein-based nanoparticles for oral co-delivery of insulin and liraglutide and preliminary in vivo evaluation in Danio rerio.

PubMed lists PMID 42442575 in International journal of biological macromolecules as Journal Article, with publication-date metadata of 2026-07-13 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Dulaglutide

PubMed record PMID 41988866

PeptideScanner retained PubMed bibliographic metadata for PMID 41988866 at 2026-08-10T18:13:46.880Z. PubMed recorded a metadata revision date of 2026-07-15 and an Entrez history date of 2026-04-16. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · GHK-Cu

PubMed record PMID 41997403

PeptideScanner retained PubMed bibliographic metadata for PMID 41997403 at 2026-08-10T18:13:46.888Z. PubMed recorded a metadata revision date of 2026-07-15 and an Entrez history date of 2026-04-17. PeptideScanner associated this retained record with the identity slug ghk-cu. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · GHK-Cu

PubMed record PMID 42041438

PeptideScanner retained PubMed bibliographic metadata for PMID 42041438 at 2026-08-10T18:13:48.795Z. PubMed recorded a metadata revision date of 2026-07-15 and an Entrez history date of 2026-04-27. PeptideScanner associated this retained record with the identity slug ghk-cu. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

Semaglutide treatment for children with obesity: an observational study.

PubMed lists PMID 38471743 in Archives of disease in childhood as Journal Article, Observational Study, with publication-date metadata of 2024-09-25 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

Real-World Clinical Evidence of Tirzepatide for Metabolic Abnormalities in Subjects With Type 2 Diabetes: The Multicenter Retrospective Observational Hokkaido-TZP Study.

PubMed lists PMID 41944182 in Diabetes, obesity & metabolism as Journal Article, Multicenter Study, Observational Study, with publication-date metadata of 2026-04-07 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

A case of multiple type I endocrine neoplasia with gastrin-producing and glucagon-producing tumors successfully resected 18 years after insulinoma surgery.

PubMed lists PMID 41945253 in Clinical journal of gastroenterology as Journal Article, Case Reports, with publication-date metadata of 2026-04-07 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Teriparatide

Development of 1 month core-shell microspheres combination formulation containing teriparatide for osteoporosis treatment.

PubMed lists PMID 41950644 in Biomaterials as Journal Article, with publication-date metadata of 2026-04-05 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Teriparatide

Teriparatide Plus Zoledronic Acid for Osteogenesis Imperfecta: Research Summary.

PubMed lists PMID 42133336 in JAMA as Journal Article, with publication-date metadata of 2026-07-14 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

Discovery of Biased Dual-Agonists of Glucagon-Like Peptide 1 and Glucagon Receptors through Mutation of a Conserved Aspartate.

PubMed lists PMID 42445014 in ACS medicinal chemistry letters as Journal Article, with publication-date metadata of 2026-06-11 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

A simple mechanistic model for insulin-glucose-glucagon dynamics and its implications for diabetes management.

PubMed lists PMID 42448581 in Mathematical biosciences and engineering : MBE as Journal Article, with publication-date metadata of 2026-05-06 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Leuprolide

PubMed record PMID 41931341

PeptideScanner retained PubMed bibliographic metadata for PMID 41931341 at 2026-08-10T18:13:46.810Z. PubMed recorded a metadata revision date of 2026-07-14 and an Entrez history date of 2026-04-03. PeptideScanner associated this retained record with the identity slug leuprolide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · MOTS-c

PubMed record PMID 41933740

PeptideScanner retained PubMed bibliographic metadata for PMID 41933740 at 2026-08-10T18:13:46.811Z. PubMed recorded a metadata revision date of 2026-07-14 and an Entrez history date of 2026-04-04. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Setmelanotide

PubMed record PMID 42339090

PeptideScanner retained PubMed bibliographic metadata for PMID 42339090 at 2026-08-10T18:13:52.307Z. PubMed recorded a metadata revision date of 2026-07-14 and an Entrez history date of 2026-06-24. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Elamipretide

PubMed record PMID 42448476

PeptideScanner retained PubMed bibliographic metadata for PMID 42448476 at 2026-08-10T18:13:55.255Z. PubMed recorded a metadata revision date of 2026-07-14 and an Entrez history date of 2026-07-14. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Plecanatide

PubMed record PMID 41604554

PeptideScanner retained PubMed bibliographic metadata for PMID 41604554 at 2026-08-10T18:13:40.573Z. PubMed recorded a metadata revision date of 2026-07-14 and an Entrez history date of 2026-01-28. PeptideScanner associated this retained record with the identity slug plecanatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · MOTS-c

PubMed record PMID 41945630

PeptideScanner retained PubMed bibliographic metadata for PMID 41945630 at 2026-08-10T18:13:46.825Z. PubMed recorded a metadata revision date of 2026-07-14 and an Entrez history date of 2026-04-07. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT05896293

PeptideScanner retained ClinicalTrials.gov record NCT05896293 at 2026-08-10T18:10:03.920Z. Its registry update date was 2026-07-13, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 14, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Elamipretide

ClinicalTrials.gov record NCT07531251

PeptideScanner retained ClinicalTrials.gov record NCT07531251 at 2026-08-10T18:10:04.223Z. Its registry update date was 2026-07-13, and PeptideScanner's reviewed identity mapping was elamipretide.

Added August 14, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Glucagon

Supramolecular Peptide Depots for Glucose-Responsive Glucagon Delivery.

PubMed lists PMID 39719890 in Journal of biomedical materials research. Part A as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2025-01 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Teriparatide

Persistence of romosozumab vs. teriparatide in Japanese older adults aged ≥ 75 years with osteoporosis: a population-based cohort study.

PubMed lists PMID 41400755 in Archives of osteoporosis as Journal Article, Comparative Study, with publication-date metadata of 2025-12-16 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Octreotide

Octreotide long-acting release in the treatment of autosomal dominant polycystic kidney disease: a meta-analysis.

PubMed lists PMID 41647114 in Frontiers in endocrinology as Journal Article, Meta-Analysis, Systematic Review, with publication-date metadata of 2026-01-21 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Exenatide

PubMed record PMID 41865922

PeptideScanner retained PubMed bibliographic metadata for PMID 41865922 at 2026-08-10T18:13:44.869Z. PubMed recorded a metadata revision date of 2026-07-13 and an Entrez history date of 2026-03-22. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · MOTS-c

PubMed record PMID 41593376

PeptideScanner retained PubMed bibliographic metadata for PMID 41593376 at 2026-08-10T18:13:40.572Z. PubMed recorded a metadata revision date of 2026-07-13 and an Entrez history date of 2026-01-27. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · BPC-157

PubMed record PMID 41898733

PeptideScanner retained PubMed bibliographic metadata for PMID 41898733 at 2026-08-10T18:13:46.758Z. PubMed recorded a metadata revision date of 2026-07-13 and an Entrez history date of 2026-03-28. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Elamipretide

PubMed record PMID 42443448

PeptideScanner retained PubMed bibliographic metadata for PMID 42443448 at 2026-08-10T18:13:55.249Z. PubMed recorded a metadata revision date of 2026-07-13 and an Entrez history date of 2026-07-13. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

Challenges in the Assessment of a Disease Model in the NICE Single Technology Appraisal of Tirzepatide for Treating Type 2 Diabetes: An External Assessment Group Perspective.

PubMed lists PMID 38717708 in PharmacoEconomics as Journal Article, with publication-date metadata of 2024-05-08 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Octreotide

Latent phosphaturic mesenchymal tumor in left planta detected by [18F]F-AlF-NOTA-octreotide PET/CT.

PubMed lists PMID 38568449 in European journal of nuclear medicine and molecular imaging as Case Reports, Journal Article, with publication-date metadata of 2024-04-03 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Octreotide

Comprehensive design and characterization of pH-gradient-loaded donkey-milk exosomes for oral octreotide delivery: A bench-to-in silico roadmap.

PubMed lists PMID 41831704 in International journal of pharmaceutics as Journal Article, with publication-date metadata of 2026-03-12 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

Semaglutide in patients with hidradenitis suppurativa and obesity.

PubMed lists PMID 41832804 in Medicina clinica as Journal Article, with publication-date metadata of 2026-03-12 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Octreotide

Recurrent ventricular asystole during octreotide infusion in a patient with pancreatic neuroendocrine tumor: a case report.

PubMed lists PMID 41840662 in Journal of medical case reports as Journal Article, Case Reports, with publication-date metadata of 2026-03-16 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

Early Tirzepatide Use After Acute Myocardial Infarction or Ischemic Stroke in Patients Without Diabetes: A Real-World Propensity-Matched Study.

PubMed lists PMID 41862113 in The American journal of cardiology as Journal Article, with publication-date metadata of 2026-03-19 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

In vivo dysregulation of insulin and glucagon secretion: Disturbed mitochonderial VDAC1 expression and localization in pancreatic β-cells convey global insulin secretory defects in diabetic GK rat.

PubMed lists PMID 42402267 in Biochimica et biophysica acta. Molecular basis of disease as Journal Article, with publication-date metadata of 2026-07-05 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

Semaglutide alters behaviour and nucleus accumbens oscillatory activity in healthy mice.

PubMed lists PMID 42436546 in Molecular brain as Journal Article, with publication-date metadata of 2026-07-11 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Pramlintide

PubMed record PMID 41022243

PeptideScanner retained PubMed bibliographic metadata for PMID 41022243 at 2026-08-10T18:13:37.942Z. PubMed recorded a metadata revision date of 2026-07-11 and an Entrez history date of 2025-09-29. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT05498272

PeptideScanner retained ClinicalTrials.gov record NCT05498272 at 2026-08-10T18:10:03.951Z. Its registry update date was 2026-07-10, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Dulaglutide

ClinicalTrials.gov record NCT07417631

PeptideScanner retained ClinicalTrials.gov record NCT07417631 at 2026-08-10T18:10:04.224Z. Its registry update date was 2026-07-10, and PeptideScanner's reviewed identity mapping was dulaglutide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Semaglutide

Bimagrumab plus semaglutide alone or in combination for the treatment of obesity: a randomized phase 2 trial.

PubMed lists PMID 41772149 in Nature medicine as Journal Article, Randomized Controlled Trial, Clinical Trial, Phase II, with publication-date metadata of 2026-03-02 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

Partially reversible bilateral non-arteritic anterior ischemic optic neuropathy and branch retinal artery occlusion following semaglutide use. a case report.

PubMed lists PMID 42432542 in BMC ophthalmology as Journal Article, with publication-date metadata of 2026-07-10 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · MOTS-c

PubMed record PMID 41764620

PeptideScanner retained PubMed bibliographic metadata for PMID 41764620 at 2026-08-10T18:13:42.760Z. PubMed recorded a metadata revision date of 2026-07-10 and an Entrez history date of 2026-03-01. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Elamipretide

PubMed record PMID 41801306

PeptideScanner retained PubMed bibliographic metadata for PMID 41801306 at 2026-08-10T18:13:44.801Z. PubMed recorded a metadata revision date of 2026-07-10 and an Entrez history date of 2026-03-09. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Setmelanotide

PubMed record PMID 32213649

PeptideScanner retained PubMed bibliographic metadata for PMID 32213649 at 2026-08-10T18:13:32.288Z. PubMed recorded a metadata revision date of 2026-07-10 and an Entrez history date of 2020-03-28. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · MOTS-c

PubMed record PMID 41802484

PeptideScanner retained PubMed bibliographic metadata for PMID 41802484 at 2026-08-10T18:13:44.802Z. PubMed recorded a metadata revision date of 2026-07-10 and an Entrez history date of 2026-03-09. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · MOTS-c

PubMed record PMID 41811086

PeptideScanner retained PubMed bibliographic metadata for PMID 41811086 at 2026-08-10T18:13:44.817Z. PubMed recorded a metadata revision date of 2026-07-10 and an Entrez history date of 2026-03-11. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT02319837

PeptideScanner retained ClinicalTrials.gov record NCT02319837 at 2026-08-10T18:10:03.933Z. Its registry update date was 2026-07-09, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT04775082

PeptideScanner retained ClinicalTrials.gov record NCT04775082 at 2026-08-10T18:10:04.224Z. Its registry update date was 2026-07-09, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT06727331

PeptideScanner retained ClinicalTrials.gov record NCT06727331 at 2026-08-10T18:10:03.948Z. Its registry update date was 2026-07-09, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07693608

PeptideScanner retained ClinicalTrials.gov record NCT07693608 at 2026-08-10T18:10:03.920Z. Its registry update date was 2026-07-09, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Elamipretide

PubMed record PMID 38237649

PeptideScanner retained PubMed bibliographic metadata for PMID 38237649 at 2026-08-10T18:13:32.340Z. PubMed recorded a metadata revision date of 2026-07-09 and an Entrez history date of 2024-01-18. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Vosoritide

PubMed record PMID 41762856

PeptideScanner retained PubMed bibliographic metadata for PMID 41762856 at 2026-08-10T18:13:42.759Z. PubMed recorded a metadata revision date of 2026-07-09 and an Entrez history date of 2026-02-28. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Setmelanotide

PubMed record PMID 42418774

PeptideScanner retained PubMed bibliographic metadata for PMID 42418774 at 2026-08-10T18:13:53.869Z. PubMed recorded a metadata revision date of 2026-07-09 and an Entrez history date of 2026-07-08. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Retatrutide

PubMed record PMID 42425580

PeptideScanner retained PubMed bibliographic metadata for PMID 42425580 at 2026-08-10T18:13:55.212Z. PubMed recorded a metadata revision date of 2026-07-09 and an Entrez history date of 2026-07-09. PeptideScanner associated this retained record with the identity slug retatrutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT05616013

PeptideScanner retained ClinicalTrials.gov record NCT05616013 at 2026-08-10T18:10:03.915Z. Its registry update date was 2026-07-08, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT06935838

PeptideScanner retained ClinicalTrials.gov record NCT06935838 at 2026-08-10T18:10:03.949Z. Its registry update date was 2026-07-08, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · MOTS-c

PubMed record PMID 41706383

PeptideScanner retained PubMed bibliographic metadata for PMID 41706383 at 2026-08-10T18:13:42.683Z. PubMed recorded a metadata revision date of 2026-07-08 and an Entrez history date of 2026-02-18. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · MOTS-c

PubMed record PMID 41710402

PeptideScanner retained PubMed bibliographic metadata for PMID 41710402 at 2026-08-10T18:13:42.691Z. PubMed recorded a metadata revision date of 2026-07-08 and an Entrez history date of 2026-02-19. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · MOTS-c

PubMed record PMID 41732124

PeptideScanner retained PubMed bibliographic metadata for PMID 41732124 at 2026-08-10T18:13:42.721Z. PubMed recorded a metadata revision date of 2026-07-08 and an Entrez history date of 2026-02-24. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Abaloparatide

PubMed record PMID 41714054

PeptideScanner retained PubMed bibliographic metadata for PMID 41714054 at 2026-08-10T18:13:42.699Z. PubMed recorded a metadata revision date of 2026-07-08 and an Entrez history date of 2026-02-19. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

Clinical Pharmacology of Glucagon.

PubMed lists PMID 38847591 in Clinical pharmacology and therapeutics as Journal Article, Review, with publication-date metadata of 2024-06-07 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT05569772

PeptideScanner retained ClinicalTrials.gov record NCT05569772 at 2026-08-10T18:10:03.935Z. Its registry update date was 2026-07-07, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT06893211

PeptideScanner retained ClinicalTrials.gov record NCT06893211 at 2026-08-10T18:10:03.966Z. Its registry update date was 2026-07-07, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Liraglutide

Liraglutide and systolic blood pressure.

PubMed lists PMID 30515941 in Journal of clinical hypertension (Greenwich, Conn.) as Letter, with publication-date metadata of 2018-12-05 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · MOTS-c

PubMed record PMID 41654147

PeptideScanner retained PubMed bibliographic metadata for PMID 41654147 at 2026-08-10T18:13:40.626Z. PubMed recorded a metadata revision date of 2026-07-07 and an Entrez history date of 2026-02-07. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Elamipretide

PubMed record PMID 42415111

PeptideScanner retained PubMed bibliographic metadata for PMID 42415111 at 2026-08-10T18:13:53.859Z. PubMed recorded a metadata revision date of 2026-07-07 and an Entrez history date of 2026-07-07. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Abaloparatide

PubMed record PMID 39789749

PeptideScanner retained PubMed bibliographic metadata for PMID 39789749 at 2026-08-10T18:13:36.068Z. PubMed recorded a metadata revision date of 2026-07-07 and an Entrez history date of 2025-01-10. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Clinical trials · Petrelintide

ClinicalTrials.gov record NCT07682818

PeptideScanner retained ClinicalTrials.gov record NCT07682818 at 2026-08-10T18:10:03.938Z. Its registry update date was 2026-07-06, and PeptideScanner's reviewed identity mapping was petrelintide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Tirzepatide

Tirzepatide, the Newest Medication for Type 2 Diabetes: A Review of the Literature and Implications for Clinical Practice.

PubMed lists PMID 38247052 in The Annals of pharmacotherapy as Review, Letter, with publication-date metadata of 2024-01-21 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

Correction: Clinical Implications of Mounjaro (Tirzepatide) for Breast Cancer Detection and Management: A Narrative Review.

PubMed lists PMID 42388932 in Cureus as Published Erratum, Journal Article, with publication-date metadata of 2026-06-30 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Vosoritide

PubMed record PMID 41621839

PeptideScanner retained PubMed bibliographic metadata for PMID 41621839 at 2026-08-10T18:13:40.584Z. PubMed recorded a metadata revision date of 2026-07-06 and an Entrez history date of 2026-02-01. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Setmelanotide

PubMed record PMID 42205046

PeptideScanner retained PubMed bibliographic metadata for PMID 42205046 at 2026-08-10T18:13:50.682Z. PubMed recorded a metadata revision date of 2026-07-06 and an Entrez history date of 2026-05-28. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Dulaglutide

PubMed record PMID 37743669

PeptideScanner retained PubMed bibliographic metadata for PMID 37743669 at 2026-08-10T18:13:32.327Z. PubMed recorded a metadata revision date of 2026-07-06 and an Entrez history date of 2023-09-25. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Liraglutide

Glycemia and Gluconeogenesis With Metformin and Liraglutide: A Randomized Trial in Youth-onset Type 2 Diabetes.

PubMed lists PMID 37967247 in The Journal of clinical endocrinology and metabolism as Randomized Controlled Trial, Journal Article, with publication-date metadata of 2024-04-19 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Pramlintide

PubMed record PMID 41174925

PeptideScanner retained PubMed bibliographic metadata for PMID 41174925 at 2026-08-10T18:13:37.974Z. PubMed recorded a metadata revision date of 2026-07-05 and an Entrez history date of 2025-11-01. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

Interlaboratory Comparison of a Glucagon and Oxyntomodulin Immuno-LC-MS/MS Assay: Implications for Diabetes Research.

PubMed lists PMID 42400596 in Clinical chemistry as Journal Article, with publication-date metadata of 2026-07-04 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Setmelanotide

PubMed record PMID 38567654

PeptideScanner retained PubMed bibliographic metadata for PMID 38567654 at 2026-08-10T18:13:32.350Z. PubMed recorded a metadata revision date of 2026-07-04 and an Entrez history date of 2024-04-03. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT05371496

PeptideScanner retained ClinicalTrials.gov record NCT05371496 at 2026-08-10T18:10:03.928Z. Its registry update date was 2026-07-02, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Maridebart cafraglutide

ClinicalTrials.gov record NCT07037459

PeptideScanner retained ClinicalTrials.gov record NCT07037459 at 2026-08-10T18:10:04.222Z. Its registry update date was 2026-07-02, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Tirzepatide

Can tirzepatide untie the Gordian knot of eating disorders among individuals with type 2 diabetes and obesity?

PubMed lists PMID 39018899 in Journal of diabetes and its complications as Editorial, with publication-date metadata of 2024-07-15 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Vosoritide

PubMed record PMID 38649657

PeptideScanner retained PubMed bibliographic metadata for PMID 38649657 at 2026-08-10T18:13:32.355Z. PubMed recorded a metadata revision date of 2026-07-02 and an Entrez history date of 2024-04-22. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Lixisenatide

PubMed record PMID 38870730

PeptideScanner retained PubMed bibliographic metadata for PMID 38870730 at 2026-08-10T18:13:32.367Z. PubMed recorded a metadata revision date of 2026-07-02 and an Entrez history date of 2024-06-13. PeptideScanner associated this retained record with the identity slug lixisenatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Regulatory · Liraglutide

Drugs@FDA application ANDA212972

The official Drugs@FDA dataset lists original submission 1 for ANDA 212972 with status AP dated 2026-07-01, and names liraglutide among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Literature metadata · Glucagon

Insulin and glucagon ratio in the patho-physiology of diabetic ketoacidosis and hyperosmolar hyperglycemic non-ketotic diabetes.

PubMed lists PMID 16441980 in Journal of the College of Physicians and Surgeons--Pakistan : JCPSP as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2006-01 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Octreotide

[Imaging of pediatric brain tumors using somatostatin analogue 111Ih-DTPA-D-Phe1-octreotide].

PubMed lists PMID 17922063 in Magyar onkologia as Journal Article, with publication-date metadata of 2007-10-07 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

Semaglutide in Schizophrenia-A Top Clinical Trial.

PubMed lists PMID 42384388 in JAMA psychiatry as Journal Article, with publication-date metadata of 2026-07-01 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Teriparatide

Bioequivalence of Recombinant Human Teriparatide Injection in Healthy Adult Female Subjects in the Fasting State.

PubMed lists PMID 38923284 in Clinical pharmacology in drug development as Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2024-06-24 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Liraglutide

Oral delivery of liraglutide using CPP/hyaluronic acid-modified mesoporous silica nanoparticles: A virus-inspired strategy for intestinal absorption.

PubMed lists PMID 41604908 in Biomaterials advances as Journal Article, with publication-date metadata of 2026-01-14 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Elamipretide

PubMed record PMID 38602181

PeptideScanner retained PubMed bibliographic metadata for PMID 38602181 at 2026-07-30T16:11:44.832Z. PubMed recorded a metadata revision date of 2026-07-01 and an Entrez history date of 2024-04-11. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Linaclotide

PubMed record PMID 39370607

PeptideScanner retained PubMed bibliographic metadata for PMID 39370607 at 2026-07-30T16:11:44.834Z. PubMed recorded a metadata revision date of 2026-07-01 and an Entrez history date of 2024-10-07. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Elamipretide

PubMed record PMID 41596703

PeptideScanner retained PubMed bibliographic metadata for PMID 41596703 at 2026-07-30T16:11:44.884Z. PubMed recorded a metadata revision date of 2026-07-01 and an Entrez history date of 2026-01-28. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Exenatide

PubMed record PMID 41597428

PeptideScanner retained PubMed bibliographic metadata for PMID 41597428 at 2026-07-30T16:11:44.888Z. PubMed recorded a metadata revision date of 2026-07-01 and an Entrez history date of 2026-01-28. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Vosoritide

PubMed record PMID 41610120

PeptideScanner retained PubMed bibliographic metadata for PMID 41610120 at 2026-07-30T16:11:44.897Z. PubMed recorded a metadata revision date of 2026-07-01 and an Entrez history date of 2026-01-29. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Abaloparatide

PubMed record PMID 41579168

PeptideScanner retained PubMed bibliographic metadata for PMID 41579168 at 2026-07-30T16:11:44.866Z. PubMed recorded a metadata revision date of 2026-07-01 and an Entrez history date of 2026-01-24. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · BPC-157

PubMed record PMID 42385164

PeptideScanner retained PubMed bibliographic metadata for PMID 42385164 at 2026-07-30T16:11:44.943Z. PubMed recorded a metadata revision date of 2026-07-01 and an Entrez history date of 2026-07-01. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Liraglutide

PubMed record PMID 42385677

PeptideScanner retained PubMed bibliographic metadata for PMID 42385677 at 2026-07-30T16:11:44.943Z. PubMed recorded a metadata revision date of 2026-07-01 and an Entrez history date of 2026-07-01. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07671248

PeptideScanner retained ClinicalTrials.gov record NCT07671248 at 2026-07-30T16:38:53.229Z. Its registry update date was 2026-07-01, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added July 31, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Liraglutide

Liraglutide for idiopathic intracranial hypertension: a real-world propensity score-matched study.

PubMed lists PMID 39949066 in Annals of clinical and translational neurology as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2025-02-13 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Vosoritide

PubMed record PMID 39305160

PeptideScanner retained PubMed bibliographic metadata for PMID 39305160 at 2026-07-30T16:14:08.845Z. PubMed recorded a metadata revision date of 2026-06-30 and an Entrez history date of 2024-09-21. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Cagrilintide

ClinicalTrials.gov record NCT07220642

PeptideScanner retained ClinicalTrials.gov record NCT07220642 at 2026-07-30T16:19:03.066Z. Its registry update date was 2026-06-30, and PeptideScanner's reviewed identity mapping was cagrilintide.

Added July 31, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Semaglutide

Balancing oral sequential absorption barriers of semaglutide-loaded nanoparticles by optimization of surface glycocholic acid density.

PubMed lists PMID 41083011 in Journal of controlled release : official journal of the Controlled Release Society as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2025-10-11 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

Thermally Stressed Solid-State Stability of Semaglutide: Understanding the Influence of Temperature on Protein Content, Secondary Structure, Phase Transition, and Chemical Degradation.

PubMed lists PMID 42086873 in Pharmaceutical research as Journal Article, with publication-date metadata of 2026-05-05 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

Can the NHS afford Mounjaro? It spent £574m on the jab last year despite most eligible patients not getting it.

PubMed lists PMID 42373101 in BMJ (Clinical research ed.) as Journal Article, with publication-date metadata of 2026-06-28 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · GHK-Cu

PubMed record PMID 42245779

PeptideScanner retained PubMed bibliographic metadata for PMID 42245779 at 2026-07-30T16:14:18.092Z. PubMed recorded a metadata revision date of 2026-06-29 and an Entrez history date of 2026-06-05. PeptideScanner associated this retained record with the identity slug ghk-cu. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT04822181

PeptideScanner retained ClinicalTrials.gov record NCT04822181 at 2026-07-30T16:19:03.054Z. Its registry update date was 2026-06-29, and PeptideScanner's reviewed identity mapping was semaglutide.

Added July 31, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Octreotide

Octreotide and Octreotide-derived delivery systems.

PubMed lists PMID 37211679 in Journal of drug targeting as Journal Article, Review, with publication-date metadata of 2023-05-23 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 16, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

An integrative view on glucagon function and putative role in the progression of pancreatic neuroendocrine tumours (pNETs) and hepatocellular carcinomas (HCC).

PubMed lists PMID 37678603 in Molecular and cellular endocrinology as Journal Article, Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2023-09-07 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

Semaglutide use in patients undergoing atrial fibrillation ablation and recurrent arrhythmia: A focused time-to-event meta-analysis.

PubMed lists PMID 42217600 in Heart rhythm as Journal Article, with publication-date metadata of 2026-05-30 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

Secondary alopecia due to semaglutide.

PubMed lists PMID 42364353 in Medicina clinica as Letter, with publication-date metadata of 2026-06-27 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 16, 2026 · Source: PubMed ↗

Literature metadata · Liraglutide

A comprehensive analysis of community pharmacists' practices, barriers, and strategies in patient education on Saxenda®: a qualitative study.

PubMed lists PMID 42015323 in Journal of pharmaceutical health care and sciences as Journal Article, with publication-date metadata of 2026-04-21 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Elamipretide

PubMed record PMID 38688894

PeptideScanner retained PubMed bibliographic metadata for PMID 38688894 at 2026-07-30T16:14:06.935Z. PubMed recorded a metadata revision date of 2026-06-27 and an Entrez history date of 2024-04-30. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Elamipretide

PubMed record PMID 41612464

PeptideScanner retained PubMed bibliographic metadata for PMID 41612464 at 2026-07-30T16:14:14.832Z. PubMed recorded a metadata revision date of 2026-06-27 and an Entrez history date of 2026-01-30. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · MOTS-c

PubMed record PMID 41680431

PeptideScanner retained PubMed bibliographic metadata for PMID 41680431 at 2026-07-30T16:14:14.846Z. PubMed recorded a metadata revision date of 2026-06-27 and an Entrez history date of 2026-02-12. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Lanreotide

PubMed record PMID 41880072

PeptideScanner retained PubMed bibliographic metadata for PMID 41880072 at 2026-07-30T16:14:14.928Z. PubMed recorded a metadata revision date of 2026-06-27 and an Entrez history date of 2026-03-25. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Abaloparatide

PubMed record PMID 42033613

PeptideScanner retained PubMed bibliographic metadata for PMID 42033613 at 2026-07-30T16:14:16.695Z. PubMed recorded a metadata revision date of 2026-06-27 and an Entrez history date of 2026-04-25. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Regulatory · Liraglutide + 2 more

Federal Register notice 2026-12937

The Federal Register published notice 2026-12937, attributed to FDA and its parent HHS department, on 2026-06-26. Its official title is “List of Bulk Drug Substances for Which There Is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic Act; Extension of Comment Period,” and PeptideScanner's exact reviewed identity mapping connects the document to Liraglutide, Semaglutide and Tirzepatide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Literature metadata · Semaglutide

Ileum targeted semaglutide delivery and pharmacokinetic study in an experimental porcine animal model via oesophagogastroduodenoscopic administration.

PubMed lists PMID 40850442 in Journal of controlled release : official journal of the Controlled Release Society as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2025-08-22 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 16, 2026 · Source: PubMed ↗

Literature metadata · Semaglutide

Real-world healthcare resource utilization and medical costs in patients with overweight or obesity and multimorbidity treated with semaglutide in the United States.

PubMed lists PMID 41524543 in Expert review of pharmacoeconomics & outcomes research as Journal Article, Observational Study, with publication-date metadata of 2026-01-12 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 16, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

Treatment Preferences For Comorbid Obesity and Obstructive Sleep Apnea (PRO-CON OSA) Survey: Patient and Provider Preferences for CPAP and/or Tirzepatide.

PubMed lists PMID 41256163 in medRxiv : the preprint server for health sciences as Journal Article, Preprint, with publication-date metadata of 2025-10-05 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

Correction: Treatment preferences for comorbid obesity and obstructive sleep apnea (PRO-CON OSA) survey: Patient and provider preferences for CPAP and/or tirzepatide.

PubMed lists PMID 42151574 in Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine as Published Erratum, with publication-date metadata of 2026-05-18 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Linaclotide

PubMed record PMID 38533633

PeptideScanner retained PubMed bibliographic metadata for PMID 38533633 at 2026-07-30T16:14:06.902Z. PubMed recorded a metadata revision date of 2026-06-26 and an Entrez history date of 2024-03-27. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · BPC-157

PubMed record PMID 40789979

PeptideScanner retained PubMed bibliographic metadata for PMID 40789979 at 2026-07-30T16:14:11.079Z. PubMed recorded a metadata revision date of 2026-06-26 and an Entrez history date of 2025-08-11. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Abaloparatide

PubMed record PMID 41023931

PeptideScanner retained PubMed bibliographic metadata for PMID 41023931 at 2026-07-30T16:14:12.886Z. PubMed recorded a metadata revision date of 2026-06-26 and an Entrez history date of 2025-09-30. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · MOTS-c

PubMed record PMID 41520850

PeptideScanner retained PubMed bibliographic metadata for PMID 41520850 at 2026-07-30T16:14:14.728Z. PubMed recorded a metadata revision date of 2026-06-26 and an Entrez history date of 2026-01-11. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Linaclotide

PubMed record PMID 41539984

PeptideScanner retained PubMed bibliographic metadata for PMID 41539984 at 2026-07-30T16:14:14.760Z. PubMed recorded a metadata revision date of 2026-06-26 and an Entrez history date of 2026-01-15. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Afamelanotide

PubMed record PMID 41547183

PeptideScanner retained PubMed bibliographic metadata for PMID 41547183 at 2026-07-30T16:14:14.777Z. PubMed recorded a metadata revision date of 2026-06-26 and an Entrez history date of 2026-01-17. PeptideScanner associated this retained record with the identity slug afamelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT04777409

PeptideScanner retained ClinicalTrials.gov record NCT04777409 at 2026-07-30T16:19:03.047Z. Its registry update date was 2026-06-26, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 8, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07592546

PeptideScanner retained ClinicalTrials.gov record NCT07592546 at 2026-07-30T16:19:03.065Z. Its registry update date was 2026-06-26, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 8, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Glucagon

Emerging Therapies in Metabolic Health: A Comprehensive Review of GLP-1, GIP, and Glucagon Agonists.

PubMed lists PMID 41518129 in Journal of peptide science : an official publication of the European Peptide Society as Journal Article, Review, with publication-date metadata of 2026-02 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 16, 2026 · Source: PubMed ↗

Literature metadata · Exenatide

PubMed record PMID 39919773

PeptideScanner retained PubMed bibliographic metadata for PMID 39919773 at 2026-07-30T16:14:10.828Z. PubMed recorded a metadata revision date of 2026-06-25 and an Entrez history date of 2025-02-07. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Elamipretide

PubMed record PMID 41500837

PeptideScanner retained PubMed bibliographic metadata for PMID 41500837 at 2026-07-30T16:14:13.067Z. PubMed recorded a metadata revision date of 2026-06-25 and an Entrez history date of 2026-01-07. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Abaloparatide

PubMed record PMID 41506099

PeptideScanner retained PubMed bibliographic metadata for PMID 41506099 at 2026-07-30T16:14:13.082Z. PubMed recorded a metadata revision date of 2026-06-25 and an Entrez history date of 2026-01-08. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Exenatide

PubMed record PMID 42330995

PeptideScanner retained PubMed bibliographic metadata for PMID 42330995 at 2026-07-30T16:14:19.343Z. PubMed recorded a metadata revision date of 2026-06-25 and an Entrez history date of 2026-06-22. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Cagrilintide

PubMed record PMID 39868309

PeptideScanner retained PubMed bibliographic metadata for PMID 39868309 at 2026-07-30T16:14:10.807Z. PubMed recorded a metadata revision date of 2026-06-25 and an Entrez history date of 2025-01-27. PeptideScanner associated this retained record with the identity slug cagrilintide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Cagrilintide

PubMed record PMID 42260118

PeptideScanner retained PubMed bibliographic metadata for PMID 42260118 at 2026-07-30T16:14:18.129Z. PubMed recorded a metadata revision date of 2026-06-25 and an Entrez history date of 2026-06-08. PeptideScanner associated this retained record with the identity slug cagrilintide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07505303

PeptideScanner retained ClinicalTrials.gov record NCT07505303 at 2026-07-30T16:19:03.067Z. Its registry update date was 2026-06-25, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07668414

PeptideScanner retained ClinicalTrials.gov record NCT07668414 at 2026-07-30T16:19:03.061Z. Its registry update date was 2026-06-25, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT03070886

PeptideScanner retained ClinicalTrials.gov record NCT03070886 at 2026-07-30T16:19:03.056Z. Its registry update date was 2026-06-25, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 8, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Tirzepatide

Experience with Tirzepatide and Weight Management During and After a Clinical Trial in Japanese Patients with Obesity Disease: A Qualitative Study.

PubMed lists PMID 42334799 in Advances in therapy as Journal Article, with publication-date metadata of 2026-06-23 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Linaclotide

PubMed record PMID 39527338

PeptideScanner retained PubMed bibliographic metadata for PMID 39527338 at 2026-07-30T16:14:08.881Z. PubMed recorded a metadata revision date of 2026-06-23 and an Entrez history date of 2024-11-11. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT07158021

PeptideScanner retained ClinicalTrials.gov record NCT07158021 at 2026-07-30T16:19:03.066Z. Its registry update date was 2026-06-23, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 8, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Tirzepatide

Residual gastric content after tirzepatide discontinuation: is one week enough?

PubMed lists PMID 42329593 in Minerva anestesiologica as Journal Article, with publication-date metadata of 2026-06-22 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Dulaglutide

PubMed record PMID 38954432

PeptideScanner retained PubMed bibliographic metadata for PMID 38954432 at 2026-07-30T16:14:08.766Z. PubMed recorded a metadata revision date of 2026-06-22 and an Entrez history date of 2024-07-02. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · MOTS-c

PubMed record PMID 40035775

PeptideScanner retained PubMed bibliographic metadata for PMID 40035775 at 2026-07-30T16:14:10.913Z. PubMed recorded a metadata revision date of 2026-06-22 and an Entrez history date of 2025-03-04. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · MOTS-c

PubMed record PMID 40072017

PeptideScanner retained PubMed bibliographic metadata for PMID 40072017 at 2026-07-30T16:14:10.926Z. PubMed recorded a metadata revision date of 2026-06-22 and an Entrez history date of 2025-03-12. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Setmelanotide

PubMed record PMID 42329358

PeptideScanner retained PubMed bibliographic metadata for PMID 42329358 at 2026-07-30T16:14:19.342Z. PubMed recorded a metadata revision date of 2026-06-22 and an Entrez history date of 2026-06-22. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Exenatide

PubMed record PMID 40246242

PeptideScanner retained PubMed bibliographic metadata for PMID 40246242 at 2026-07-30T16:14:10.971Z. PubMed recorded a metadata revision date of 2026-06-21 and an Entrez history date of 2025-04-17. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · MOTS-c

PubMed record PMID 42324588

PeptideScanner retained PubMed bibliographic metadata for PMID 42324588 at 2026-07-30T16:14:19.320Z. PubMed recorded a metadata revision date of 2026-06-21 and an Entrez history date of 2026-06-21. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Dulaglutide

PubMed record PMID 39718468

PeptideScanner retained PubMed bibliographic metadata for PMID 39718468 at 2026-07-30T16:14:08.915Z. PubMed recorded a metadata revision date of 2026-06-20 and an Entrez history date of 2024-12-24. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Dulaglutide

PubMed record PMID 38600796

PeptideScanner retained PubMed bibliographic metadata for PMID 38600796 at 2026-07-30T16:14:06.917Z. PubMed recorded a metadata revision date of 2026-06-19 and an Entrez history date of 2024-04-11. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Abaloparatide

PubMed record PMID 40890141

PeptideScanner retained PubMed bibliographic metadata for PMID 40890141 at 2026-07-30T16:14:11.108Z. PubMed recorded a metadata revision date of 2026-06-19 and an Entrez history date of 2025-09-01. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Dulaglutide

PubMed record PMID 38715179

PeptideScanner retained PubMed bibliographic metadata for PMID 38715179 at 2026-07-30T16:14:06.944Z. PubMed recorded a metadata revision date of 2026-06-18 and an Entrez history date of 2024-05-07. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Lixisenatide

PubMed record PMID 38685598

PeptideScanner retained PubMed bibliographic metadata for PMID 38685598 at 2026-07-30T16:14:06.932Z. PubMed recorded a metadata revision date of 2026-06-18 and an Entrez history date of 2024-04-30. PeptideScanner associated this retained record with the identity slug lixisenatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT04423211

PeptideScanner retained ClinicalTrials.gov record NCT04423211 at 2026-07-30T16:19:03.058Z. Its registry update date was 2026-06-18, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Maridebart cafraglutide

ClinicalTrials.gov record NCT07441252

PeptideScanner retained ClinicalTrials.gov record NCT07441252 at 2026-07-30T16:19:03.063Z. Its registry update date was 2026-06-18, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.

Added August 8, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Mazdutide

ClinicalTrials.gov record NCT07657676

PeptideScanner retained ClinicalTrials.gov record NCT07657676 at 2026-07-30T16:19:03.062Z. Its registry update date was 2026-06-18, and PeptideScanner's reviewed identity mapping was mazdutide.

Added August 8, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Liraglutide

Total and H-specific growth/differentiation factor 15 levels are unaffected by liraglutide or naltrexone/bupropion administration.

PubMed lists PMID 38757729 in Diabetes, obesity & metabolism as Journal Article, Clinical Trial, with publication-date metadata of 2024-05-17 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Elamipretide

PubMed record PMID 40570323

PeptideScanner retained PubMed bibliographic metadata for PMID 40570323 at 2026-07-30T16:14:11.030Z. PubMed recorded a metadata revision date of 2026-06-17 and an Entrez history date of 2025-06-26. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT05669664

PeptideScanner retained ClinicalTrials.gov record NCT05669664 at 2026-07-30T16:19:03.066Z. Its registry update date was 2026-06-17, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT07650240

PeptideScanner retained ClinicalTrials.gov record NCT07650240 at 2026-07-30T16:19:03.043Z. Its registry update date was 2026-06-17, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Mazdutide

ClinicalTrials.gov record NCT07654062

PeptideScanner retained ClinicalTrials.gov record NCT07654062 at 2026-07-30T16:19:03.055Z. Its registry update date was 2026-06-17, and PeptideScanner's reviewed identity mapping was mazdutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Leuprolide

Development and Validation of a Stability-Indicating RS HPLC Method for Leuprolide Acetate and Its Related Substances: Characterization of Degradation Products With LC-MS.

PubMed lists PMID 42299119 in Biomedical chromatography : BMC as Journal Article, with publication-date metadata of 2026-07 (month precision). PeptideScanner associated the retained record with the identity slug leuprolide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Linaclotide

PubMed record PMID 38869953

PeptideScanner retained PubMed bibliographic metadata for PMID 38869953 at 2026-07-30T16:14:08.743Z. PubMed recorded a metadata revision date of 2026-06-16 and an Entrez history date of 2024-06-13. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT05726227

PeptideScanner retained ClinicalTrials.gov record NCT05726227 at 2026-07-30T16:19:03.202Z. Its registry update date was 2026-06-16, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT07027124

PeptideScanner retained ClinicalTrials.gov record NCT07027124 at 2026-07-30T16:19:03.054Z. Its registry update date was 2026-06-16, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Liraglutide

Drugs@FDA application ANDA213155

The official Drugs@FDA dataset lists original submission 1 for ANDA 213155 with status AP dated 2026-06-15, and names liraglutide among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Literature metadata · Ziconotide

PubMed record PMID 41910723

PeptideScanner retained PubMed bibliographic metadata for PMID 41910723 at 2026-07-30T16:14:16.607Z. PubMed recorded a metadata revision date of 2026-06-15 and an Entrez history date of 2026-03-30. PeptideScanner associated this retained record with the identity slug ziconotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Elamipretide

PubMed record PMID 42290373

PeptideScanner retained PubMed bibliographic metadata for PMID 42290373 at 2026-07-30T16:14:18.165Z. PubMed recorded a metadata revision date of 2026-06-15 and an Entrez history date of 2026-06-15. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Elamipretide

PubMed record PMID 42291734

PeptideScanner retained PubMed bibliographic metadata for PMID 42291734 at 2026-07-30T16:14:19.224Z. PubMed recorded a metadata revision date of 2026-06-15 and an Entrez history date of 2026-06-15. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT05605964

PeptideScanner retained ClinicalTrials.gov record NCT05605964 at 2026-07-30T16:19:03.061Z. Its registry update date was 2026-06-15, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Epitalon

PubMed record PMID 40493162

PeptideScanner retained PubMed bibliographic metadata for PMID 40493162 at 2026-07-30T16:14:11.014Z. PubMed recorded a metadata revision date of 2026-06-13 and an Entrez history date of 2025-06-10. PeptideScanner associated this retained record with the identity slug epitalon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Setmelanotide

PubMed record PMID 42070740

PeptideScanner retained PubMed bibliographic metadata for PMID 42070740 at 2026-07-30T16:14:16.709Z. PubMed recorded a metadata revision date of 2026-06-13 and an Entrez history date of 2026-05-03. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Elamipretide

PubMed record PMID 42082001

PeptideScanner retained PubMed bibliographic metadata for PMID 42082001 at 2026-07-30T16:14:16.712Z. PubMed recorded a metadata revision date of 2026-06-12 and an Entrez history date of 2026-05-04. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · MOTS-c

PubMed record PMID 42142418

PeptideScanner retained PubMed bibliographic metadata for PMID 42142418 at 2026-07-30T16:14:16.748Z. PubMed recorded a metadata revision date of 2026-06-12 and an Entrez history date of 2026-05-16. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Dulaglutide

PubMed record PMID 42239562

PeptideScanner retained PubMed bibliographic metadata for PMID 42239562 at 2026-07-30T16:14:18.074Z. PubMed recorded a metadata revision date of 2026-06-12 and an Entrez history date of 2026-06-04. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT00329043

PeptideScanner retained ClinicalTrials.gov record NCT00329043 at 2026-07-30T16:19:03.050Z. Its registry update date was 2026-06-12, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Maridebart cafraglutide

ClinicalTrials.gov record NCT07226765

PeptideScanner retained ClinicalTrials.gov record NCT07226765 at 2026-07-30T16:19:03.046Z. Its registry update date was 2026-06-12, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Maridebart cafraglutide

ClinicalTrials.gov record NCT07225686

PeptideScanner retained ClinicalTrials.gov record NCT07225686 at 2026-07-30T16:19:03.064Z. Its registry update date was 2026-06-12, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.

Added August 8, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07382024

PeptideScanner retained ClinicalTrials.gov record NCT07382024 at 2026-07-30T16:19:03.058Z. Its registry update date was 2026-06-12, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 8, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT06864026

PeptideScanner retained ClinicalTrials.gov record NCT06864026 at 2026-07-30T16:19:03.062Z. Its registry update date was 2026-06-11, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 8, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Teriparatide

Bonegraft Using Octacalcium Phosphate Collagen Composite with Teriparatide and Polylactic Acid Cage.

PubMed lists PMID 41311271 in Tissue engineering. Part A as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2026-02-16 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Exenatide

PubMed record PMID 39805462

PeptideScanner retained PubMed bibliographic metadata for PMID 39805462 at 2026-07-30T16:14:08.923Z. PubMed recorded a metadata revision date of 2026-06-10 and an Entrez history date of 2025-01-13. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · MOTS-c

PubMed record PMID 42266945

PeptideScanner retained PubMed bibliographic metadata for PMID 42266945 at 2026-07-30T16:14:18.139Z. PubMed recorded a metadata revision date of 2026-06-10 and an Entrez history date of 2026-06-10. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT06305598

PeptideScanner retained ClinicalTrials.gov record NCT06305598 at 2026-07-30T16:19:03.055Z. Its registry update date was 2026-06-10, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07282769

PeptideScanner retained ClinicalTrials.gov record NCT07282769 at 2026-07-30T16:19:03.054Z. Its registry update date was 2026-06-10, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07462663

PeptideScanner retained ClinicalTrials.gov record NCT07462663 at 2026-07-30T16:19:03.043Z. Its registry update date was 2026-06-10, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Lanreotide

PubMed record PMID 39933708

PeptideScanner retained PubMed bibliographic metadata for PMID 39933708 at 2026-07-30T16:14:10.854Z. PubMed recorded a metadata revision date of 2026-06-09 and an Entrez history date of 2025-02-11. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Vosoritide

PubMed record PMID 40099812

PeptideScanner retained PubMed bibliographic metadata for PMID 40099812 at 2026-07-30T16:14:10.937Z. PubMed recorded a metadata revision date of 2026-06-09 and an Entrez history date of 2025-03-18. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · MOTS-c

PubMed record PMID 40246631

PeptideScanner retained PubMed bibliographic metadata for PMID 40246631 at 2026-07-30T16:14:10.971Z. PubMed recorded a metadata revision date of 2026-06-09 and an Entrez history date of 2025-04-17. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Retatrutide

PubMed record PMID 42264536

PeptideScanner retained PubMed bibliographic metadata for PMID 42264536 at 2026-07-30T16:14:18.135Z. PubMed recorded a metadata revision date of 2026-06-09 and an Entrez history date of 2026-06-09. PeptideScanner associated this retained record with the identity slug retatrutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Setmelanotide

PubMed record PMID 34561620

PeptideScanner retained PubMed bibliographic metadata for PMID 34561620 at 2026-07-30T16:14:06.776Z. PubMed recorded a metadata revision date of 2026-06-08 and an Entrez history date of 2021-09-25. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Setmelanotide

PubMed record PMID 41866701

PeptideScanner retained PubMed bibliographic metadata for PMID 41866701 at 2026-07-30T16:14:14.923Z. PubMed recorded a metadata revision date of 2026-06-08 and an Entrez history date of 2026-03-23. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Abaloparatide

ClinicalTrials.gov record NCT04467983

PeptideScanner retained ClinicalTrials.gov record NCT04467983 at 2026-07-30T16:19:03.055Z. Its registry update date was 2026-06-08, and PeptideScanner's reviewed identity mapping was abaloparatide.

Added August 8, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Vosoritide

PubMed record PMID 39740666

PeptideScanner retained PubMed bibliographic metadata for PMID 39740666 at 2026-07-30T16:14:08.917Z. PubMed recorded a metadata revision date of 2026-06-07 and an Entrez history date of 2024-12-31. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

Early cardiovascular-kidney-metabolic progression with tirzepatide: population definition and clinical interpretation.

PubMed lists PMID 42155604 in Diabetes research and clinical practice as Letter, with publication-date metadata of 2026-05-19 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Linaclotide

PubMed record PMID 41413756

PeptideScanner retained PubMed bibliographic metadata for PMID 41413756 at 2026-07-30T16:14:13.037Z. PubMed recorded a metadata revision date of 2026-06-05 and an Entrez history date of 2025-12-18. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT06976853

PeptideScanner retained ClinicalTrials.gov record NCT06976853 at 2026-07-30T16:19:03.055Z. Its registry update date was 2026-06-05, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07218445

PeptideScanner retained ClinicalTrials.gov record NCT07218445 at 2026-07-30T16:19:03.065Z. Its registry update date was 2026-06-05, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07630454

PeptideScanner retained ClinicalTrials.gov record NCT07630454 at 2026-07-30T16:19:03.064Z. Its registry update date was 2026-06-05, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Abaloparatide

ClinicalTrials.gov record NCT04167163

PeptideScanner retained ClinicalTrials.gov record NCT04167163 at 2026-07-30T16:19:03.051Z. Its registry update date was 2026-06-05, and PeptideScanner's reviewed identity mapping was abaloparatide.

Added August 8, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Liraglutide

Approaching therapy of Alzheimer's disease via the antidiabetic drug liraglutide-a study with streptozotocin intracerebroventricularly treated Wistar rats.

PubMed lists PMID 40646278 in Journal of neural transmission (Vienna, Austria : 1996) as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2025-07-12 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Pramlintide

PubMed record PMID 39109464

PeptideScanner retained PubMed bibliographic metadata for PMID 39109464 at 2026-07-30T16:14:08.819Z. PubMed recorded a metadata revision date of 2026-06-04 and an Entrez history date of 2024-08-07. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · MOTS-c

PubMed record PMID 42228044

PeptideScanner retained PubMed bibliographic metadata for PMID 42228044 at 2026-07-30T16:14:18.046Z. PubMed recorded a metadata revision date of 2026-06-04 and an Entrez history date of 2026-06-02. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Vosoritide

PubMed record PMID 42238253

PeptideScanner retained PubMed bibliographic metadata for PMID 42238253 at 2026-07-30T16:14:18.068Z. PubMed recorded a metadata revision date of 2026-06-04 and an Entrez history date of 2026-06-04. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT05424003

PeptideScanner retained ClinicalTrials.gov record NCT05424003 at 2026-07-30T16:19:03.066Z. Its registry update date was 2026-06-04, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07228741

PeptideScanner retained ClinicalTrials.gov record NCT07228741 at 2026-07-30T16:19:03.065Z. Its registry update date was 2026-06-04, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07627074

PeptideScanner retained ClinicalTrials.gov record NCT07627074 at 2026-07-30T16:19:03.066Z. Its registry update date was 2026-06-04, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Tirzepatide

On the Noninferiority of Tirzepatide: Insights From SURPASS-CVOT.

PubMed lists PMID 42233554 in Journal of the American College of Cardiology as Journal Article, with publication-date metadata of 2026-06-02 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Vosoritide

PubMed record PMID 39864410

PeptideScanner retained PubMed bibliographic metadata for PMID 39864410 at 2026-07-30T16:14:08.934Z. PubMed recorded a metadata revision date of 2026-06-03 and an Entrez history date of 2025-01-26. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07204249

PeptideScanner retained ClinicalTrials.gov record NCT07204249 at 2026-07-30T16:19:03.057Z. Its registry update date was 2026-06-03, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · MOTS-c

PubMed record PMID 42153537

PeptideScanner retained PubMed bibliographic metadata for PMID 42153537 at 2026-07-30T16:14:16.751Z. PubMed recorded a metadata revision date of 2026-06-02 and an Entrez history date of 2026-05-19. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT06571383

PeptideScanner retained ClinicalTrials.gov record NCT06571383 at 2026-07-30T16:19:03.050Z. Its registry update date was 2026-06-02, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Liraglutide

Current status of Liraglutide delivery systems for the management of type 2 diabetes mellitus.

PubMed lists PMID 40914786 in Drug delivery and translational research as Journal Article, Review, with publication-date metadata of 2025-09-06 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

Understanding Weight Regain After Tirzepatide Withdrawal.

PubMed lists PMID 42043833 in JAMA internal medicine as Journal Article, with publication-date metadata of 2026-06-01 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Elamipretide

PubMed record PMID 38990651

PeptideScanner retained PubMed bibliographic metadata for PMID 38990651 at 2026-07-30T16:14:08.785Z. PubMed recorded a metadata revision date of 2026-06-01 and an Entrez history date of 2024-07-11. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Lixisenatide

PubMed record PMID 38877681

PeptideScanner retained PubMed bibliographic metadata for PMID 38877681 at 2026-07-30T16:20:38.897Z. PubMed recorded a metadata revision date of 2026-05-31 and an Entrez history date of 2024-06-15. PeptideScanner associated this retained record with the identity slug lixisenatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Lixisenatide

PubMed record PMID 39407425

PeptideScanner retained PubMed bibliographic metadata for PMID 39407425 at 2026-07-30T16:20:39.038Z. PubMed recorded a metadata revision date of 2026-05-31 and an Entrez history date of 2024-10-16. PeptideScanner associated this retained record with the identity slug lixisenatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Exenatide

PubMed record PMID 42175654

PeptideScanner retained PubMed bibliographic metadata for PMID 42175654 at 2026-07-30T16:20:45.825Z. PubMed recorded a metadata revision date of 2026-05-30 and an Entrez history date of 2026-05-23. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Exenatide

PubMed record PMID 42217255

PeptideScanner retained PubMed bibliographic metadata for PMID 42217255 at 2026-07-30T16:20:46.631Z. PubMed recorded a metadata revision date of 2026-05-30 and an Entrez history date of 2026-05-30. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · BPC-157

PubMed record PMID 42198317

PeptideScanner retained PubMed bibliographic metadata for PMID 42198317 at 2026-07-30T16:20:45.939Z. PubMed recorded a metadata revision date of 2026-05-29 and an Entrez history date of 2026-05-27. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07610174

PeptideScanner retained ClinicalTrials.gov record NCT07610174 at 2026-07-30T16:19:36.923Z. Its registry update date was 2026-05-29, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Setmelanotide

ClinicalTrials.gov record NCT05774756

PeptideScanner retained ClinicalTrials.gov record NCT05774756 at 2026-07-30T16:19:36.905Z. Its registry update date was 2026-05-29, and PeptideScanner's reviewed identity mapping was setmelanotide.

Added August 8, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Teriparatide

Can Intermittent Teriparatide Facilitate Supraphysiological-Rate Distraction Osteogenesis? A Feasibility Study in the Rabbit Tibial Lengthening Model.

PubMed lists PMID 40657227 in Indian journal of orthopaedics as Journal Article, with publication-date metadata of 2025-05-27 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Dulaglutide

PubMed record PMID 42127399

PeptideScanner retained PubMed bibliographic metadata for PMID 42127399 at 2026-07-30T16:20:45.678Z. PubMed recorded a metadata revision date of 2026-05-28 and an Entrez history date of 2026-05-13. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT06485089

PeptideScanner retained ClinicalTrials.gov record NCT06485089 at 2026-07-30T16:19:36.906Z. Its registry update date was 2026-05-28, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Safety · Liraglutide

FDA enforcement report D-0541-2026

FDA's dated enforcement report D-0541-2026 lists Class II and source status Ongoing for Lupin Pharmaceuticals Inc. PeptideScanner connects the report to reviewed application ANDA215421 through exact openFDA application-number annotations.

Added August 25, 2026 · Source: FDA enforcement reports via openFDA ↗

Clinical trials · Mazdutide

ClinicalTrials.gov record NCT07469800

PeptideScanner retained ClinicalTrials.gov record NCT07469800 at 2026-07-30T16:19:36.903Z. Its registry update date was 2026-05-27, and PeptideScanner's reviewed identity mapping was mazdutide.

Added August 14, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT04126070

PeptideScanner retained ClinicalTrials.gov record NCT04126070 at 2026-07-30T16:19:36.912Z. Its registry update date was 2026-05-27, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT05333003

PeptideScanner retained ClinicalTrials.gov record NCT05333003 at 2026-07-30T16:19:36.906Z. Its registry update date was 2026-05-27, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Ziconotide

PubMed record PMID 42189020

PeptideScanner retained PubMed bibliographic metadata for PMID 42189020 at 2026-07-30T16:20:45.877Z. PubMed recorded a metadata revision date of 2026-05-26 and an Entrez history date of 2026-05-26. PeptideScanner associated this retained record with the identity slug ziconotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Ipamorelin

PubMed record PMID 39043357

PeptideScanner retained PubMed bibliographic metadata for PMID 39043357 at 2026-07-30T16:20:38.933Z. PubMed recorded a metadata revision date of 2026-05-24 and an Entrez history date of 2024-07-23. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Bremelanotide

PubMed record PMID 39793696

PeptideScanner retained PubMed bibliographic metadata for PMID 39793696 at 2026-07-30T16:20:39.143Z. PubMed recorded a metadata revision date of 2026-05-24 and an Entrez history date of 2025-01-10. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Vosoritide

PubMed record PMID 42043535

PeptideScanner retained PubMed bibliographic metadata for PMID 42043535 at 2026-07-30T16:20:43.712Z. PubMed recorded a metadata revision date of 2026-05-22 and an Entrez history date of 2026-04-27. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Retatrutide

PubMed record PMID 41056349

PeptideScanner retained PubMed bibliographic metadata for PMID 41056349 at 2026-07-30T16:20:41.592Z. PubMed recorded a metadata revision date of 2026-05-22 and an Entrez history date of 2025-10-07. PeptideScanner associated this retained record with the identity slug retatrutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07605247

PeptideScanner retained ClinicalTrials.gov record NCT07605247 at 2026-07-30T16:19:36.902Z. Its registry update date was 2026-05-22, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Exenatide

ClinicalTrials.gov record NCT02860923

PeptideScanner retained ClinicalTrials.gov record NCT02860923 at 2026-07-30T16:19:36.924Z. Its registry update date was 2026-05-22, and PeptideScanner's reviewed identity mapping was exenatide.

Added August 8, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Elamipretide

ClinicalTrials.gov record NCT06373731

PeptideScanner retained ClinicalTrials.gov record NCT06373731 at 2026-07-30T16:19:36.914Z. Its registry update date was 2026-05-20, and PeptideScanner's reviewed identity mapping was elamipretide.

Added August 14, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Liraglutide

Microneedle patch with pure drug tips for delivery of liraglutide: pharmacokinetics in rats and minipigs.

PubMed lists PMID 38619705 in Drug delivery and translational research as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2024-04-15 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Epitalon

PubMed record PMID 41240216

PeptideScanner retained PubMed bibliographic metadata for PMID 41240216 at 2026-07-30T16:20:41.667Z. PubMed recorded a metadata revision date of 2026-05-20 and an Entrez history date of 2025-11-15. PeptideScanner associated this retained record with the identity slug epitalon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Vosoritide

PubMed record PMID 39289684

PeptideScanner retained PubMed bibliographic metadata for PMID 39289684 at 2026-07-30T16:20:39.015Z. PubMed recorded a metadata revision date of 2026-05-19 and an Entrez history date of 2024-09-17. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Elamipretide

PubMed record PMID 39574155

PeptideScanner retained PubMed bibliographic metadata for PMID 39574155 at 2026-07-30T16:20:39.074Z. PubMed recorded a metadata revision date of 2026-05-19 and an Entrez history date of 2024-11-22. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT04469855

PeptideScanner retained ClinicalTrials.gov record NCT04469855 at 2026-07-30T16:19:36.922Z. Its registry update date was 2026-05-19, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT01293292

PeptideScanner retained ClinicalTrials.gov record NCT01293292 at 2026-07-30T16:19:36.921Z. Its registry update date was 2026-05-19, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 8, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tesamorelin

ClinicalTrials.gov record NCT06554717

PeptideScanner retained ClinicalTrials.gov record NCT06554717 at 2026-07-30T16:19:36.918Z. Its registry update date was 2026-05-19, and PeptideScanner's reviewed identity mapping was tesamorelin.

Added August 8, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Teriparatide

Teriparatide use during an economic crisis: baseline data from the Greek cohort of the Extended Forsteo Observational Study (ExFOS).

PubMed lists PMID 26044820 in BMC musculoskeletal disorders as Journal Article, Multicenter Study, Observational Study, Research Support, Non-U.S. Gov't, with publication-date metadata of 2015-06-05 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 16, 2026 · Source: PubMed ↗

Literature metadata · Liraglutide

Liraglutide in Children and Adolescents with Type 2 Diabetes.

PubMed lists PMID 31034184 in The New England journal of medicine as Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2019-04-28 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 16, 2026 · Source: PubMed ↗

Literature metadata · Setmelanotide

PubMed record PMID 33137293

PeptideScanner retained PubMed bibliographic metadata for PMID 33137293 at 2026-07-30T16:20:34.542Z. PubMed recorded a metadata revision date of 2026-05-18 and an Entrez history date of 2020-11-02. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Elamipretide

PubMed record PMID 37268435

PeptideScanner retained PubMed bibliographic metadata for PMID 37268435 at 2026-07-30T16:20:36.524Z. PubMed recorded a metadata revision date of 2026-05-18 and an Entrez history date of 2023-06-02. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Lanreotide

PubMed record PMID 38071418

PeptideScanner retained PubMed bibliographic metadata for PMID 38071418 at 2026-07-30T16:20:36.586Z. PubMed recorded a metadata revision date of 2026-05-18 and an Entrez history date of 2023-12-10. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Ziconotide

PubMed record PMID 39244617

PeptideScanner retained PubMed bibliographic metadata for PMID 39244617 at 2026-07-30T16:20:38.998Z. PubMed recorded a metadata revision date of 2026-05-18 and an Entrez history date of 2024-09-07. PeptideScanner associated this retained record with the identity slug ziconotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Elamipretide

PubMed record PMID 39605874

PeptideScanner retained PubMed bibliographic metadata for PMID 39605874 at 2026-07-30T16:20:39.082Z. PubMed recorded a metadata revision date of 2026-05-18 and an Entrez history date of 2024-11-28. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Lixisenatide

PubMed record PMID 22564709

PeptideScanner retained PubMed bibliographic metadata for PMID 22564709 at 2026-07-30T16:20:34.419Z. PubMed recorded a metadata revision date of 2026-05-18 and an Entrez history date of 2012-05-09. PeptideScanner associated this retained record with the identity slug lixisenatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Ipamorelin

PubMed record PMID 25331030

PeptideScanner retained PubMed bibliographic metadata for PMID 25331030 at 2026-07-30T16:20:34.456Z. PubMed recorded a metadata revision date of 2026-05-18 and an Entrez history date of 2014-10-22. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Clinical trials · Pemvidutide

ClinicalTrials.gov record NCT05989711

PeptideScanner retained ClinicalTrials.gov record NCT05989711 at 2026-07-30T16:19:36.923Z. Its registry update date was 2026-05-18, and PeptideScanner's reviewed identity mapping was pemvidutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT06041217

PeptideScanner retained ClinicalTrials.gov record NCT06041217 at 2026-07-30T16:19:36.910Z. Its registry update date was 2026-05-18, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Lanreotide

β-Cyclodextrin derivatives bind aromatic side chains of the cyclic peptide lanreotide.

PubMed lists PMID 39491674 in Journal of pharmaceutical sciences as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2024-11-02 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

GLP-1/GIP dual agonist tirzepatide in obstructive sleep apnea syndrome: mechanisms, evidence, and clinical perspectives.

PubMed lists PMID 42136855 in Frontiers in medicine as Journal Article, Review, with publication-date metadata of 2026-04-29 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Linaclotide

PubMed record PMID 38159221

PeptideScanner retained PubMed bibliographic metadata for PMID 38159221 at 2026-07-30T16:20:36.597Z. PubMed recorded a metadata revision date of 2026-05-15 and an Entrez history date of 2023-12-30. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · BPC-157

PubMed record PMID 42123221

PeptideScanner retained PubMed bibliographic metadata for PMID 42123221 at 2026-07-30T16:20:45.661Z. PubMed recorded a metadata revision date of 2026-05-15 and an Entrez history date of 2026-05-13. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT00544830

PeptideScanner retained ClinicalTrials.gov record NCT00544830 at 2026-07-30T16:19:36.909Z. Its registry update date was 2026-05-15, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Cagrilintide

ClinicalTrials.gov record NCT07557953

PeptideScanner retained ClinicalTrials.gov record NCT07557953 at 2026-07-30T16:19:36.906Z. Its registry update date was 2026-05-15, and PeptideScanner's reviewed identity mapping was cagrilintide.

Added August 8, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Linaclotide

ClinicalTrials.gov record NCT05652205

PeptideScanner retained ClinicalTrials.gov record NCT05652205 at 2026-07-30T16:19:36.913Z. Its registry update date was 2026-05-14, and PeptideScanner's reviewed identity mapping was linaclotide.

Added August 14, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT05151484

PeptideScanner retained ClinicalTrials.gov record NCT05151484 at 2026-07-30T16:19:36.911Z. Its registry update date was 2026-05-14, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07523633

PeptideScanner retained ClinicalTrials.gov record NCT07523633 at 2026-07-30T16:19:36.919Z. Its registry update date was 2026-05-14, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT03770338

PeptideScanner retained ClinicalTrials.gov record NCT03770338 at 2026-07-30T16:19:36.903Z. Its registry update date was 2026-05-14, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 8, 2026 · Source: ClinicalTrials.gov ↗

Safety · Octreotide

FDA enforcement report D-0519-2026

FDA's dated enforcement report D-0519-2026 lists Class II and source status Ongoing for Teva Pharmaceuticals USA, Inc. PeptideScanner connects the report to reviewed application ANDA210317 through exact openFDA application-number annotations.

Added August 25, 2026 · Source: FDA enforcement reports via openFDA ↗

Literature metadata · Dulaglutide

PubMed record PMID 38871561

PeptideScanner retained PubMed bibliographic metadata for PMID 38871561 at 2026-07-30T16:20:38.896Z. PubMed recorded a metadata revision date of 2026-05-13 and an Entrez history date of 2024-06-13. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT01155232

PeptideScanner retained ClinicalTrials.gov record NCT01155232 at 2026-07-30T16:19:36.922Z. Its registry update date was 2026-05-11, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT05586802

PeptideScanner retained ClinicalTrials.gov record NCT05586802 at 2026-07-30T16:19:36.909Z. Its registry update date was 2026-05-11, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07059377

PeptideScanner retained ClinicalTrials.gov record NCT07059377 at 2026-07-30T16:19:36.906Z. Its registry update date was 2026-05-11, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT06734273

PeptideScanner retained ClinicalTrials.gov record NCT06734273 at 2026-07-30T16:19:36.910Z. Its registry update date was 2026-05-08, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Dulaglutide

PubMed record PMID 38719260

PeptideScanner retained PubMed bibliographic metadata for PMID 38719260 at 2026-07-30T16:20:36.695Z. PubMed recorded a metadata revision date of 2026-05-07 and an Entrez history date of 2024-05-08. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07298915

PeptideScanner retained ClinicalTrials.gov record NCT07298915 at 2026-07-30T16:19:36.919Z. Its registry update date was 2026-05-06, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Dulaglutide

PubMed record PMID 42083939

PeptideScanner retained PubMed bibliographic metadata for PMID 42083939 at 2026-07-30T16:20:43.803Z. PubMed recorded a metadata revision date of 2026-05-05 and an Entrez history date of 2026-05-05. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Dulaglutide

PubMed record PMID 40536052

PeptideScanner retained PubMed bibliographic metadata for PMID 40536052 at 2026-07-30T16:20:41.387Z. PubMed recorded a metadata revision date of 2026-05-04 and an Entrez history date of 2025-06-19. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT04019197

PeptideScanner retained ClinicalTrials.gov record NCT04019197 at 2026-07-30T16:19:36.918Z. Its registry update date was 2026-05-04, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07443956

PeptideScanner retained ClinicalTrials.gov record NCT07443956 at 2026-07-30T16:19:36.909Z. Its registry update date was 2026-05-04, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07554638

PeptideScanner retained ClinicalTrials.gov record NCT07554638 at 2026-07-30T16:19:36.907Z. Its registry update date was 2026-05-04, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Setmelanotide

PubMed record PMID 42068058

PeptideScanner retained PubMed bibliographic metadata for PMID 42068058 at 2026-07-30T16:20:43.725Z. PubMed recorded a metadata revision date of 2026-05-02 and an Entrez history date of 2026-05-02. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Regulatory · Glucagon + 3 more

Federal Register notice 2026-08552

The Federal Register published notice 2026-08552, attributed to FDA and its parent HHS department, on 2026-05-01. Its official title is “List of Bulk Drug Substances for Which There Is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic Act,” and PeptideScanner's exact reviewed identity mapping connects the document to Glucagon, Liraglutide, Semaglutide and Tirzepatide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT04194554

PeptideScanner retained ClinicalTrials.gov record NCT04194554 at 2026-07-30T16:19:36.919Z. Its registry update date was 2026-05-01, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT02944500

PeptideScanner retained ClinicalTrials.gov record NCT02944500 at 2026-07-30T16:19:36.903Z. Its registry update date was 2026-05-01, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 8, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT03856632

PeptideScanner retained ClinicalTrials.gov record NCT03856632 at 2026-07-30T16:19:36.910Z. Its registry update date was 2026-05-01, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 8, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Semaglutide

Federal Register notice 2026-08435

The Federal Register published notice 2026-08435, attributed to FDA and its parent HHS department, on 2026-04-30. Its official title is “Determination That OZEMPIC (Semaglutide) Solution, 2 Milligrams Per 1.5 Milliliters Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness,” and PeptideScanner's exact reviewed identity mapping connects the document to Semaglutide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Literature metadata · Lanreotide

Combined Lanreotide Autogel and Temozolomide Treatment of Progressive Pancreatic and Intestinal Neuroendocrine Tumors: The Phase II SONNET Study.

PubMed lists PMID 38206830 in The oncologist as Journal Article, Clinical Trial, Phase II, Research Support, Non-U.S. Gov't, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 2024-05-03 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Survodutide

ClinicalTrials.gov record NCT06176365

PeptideScanner retained ClinicalTrials.gov record NCT06176365 at 2026-07-30T16:20:49.317Z. Its registry update date was 2026-04-30, and PeptideScanner's reviewed identity mapping was survodutide.

Added August 8, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Survodutide

ClinicalTrials.gov record NCT06309992

PeptideScanner retained ClinicalTrials.gov record NCT06309992 at 2026-07-30T16:20:49.307Z. Its registry update date was 2026-04-30, and PeptideScanner's reviewed identity mapping was survodutide.

Added August 8, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Insulin glargine-aldy

Drugs@FDA application BLA761412

The official Drugs@FDA dataset lists original submission 1 for BLA 761412 with status AP dated 2026-04-29, and names insulin glargine-aldy among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT04174755

PeptideScanner retained ClinicalTrials.gov record NCT04174755 at 2026-07-30T16:20:49.311Z. Its registry update date was 2026-04-29, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Glucagon

ClinicalTrials.gov record NCT05500586

PeptideScanner retained ClinicalTrials.gov record NCT05500586 at 2026-07-30T16:20:49.307Z. Its registry update date was 2026-04-29, and PeptideScanner's reviewed identity mapping was glucagon.

Added August 8, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Abaloparatide

ClinicalTrials.gov record NCT03841058

PeptideScanner retained ClinicalTrials.gov record NCT03841058 at 2026-07-30T16:20:49.320Z. Its registry update date was 2026-04-28, and PeptideScanner's reviewed identity mapping was abaloparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07065552

PeptideScanner retained ClinicalTrials.gov record NCT07065552 at 2026-07-30T16:20:49.313Z. Its registry update date was 2026-04-28, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Tirzepatide

Tirzepatide and metabolic surgery: complementary approaches for multimodal management of MASLD.

PubMed lists PMID 41258966 in Hepatology international as Letter, Comment, with publication-date metadata of 2025-11-19 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 16, 2026 · Source: PubMed ↗

Literature metadata · Tirzepatide

Real world tirzepatide treatment for fatty liver disease.

PubMed lists PMID 41776028 in Hepatology international as Editorial, with publication-date metadata of 2026-03-03 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Setmelanotide

PubMed record PMID 41959165

PeptideScanner retained PubMed bibliographic metadata for PMID 41959165 at 2026-07-30T16:22:18.487Z. PubMed recorded a metadata revision date of 2026-04-27 and an Entrez history date of 2026-04-10. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Bremelanotide

PubMed record PMID 41960633

PeptideScanner retained PubMed bibliographic metadata for PMID 41960633 at 2026-07-30T16:22:18.490Z. PubMed recorded a metadata revision date of 2026-04-24 and an Entrez history date of 2026-04-10. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT05646706

PeptideScanner retained ClinicalTrials.gov record NCT05646706 at 2026-07-30T16:20:49.307Z. Its registry update date was 2026-04-23, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Setmelanotide

Federal Register rule 2026-07863

The Federal Register published rule 2026-07863, attributed to FDA and its parent HHS department, on 2026-04-22. Its official title is “Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Setmelanotide Eligibility Gene Variant Detection System,” and PeptideScanner's exact reviewed identity mapping connects the document to Setmelanotide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT06283667

PeptideScanner retained ClinicalTrials.gov record NCT06283667 at 2026-07-30T16:20:49.310Z. Its registry update date was 2026-04-22, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Mazdutide

ClinicalTrials.gov record NCT06124807

PeptideScanner retained ClinicalTrials.gov record NCT06124807 at 2026-07-30T16:20:49.321Z. Its registry update date was 2026-04-21, and PeptideScanner's reviewed identity mapping was mazdutide.

Added August 14, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Vosoritide

PubMed record PMID 41157964

PeptideScanner retained PubMed bibliographic metadata for PMID 41157964 at 2026-07-30T16:22:16.190Z. PubMed recorded a metadata revision date of 2026-04-21 and an Entrez history date of 2025-10-29. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT05746039

PeptideScanner retained ClinicalTrials.gov record NCT05746039 at 2026-07-30T16:20:49.311Z. Its registry update date was 2026-04-21, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Glucagon

ClinicalTrials.gov record NCT06424106

PeptideScanner retained ClinicalTrials.gov record NCT06424106 at 2026-07-30T16:20:49.305Z. Its registry update date was 2026-04-20, and PeptideScanner's reviewed identity mapping was glucagon.

Added August 14, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT06657209

PeptideScanner retained ClinicalTrials.gov record NCT06657209 at 2026-07-30T16:20:49.310Z. Its registry update date was 2026-04-20, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Exenatide

ClinicalTrials.gov record NCT05482789

PeptideScanner retained ClinicalTrials.gov record NCT05482789 at 2026-07-30T16:20:49.324Z. Its registry update date was 2026-04-20, and PeptideScanner's reviewed identity mapping was exenatide.

Added August 8, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Setmelanotide

PubMed record PMID 38987029

PeptideScanner retained PubMed bibliographic metadata for PMID 38987029 at 2026-07-30T16:22:12.162Z. PubMed recorded a metadata revision date of 2026-04-17 and an Entrez history date of 2024-07-10. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Setmelanotide

PubMed record PMID 39284294

PeptideScanner retained PubMed bibliographic metadata for PMID 39284294 at 2026-07-30T16:22:15.952Z. PubMed recorded a metadata revision date of 2026-04-17 and an Entrez history date of 2024-09-16. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Setmelanotide

PubMed record PMID 41401696

PeptideScanner retained PubMed bibliographic metadata for PMID 41401696 at 2026-07-30T16:22:18.312Z. PubMed recorded a metadata revision date of 2026-04-17 and an Entrez history date of 2025-12-16. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Setmelanotide

PubMed record PMID 41994885

PeptideScanner retained PubMed bibliographic metadata for PMID 41994885 at 2026-07-30T16:22:19.404Z. PubMed recorded a metadata revision date of 2026-04-17 and an Entrez history date of 2026-04-17. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT06558188

PeptideScanner retained ClinicalTrials.gov record NCT06558188 at 2026-07-30T16:20:49.311Z. Its registry update date was 2026-04-17, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · BPC-157 + 6 more

Federal Register notice 2026-07361

The Federal Register published notice 2026-07361, attributed to FDA and its parent HHS department, on 2026-04-16. Its official title is “Pharmacy Compounding Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Bulk Drug Substances Nominated for Inclusion on the Section 503A Bulk Drug Substances List,” and PeptideScanner's exact reviewed identity mapping connects the document to BPC-157, Emideltide, Epitalon, KPV, MOTS-c, Semax and TB-500.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT06811324

PeptideScanner retained ClinicalTrials.gov record NCT06811324 at 2026-07-30T16:20:49.320Z. Its registry update date was 2026-04-15, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT02772588

PeptideScanner retained ClinicalTrials.gov record NCT02772588 at 2026-07-30T16:20:49.312Z. Its registry update date was 2026-04-13, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT02960022

PeptideScanner retained ClinicalTrials.gov record NCT02960022 at 2026-07-30T16:20:49.311Z. Its registry update date was 2026-04-13, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT06751589

PeptideScanner retained ClinicalTrials.gov record NCT06751589 at 2026-07-30T16:20:49.318Z. Its registry update date was 2026-04-13, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Vosoritide

PubMed record PMID 41967490

PeptideScanner retained PubMed bibliographic metadata for PMID 41967490 at 2026-07-30T16:22:18.495Z. PubMed recorded a metadata revision date of 2026-04-12 and an Entrez history date of 2026-04-12. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Linaclotide

PubMed record PMID 41123247

PeptideScanner retained PubMed bibliographic metadata for PMID 41123247 at 2026-07-30T16:22:16.181Z. PubMed recorded a metadata revision date of 2026-04-10 and an Entrez history date of 2025-10-22. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Lanreotide

ClinicalTrials.gov record NCT05048901

PeptideScanner retained ClinicalTrials.gov record NCT05048901 at 2026-07-30T16:20:49.324Z. Its registry update date was 2026-04-09, and PeptideScanner's reviewed identity mapping was lanreotide.

Added August 8, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Lanreotide

ClinicalTrials.gov record NCT02127437

PeptideScanner retained ClinicalTrials.gov record NCT02127437 at 2026-07-30T16:20:49.305Z. Its registry update date was 2026-04-08, and PeptideScanner's reviewed identity mapping was lanreotide.

Added August 8, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Petrelintide

ClinicalTrials.gov record NCT07338214

PeptideScanner retained ClinicalTrials.gov record NCT07338214 at 2026-07-30T16:20:49.304Z. Its registry update date was 2026-04-08, and PeptideScanner's reviewed identity mapping was petrelintide.

Added August 8, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Tesamorelin

PubMed record PMID 34006921

PeptideScanner retained PubMed bibliographic metadata for PMID 34006921 at 2026-07-30T16:22:11.959Z. PubMed recorded a metadata revision date of 2026-04-07 and an Entrez history date of 2021-05-19. PeptideScanner associated this retained record with the identity slug tesamorelin. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Linaclotide

PubMed record PMID 33858329

PeptideScanner retained PubMed bibliographic metadata for PMID 33858329 at 2026-07-30T16:22:11.958Z. PubMed recorded a metadata revision date of 2026-04-06 and an Entrez history date of 2021-04-16. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT06604624

PeptideScanner retained ClinicalTrials.gov record NCT06604624 at 2026-07-30T16:20:49.309Z. Its registry update date was 2026-04-06, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Vosoritide

PubMed record PMID 41615893

PeptideScanner retained PubMed bibliographic metadata for PMID 41615893 at 2026-07-30T16:22:18.348Z. PubMed recorded a metadata revision date of 2026-04-04 and an Entrez history date of 2026-01-30. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Linaclotide

ClinicalTrials.gov record NCT03119584

PeptideScanner retained ClinicalTrials.gov record NCT03119584 at 2026-07-30T16:20:49.311Z. Its registry update date was 2026-04-03, and PeptideScanner's reviewed identity mapping was linaclotide.

Added August 8, 2026 · Source: ClinicalTrials.gov ↗

Safety · Octreotide

FDA enforcement report D-0404-2026

FDA's dated enforcement report D-0404-2026 lists Class II and source status Ongoing for Teva Pharmaceuticals USA, Inc. PeptideScanner connects the report to reviewed application ANDA210317 through exact openFDA application-number annotations.

Added August 25, 2026 · Source: FDA enforcement reports via openFDA ↗

Safety · Octreotide

FDA enforcement report D-0405-2026

FDA's dated enforcement report D-0405-2026 lists Class II and source status Ongoing for Teva Pharmaceuticals USA, Inc. PeptideScanner connects the report to reviewed application ANDA210317 through exact openFDA application-number annotations.

Added August 25, 2026 · Source: FDA enforcement reports via openFDA ↗

Safety · Octreotide

FDA enforcement report D-0406-2026

FDA's dated enforcement report D-0406-2026 lists Class II and source status Ongoing for Teva Pharmaceuticals USA, Inc. PeptideScanner connects the report to reviewed application ANDA210317 through exact openFDA application-number annotations.

Added August 25, 2026 · Source: FDA enforcement reports via openFDA ↗

Literature metadata · Tesamorelin

PubMed record PMID 38905488

PeptideScanner retained PubMed bibliographic metadata for PMID 38905488 at 2026-07-30T16:22:12.148Z. PubMed recorded a metadata revision date of 2026-04-01 and an Entrez history date of 2024-06-21. PeptideScanner associated this retained record with the identity slug tesamorelin. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT06264609

PeptideScanner retained ClinicalTrials.gov record NCT06264609 at 2026-07-30T16:20:49.326Z. Its registry update date was 2026-04-01, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT06734130

PeptideScanner retained ClinicalTrials.gov record NCT06734130 at 2026-07-30T16:20:49.318Z. Its registry update date was 2026-04-01, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Vosoritide

ClinicalTrials.gov record NCT07126262

PeptideScanner retained ClinicalTrials.gov record NCT07126262 at 2026-07-30T16:22:22.346Z. Its registry update date was 2026-03-31, and PeptideScanner's reviewed identity mapping was vosoritide.

Added August 14, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Lanreotide

ClinicalTrials.gov record NCT06807437

PeptideScanner retained ClinicalTrials.gov record NCT06807437 at 2026-07-30T16:22:22.334Z. Its registry update date was 2026-03-31, and PeptideScanner's reviewed identity mapping was lanreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Glucagon

ClinicalTrials.gov record NCT02817659

PeptideScanner retained ClinicalTrials.gov record NCT02817659 at 2026-07-30T16:22:22.328Z. Its registry update date was 2026-03-30, and PeptideScanner's reviewed identity mapping was glucagon.

Added August 14, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Ziconotide

ClinicalTrials.gov record NCT07499882

PeptideScanner retained ClinicalTrials.gov record NCT07499882 at 2026-07-30T16:22:22.324Z. Its registry update date was 2026-03-30, and PeptideScanner's reviewed identity mapping was ziconotide.

Added August 14, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Liraglutide

Drugs@FDA application ANDA212552

The official Drugs@FDA dataset lists original submission 1 for ANDA 212552 with status AP dated 2026-03-30, and names liraglutide among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Literature metadata · BPC-157

PubMed record PMID 41901308

PeptideScanner retained PubMed bibliographic metadata for PMID 41901308 at 2026-07-30T16:23:42.486Z. PubMed recorded a metadata revision date of 2026-03-30 and an Entrez history date of 2026-03-28. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Mazdutide

PubMed record PMID 41901218

PeptideScanner retained PubMed bibliographic metadata for PMID 41901218 at 2026-07-30T16:23:42.462Z. PubMed recorded a metadata revision date of 2026-03-30 and an Entrez history date of 2026-03-28. PeptideScanner associated this retained record with the identity slug mazdutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Retatrutide

PubMed record PMID 37178114

PeptideScanner retained PubMed bibliographic metadata for PMID 37178114 at 2026-07-30T16:23:33.798Z. PubMed recorded a metadata revision date of 2026-03-27 and an Entrez history date of 2023-05-13. PeptideScanner associated this retained record with the identity slug retatrutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT05933499

PeptideScanner retained ClinicalTrials.gov record NCT05933499 at 2026-07-30T16:22:22.327Z. Its registry update date was 2026-03-27, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT06118203

PeptideScanner retained ClinicalTrials.gov record NCT06118203 at 2026-07-30T16:22:22.346Z. Its registry update date was 2026-03-27, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Linaclotide

PubMed record PMID 40423516

PeptideScanner retained PubMed bibliographic metadata for PMID 40423516 at 2026-07-30T16:23:36.824Z. PubMed recorded a metadata revision date of 2026-03-26 and an Entrez history date of 2025-05-27. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Lanreotide

Lanreotide in endothelial corneal inflammation.

PubMed lists PMID 41071230 in Hormones (Athens, Greece) as Letter, with publication-date metadata of 2025-10-10 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07220473

PeptideScanner retained ClinicalTrials.gov record NCT07220473 at 2026-07-30T16:22:22.342Z. Its registry update date was 2026-03-24, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Petrelintide

ClinicalTrials.gov record NCT06662539

PeptideScanner retained ClinicalTrials.gov record NCT06662539 at 2026-07-30T16:22:22.334Z. Its registry update date was 2026-03-23, and PeptideScanner's reviewed identity mapping was petrelintide.

Added August 14, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · TB-500

ClinicalTrials.gov record NCT07487363

PeptideScanner retained ClinicalTrials.gov record NCT07487363 at 2026-07-30T16:22:22.342Z. Its registry update date was 2026-03-23, and PeptideScanner's reviewed identity mapping was tb-500.

Added August 14, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Lixisenatide

PubMed record PMID 39157869

PeptideScanner retained PubMed bibliographic metadata for PMID 39157869 at 2026-07-30T16:23:36.341Z. PubMed recorded a metadata revision date of 2026-03-23 and an Entrez history date of 2024-08-19. PeptideScanner associated this retained record with the identity slug lixisenatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Pemvidutide

ClinicalTrials.gov record NCT07009860

PeptideScanner retained ClinicalTrials.gov record NCT07009860 at 2026-07-30T16:22:22.335Z. Its registry update date was 2026-03-20, and PeptideScanner's reviewed identity mapping was pemvidutide.

Added August 14, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07227948

PeptideScanner retained ClinicalTrials.gov record NCT07227948 at 2026-07-30T16:22:22.326Z. Its registry update date was 2026-03-19, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tesamorelin

ClinicalTrials.gov record NCT07481734

PeptideScanner retained ClinicalTrials.gov record NCT07481734 at 2026-07-30T16:22:22.324Z. Its registry update date was 2026-03-19, and PeptideScanner's reviewed identity mapping was tesamorelin.

Added August 8, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Vosoritide

ClinicalTrials.gov record NCT04219007

PeptideScanner retained ClinicalTrials.gov record NCT04219007 at 2026-07-30T16:22:22.347Z. Its registry update date was 2026-03-18, and PeptideScanner's reviewed identity mapping was vosoritide.

Added August 8, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT06934655

PeptideScanner retained ClinicalTrials.gov record NCT06934655 at 2026-07-30T16:22:22.326Z. Its registry update date was 2026-03-17, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT06989177

PeptideScanner retained ClinicalTrials.gov record NCT06989177 at 2026-07-30T16:22:22.331Z. Its registry update date was 2026-03-17, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT06989203

PeptideScanner retained ClinicalTrials.gov record NCT06989203 at 2026-07-30T16:22:22.329Z. Its registry update date was 2026-03-17, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Vosoritide

ClinicalTrials.gov record NCT02724228

PeptideScanner retained ClinicalTrials.gov record NCT02724228 at 2026-07-30T16:22:22.336Z. Its registry update date was 2026-03-13, and PeptideScanner's reviewed identity mapping was vosoritide.

Added August 14, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Vosoritide

ClinicalTrials.gov record NCT04554940

PeptideScanner retained ClinicalTrials.gov record NCT04554940 at 2026-07-30T16:22:22.328Z. Its registry update date was 2026-03-13, and PeptideScanner's reviewed identity mapping was vosoritide.

Added August 8, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tesamorelin

ClinicalTrials.gov record NCT02572323

PeptideScanner retained ClinicalTrials.gov record NCT02572323 at 2026-07-30T16:22:22.328Z. Its registry update date was 2026-03-12, and PeptideScanner's reviewed identity mapping was tesamorelin.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07468552

PeptideScanner retained ClinicalTrials.gov record NCT07468552 at 2026-07-30T16:22:22.342Z. Its registry update date was 2026-03-12, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Glucagon

ClinicalTrials.gov record NCT06252493

PeptideScanner retained ClinicalTrials.gov record NCT06252493 at 2026-07-30T16:22:22.324Z. Its registry update date was 2026-03-12, and PeptideScanner's reviewed identity mapping was glucagon.

Added August 8, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Liraglutide

Drugs@FDA application ANDA215245

The official Drugs@FDA dataset lists original submission 1 for ANDA 215245 with status AP dated 2026-03-11, and names liraglutide among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07213466

PeptideScanner retained ClinicalTrials.gov record NCT07213466 at 2026-07-30T16:22:22.332Z. Its registry update date was 2026-03-11, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Vosoritide

ClinicalTrials.gov record NCT05845749

PeptideScanner retained ClinicalTrials.gov record NCT05845749 at 2026-07-30T16:22:22.324Z. Its registry update date was 2026-03-10, and PeptideScanner's reviewed identity mapping was vosoritide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT07460908

PeptideScanner retained ClinicalTrials.gov record NCT07460908 at 2026-07-30T16:22:22.346Z. Its registry update date was 2026-03-10, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 8, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Exenatide

Federal Register notice 2026-04546

The Federal Register published notice 2026-04546, attributed to FDA and its parent HHS department, on 2026-03-09. Its official title is “Aspen Global Inc. c/o Lachman Consultant Services, Inc., et al.; Withdrawal of Approval of 46 New Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Exenatide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Literature metadata · Abaloparatide

PubMed record PMID 41798079

PeptideScanner retained PubMed bibliographic metadata for PMID 41798079 at 2026-07-30T16:23:41.290Z. PubMed recorded a metadata revision date of 2026-03-09 and an Entrez history date of 2026-03-09. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT06330805

PeptideScanner retained ClinicalTrials.gov record NCT06330805 at 2026-07-30T16:22:22.335Z. Its registry update date was 2026-03-09, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Retatrutide

PubMed record PMID 40735804

PeptideScanner retained PubMed bibliographic metadata for PMID 40735804 at 2026-07-30T16:23:38.757Z. PubMed recorded a metadata revision date of 2026-03-07 and an Entrez history date of 2025-07-30. PeptideScanner associated this retained record with the identity slug retatrutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Afamelanotide

PubMed record PMID 41793078

PeptideScanner retained PubMed bibliographic metadata for PMID 41793078 at 2026-07-30T16:23:41.287Z. PubMed recorded a metadata revision date of 2026-03-07 and an Entrez history date of 2026-03-07. PeptideScanner associated this retained record with the identity slug afamelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Afamelanotide

PubMed record PMID 38634774

PeptideScanner retained PubMed bibliographic metadata for PMID 38634774 at 2026-07-30T16:23:36.263Z. PubMed recorded a metadata revision date of 2026-03-06 and an Entrez history date of 2024-04-18. PeptideScanner associated this retained record with the identity slug afamelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Afamelanotide

PubMed record PMID 38736212

PeptideScanner retained PubMed bibliographic metadata for PMID 38736212 at 2026-07-30T16:23:36.274Z. PubMed recorded a metadata revision date of 2026-03-06 and an Entrez history date of 2024-05-13. PeptideScanner associated this retained record with the identity slug afamelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT00936390

PeptideScanner retained ClinicalTrials.gov record NCT00936390 at 2026-07-30T16:22:22.345Z. Its registry update date was 2026-03-06, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT05965908

PeptideScanner retained ClinicalTrials.gov record NCT05965908 at 2026-07-30T16:22:22.342Z. Its registry update date was 2026-03-06, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Vosoritide

PubMed record PMID 41783511

PeptideScanner retained PubMed bibliographic metadata for PMID 41783511 at 2026-07-30T16:23:41.272Z. PubMed recorded a metadata revision date of 2026-03-05 and an Entrez history date of 2026-03-05. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Maridebart cafraglutide

PubMed record PMID 41337722

PeptideScanner retained PubMed bibliographic metadata for PMID 41337722 at 2026-07-30T16:23:39.188Z. PubMed recorded a metadata revision date of 2026-03-04 and an Entrez history date of 2025-12-03. PeptideScanner associated this retained record with the identity slug maridebart-cafraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Maridebart cafraglutide

PubMed record PMID 41337723

PeptideScanner retained PubMed bibliographic metadata for PMID 41337723 at 2026-07-30T16:23:39.188Z. PubMed recorded a metadata revision date of 2026-03-04 and an Entrez history date of 2025-12-03. PeptideScanner associated this retained record with the identity slug maridebart-cafraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT05681299

PeptideScanner retained ClinicalTrials.gov record NCT05681299 at 2026-07-30T16:22:22.328Z. Its registry update date was 2026-03-04, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Dulaglutide

PubMed record PMID 41231281

PeptideScanner retained PubMed bibliographic metadata for PMID 41231281 at 2026-07-30T16:23:39.111Z. PubMed recorded a metadata revision date of 2026-03-03 and an Entrez history date of 2025-11-13. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Lanreotide

ClinicalTrials.gov record NCT03946527

PeptideScanner retained ClinicalTrials.gov record NCT03946527 at 2026-07-30T16:22:22.335Z. Its registry update date was 2026-03-02, and PeptideScanner's reviewed identity mapping was lanreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT05700903

PeptideScanner retained ClinicalTrials.gov record NCT05700903 at 2026-07-30T16:22:22.343Z. Its registry update date was 2026-03-02, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Octreotide + 1 more

Federal Register notice 2026-03963

The Federal Register published notice 2026-03963, attributed to FDA and its parent HHS department, on 2026-02-27. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Octreotide and Semaglutide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT06027567

PeptideScanner retained ClinicalTrials.gov record NCT06027567 at 2026-07-30T16:23:45.644Z. Its registry update date was 2026-02-27, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT06759701

PeptideScanner retained ClinicalTrials.gov record NCT06759701 at 2026-07-30T16:23:45.658Z. Its registry update date was 2026-02-27, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07095517

PeptideScanner retained ClinicalTrials.gov record NCT07095517 at 2026-07-30T16:23:45.642Z. Its registry update date was 2026-02-27, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Liraglutide

Drugs@FDA application ANDA217063

The official Drugs@FDA dataset lists original submission 1 for ANDA 217063 with status AP dated 2026-02-24, and names liraglutide among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Regulatory · Liraglutide

Drugs@FDA application ANDA217234

The official Drugs@FDA dataset lists original submission 1 for ANDA 217234 with status AP dated 2026-02-24, and names liraglutide among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT05891496

PeptideScanner retained ClinicalTrials.gov record NCT05891496 at 2026-07-30T16:23:45.669Z. Its registry update date was 2026-02-24, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT01786265

PeptideScanner retained ClinicalTrials.gov record NCT01786265 at 2026-07-30T16:23:45.644Z. Its registry update date was 2026-02-20, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07423247

PeptideScanner retained ClinicalTrials.gov record NCT07423247 at 2026-07-30T16:23:45.670Z. Its registry update date was 2026-02-20, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Setmelanotide

PubMed record PMID 40903014

PeptideScanner retained PubMed bibliographic metadata for PMID 40903014 at 2026-07-30T16:25:12.584Z. PubMed recorded a metadata revision date of 2026-02-19 and an Entrez history date of 2025-09-03. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Dulaglutide

PubMed record PMID 41693775

PeptideScanner retained PubMed bibliographic metadata for PMID 41693775 at 2026-07-30T16:25:14.309Z. PubMed recorded a metadata revision date of 2026-02-18 and an Entrez history date of 2026-02-16. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · KPV

PubMed record PMID 39252648

PeptideScanner retained PubMed bibliographic metadata for PMID 39252648 at 2026-07-30T16:25:12.445Z. PubMed recorded a metadata revision date of 2026-02-17 and an Entrez history date of 2024-09-10. PeptideScanner associated this retained record with the identity slug kpv. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Survodutide

PubMed record PMID 41388343

PeptideScanner retained PubMed bibliographic metadata for PMID 41388343 at 2026-07-30T16:25:14.127Z. PubMed recorded a metadata revision date of 2026-02-14 and an Entrez history date of 2025-12-13. PeptideScanner associated this retained record with the identity slug survodutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Regulatory · Semaglutide

Federal Register notice 2026-02786

The Federal Register published notice 2026-02786, attributed to FDA and its parent HHS department, on 2026-02-12. Its official title is “Jeremy Spencer Brown: Final Debarment Order,” and PeptideScanner's exact reviewed identity mapping connects the document to Semaglutide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT05320406

PeptideScanner retained ClinicalTrials.gov record NCT05320406 at 2026-07-30T16:23:45.670Z. Its registry update date was 2026-02-12, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT06517212

PeptideScanner retained ClinicalTrials.gov record NCT06517212 at 2026-07-30T16:23:45.659Z. Its registry update date was 2026-02-12, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Setmelanotide

ClinicalTrials.gov record NCT06772597

PeptideScanner retained ClinicalTrials.gov record NCT06772597 at 2026-07-30T16:23:45.672Z. Its registry update date was 2026-02-12, and PeptideScanner's reviewed identity mapping was setmelanotide.

Added August 8, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Survodutide

PubMed record PMID 41424209

PeptideScanner retained PubMed bibliographic metadata for PMID 41424209 at 2026-07-30T16:25:14.150Z. PubMed recorded a metadata revision date of 2026-02-10 and an Entrez history date of 2025-12-22. PeptideScanner associated this retained record with the identity slug survodutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT06939088

PeptideScanner retained ClinicalTrials.gov record NCT06939088 at 2026-07-30T16:23:45.670Z. Its registry update date was 2026-02-10, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT03879694

PeptideScanner retained ClinicalTrials.gov record NCT03879694 at 2026-07-30T16:23:45.670Z. Its registry update date was 2026-02-06, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 8, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT03902951

PeptideScanner retained ClinicalTrials.gov record NCT03902951 at 2026-07-30T16:23:45.660Z. Its registry update date was 2026-02-05, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT04455750

PeptideScanner retained ClinicalTrials.gov record NCT04455750 at 2026-07-30T16:23:45.647Z. Its registry update date was 2026-02-05, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · MOTS-c

Exercise, Mitohormesis, and Mitochondrial ORF of the 12S rRNA Type-C (MOTS-c).

PubMed lists PMID 35656563 in Diabetes & metabolism journal as Journal Article, Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2022-05-25 (day precision). PeptideScanner associated the retained record with the identity slug mots-c. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Lixisenatide

PubMed record PMID 41623754

PeptideScanner retained PubMed bibliographic metadata for PMID 41623754 at 2026-07-30T16:25:14.225Z. PubMed recorded a metadata revision date of 2026-02-04 and an Entrez history date of 2026-02-02. PeptideScanner associated this retained record with the identity slug lixisenatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Plecanatide

PubMed record PMID 41625188

PeptideScanner retained PubMed bibliographic metadata for PMID 41625188 at 2026-07-30T16:25:14.231Z. PubMed recorded a metadata revision date of 2026-02-04 and an Entrez history date of 2026-02-02. PeptideScanner associated this retained record with the identity slug plecanatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Plecanatide

PubMed record PMID 41625190

PeptideScanner retained PubMed bibliographic metadata for PMID 41625190 at 2026-07-30T16:25:14.232Z. PubMed recorded a metadata revision date of 2026-02-04 and an Entrez history date of 2026-02-02. PeptideScanner associated this retained record with the identity slug plecanatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Clinical trials · Glucagon

ClinicalTrials.gov record NCT07366710

PeptideScanner retained ClinicalTrials.gov record NCT07366710 at 2026-07-30T16:23:45.659Z. Its registry update date was 2026-02-02, and PeptideScanner's reviewed identity mapping was glucagon.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · BPC-157

Tracheocutaneous Fistula Resolved by Pentadecapeptide BPC 157 Therapy Through the NO-System-Triple NO-Agent Approach in Rats.

PubMed lists PMID 41599743 in Pharmaceuticals (Basel, Switzerland) as Journal Article, with publication-date metadata of 2026-01-14 (day precision). PeptideScanner associated the retained record with the identity slug bpc-157. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · BPC-157

Fourier Transform Infrared Spectroscopic Characterization of Aortic Wall Remodeling by Stable Gastric Pentadecapeptide BPC 157 After Unilateral Adrenalectomy in Rats.

PubMed lists PMID 41599787 in Pharmaceuticals (Basel, Switzerland) as Journal Article, with publication-date metadata of 2026-01-22 (day precision). PeptideScanner associated the retained record with the identity slug bpc-157. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Setmelanotide

PubMed record PMID 41601974

PeptideScanner retained PubMed bibliographic metadata for PMID 41601974 at 2026-07-30T16:31:25.541Z. PubMed recorded a metadata revision date of 2026-01-31 and an Entrez history date of 2026-01-28. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Exenatide

The use of exenatide in severely burned pediatric patients.

PubMed lists PMID 20701787 in Critical care (London, England) as Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S., with publication-date metadata of 2010-08-11 (day precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT06914102

PeptideScanner retained ClinicalTrials.gov record NCT06914102 at 2026-07-30T16:25:18.004Z. Its registry update date was 2026-01-30, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT06914154

PeptideScanner retained ClinicalTrials.gov record NCT06914154 at 2026-07-30T16:25:18.014Z. Its registry update date was 2026-01-30, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT04251156

PeptideScanner retained ClinicalTrials.gov record NCT04251156 at 2026-07-30T16:25:18.009Z. Its registry update date was 2026-01-29, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07364175

PeptideScanner retained ClinicalTrials.gov record NCT07364175 at 2026-07-30T16:25:18.007Z. Its registry update date was 2026-01-29, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Lanreotide

Four-year follow-up of acromegalic patients treated with the new long-acting formulation of Lanreotide (Lanreotide Autogel).

PubMed lists PMID 15789272 in Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association as Journal Article, with publication-date metadata of 2005-03 (month precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Exenatide

Pharmacology of exenatide (synthetic exendin-4) for the treatment of type 2 diabetes.

PubMed lists PMID 12808878 in Current opinion in investigational drugs (London, England : 2000) as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2003-04 (month precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Ziconotide

Intrathecal ziconotide for refractory pain.

PubMed lists PMID 15212625 in Expert opinion on investigational drugs as Clinical Trial, Controlled Clinical Trial, Journal Article, Review, with publication-date metadata of 2004-07 (month precision). PeptideScanner associated the retained record with the identity slug ziconotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Ziconotide

Intrathecal ziconotide for chronic pain.

PubMed lists PMID 15479926 in JAMA as Letter, Comment, with publication-date metadata of 2004-10-13 (day precision). PeptideScanner associated the retained record with the identity slug ziconotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Ziconotide

Ziconotide: can we use it in palliative care?

PubMed lists PMID 16225359 in The American journal of hospice & palliative care as Journal Article, Review, with publication-date metadata of 2005 Sep-Oct (source-text precision). PeptideScanner associated the retained record with the identity slug ziconotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Ziconotide

Elan: ziconotide review focused on off-label uses.

PubMed lists PMID 16323709 in The American journal of hospice & palliative care as Letter, Comment, with publication-date metadata of 2005 Nov-Dec (source-text precision). PeptideScanner associated the retained record with the identity slug ziconotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Ziconotide

Ziconotide.

PubMed lists PMID 16599651 in CNS drugs as Evaluation Study, Journal Article, with publication-date metadata of 2006 (year precision). PeptideScanner associated the retained record with the identity slug ziconotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Ziconotide

Treatment challenges and complications with ziconotide monotherapy in established pump patients.

PubMed lists PMID 16703976 in Pain physician as Case Reports, Comparative Study, Journal Article, with publication-date metadata of 2006-04 (month precision). PeptideScanner associated the retained record with the identity slug ziconotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Ziconotide

Intrathecal ziconotide for refractory chronic pain.

PubMed lists PMID 16849624 in The Annals of pharmacotherapy as Journal Article, Review, with publication-date metadata of 2006-07-18 (day precision). PeptideScanner associated the retained record with the identity slug ziconotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Pramlintide

Adjunctive therapy with pramlintide in patients with type 1 or type 2 diabetes mellitus.

PubMed lists PMID 17064208 in Pharmacotherapy as Journal Article, Review, with publication-date metadata of 2006-11 (month precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Exenatide

Summaries for patients. Exenatide therapy for type 2 diabetes.

PubMed lists PMID 17404346 in Annals of internal medicine as Journal Article, Patient Education Handout, with publication-date metadata of 2007-04-03 (day precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Exenatide

Exploring the substitution of exenatide for insulin in patients with type 2 diabetes treated with insulin in combination with oral antidiabetes agents.

PubMed lists PMID 17595353 in Diabetes care as Journal Article, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 2007-06-26 (day precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Pramlintide

Assessing treatment satisfaction in patients treated with pramlintide as an adjunct to insulin therapy.

PubMed lists PMID 17624233 in Current medical research and opinion as Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't, with publication-date metadata of 2007-08 (month precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Exenatide

The incretin mimetic exenatide as a monotherapy in patients with type 2 diabetes.

PubMed lists PMID 17705687 in Diabetes technology & therapeutics as Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2007-08 (month precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Exenatide

Exenatide therapy in obese patients with type 2 diabetes mellitus treated with insulin.

PubMed lists PMID 17872344 in Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists as Journal Article, with publication-date metadata of 2007-09 (month precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Pramlintide

Clinical experience with the addition of pramlintide in patients with insulin-requiring type 2 diabetes.

PubMed lists PMID 17909093 in Diabetes care as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2007-10-01 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Exenatide

Exenatide: new drug. Type 2 diabetes for some overweight patients.

PubMed lists PMID 18087791 in Prescrire international as Journal Article, with publication-date metadata of 2007-12 (month precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Semax

Therapeutic possibility of "Semax" for depression.

PubMed lists PMID 18204410 in CNS spectrums as Letter, Research Support, Non-U.S. Gov't, with publication-date metadata of 2008-01 (month precision). PeptideScanner associated the retained record with the identity slug semax. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Exenatide

Exenatide and pancreatitis: an update.

PubMed lists PMID 18983211 in Expert opinion on drug safety as Editorial, with publication-date metadata of 2008-11 (month precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Exenatide

Exenatide for type 2 diabetes.

PubMed lists PMID 19135608 in Lancet (London, England) as Letter, Comment, with publication-date metadata of 2009-01-10 (day precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Exenatide

Comparison of costs among patients with type 2 diabetes treated with exenatide or sitagliptin therapy.

PubMed lists PMID 19219409 in Advances in therapy as Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2009-02-14 (day precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Pramlintide

Continuous subcutaneous pramlintide infusion therapy in patients with type 1 diabetes: observations from a pilot study.

PubMed lists PMID 19546056 in Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists as Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2009 Nov-Dec (source-text precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Exenatide

Exenatide added to insulin therapy: a retrospective review of clinical practice over two years in an academic endocrinology outpatient setting.

PubMed lists PMID 19695400 in Clinical therapeutics as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2009-07 (month precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Exenatide

The European Exenatide study of long-term exenatide vs. glimepiride for type 2 diabetes: rationale and patient characteristics.

PubMed lists PMID 19758357 in Diabetes, obesity & metabolism as Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't, with publication-date metadata of 2009-09-16 (day precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Pramlintide

A pilot trial of pramlintide home usage in adolescents with type 1 diabetes.

PubMed lists PMID 19858155 in Pediatrics as Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Extramural, with publication-date metadata of 2009-10-26 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Exenatide

Clinical experience with exenatide in a routine secondary care diabetes clinic.

PubMed lists PMID 20022310 in Primary care diabetes as Journal Article, with publication-date metadata of 2010-04 (month precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Ziconotide

Considerations and methodology for trialing ziconotide.

PubMed lists PMID 20119460 in Pain physician as Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2010 Jan-Feb (source-text precision). PeptideScanner associated the retained record with the identity slug ziconotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Exenatide

Exenatide versus glibenclamide in patients with diabetes.

PubMed lists PMID 20151774 in Diabetes technology & therapeutics as Journal Article, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 2010-03 (month precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Exenatide

[The influence of 6-months treatment with exenatide on type 2 diabetes mellitus compensation, anthropometric and biochemical parameters].

PubMed lists PMID 20184107 in Vnitrni lekarstvi as Clinical Trial, Journal Article, with publication-date metadata of 2010-01 (month precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · BPC-157

Abdominal aorta anastomosis in rats and stable gastric pentadecapeptide BPC 157, prophylaxis and therapy.

PubMed lists PMID 20388960 in Journal of physiology and pharmacology : an official journal of the Polish Physiological Society as Comparative Study, Journal Article, with publication-date metadata of 2009-12 (month precision). PeptideScanner associated the retained record with the identity slug bpc-157. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Ziconotide

Ziconotide for treatment of severe chronic pain.

PubMed lists PMID 20413151 in Lancet (London, England) as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2010-04-21 (day precision). PeptideScanner associated the retained record with the identity slug ziconotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Exenatide

[Sequential treatment with insulin glargine and metformin, and exenatide in a patient with newly diagnosed type-2 diabetes].

PubMed lists PMID 20425675 in Deutsche medizinische Wochenschrift (1946) as Case Reports, Journal Article, with publication-date metadata of 2010-04-27 (day precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Ziconotide

[Recommendations for the management of chronic pain by intrathecal ziconotide].

PubMed lists PMID 21595155 in MMW Fortschritte der Medizin as Journal Article, with publication-date metadata of 2010-10-14 (day precision). PeptideScanner associated the retained record with the identity slug ziconotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Ziconotide

[Experience in treatment of patients with neuropathic facial pain using ziconotide].

PubMed lists PMID 21818721 in Schmerz (Berlin, Germany) as Case Reports, Journal Article, with publication-date metadata of 2011-08 (month precision). PeptideScanner associated the retained record with the identity slug ziconotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Exenatide

Combination exenatide-sitagliptin therapy used with glipizide in a patient with type 2 diabetes mellitus.

PubMed lists PMID 22644981 in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists as Case Reports, Journal Article, with publication-date metadata of 2012-06-15 (day precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Exenatide

Expenditures for medicaid patients treated with exenatide compared with other diabetes management regimens.

PubMed lists PMID 23039898 in The American journal of managed care as Comparative Study, Journal Article, with publication-date metadata of 2012-09 (month precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Linaclotide

Linaclotide (Linzess) for constipation.

PubMed lists PMID 23183319 in The Medical letter on drugs and therapeutics as Journal Article, with publication-date metadata of 2012-11-12 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Linaclotide

An evaluation of the FDA responder endpoint for IBS-C clinical trials: analysis of data from linaclotide Phase 3 clinical trials.

PubMed lists PMID 23384406 in Neurogastroenterology and motility as Clinical Trial, Phase III, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2013-02-06 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Epitalon

PubMed record PMID 12209581

PeptideScanner retained PubMed bibliographic metadata for PMID 12209581 at 2026-07-30T16:30:44.156Z. PubMed recorded a metadata revision date of 2026-01-28 and an Entrez history date of 2002-09-05. PeptideScanner associated this retained record with the identity slug epitalon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Tesamorelin

PubMed record PMID 17571443

PeptideScanner retained PubMed bibliographic metadata for PMID 17571443 at 2026-07-30T16:30:45.652Z. PubMed recorded a metadata revision date of 2026-01-28 and an Entrez history date of 2007-06-19. PeptideScanner associated this retained record with the identity slug tesamorelin. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Tesamorelin

PubMed record PMID 21115997

PeptideScanner retained PubMed bibliographic metadata for PMID 21115997 at 2026-07-30T16:30:48.398Z. PubMed recorded a metadata revision date of 2026-01-28 and an Entrez history date of 2010-12-01. PeptideScanner associated this retained record with the identity slug tesamorelin. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Tesamorelin

PubMed record PMID 21591600

PeptideScanner retained PubMed bibliographic metadata for PMID 21591600 at 2026-07-30T16:30:48.420Z. PubMed recorded a metadata revision date of 2026-01-28 and an Entrez history date of 2011-05-20. PeptideScanner associated this retained record with the identity slug tesamorelin. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Lixisenatide

PubMed record PMID 25012990

PeptideScanner retained PubMed bibliographic metadata for PMID 25012990 at 2026-07-30T16:30:52.644Z. PubMed recorded a metadata revision date of 2026-01-28 and an Entrez history date of 2014-07-12. PeptideScanner associated this retained record with the identity slug lixisenatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Lixisenatide

PubMed record PMID 25055456

PeptideScanner retained PubMed bibliographic metadata for PMID 25055456 at 2026-07-30T16:30:52.649Z. PubMed recorded a metadata revision date of 2026-01-28 and an Entrez history date of 2014-07-25. PeptideScanner associated this retained record with the identity slug lixisenatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Lixisenatide

PubMed record PMID 25115916

PeptideScanner retained PubMed bibliographic metadata for PMID 25115916 at 2026-07-30T16:30:52.653Z. PubMed recorded a metadata revision date of 2026-01-28 and an Entrez history date of 2014-08-14. PeptideScanner associated this retained record with the identity slug lixisenatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Lixisenatide

PubMed record PMID 25130920

PeptideScanner retained PubMed bibliographic metadata for PMID 25130920 at 2026-07-30T16:30:52.654Z. PubMed recorded a metadata revision date of 2026-01-28 and an Entrez history date of 2014-08-19. PeptideScanner associated this retained record with the identity slug lixisenatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Afamelanotide

PubMed record PMID 25494545

PeptideScanner retained PubMed bibliographic metadata for PMID 25494545 at 2026-07-30T16:30:52.686Z. PubMed recorded a metadata revision date of 2026-01-28 and an Entrez history date of 2014-12-16. PeptideScanner associated this retained record with the identity slug afamelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Lixisenatide

PubMed record PMID 26039935

PeptideScanner retained PubMed bibliographic metadata for PMID 26039935 at 2026-07-30T16:30:54.214Z. PubMed recorded a metadata revision date of 2026-01-28 and an Entrez history date of 2015-06-04. PeptideScanner associated this retained record with the identity slug lixisenatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Lixisenatide

PubMed record PMID 26423184

PeptideScanner retained PubMed bibliographic metadata for PMID 26423184 at 2026-07-30T16:30:54.263Z. PubMed recorded a metadata revision date of 2026-01-28 and an Entrez history date of 2015-10-02. PeptideScanner associated this retained record with the identity slug lixisenatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · TB-500

PubMed record PMID 22962027

PeptideScanner retained PubMed bibliographic metadata for PMID 22962027 at 2026-07-30T16:30:49.822Z. PubMed recorded a metadata revision date of 2026-01-28 and an Entrez history date of 2012-09-11. PeptideScanner associated this retained record with the identity slug tb-500. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · TB-500

PubMed record PMID 23084823

PeptideScanner retained PubMed bibliographic metadata for PMID 23084823 at 2026-07-30T16:30:49.836Z. PubMed recorded a metadata revision date of 2026-01-28 and an Entrez history date of 2012-10-23. PeptideScanner associated this retained record with the identity slug tb-500. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT04734730

PeptideScanner retained ClinicalTrials.gov record NCT04734730 at 2026-07-30T16:25:18.017Z. Its registry update date was 2026-01-28, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07373834

PeptideScanner retained ClinicalTrials.gov record NCT07373834 at 2026-07-30T16:25:18.006Z. Its registry update date was 2026-01-28, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Linaclotide

Economic Evaluation of Linaclotide for the Treatment of Adult Patients With Chronic Idiopathic Constipation in the United States.

PubMed lists PMID 27008836 in Managed care (Langhorne, Pa.) as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2016-02 (month precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Setmelanotide

Magel2-null mice are hyper-responsive to setmelanotide, a melanocortin 4 receptor agonist.

PubMed lists PMID 27339818 in British journal of pharmacology as Journal Article, with publication-date metadata of 2016-07-27 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Lixisenatide

Insulin degludec, Lixisenatide, and Patiromer sorbitex calcium.

PubMed lists PMID 27836130 in Journal of the American Pharmacists Association : JAPhA as Journal Article, with publication-date metadata of 2016 Nov-Dec (source-text precision). PeptideScanner associated the retained record with the identity slug lixisenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Lixisenatide

Lixisenatide for type 2 diabetes.

PubMed lists PMID 28118649 in The Medical letter on drugs and therapeutics as Journal Article, Review, with publication-date metadata of 2017-01-30 (day precision). PeptideScanner associated the retained record with the identity slug lixisenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Abaloparatide

Abaloparatide: First Global Approval.

PubMed lists PMID 28624872 in Drugs as Journal Article, with publication-date metadata of 2017-08 (month precision). PeptideScanner associated the retained record with the identity slug abaloparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Lixisenatide

Lixisenatide (Adlyxin) for Type 2 Diabetes Mellitus.

PubMed lists PMID 28925668 in American family physician as Journal Article, with publication-date metadata of 2017-08-15 (day precision). PeptideScanner associated the retained record with the identity slug lixisenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Dulaglutide

Dulaglutide (Trulicity) for Type 2 Diabetes Mellitus.

PubMed lists PMID 29094890 in American family physician as Journal Article, with publication-date metadata of 2017-10-15 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Linaclotide

Health Care Resource Use and Costs Pre- and Post-Treatment Initiation With Linaclotide: Retrospective Analyses of a U.S. Insured Population.

PubMed lists PMID 29451468 in Managed care (Langhorne, Pa.) as Journal Article, with publication-date metadata of 2018-02 (month precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Ziconotide

Validated chromatographic method for the simultaneous determination of eight drugs (morphine, ropivacaine, bupivacaine, baclofen, clonidine, sufentanil, fentanyl and ziconotide) for intrathecal analg…

PubMed lists PMID 29478715 in Annales pharmaceutiques francaises as Journal Article, Validation Study, with publication-date metadata of 2018-02-23 (day precision). PeptideScanner associated the retained record with the identity slug ziconotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Dulaglutide

Largest single-centre experience of dulaglutide for management of diabetes mellitus in solid organ transplant recipients.

PubMed lists PMID 30565376 in Diabetes, obesity & metabolism as Journal Article, with publication-date metadata of 2019-01-20 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Lixisenatide

Glycaemic target attainment in people with Type 2 diabetes treated with insulin glargine/lixisenatide fixed-ratio combination: a post hoc analysis of the LixiLan-O and LixiLan-L trials.

PubMed lists PMID 31365765 in Diabetic medicine : a journal of the British Diabetic Association as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2019-11-26 (day precision). PeptideScanner associated the retained record with the identity slug lixisenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Lixisenatide

Lixisenatide versus insulin glulisine on top of insulin glargine in patients with type 2 diabetes mellitus: a cost-per-responder analysis in China.

PubMed lists PMID 31469303 in Current medical research and opinion as Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2019-09-11 (day precision). PeptideScanner associated the retained record with the identity slug lixisenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Lixisenatide

Mexican population sub-analysis of the lixilan clinical program with the fixed ratio combination of insulin glargine and lixisenatide (iGlarLixi).

PubMed lists PMID 32561160 in Journal of diabetes and its complications as Clinical Trial, Phase II, Clinical Trial, Phase III, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2019-05-31 (day precision). PeptideScanner associated the retained record with the identity slug lixisenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Lixisenatide

Insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi) compared with premix or addition of meal-time insulin to basal insulin in people with type 2 diabetes: A systematic review and Bayesi…

PubMed lists PMID 32700442 in Diabetes, obesity & metabolism as Journal Article, Research Support, Non-U.S. Gov't, Systematic Review, Network Meta-Analysis, with publication-date metadata of 2020-09-03 (day precision). PeptideScanner associated the retained record with the identity slug lixisenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Dulaglutide

A case report on use of dulaglutide during the first weeks of pregnancy in woman affected by type 2 diabetes mellitus.

PubMed lists PMID 36136154 in Acta diabetologica as Case Reports, Journal Article, with publication-date metadata of 2022-09-22 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · MOTS-c

Circulating levels of MOTS-c in patients with breast cancer treated with metformin.

PubMed lists PMID 36490309 in Aging as Randomized Controlled Trial, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2022-12-06 (day precision). PeptideScanner associated the retained record with the identity slug mots-c. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · MOTS-c

Evaluation of Serum Humanin and MOTS-c Peptide Levels in Patients with COVID-19 and Healthy Subjects.

PubMed lists PMID 36799414 in Current protein & peptide science as Journal Article, with publication-date metadata of 2023 (year precision). PeptideScanner associated the retained record with the identity slug mots-c. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Elamipretide

Identifying responders to elamipretide in Barth syndrome: Hierarchical clustering for time series data.

PubMed lists PMID 37041653 in Orphanet journal of rare diseases as Randomized Controlled Trial, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2023-04-11 (day precision). PeptideScanner associated the retained record with the identity slug elamipretide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Elamipretide

Temporal evolution of the heart failure phenotype in Barth syndrome and treatment with elamipretide.

PubMed lists PMID 37325898 in Future cardiology as Journal Article, Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2023-06-16 (day precision). PeptideScanner associated the retained record with the identity slug elamipretide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Linaclotide

Characterization of disulfide bridges containing cyclic peptide Linaclotide and its degradation products by using LC-HRMS/MS.

PubMed lists PMID 39427438 in Journal of pharmaceutical and biomedical analysis as Journal Article, with publication-date metadata of 2024-10-17 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · MOTS-c

Evaluation of vascular peroxidase 1, humanin, MOTS-c and miR-200c expression levels in untreated preeclampsia patients.

PubMed lists PMID 39704971 in Molecular biology reports as Journal Article, with publication-date metadata of 2024-12-20 (day precision). PeptideScanner associated the retained record with the identity slug mots-c. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Plecanatide

PubMed record PMID 28255961

PeptideScanner retained PubMed bibliographic metadata for PMID 28255961 at 2026-07-30T16:30:57.042Z. PubMed recorded a metadata revision date of 2026-01-27 and an Entrez history date of 2017-03-04. PeptideScanner associated this retained record with the identity slug plecanatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · GHK-Cu

PubMed record PMID 37062921

PeptideScanner retained PubMed bibliographic metadata for PMID 37062921 at 2026-07-30T16:31:12.094Z. PubMed recorded a metadata revision date of 2026-01-27 and an Entrez history date of 2023-04-17. PeptideScanner associated this retained record with the identity slug ghk-cu. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Retatrutide

PubMed record PMID 39868848

PeptideScanner retained PubMed bibliographic metadata for PMID 39868848 at 2026-07-30T16:31:18.163Z. PubMed recorded a metadata revision date of 2026-01-27 and an Entrez history date of 2025-01-27. PeptideScanner associated this retained record with the identity slug retatrutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Plecanatide

PubMed record PMID 38594429

PeptideScanner retained PubMed bibliographic metadata for PMID 38594429 at 2026-07-30T16:31:15.180Z. PubMed recorded a metadata revision date of 2026-01-27 and an Entrez history date of 2024-04-09. PeptideScanner associated this retained record with the identity slug plecanatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT06445075

PeptideScanner retained ClinicalTrials.gov record NCT06445075 at 2026-07-30T16:25:18.017Z. Its registry update date was 2026-01-23, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Maridebart cafraglutide

ClinicalTrials.gov record NCT07229157

PeptideScanner retained ClinicalTrials.gov record NCT07229157 at 2026-07-30T16:25:18.016Z. Its registry update date was 2026-01-23, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT05788965

PeptideScanner retained ClinicalTrials.gov record NCT05788965 at 2026-07-30T16:25:18.013Z. Its registry update date was 2026-01-21, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07242534

PeptideScanner retained ClinicalTrials.gov record NCT07242534 at 2026-07-30T16:25:18.005Z. Its registry update date was 2026-01-21, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Vosoritide

ClinicalTrials.gov record NCT06455059

PeptideScanner retained ClinicalTrials.gov record NCT06455059 at 2026-07-30T16:25:18.005Z. Its registry update date was 2026-01-20, and PeptideScanner's reviewed identity mapping was vosoritide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Afamelanotide

From darkness to light: Case report on afamelanotide-treatment in a 9-year-old child with erythropoietic protoporphyria.

PubMed lists PMID 41542313 in JAAD case reports as Case Reports, Journal Article, with publication-date metadata of 2025-11-24 (day precision). PeptideScanner associated the retained record with the identity slug afamelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Regulatory · Liraglutide

Drugs@FDA application ANDA217590

The official Drugs@FDA dataset lists original submission 1 for ANDA 217590 with status AP dated 2026-01-14, and names liraglutide among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Literature metadata · Elamipretide

Elamipretide: The first cardiolipin-directed mitochondrial therapeutic for Barth syndrome approved under accelerated approval.

PubMed lists PMID 41260682 in Drug discoveries & therapeutics as Letter, with publication-date metadata of 2025-11-20 (day precision). PeptideScanner associated the retained record with the identity slug elamipretide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT06852391

PeptideScanner retained ClinicalTrials.gov record NCT06852391 at 2026-07-30T16:25:18.005Z. Its registry update date was 2026-01-14, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT06042153

PeptideScanner retained ClinicalTrials.gov record NCT06042153 at 2026-07-30T16:25:18.002Z. Its registry update date was 2026-01-13, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT06802081

PeptideScanner retained ClinicalTrials.gov record NCT06802081 at 2026-07-30T16:25:18.015Z. Its registry update date was 2026-01-13, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT05866029

PeptideScanner retained ClinicalTrials.gov record NCT05866029 at 2026-07-30T16:25:18.004Z. Its registry update date was 2026-01-12, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT06283641

PeptideScanner retained ClinicalTrials.gov record NCT06283641 at 2026-07-30T16:25:18.013Z. Its registry update date was 2026-01-09, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Cagrilintide

PubMed record PMID 40847076

PeptideScanner retained PubMed bibliographic metadata for PMID 40847076 at 2026-07-30T16:31:19.891Z. PubMed recorded a metadata revision date of 2026-01-06 and an Entrez history date of 2025-08-22. PeptideScanner associated this retained record with the identity slug cagrilintide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Dulaglutide

Production of a Dulaglutide Analogue by Apoptosis-Resistant Chinese Hamster Ovary Cells in a 3-Week Fed-Batch Process.

PubMed lists PMID 41471386 in Pharmaceuticals (Basel, Switzerland) as Journal Article, with publication-date metadata of 2025-12-16 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Plecanatide

ClinicalTrials.gov record NCT03596905

PeptideScanner retained ClinicalTrials.gov record NCT03596905 at 2026-07-30T18:18:33.534Z. Its registry update date was 2025-12-31, and PeptideScanner's reviewed identity mapping was plecanatide.

Added August 14, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Emideltide

Immunohistochemical distribution of DSIP immunoreactivity in the human hypothalamus during the first postnatal year. A preliminary report.

PubMed lists PMID 11321250 in Folia biologica as Journal Article, with publication-date metadata of 2001 (year precision). PeptideScanner associated the retained record with the identity slug emideltide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT03809000

PeptideScanner retained ClinicalTrials.gov record NCT03809000 at 2026-07-30T18:18:33.523Z. Its registry update date was 2025-12-30, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT05702931

PeptideScanner retained ClinicalTrials.gov record NCT05702931 at 2026-07-30T18:18:33.515Z. Its registry update date was 2025-12-29, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Glucagon

ClinicalTrials.gov record NCT06921824

PeptideScanner retained ClinicalTrials.gov record NCT06921824 at 2026-07-30T18:18:33.507Z. Its registry update date was 2025-12-24, and PeptideScanner's reviewed identity mapping was glucagon.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Glucagon

ClinicalTrials.gov record NCT07300982

PeptideScanner retained ClinicalTrials.gov record NCT07300982 at 2026-07-30T18:18:33.509Z. Its registry update date was 2025-12-24, and PeptideScanner's reviewed identity mapping was glucagon.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07128082

PeptideScanner retained ClinicalTrials.gov record NCT07128082 at 2026-07-30T18:18:33.504Z. Its registry update date was 2025-12-23, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Semaglutide

Drugs@FDA application NDA218316

The official Drugs@FDA dataset lists original submission 1 for NDA 218316 with status AP dated 2025-12-22, and names semaglutide among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT07262957

PeptideScanner retained ClinicalTrials.gov record NCT07262957 at 2026-07-30T18:18:33.513Z. Its registry update date was 2025-12-22, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Elamipretide

Federal Register notice 2025-23409

The Federal Register published notice 2025-23409, attributed to FDA and its parent HHS department, on 2025-12-19. Its official title is “Issuance of Priority Review Voucher; Rare Pediatric Disease Product; FORZINITY (Elamipretide),” and PeptideScanner's exact reviewed identity mapping connects the document to Elamipretide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07265752

PeptideScanner retained ClinicalTrials.gov record NCT07265752 at 2026-07-30T18:18:33.524Z. Its registry update date was 2025-12-18, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07292519

PeptideScanner retained ClinicalTrials.gov record NCT07292519 at 2026-07-30T18:18:33.513Z. Its registry update date was 2025-12-18, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT05891587

PeptideScanner retained ClinicalTrials.gov record NCT05891587 at 2026-07-30T18:18:33.508Z. Its registry update date was 2025-12-17, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Maridebart cafraglutide

ClinicalTrials.gov record NCT06987695

PeptideScanner retained ClinicalTrials.gov record NCT06987695 at 2026-07-30T18:18:33.507Z. Its registry update date was 2025-12-17, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT07029009

PeptideScanner retained ClinicalTrials.gov record NCT07029009 at 2026-07-30T18:18:33.514Z. Its registry update date was 2025-12-17, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07176663

PeptideScanner retained ClinicalTrials.gov record NCT07176663 at 2026-07-30T18:18:33.508Z. Its registry update date was 2025-12-15, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Teriparatide

Drugs@FDA application ANDA213641

The official Drugs@FDA dataset lists original submission 1 for ANDA 213641 with status AP dated 2025-12-12, and names teriparatide among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Regulatory · Octreotide

Drugs@FDA application ANDA216589

The official Drugs@FDA dataset lists original submission 1 for ANDA 216589 with status AP dated 2025-12-12, and names octreotide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07280221

PeptideScanner retained ClinicalTrials.gov record NCT07280221 at 2026-07-30T18:18:33.524Z. Its registry update date was 2025-12-12, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Elamipretide

ClinicalTrials.gov record NCT05168774

PeptideScanner retained ClinicalTrials.gov record NCT05168774 at 2026-07-30T18:18:33.506Z. Its registry update date was 2025-12-12, and PeptideScanner's reviewed identity mapping was elamipretide.

Added August 8, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT04102189

PeptideScanner retained ClinicalTrials.gov record NCT04102189 at 2026-07-30T18:18:33.504Z. Its registry update date was 2025-12-11, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Vosoritide

Three-dimensional craniofacial imaging in children with achondroplasia treated with vosoritide.

PubMed lists PMID 41340868 in Genetics in medicine open as Journal Article, with publication-date metadata of 2025-10-13 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Regulatory · Glucagon + 5 more

Federal Register notice 2025-22131

The Federal Register published notice 2025-22131, attributed to FDA and its parent HHS department, on 2025-12-05. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Glucagon, Liraglutide, Semaglutide, Teriparatide, Tirzepatide and Vosoritide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT00001481

PeptideScanner retained ClinicalTrials.gov record NCT00001481 at 2026-07-30T18:18:33.509Z. Its registry update date was 2025-12-05, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT04788511

PeptideScanner retained ClinicalTrials.gov record NCT04788511 at 2026-07-30T18:18:33.488Z. Its registry update date was 2025-12-05, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT05189457

PeptideScanner retained ClinicalTrials.gov record NCT05189457 at 2026-07-30T18:18:33.510Z. Its registry update date was 2025-12-04, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Maridebart cafraglutide

PubMed record PMID 41337724

PeptideScanner retained PubMed bibliographic metadata for PMID 41337724 at 2026-07-30T18:19:18.413Z. PubMed recorded a metadata revision date of 2025-12-03 and an Entrez history date of 2025-12-03. PeptideScanner associated this retained record with the identity slug maridebart-cafraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT01225055

PeptideScanner retained ClinicalTrials.gov record NCT01225055 at 2026-07-30T18:18:33.512Z. Its registry update date was 2025-12-02, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Lixisenatide

ClinicalTrials.gov record NCT03439943

PeptideScanner retained ClinicalTrials.gov record NCT03439943 at 2026-07-30T18:19:48.216Z. Its registry update date was 2025-11-28, and PeptideScanner's reviewed identity mapping was lixisenatide.

Added August 8, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT02023463

PeptideScanner retained ClinicalTrials.gov record NCT02023463 at 2026-07-30T18:19:48.219Z. Its registry update date was 2025-11-25, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Glucagon + 1 more

Federal Register notice 2025-20548

The Federal Register published notice 2025-20548, attributed to FDA and its parent HHS department, on 2025-11-21. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Glucagon and Tirzepatide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Literature metadata · Vosoritide

Thanatophoric Dysplasia Type 1 Treated with Vosoritide: A Case Report.

PubMed lists PMID 41078071 in Hormone research in paediatrics as Case Reports, Journal Article, with publication-date metadata of 2025-10-10 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT07242612

PeptideScanner retained ClinicalTrials.gov record NCT07242612 at 2026-07-30T18:19:48.219Z. Its registry update date was 2025-11-21, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tesamorelin

ClinicalTrials.gov record NCT03375788

PeptideScanner retained ClinicalTrials.gov record NCT03375788 at 2026-07-30T18:19:48.220Z. Its registry update date was 2025-11-20, and PeptideScanner's reviewed identity mapping was tesamorelin.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07239570

PeptideScanner retained ClinicalTrials.gov record NCT07239570 at 2026-07-30T18:19:48.218Z. Its registry update date was 2025-11-20, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Setmelanotide

Carbocyclic setmelanotide analogs maintain biochemical potency at melanocortin 4 receptors.

PubMed lists PMID 39394922 in Journal of peptide science : an official publication of the European Peptide Society as Journal Article, with publication-date metadata of 2024-10-12 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Elamipretide

Elamipretide in the Management of Barth Syndrome: Current Evidence and a Case Report.

PubMed lists PMID 40816230 in Molecular genetics and metabolism as Journal Article, Case Reports, Review, with publication-date metadata of 2025-08-11 (day precision). PeptideScanner associated the retained record with the identity slug elamipretide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT06499857

PeptideScanner retained ClinicalTrials.gov record NCT06499857 at 2026-07-30T18:19:48.219Z. Its registry update date was 2025-11-14, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Leuprolide

Drugs@FDA application ANDA215826

The official Drugs@FDA dataset lists original submission 1 for ANDA 215826 with status AP dated 2025-11-13, and names leuprolide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Clinical trials · Tesamorelin

ClinicalTrials.gov record NCT03150511

PeptideScanner retained ClinicalTrials.gov record NCT03150511 at 2026-07-30T18:19:48.216Z. Its registry update date was 2025-11-12, and PeptideScanner's reviewed identity mapping was tesamorelin.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT06446531

PeptideScanner retained ClinicalTrials.gov record NCT06446531 at 2026-07-30T18:19:48.219Z. Its registry update date was 2025-11-12, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Afamelanotide

Afamelanotide in managing cutaneous phototoxicity in erythropoietic protoporphyria: a Scottish perspective.

PubMed lists PMID 40692281 in Clinical and experimental dermatology as Journal Article, with publication-date metadata of 2025-10-27 (day precision). PeptideScanner associated the retained record with the identity slug afamelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Elamipretide

ClinicalTrials.gov record NCT05162768

PeptideScanner retained ClinicalTrials.gov record NCT05162768 at 2026-07-30T18:20:54.428Z. Its registry update date was 2025-10-24, and PeptideScanner's reviewed identity mapping was elamipretide.

Added August 8, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT06994338

PeptideScanner retained ClinicalTrials.gov record NCT06994338 at 2026-07-30T18:20:54.428Z. Its registry update date was 2025-10-14, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT00262470

PeptideScanner retained ClinicalTrials.gov record NCT00262470 at 2026-07-30T18:20:54.428Z. Its registry update date was 2025-10-08, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Glucagon

ClinicalTrials.gov record NCT06872060

PeptideScanner retained ClinicalTrials.gov record NCT06872060 at 2026-07-30T18:20:54.427Z. Its registry update date was 2025-10-03, and PeptideScanner's reviewed identity mapping was glucagon.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Exenatide + 1 more

Federal Register notice 2025-19281

The Federal Register published notice 2025-19281, attributed to FDA and its parent HHS department, on 2025-10-02. Its official title is “Pediatric Advisory Committee (PAC); Notice of Meeting; Establishment of a Public Docket; Request for Comments,” and PeptideScanner's exact reviewed identity mapping connects the document to Exenatide and Linaclotide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Regulatory · Semaglutide

Federal Register notice 2025-19345

The Federal Register published notice 2025-19345, attributed to FDA and its parent HHS department, on 2025-10-02. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Semaglutide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT04466345

PeptideScanner retained ClinicalTrials.gov record NCT04466345 at 2026-07-30T18:20:54.428Z. Its registry update date was 2025-10-02, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · MOTS-c

MOTS-c: an equal opportunity insulin sensitizer.

PubMed lists PMID 30788534 in Journal of molecular medicine (Berlin, Germany) as Letter, Research Support, Non-U.S. Gov't, with publication-date metadata of 2019-02-20 (day precision). PeptideScanner associated the retained record with the identity slug mots-c. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · MOTS-c

A pro-diabetogenic mtDNA polymorphism in the mitochondrial-derived peptide, MOTS-c.

PubMed lists PMID 33468709 in Aging as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2021-01-19 (day precision). PeptideScanner associated the retained record with the identity slug mots-c. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT06639464

PeptideScanner retained ClinicalTrials.gov record NCT06639464 at 2026-07-30T18:22:04.916Z. Its registry update date was 2025-09-26, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Ziconotide

Can Ziconotide Be Used to Replace Opioids? Exploratory Clinical Experience in 5 Patients Treated in the Pain Unit.

PubMed lists PMID 40985013 in Journal of pain research as Journal Article, with publication-date metadata of 2025-09-17 (day precision). PeptideScanner associated the retained record with the identity slug ziconotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT06348264

PeptideScanner retained ClinicalTrials.gov record NCT06348264 at 2026-07-30T18:22:04.916Z. Its registry update date was 2025-09-23, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT06847399

PeptideScanner retained ClinicalTrials.gov record NCT06847399 at 2026-07-30T18:22:04.915Z. Its registry update date was 2025-09-22, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT06901245

PeptideScanner retained ClinicalTrials.gov record NCT06901245 at 2026-07-30T18:22:04.914Z. Its registry update date was 2025-09-16, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Glucagon

Drugs@FDA application ANDA218813

The official Drugs@FDA dataset lists original submission 1 for ANDA 218813 with status AP dated 2025-09-15, and names glucagon among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Literature metadata · Vosoritide

Vosoritide (Voxzogo) for Achondroplasia: A Review of Clinical and Real-World Evidence.

PubMed lists PMID 40821249 in Cureus as Journal Article, Review, with publication-date metadata of 2025-07-15 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Linaclotide

Linaclotide as a Single Agent Bowel Preparation Regimen Before Colonoscopy.

PubMed lists PMID 39530977 in The American surgeon as Journal Article, with publication-date metadata of 2024-11-12 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Dulaglutide

Inequity in adherence to empagliflozin and dulaglutide for type 2 diabetes in Aotearoa New Zealand.

PubMed lists PMID 40555685 in Diabetes, obesity & metabolism as Letter, with publication-date metadata of 2025-06-24 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Abaloparatide

▼Abaloparatide (Eladynos) for osteoporosis.

PubMed lists PMID 40588314 in Drug and therapeutics bulletin as Journal Article, with publication-date metadata of 2025-06-30 (day precision). PeptideScanner associated the retained record with the identity slug abaloparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Amycretin

PubMed record PMID 40550232

PeptideScanner retained PubMed bibliographic metadata for PMID 40550232 at 2026-07-30T18:22:52.359Z. PubMed recorded a metadata revision date of 2025-09-11 and an Entrez history date of 2025-06-23. PeptideScanner associated this retained record with the identity slug amycretin. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT03000946

PeptideScanner retained ClinicalTrials.gov record NCT03000946 at 2026-07-30T18:22:04.914Z. Its registry update date was 2025-09-11, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT03678025

PeptideScanner retained ClinicalTrials.gov record NCT03678025 at 2026-07-30T18:22:04.918Z. Its registry update date was 2025-09-11, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Mazdutide

PubMed record PMID 40929642

PeptideScanner retained PubMed bibliographic metadata for PMID 40929642 at 2026-07-30T18:22:54.035Z. PubMed recorded a metadata revision date of 2025-09-10 and an Entrez history date of 2025-09-10. PeptideScanner associated this retained record with the identity slug mazdutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Mazdutide

PubMed record PMID 40929641

PeptideScanner retained PubMed bibliographic metadata for PMID 40929641 at 2026-07-30T18:22:54.035Z. PubMed recorded a metadata revision date of 2025-09-10 and an Entrez history date of 2025-09-10. PeptideScanner associated this retained record with the identity slug mazdutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT05548647

PeptideScanner retained ClinicalTrials.gov record NCT05548647 at 2026-07-30T18:22:04.915Z. Its registry update date was 2025-09-08, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT06193616

PeptideScanner retained ClinicalTrials.gov record NCT06193616 at 2026-07-30T18:22:04.914Z. Its registry update date was 2025-09-05, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Retatrutide

Retatrutide.

PubMed lists PMID 39429457 in Clinical diabetes : a publication of the American Diabetes Association as Journal Article, with publication-date metadata of 2024-08-01 (day precision). PeptideScanner associated the retained record with the identity slug retatrutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Regulatory · Liraglutide

Drugs@FDA application ANDA214568

The official Drugs@FDA dataset lists original submission 1 for ANDA 214568 with status AP dated 2025-08-27, and names liraglutide among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT06986993

PeptideScanner retained ClinicalTrials.gov record NCT06986993 at 2026-07-30T18:23:09.822Z. Its registry update date was 2025-08-27, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Cagrilintide

PubMed record PMID 40609154

PeptideScanner retained PubMed bibliographic metadata for PMID 40609154 at 2026-07-30T18:24:19.064Z. PubMed recorded a metadata revision date of 2025-08-26 and an Entrez history date of 2025-07-03. PeptideScanner associated this retained record with the identity slug cagrilintide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT06691243

PeptideScanner retained ClinicalTrials.gov record NCT06691243 at 2026-07-30T18:23:09.829Z. Its registry update date was 2025-08-24, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT05530577

PeptideScanner retained ClinicalTrials.gov record NCT05530577 at 2026-07-30T18:23:09.828Z. Its registry update date was 2025-08-22, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Setmelanotide

Development of Dysplastic Nevi in a Child with LEPR Deficiency Treated with Setmelanotide.

PubMed lists PMID 40836563 in Journal of clinical research in pediatric endocrinology as Journal Article, with publication-date metadata of 2025-08-21 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Pramlintide

Randomized comparison of pramlintide or mealtime insulin added to basal insulin treatment for patients with type 2 diabetes.

PubMed lists PMID 19502544 in Diabetes care as Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2009-06-05 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT05895643

PeptideScanner retained ClinicalTrials.gov record NCT05895643 at 2026-07-30T18:23:09.822Z. Its registry update date was 2025-08-05, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Exenatide

Federal Register notice 2025-14683

The Federal Register published notice 2025-14683, attributed to FDA and its parent HHS department, on 2025-08-04. Its official title is “Teva Branded Pharmaceutical Products R&D, Inc., et al.; Withdrawal of Approval of 39 New Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Exenatide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT03298087

PeptideScanner retained ClinicalTrials.gov record NCT03298087 at 2026-07-30T18:23:09.823Z. Its registry update date was 2025-08-01, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Abaloparatide

Biodegradable Nanoflowers with Abaloparatide Spatiotemporal Management of Functional Alveolar Bone Regeneration.

PubMed lists PMID 38350110 in Nano letters as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2024-02-13 (day precision). PeptideScanner associated the retained record with the identity slug abaloparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07090343

PeptideScanner retained ClinicalTrials.gov record NCT07090343 at 2026-07-30T18:24:37.186Z. Its registry update date was 2025-07-29, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Elamipretide

Elamipretide for Barth syndrome cardiomyopathy: gradual rebuilding of a failed power grid.

PubMed lists PMID 34623544 in Heart failure reviews as Journal Article, Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2021-10-08 (day precision). PeptideScanner associated the retained record with the identity slug elamipretide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Elamipretide

Targeting mitochondrial dysfunction with elamipretide.

PubMed lists PMID 35037146 in Heart failure reviews as Journal Article, Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2022-01-17 (day precision). PeptideScanner associated the retained record with the identity slug elamipretide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · MOTS-c

MOTS-c as a predictor of coronary lesions and complexity in patients with stable coronary artery disease.

PubMed lists PMID 36066139 in European review for medical and pharmacological sciences as Journal Article, with publication-date metadata of 2022-08 (month precision). PeptideScanner associated the retained record with the identity slug mots-c. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Glucagon

ClinicalTrials.gov record NCT03241706

PeptideScanner retained ClinicalTrials.gov record NCT03241706 at 2026-07-30T18:24:37.180Z. Its registry update date was 2025-07-25, and PeptideScanner's reviewed identity mapping was glucagon.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Glucagon

Drugs@FDA application ANDA214457

The official Drugs@FDA dataset lists original submission 1 for ANDA 214457 with status AP dated 2025-07-22, and names glucagon among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Regulatory · Liraglutide

Drugs@FDA application ANDA215421

The official Drugs@FDA dataset lists original submission 1 for ANDA 215421 with status AP dated 2025-07-22, and names liraglutide among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Clinical trials · Vosoritide

ClinicalTrials.gov record NCT07073014

PeptideScanner retained ClinicalTrials.gov record NCT07073014 at 2026-07-30T18:24:37.179Z. Its registry update date was 2025-07-18, and PeptideScanner's reviewed identity mapping was vosoritide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT04451837

PeptideScanner retained ClinicalTrials.gov record NCT04451837 at 2026-07-30T18:24:37.186Z. Its registry update date was 2025-07-16, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Amycretin

PubMed record PMID 40550229

PeptideScanner retained PubMed bibliographic metadata for PMID 40550229 at 2026-07-30T18:25:48.707Z. PubMed recorded a metadata revision date of 2025-07-14 and an Entrez history date of 2025-06-23. PeptideScanner associated this retained record with the identity slug amycretin. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Amycretin

PubMed record PMID 40550231

PeptideScanner retained PubMed bibliographic metadata for PMID 40550231 at 2026-07-30T18:25:48.707Z. PubMed recorded a metadata revision date of 2025-07-14 and an Entrez history date of 2025-06-23. PeptideScanner associated this retained record with the identity slug amycretin. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07043361

PeptideScanner retained ClinicalTrials.gov record NCT07043361 at 2026-07-30T18:24:37.183Z. Its registry update date was 2025-07-09, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Retatrutide

Triple-Hormone-Receptor Agonist Retatrutide for Obesity.

PubMed lists PMID 37888925 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2023-10-26 (day precision). PeptideScanner associated the retained record with the identity slug retatrutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Retatrutide

Triple-Hormone-Receptor Agonist Retatrutide for Obesity.

PubMed lists PMID 37888926 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2023-10-26 (day precision). PeptideScanner associated the retained record with the identity slug retatrutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Retatrutide

Triple-Hormone-Receptor Agonist Retatrutide for Obesity. Reply.

PubMed lists PMID 37888927 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2023-10-26 (day precision). PeptideScanner associated the retained record with the identity slug retatrutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Glucagon

ClinicalTrials.gov record NCT02078726

PeptideScanner retained ClinicalTrials.gov record NCT02078726 at 2026-07-30T18:24:37.187Z. Its registry update date was 2025-07-03, and PeptideScanner's reviewed identity mapping was glucagon.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · BPC-157

Acute Compartment Syndrome and Intra-Abdominal Hypertension, Decompression, Current Pharmacotherapy, and Stable Gastric Pentadecapeptide BPC 157 Solution.

PubMed lists PMID 40573261 in Pharmaceuticals (Basel, Switzerland) as Journal Article, Review, with publication-date metadata of 2025-06-10 (day precision). PeptideScanner associated the retained record with the identity slug bpc-157. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Survodutide

PubMed record PMID 40557206

PeptideScanner retained PubMed bibliographic metadata for PMID 40557206 at 2026-07-30T18:26:54.791Z. PubMed recorded a metadata revision date of 2025-06-25 and an Entrez history date of 2025-06-25. PeptideScanner associated this retained record with the identity slug survodutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT02903368

PeptideScanner retained ClinicalTrials.gov record NCT02903368 at 2026-07-30T18:26:04.260Z. Its registry update date was 2025-06-13, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT06745128

PeptideScanner retained ClinicalTrials.gov record NCT06745128 at 2026-07-30T18:26:04.261Z. Its registry update date was 2025-06-12, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07018544

PeptideScanner retained ClinicalTrials.gov record NCT07018544 at 2026-07-30T18:26:04.261Z. Its registry update date was 2025-06-12, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Setmelanotide

Patient and caregiver experiences with a patient-support program for setmelanotide treatment of patients with Bardet-Biedl syndrome.

PubMed lists PMID 40484968 in Orphanet journal of rare diseases as Journal Article, with publication-date metadata of 2025-06-08 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT06073184

PeptideScanner retained ClinicalTrials.gov record NCT06073184 at 2026-07-30T18:26:04.258Z. Its registry update date was 2025-06-10, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Leuprolide

Drugs@FDA application ANDA217437

The official Drugs@FDA dataset lists original submission 1 for ANDA 217437 with status AP dated 2025-06-09, and names leuprolide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Literature metadata · Linaclotide

Linaclotide for paediatric functional constipation.

PubMed lists PMID 38211605 in The lancet. Gastroenterology & hepatology as Journal Article, Comment, with publication-date metadata of 2024-01-08 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · MOTS-c

Mitochondria-encoded peptide MOTS-c participates in plasma membrane repair by facilitating the translocation of TRIM72 to membrane.

PubMed lists PMID 39267782 in Theranostics as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2024-08-19 (day precision). PeptideScanner associated the retained record with the identity slug mots-c. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · MOTS-c

Could MOTS-c Levels in Children with Type 1 Diabetes Mellitus Be an Indicator for Early Diabetic Kidney Disease?

PubMed lists PMID 39711006 in Journal of clinical research in pediatric endocrinology as Journal Article, with publication-date metadata of 2024-12-23 (day precision). PeptideScanner associated the retained record with the identity slug mots-c. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Setmelanotide

ClinicalTrials.gov record NCT03651765

PeptideScanner retained ClinicalTrials.gov record NCT03651765 at 2026-07-30T18:27:14.161Z. Its registry update date was 2025-05-31, and PeptideScanner's reviewed identity mapping was setmelanotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Setmelanotide

Evaluation of a melanocortin-4 receptor (MC4R) agonist (Setmelanotide) in MC4R deficiency.

PubMed lists PMID 29031731 in Molecular metabolism as Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2017-07-08 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · KPV

PubMed record PMID 27458604

PeptideScanner retained PubMed bibliographic metadata for PMID 27458604 at 2026-07-30T18:28:30.778Z. PubMed recorded a metadata revision date of 2025-05-30 and an Entrez history date of 2016-07-27. PeptideScanner associated this retained record with the identity slug kpv. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · CJC-1295

PubMed record PMID 19386527

PeptideScanner retained PubMed bibliographic metadata for PMID 19386527 at 2026-07-30T18:28:26.873Z. PubMed recorded a metadata revision date of 2025-05-29 and an Entrez history date of 2009-04-24. PeptideScanner associated this retained record with the identity slug cjc-1295. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Pramlintide

Simple meal announcements and pramlintide delivery versus carbohydrate counting in type 1 diabetes with automated fast-acting insulin aspart delivery: a randomised crossover trial in Montreal, Canada.

PubMed lists PMID 38906614 in The Lancet. Digital health as Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2024-07 (month precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT06606821

PeptideScanner retained ClinicalTrials.gov record NCT06606821 at 2026-07-30T18:27:14.157Z. Its registry update date was 2025-05-22, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Setmelanotide

Setmelanotide: new promise for the treatment of hypothalamic obesity?

PubMed lists PMID 38697183 in The lancet. Diabetes & endocrinology as Journal Article, Comment, with publication-date metadata of 2024-04-30 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Setmelanotide

Setmelanotide for the treatment of acquired hypothalamic obesity: a phase 2, open-label, multicentre trial.

PubMed lists PMID 38697184 in The lancet. Diabetes & endocrinology as Journal Article, Clinical Trial, Phase II, Multicenter Study, Research Support, Non-U.S. Gov't, with publication-date metadata of 2024-04-30 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · GHK-Cu

Are We Ready to Measure Skin Permeation of Modern Antiaging GHK-Cu Tripeptide Encapsulated in Liposomes?

PubMed lists PMID 39795193 in Molecules (Basel, Switzerland) as Journal Article, Review, with publication-date metadata of 2025-01-01 (day precision). PeptideScanner associated the retained record with the identity slug ghk-cu. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Linaclotide

Linaclotide Use for the Treatment of Constipation and Gastrointestinal Symptoms in People With Cystic Fibrosis.

PubMed lists PMID 39620387 in Pediatric pulmonology as Journal Article, with publication-date metadata of 2024-12-02 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT06974344

PeptideScanner retained ClinicalTrials.gov record NCT06974344 at 2026-07-30T18:27:14.162Z. Its registry update date was 2025-05-15, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT06937060

PeptideScanner retained ClinicalTrials.gov record NCT06937060 at 2026-07-30T18:27:14.162Z. Its registry update date was 2025-05-13, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT02278185

PeptideScanner retained ClinicalTrials.gov record NCT02278185 at 2026-07-30T18:27:14.158Z. Its registry update date was 2025-05-11, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT03289741

PeptideScanner retained ClinicalTrials.gov record NCT03289741 at 2026-07-30T18:27:14.159Z. Its registry update date was 2025-05-09, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT06959784

PeptideScanner retained ClinicalTrials.gov record NCT06959784 at 2026-07-30T18:27:14.158Z. Its registry update date was 2025-05-07, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT04889183

PeptideScanner retained ClinicalTrials.gov record NCT04889183 at 2026-07-30T18:29:04.229Z. Its registry update date was 2025-04-22, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT05302596

PeptideScanner retained ClinicalTrials.gov record NCT05302596 at 2026-07-30T18:29:04.234Z. Its registry update date was 2025-04-17, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Cagrilintide

PubMed record PMID 40204768

PeptideScanner retained PubMed bibliographic metadata for PMID 40204768 at 2026-07-30T18:29:52.187Z. PubMed recorded a metadata revision date of 2025-04-12 and an Entrez history date of 2025-04-09. PeptideScanner associated this retained record with the identity slug cagrilintide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT06918405

PeptideScanner retained ClinicalTrials.gov record NCT06918405 at 2026-07-30T18:29:04.229Z. Its registry update date was 2025-04-09, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Liraglutide

Drugs@FDA application ANDA218115

The official Drugs@FDA dataset lists original submission 1 for ANDA 218115 with status AP dated 2025-04-02, and names liraglutide among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT05520775

PeptideScanner retained ClinicalTrials.gov record NCT05520775 at 2026-07-30T18:29:04.228Z. Its registry update date was 2025-04-02, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT00687739

PeptideScanner retained ClinicalTrials.gov record NCT00687739 at 2026-07-30T18:29:04.227Z. Its registry update date was 2025-04-01, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT02457156

PeptideScanner retained ClinicalTrials.gov record NCT02457156 at 2026-07-30T18:30:10.981Z. Its registry update date was 2025-03-13, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT04873050

PeptideScanner retained ClinicalTrials.gov record NCT04873050 at 2026-07-30T18:30:10.991Z. Its registry update date was 2025-03-13, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT03158805

PeptideScanner retained ClinicalTrials.gov record NCT03158805 at 2026-07-30T18:30:10.979Z. Its registry update date was 2025-03-12, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT00463983

PeptideScanner retained ClinicalTrials.gov record NCT00463983 at 2026-07-30T18:30:10.977Z. Its registry update date was 2025-03-05, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT04881110

PeptideScanner retained ClinicalTrials.gov record NCT04881110 at 2026-07-30T18:30:10.981Z. Its registry update date was 2025-03-03, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · BPC-157

Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review.

PubMed lists PMID 40005999 in Pharmaceuticals (Basel, Switzerland) as Journal Article, Review, with publication-date metadata of 2025-01-30 (day precision). PeptideScanner associated the retained record with the identity slug bpc-157. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT03944434

PeptideScanner retained ClinicalTrials.gov record NCT03944434 at 2026-07-30T18:31:14.558Z. Its registry update date was 2025-02-26, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Elamipretide

Expanded-access use of elamipretide in a newborn with Barth syndrome: a case report.

PubMed lists PMID 39917770 in European heart journal. Case reports as Case Reports, Journal Article, with publication-date metadata of 2025-01-22 (day precision). PeptideScanner associated the retained record with the identity slug elamipretide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Setmelanotide

ClinicalTrials.gov record NCT04725240

PeptideScanner retained ClinicalTrials.gov record NCT04725240 at 2026-07-30T18:31:14.558Z. Its registry update date was 2025-02-07, and PeptideScanner's reviewed identity mapping was setmelanotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Ziconotide

Ziconotide and psychosis: from a case report to a scoping review.

PubMed lists PMID 39479264 in Frontiers in molecular neuroscience as Journal Article, Scoping Review, with publication-date metadata of 2024-10-16 (day precision). PeptideScanner associated the retained record with the identity slug ziconotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT03133195

PeptideScanner retained ClinicalTrials.gov record NCT03133195 at 2026-07-30T18:32:24.991Z. Its registry update date was 2025-01-15, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT06764056

PeptideScanner retained ClinicalTrials.gov record NCT06764056 at 2026-07-30T18:32:24.991Z. Its registry update date was 2025-01-08, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Lixisenatide

Lixisenatide in Type 2 Diabetes and Acute Coronary Syndrome.

PubMed lists PMID 26981945 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2016-03-17 (day precision). PeptideScanner associated the retained record with the identity slug lixisenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Lixisenatide

Lixisenatide in Type 2 Diabetes and Acute Coronary Syndrome.

PubMed lists PMID 26981946 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2016-03-17 (day precision). PeptideScanner associated the retained record with the identity slug lixisenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Lixisenatide

Lixisenatide in Type 2 Diabetes and Acute Coronary Syndrome.

PubMed lists PMID 26981947 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2016-03-17 (day precision). PeptideScanner associated the retained record with the identity slug lixisenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Linaclotide

Bioactivity of Oral Linaclotide in Human Colorectum for Cancer Chemoprevention.

PubMed lists PMID 28396341 in Cancer prevention research (Philadelphia, Pa.) as Clinical Trial, Journal Article, with publication-date metadata of 2017-04-10 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Setmelanotide

Setmelanotide for the treatment of severe early-childhood genetic obesity.

PubMed lists PMID 39549717 in The lancet. Diabetes & endocrinology as Journal Article, with publication-date metadata of 2024-11-13 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Regulatory · Liraglutide

Drugs@FDA application ANDA215503

The official Drugs@FDA dataset lists original submission 1 for ANDA 215503 with status AP dated 2024-12-23, and names liraglutide among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Clinical trials · Lixisenatide

ClinicalTrials.gov record NCT02049034

PeptideScanner retained ClinicalTrials.gov record NCT02049034 at 2026-07-30T18:37:14.684Z. Its registry update date was 2024-12-16, and PeptideScanner's reviewed identity mapping was lixisenatide.

Added August 14, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Elamipretide

Expanded-access use of elamipretide in a critically ill patient with Barth syndrome.

PubMed lists PMID 39669625 in Genetics in medicine open as Journal Article, with publication-date metadata of 2024-06-22 (day precision). PeptideScanner associated the retained record with the identity slug elamipretide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Regulatory · Glucagon

Drugs@FDA application ANDA204468

The official Drugs@FDA dataset lists original submission 1 for ANDA 204468 with status AP dated 2024-12-12, and names glucagon among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT06234111

PeptideScanner retained ClinicalTrials.gov record NCT06234111 at 2026-07-30T18:37:14.697Z. Its registry update date was 2024-12-12, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Linaclotide

ClinicalTrials.gov record NCT01950403

PeptideScanner retained ClinicalTrials.gov record NCT01950403 at 2026-07-30T18:37:14.701Z. Its registry update date was 2024-12-09, and PeptideScanner's reviewed identity mapping was linaclotide.

Added August 8, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT06629688

PeptideScanner retained ClinicalTrials.gov record NCT06629688 at 2026-07-30T18:37:14.696Z. Its registry update date was 2024-12-05, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT02685397

PeptideScanner retained ClinicalTrials.gov record NCT02685397 at 2026-07-30T18:37:14.689Z. Its registry update date was 2024-12-04, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT05912621

PeptideScanner retained ClinicalTrials.gov record NCT05912621 at 2026-07-30T18:37:14.695Z. Its registry update date was 2024-12-04, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Setmelanotide

ClinicalTrials.gov record NCT04966741

PeptideScanner retained ClinicalTrials.gov record NCT04966741 at 2026-07-30T18:38:25.516Z. Its registry update date was 2024-11-27, and PeptideScanner's reviewed identity mapping was setmelanotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT03035032

PeptideScanner retained ClinicalTrials.gov record NCT03035032 at 2026-07-30T18:38:25.519Z. Its registry update date was 2024-11-26, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Glucagon

ClinicalTrials.gov record NCT03965130

PeptideScanner retained ClinicalTrials.gov record NCT03965130 at 2026-07-30T18:38:25.510Z. Its registry update date was 2024-11-26, and PeptideScanner's reviewed identity mapping was glucagon.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT02366494

PeptideScanner retained ClinicalTrials.gov record NCT02366494 at 2026-07-30T18:38:25.510Z. Its registry update date was 2024-11-25, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Setmelanotide

Setmelanotide: A Melanocortin-4 Receptor Agonist for the Treatment of Severe Obesity Due to Hypothalamic Dysfunction.

PubMed lists PMID 39526054 in TouchREVIEWS in endocrinology as Journal Article, Review, with publication-date metadata of 2024-02-09 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Regulatory · Liraglutide

Federal Register notice 2024-27048

The Federal Register published notice 2024-27048, attributed to FDA and its parent HHS department, on 2024-11-20. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Liraglutide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT04883346

PeptideScanner retained ClinicalTrials.gov record NCT04883346 at 2026-07-30T18:38:25.517Z. Its registry update date was 2024-11-20, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Exenatide

Drugs@FDA application ANDA206697

The official Drugs@FDA dataset lists original submission 1 for ANDA 206697 with status AP dated 2024-11-19, and names exenatide synthetic among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Clinical trials · Bremelanotide

ClinicalTrials.gov record NCT04943068

PeptideScanner retained ClinicalTrials.gov record NCT04943068 at 2026-07-30T18:38:25.522Z. Its registry update date was 2024-11-13, and PeptideScanner's reviewed identity mapping was bremelanotide.

Added August 14, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Dulaglutide

Use of dulaglutide in a pregnant woman with type 2 diabetes until third trimester of pregnancy.

PubMed lists PMID 39126516 in Acta diabetologica as Journal Article, with publication-date metadata of 2024-08-10 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Cagrilintide

ClinicalTrials.gov record NCT05804162

PeptideScanner retained ClinicalTrials.gov record NCT05804162 at 2026-07-30T18:38:25.523Z. Its registry update date was 2024-11-01, and PeptideScanner's reviewed identity mapping was cagrilintide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Lixisenatide

Poly(l-threonine-co-l-threonine Succinate) Thermogels for Sustained Release of Lixisenatide.

PubMed lists PMID 38949062 in Biomacromolecules as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2024-07-01 (day precision). PeptideScanner associated the retained record with the identity slug lixisenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · MOTS-c

Serum MOTS-c levels remain unchanged in patients with preeclampsia.

PubMed lists PMID 39469962 in Ginekologia polska as Journal Article, with publication-date metadata of 2023 (year precision). PeptideScanner associated the retained record with the identity slug mots-c. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Regulatory · CJC-1295

Federal Register notice 2024-24828

The Federal Register published notice 2024-24828, attributed to FDA and its parent HHS department, on 2024-10-25. Its official title is “Pharmacy Compounding Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Bulk Drug Substances Nominated for Inclusion on the Section 503A Bulk Drug Substances List,” and PeptideScanner's exact reviewed identity mapping connects the document to CJC-1295.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Clinical trials · Mazdutide

ClinicalTrials.gov record NCT06519656

PeptideScanner retained ClinicalTrials.gov record NCT06519656 at 2026-07-30T18:39:33.787Z. Its registry update date was 2024-10-24, and PeptideScanner's reviewed identity mapping was mazdutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Linaclotide

ClinicalTrials.gov record NCT03471728

PeptideScanner retained ClinicalTrials.gov record NCT03471728 at 2026-07-30T18:39:33.779Z. Its registry update date was 2024-10-18, and PeptideScanner's reviewed identity mapping was linaclotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Leuprolide

Drugs@FDA application ANDA217957

The official Drugs@FDA dataset lists original submission 1 for ANDA 217957 with status AP dated 2024-10-17, and names leuprolide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Clinical trials · Bremelanotide

ClinicalTrials.gov record NCT05709444

PeptideScanner retained ClinicalTrials.gov record NCT05709444 at 2026-07-30T18:39:33.780Z. Its registry update date was 2024-10-17, and PeptideScanner's reviewed identity mapping was bremelanotide.

Added August 8, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Vosoritide

Vosoritide therapy in children with achondroplasia under 5 years of age.

PubMed lists PMID 39399714 in Translational pediatrics as Editorial, Comment, with publication-date metadata of 2024-09-11 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT05708859

PeptideScanner retained ClinicalTrials.gov record NCT05708859 at 2026-07-30T18:39:33.781Z. Its registry update date was 2024-10-15, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Ziconotide

Determination of related substances in disulfide-rich peptide ziconotide by establishing tandem mass spectrometry methods.

PubMed lists PMID 39386004 in Journal of pharmaceutical analysis as Journal Article, with publication-date metadata of 2024-07-02 (day precision). PeptideScanner associated the retained record with the identity slug ziconotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · MOTS-c

Downregulation of circulating MOTS-c levels in patients with coronary endothelial dysfunction.

PubMed lists PMID 29242099 in International journal of cardiology as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2017-12-06 (day precision). PeptideScanner associated the retained record with the identity slug mots-c. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT04216589

PeptideScanner retained ClinicalTrials.gov record NCT04216589 at 2026-07-30T18:39:33.783Z. Its registry update date was 2024-10-01, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Octreotide

Drugs@FDA application NDA213224

The official Drugs@FDA dataset lists original submission 1 for NDA 213224 with status AP dated 2024-09-27, and names octreotide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Regulatory · Ipamorelin

Federal Register notice 2024-21241

The Federal Register published notice 2024-21241, attributed to FDA and its parent HHS department, on 2024-09-18. Its official title is “Pharmacy Compounding Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Bulk Drug Substances Nominated for Inclusion on the Section 503A Bulk Drug Substances List; Revisions to the Withdrawn or Removed List,” and PeptideScanner's exact reviewed identity mapping connects the document to Ipamorelin.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Regulatory · Elamipretide

Federal Register notice 2024-20062

The Federal Register published notice 2024-20062, attributed to FDA and its parent HHS department, on 2024-09-06. Its official title is “Cardiovascular and Renal Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-New Drug Application 215244 for Elamipretide Hydrochloride Injection,” and PeptideScanner's exact reviewed identity mapping connects the document to Elamipretide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Literature metadata · BPC-157

Stable Gastric Pentadecapeptide BPC 157 and Intestinal Anastomoses Therapy in Rats-A Review.

PubMed lists PMID 39204186 in Pharmaceuticals (Basel, Switzerland) as Journal Article, Review, with publication-date metadata of 2024-08-17 (day precision). PeptideScanner associated the retained record with the identity slug bpc-157. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT03574597

PeptideScanner retained ClinicalTrials.gov record NCT03574597 at 2026-07-30T18:41:37.951Z. Its registry update date was 2024-08-30, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT06099067

PeptideScanner retained ClinicalTrials.gov record NCT06099067 at 2026-07-30T18:41:37.931Z. Its registry update date was 2024-08-30, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Ipamorelin

The influence of ghrelin agonist ipamorelin acetate on the hypothalamic-pituitary-testicular axis in a cichlid fish, Oreochromis mossambicus.

PubMed lists PMID 38996787 in Animal reproduction science as Journal Article, with publication-date metadata of 2024-07-05 (day precision). PeptideScanner associated the retained record with the identity slug ipamorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Regulatory · Exenatide + 1 more

Federal Register notice 2024-18898

The Federal Register published notice 2024-18898, attributed to FDA and its parent HHS department, on 2024-08-23. Its official title is “Final Decision on the Proposal To Refuse To Approve a New Drug Application for ITCA 650,” and PeptideScanner's exact reviewed identity mapping connects the document to Exenatide and Glucagon.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Regulatory · Teriparatide

Federal Register notice 2024-18997

The Federal Register published notice 2024-18997, attributed to FDA and its parent HHS department, on 2024-08-23. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Teriparatide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Literature metadata · BPC-157

Stable Gastric Pentadecapeptide BPC 157 as a Therapy for the Disable Myotendinous Junctions in Rats.

PubMed lists PMID 34829776 in Biomedicines as Journal Article, with publication-date metadata of 2021-10-27 (day precision). PeptideScanner associated the retained record with the identity slug bpc-157. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 16, 2026 · Source: PubMed ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT03036800

PeptideScanner retained ClinicalTrials.gov record NCT03036800 at 2026-07-30T18:41:37.923Z. Its registry update date was 2024-08-13, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Glucagon

Federal Register notice 2024-17649

The Federal Register published notice 2024-17649, attributed to FDA and its parent HHS department, on 2024-08-08. Its official title is “Determination That DELATESTRYL (Testosterone Enanthate) Injection, 200 Milligrams/Milliliter, and Other Drug Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness,” and PeptideScanner's exact reviewed identity mapping connects the document to Glucagon.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT06541509

PeptideScanner retained ClinicalTrials.gov record NCT06541509 at 2026-07-30T18:41:37.930Z. Its registry update date was 2024-08-07, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Elamipretide

A randomized crossover trial of elamipretide in adults with primary mitochondrial myopathy.

PubMed lists PMID 32096613 in Journal of cachexia, sarcopenia and muscle as Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2020-02-25 (day precision). PeptideScanner associated the retained record with the identity slug elamipretide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Bremelanotide

Ultra-sensitive quantification of the therapeutic cyclic peptide bremelanotide utilizing UHPLC-MS/MS for evaluation of its oral plasma pharmacokinetics.

PubMed lists PMID 32353679 in Journal of pharmaceutical and biomedical analysis as Journal Article, with publication-date metadata of 2020-03-27 (day precision). PeptideScanner associated the retained record with the identity slug bremelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Vosoritide

Consensus Guidelines for the Use of Vosoritide in Children with Achondroplasia in Australia.

PubMed lists PMID 39062238 in Children (Basel, Switzerland) as Journal Article, with publication-date metadata of 2024-06-28 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT02403284

PeptideScanner retained ClinicalTrials.gov record NCT02403284 at 2026-07-30T18:42:56.623Z. Its registry update date was 2024-07-22, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Elamipretide

Intermittent treatment with elamipretide preserves exercise tolerance in aged female mice.

PubMed lists PMID 36840897 in GeroScience as Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, with publication-date metadata of 2023-02-25 (day precision). PeptideScanner associated the retained record with the identity slug elamipretide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Glucagon

ClinicalTrials.gov record NCT06498063

PeptideScanner retained ClinicalTrials.gov record NCT06498063 at 2026-07-30T18:42:56.616Z. Its registry update date was 2024-07-12, and PeptideScanner's reviewed identity mapping was glucagon.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Plecanatide

ClinicalTrials.gov record NCT05151328

PeptideScanner retained ClinicalTrials.gov record NCT05151328 at 2026-07-30T18:42:56.581Z. Its registry update date was 2024-07-11, and PeptideScanner's reviewed identity mapping was plecanatide.

Added August 8, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Vosoritide

ClinicalTrials.gov record NCT05849389

PeptideScanner retained ClinicalTrials.gov record NCT05849389 at 2026-07-30T18:43:56.187Z. Its registry update date was 2024-06-24, and PeptideScanner's reviewed identity mapping was vosoritide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Abaloparatide

ClinicalTrials.gov record NCT04249232

PeptideScanner retained ClinicalTrials.gov record NCT04249232 at 2026-07-30T18:43:56.172Z. Its registry update date was 2024-06-14, and PeptideScanner's reviewed identity mapping was abaloparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT02927392

PeptideScanner retained ClinicalTrials.gov record NCT02927392 at 2026-07-30T18:43:56.185Z. Its registry update date was 2024-06-13, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT05766358

PeptideScanner retained ClinicalTrials.gov record NCT05766358 at 2026-07-30T18:43:56.186Z. Its registry update date was 2024-06-10, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT01194271

PeptideScanner retained ClinicalTrials.gov record NCT01194271 at 2026-07-30T18:43:56.180Z. Its registry update date was 2024-06-06, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Teriparatide

Drugs@FDA application NDA218771

The official Drugs@FDA dataset lists original submission 1 for NDA 218771 with status AP dated 2024-06-04, and names teriparatide among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Clinical trials · Exenatide

ClinicalTrials.gov record NCT02157974

PeptideScanner retained ClinicalTrials.gov record NCT02157974 at 2026-07-30T18:43:56.184Z. Its registry update date was 2024-06-04, and PeptideScanner's reviewed identity mapping was exenatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Glucagon

Federal Register notice 2024-12065

The Federal Register published notice 2024-12065, attributed to FDA and its parent HHS department, on 2024-06-03. Its official title is “Pfizer, Inc., et al.; Withdrawal of Approval of 23 New Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Glucagon.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Literature metadata · Vosoritide

Vosoritide treatment for children with hypochondroplasia: a phase 2 trial.

PubMed lists PMID 38813446 in EClinicalMedicine as Journal Article, with publication-date metadata of 2024-04-11 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT03987451

PeptideScanner retained ClinicalTrials.gov record NCT03987451 at 2026-07-30T18:45:10.889Z. Its registry update date was 2024-05-29, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Afamelanotide

Afamelanotide in protoporphyria and other skin diseases: a review.

PubMed lists PMID 38784937 in Postepy dermatologii i alergologii as Journal Article, Review, with publication-date metadata of 2024-04-12 (day precision). PeptideScanner associated the retained record with the identity slug afamelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Lixisenatide

Lixisenatide.

PubMed lists PMID 28179743 in Hospital pharmacy as Journal Article, with publication-date metadata of 2017-01 (month precision). PeptideScanner associated the retained record with the identity slug lixisenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Regulatory · Lanreotide

Drugs@FDA application ANDA217193

The official Drugs@FDA dataset lists original submission 1 for ANDA 217193 with status AP dated 2024-05-21, and names lanreotide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Regulatory · Liraglutide

Federal Register notice 2024-10896

The Federal Register published notice 2024-10896, attributed to FDA and its parent HHS department, on 2024-05-17. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Liraglutide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Clinical trials · Exenatide

ClinicalTrials.gov record NCT04909333

PeptideScanner retained ClinicalTrials.gov record NCT04909333 at 2026-07-30T18:45:10.887Z. Its registry update date was 2024-05-08, and PeptideScanner's reviewed identity mapping was exenatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Setmelanotide

ClinicalTrials.gov record NCT05046132

PeptideScanner retained ClinicalTrials.gov record NCT05046132 at 2026-07-30T18:45:10.886Z. Its registry update date was 2024-05-03, and PeptideScanner's reviewed identity mapping was setmelanotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Octreotide

Drugs@FDA application ANDA217860

The official Drugs@FDA dataset lists original submission 1 for ANDA 217860 with status AP dated 2024-05-02, and names octreotide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Regulatory · Leuprolide

Federal Register notice 2024-08657

The Federal Register published notice 2024-08657, attributed to FDA and its parent HHS department, on 2024-04-23. Its official title is “PAI Holdings, LLC DBA Pharmaceutical Associates, Inc., et al.; Withdrawal of Approval of 23 New Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Leuprolide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT04522622

PeptideScanner retained ClinicalTrials.gov record NCT04522622 at 2026-07-30T18:46:20.407Z. Its registry update date was 2024-04-23, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Elamipretide

ClinicalTrials.gov record NCT03098797

PeptideScanner retained ClinicalTrials.gov record NCT03098797 at 2026-07-30T18:46:20.414Z. Its registry update date was 2024-04-16, and PeptideScanner's reviewed identity mapping was elamipretide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT05813249

PeptideScanner retained ClinicalTrials.gov record NCT05813249 at 2026-07-30T18:46:20.405Z. Its registry update date was 2024-04-02, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · MOTS-c

Central MOTS-c infusion affects reproductive hormones in obese and non-obese rats.

PubMed lists PMID 38462167 in Neuroscience letters as Journal Article, with publication-date metadata of 2024-03-08 (day precision). PeptideScanner associated the retained record with the identity slug mots-c. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Abaloparatide

Phase 1b Evaluation of Abaloparatide Solid Microstructured Transdermal System (Abaloparatide-sMTS) in Postmenopausal Women with Low Bone Mineral Density.

PubMed lists PMID 33638863 in Clinical drug investigation as Clinical Trial, Phase I, Journal Article, with publication-date metadata of 2021-02-27 (day precision). PeptideScanner associated the retained record with the identity slug abaloparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Elamipretide

Mitochondrial protein interaction landscape of SS-31.

PubMed lists PMID 32554501 in Proceedings of the National Academy of Sciences of the United States of America as Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, with publication-date metadata of 2020-06-17 (day precision). PeptideScanner associated the retained record with the identity slug elamipretide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Linaclotide

Diagnosis and treatment of irritable bowel syndrome with predominant constipation in the primary-care setting: focus on linaclotide.

PubMed lists PMID 29184433 in International journal of general medicine as Journal Article, Review, with publication-date metadata of 2017-10-31 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT06303284

PeptideScanner retained ClinicalTrials.gov record NCT06303284 at 2026-07-30T18:47:17.466Z. Its registry update date was 2024-03-18, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Elamipretide

Abnormalities of Mitochondrial Dynamics in the Failing Heart: Normalization Following Long-Term Therapy with Elamipretide.

PubMed lists PMID 29951944 in Cardiovascular drugs and therapy as Journal Article, with publication-date metadata of 2018-08 (month precision). PeptideScanner associated the retained record with the identity slug elamipretide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · TB-500

PubMed record PMID 38382158

PeptideScanner retained PubMed bibliographic metadata for PMID 38382158 at 2026-07-30T18:48:13.580Z. PubMed recorded a metadata revision date of 2024-03-11 and an Entrez history date of 2024-02-21. PeptideScanner associated this retained record with the identity slug tb-500. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Mazdutide

PubMed record PMID 38440786

PeptideScanner retained PubMed bibliographic metadata for PMID 38440786 at 2026-07-30T18:48:13.638Z. PubMed recorded a metadata revision date of 2024-03-07 and an Entrez history date of 2024-03-05. PeptideScanner associated this retained record with the identity slug mazdutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT02953665

PeptideScanner retained ClinicalTrials.gov record NCT02953665 at 2026-07-30T18:47:17.465Z. Its registry update date was 2024-03-07, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT03672812

PeptideScanner retained ClinicalTrials.gov record NCT03672812 at 2026-07-30T18:47:17.466Z. Its registry update date was 2024-03-05, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Vosoritide

Federal Register notice 2024-04479

The Federal Register published notice 2024-04479, attributed to FDA and its parent HHS department, on 2024-03-04. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; VOXZOGO,” and PeptideScanner's exact reviewed identity mapping connects the document to Vosoritide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Regulatory · Tirzepatide

Federal Register notice 2024-04157

The Federal Register published notice 2024-04157, attributed to FDA and its parent HHS department, on 2024-02-29. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; MOUNJARO,” and PeptideScanner's exact reviewed identity mapping connects the document to Tirzepatide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Regulatory · Leuprolide

Federal Register notice 2024-04218

The Federal Register published notice 2024-04218, attributed to FDA and its parent HHS department, on 2024-02-29. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; CAMCEVI,” and PeptideScanner's exact reviewed identity mapping connects the document to Leuprolide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT04081337

PeptideScanner retained ClinicalTrials.gov record NCT04081337 at 2026-07-30T18:48:25.645Z. Its registry update date was 2024-02-08, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT00099086

PeptideScanner retained ClinicalTrials.gov record NCT00099086 at 2026-07-30T18:49:14.746Z. Its registry update date was 2024-01-31, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT02543255

PeptideScanner retained ClinicalTrials.gov record NCT02543255 at 2026-07-30T18:49:14.746Z. Its registry update date was 2024-01-31, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT04407234

PeptideScanner retained ClinicalTrials.gov record NCT04407234 at 2026-07-30T18:49:14.741Z. Its registry update date was 2024-01-08, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Exenatide

ClinicalTrials.gov record NCT01524705

PeptideScanner retained ClinicalTrials.gov record NCT01524705 at 2026-07-30T19:03:45.487Z. Its registry update date was 2023-12-29, and PeptideScanner's reviewed identity mapping was exenatide.

Added August 14, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Octreotide

Drugs@FDA application ANDA210317

The official Drugs@FDA dataset lists original submission 1 for ANDA 210317 with status AP dated 2023-12-05, and names octreotide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT03795701

PeptideScanner retained ClinicalTrials.gov record NCT03795701 at 2026-07-30T19:03:45.488Z. Its registry update date was 2023-12-04, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT02381249

PeptideScanner retained ClinicalTrials.gov record NCT02381249 at 2026-07-30T19:04:52.219Z. Its registry update date was 2023-11-27, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT02385617

PeptideScanner retained ClinicalTrials.gov record NCT02385617 at 2026-07-30T19:04:52.214Z. Its registry update date was 2023-11-27, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Semaglutide

Federal Register notice 2023-25485

The Federal Register published notice 2023-25485, attributed to FDA and its parent HHS department, on 2023-11-17. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Semaglutide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Regulatory · Teriparatide

Drugs@FDA application ANDA208569

The official Drugs@FDA dataset lists original submission 1 for ANDA 208569 with status AP dated 2023-11-16, and names teriparatide among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Regulatory · Teriparatide

Drugs@FDA application ANDA211097

The official Drugs@FDA dataset lists original submission 1 for ANDA 211097 with status AP dated 2023-11-16, and names teriparatide among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT00541047

PeptideScanner retained ClinicalTrials.gov record NCT00541047 at 2026-07-30T19:04:52.204Z. Its registry update date was 2023-11-13, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Linaclotide

Pharmacotherapy patterns in patients with chronic idiopathic constipation beginning treatment with linaclotide or lubiprostone in the United States.

PubMed lists PMID 32863841 in Drugs in context as Journal Article, with publication-date metadata of 2020-08-12 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Afamelanotide

Advances in the management of erythropoietic protoporphyria - role of afamelanotide.

PubMed lists PMID 28003770 in The application of clinical genetics as Review, Journal Article, with publication-date metadata of 2016-12-12 (day precision). PeptideScanner associated the retained record with the identity slug afamelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Regulatory · Tirzepatide

Drugs@FDA application NDA217806

The official Drugs@FDA dataset lists original submission 1 for NDA 217806 with status AP dated 2023-11-08, and names tirzepatide among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Literature metadata · GHK-Cu

Phenothiazine-Based Cu(II)-Selective Fluorescent Sensor: GHK-Cu Sensing Applications.

PubMed lists PMID 37830186 in The Journal of organic chemistry as Journal Article, with publication-date metadata of 2023-10-13 (day precision). PeptideScanner associated the retained record with the identity slug ghk-cu. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · GHK-Cu

Liposomes as Carriers of GHK-Cu Tripeptide for Cosmetic Application.

PubMed lists PMID 37896245 in Pharmaceutics as Journal Article, with publication-date metadata of 2023-10-18 (day precision). PeptideScanner associated the retained record with the identity slug ghk-cu. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT06106932

PeptideScanner retained ClinicalTrials.gov record NCT06106932 at 2026-07-30T19:07:27.301Z. Its registry update date was 2023-10-30, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Pramlintide

ClinicalTrials.gov record NCT05199714

PeptideScanner retained ClinicalTrials.gov record NCT05199714 at 2026-07-30T19:07:27.301Z. Its registry update date was 2023-10-25, and PeptideScanner's reviewed identity mapping was pramlintide.

Added August 14, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · GHK-Cu

In Vitro and in Vivo Studies of pH-Sensitive GHK-Cu-Incorporated Polyaspartic and Polyacrylic Acid Superabsorbent Polymer.

PubMed lists PMID 31815212 in ACS omega as Journal Article, with publication-date metadata of 2019-11-19 (day precision). PeptideScanner associated the retained record with the identity slug ghk-cu. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Linaclotide

UK clinical experience up to 52 weeks with linaclotide for irritable bowel syndrome with constipation.

PubMed lists PMID 30302125 in Therapeutic advances in gastroenterology as Journal Article, with publication-date metadata of 2018-10-03 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Clinical trials · Afamelanotide

ClinicalTrials.gov record NCT04525157

PeptideScanner retained ClinicalTrials.gov record NCT04525157 at 2026-07-30T19:08:50.172Z. Its registry update date was 2023-09-22, and PeptideScanner's reviewed identity mapping was afamelanotide.

Added August 8, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Setmelanotide

ClinicalTrials.gov record NCT02896192

PeptideScanner retained ClinicalTrials.gov record NCT02896192 at 2026-07-30T19:08:50.175Z. Its registry update date was 2023-09-21, and PeptideScanner's reviewed identity mapping was setmelanotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT04263415

PeptideScanner retained ClinicalTrials.gov record NCT04263415 at 2026-07-30T19:08:50.175Z. Its registry update date was 2023-09-08, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT03737240

PeptideScanner retained ClinicalTrials.gov record NCT03737240 at 2026-07-30T19:08:50.174Z. Its registry update date was 2023-09-08, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Linaclotide

Linaclotide (Linzess) for functional constipation.

PubMed lists PMID 37651297 in The Medical letter on drugs and therapeutics as Journal Article, with publication-date metadata of 2023-08-21 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 16, 2026 · Source: PubMed ↗

Regulatory · Exenatide

Federal Register notice 2023-18241

The Federal Register published notice 2023-18241, attributed to FDA and its parent HHS department, on 2023-08-24. Its official title is “Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Alternative Form of Hearing,” and PeptideScanner's exact reviewed identity mapping connects the document to Exenatide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Regulatory · Exenatide

Federal Register notice 2023-18250

The Federal Register published notice 2023-18250, attributed to FDA and its parent HHS department, on 2023-08-24. Its official title is “Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments,” and PeptideScanner's exact reviewed identity mapping connects the document to Exenatide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Regulatory · Glucagon + 1 more

Federal Register notice 2023-18026

The Federal Register published notice 2023-18026, attributed to FDA and its parent HHS department, on 2023-08-22. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Glucagon and Tirzepatide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT00002889

PeptideScanner retained ClinicalTrials.gov record NCT00002889 at 2026-07-30T19:09:38.368Z. Its registry update date was 2023-08-18, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Elamipretide

Use of Elamipretide in patients assigned treatment in the compassionate use program: Case series in pediatric patients with rare orphan diseases.

PubMed lists PMID 36636586 in JIMD reports as Journal Article, with publication-date metadata of 2022-09-21 (day precision). PeptideScanner associated the retained record with the identity slug elamipretide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT04026256

PeptideScanner retained ClinicalTrials.gov record NCT04026256 at 2026-07-30T19:09:38.366Z. Its registry update date was 2023-08-02, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 14, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT03936049

PeptideScanner retained ClinicalTrials.gov record NCT03936049 at 2026-07-30T19:10:42.712Z. Its registry update date was 2023-07-27, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT04879420

PeptideScanner retained ClinicalTrials.gov record NCT04879420 at 2026-07-30T19:10:42.715Z. Its registry update date was 2023-07-27, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT04897958

PeptideScanner retained ClinicalTrials.gov record NCT04897958 at 2026-07-30T19:10:42.712Z. Its registry update date was 2023-07-27, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Exenatide

ClinicalTrials.gov record NCT03331289

PeptideScanner retained ClinicalTrials.gov record NCT03331289 at 2026-07-30T19:10:42.713Z. Its registry update date was 2023-07-24, and PeptideScanner's reviewed identity mapping was exenatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT03374956

PeptideScanner retained ClinicalTrials.gov record NCT03374956 at 2026-07-30T19:10:42.750Z. Its registry update date was 2023-07-18, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT02527200

PeptideScanner retained ClinicalTrials.gov record NCT02527200 at 2026-07-30T19:10:42.748Z. Its registry update date was 2023-07-06, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT00427349

PeptideScanner retained ClinicalTrials.gov record NCT00427349 at 2026-07-30T19:10:42.711Z. Its registry update date was 2023-07-05, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 14, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Lanreotide

ClinicalTrials.gov record NCT03043664

PeptideScanner retained ClinicalTrials.gov record NCT03043664 at 2026-07-30T19:11:49.726Z. Its registry update date was 2023-06-29, and PeptideScanner's reviewed identity mapping was lanreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Pramlintide

ClinicalTrials.gov record NCT01841359

PeptideScanner retained ClinicalTrials.gov record NCT01841359 at 2026-07-30T19:11:49.725Z. Its registry update date was 2023-06-29, and PeptideScanner's reviewed identity mapping was pramlintide.

Added August 8, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Octreotide

Drugs@FDA application ANDA216839

The official Drugs@FDA dataset lists original submission 1 for ANDA 216839 with status AP dated 2023-06-22, and names octreotide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT00003057

PeptideScanner retained ClinicalTrials.gov record NCT00003057 at 2026-07-30T19:11:49.726Z. Its registry update date was 2023-06-18, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT00003283

PeptideScanner retained ClinicalTrials.gov record NCT00003283 at 2026-07-30T19:11:49.727Z. Its registry update date was 2023-06-15, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Octreotide

Drugs@FDA application ANDA216807

The official Drugs@FDA dataset lists original submission 1 for ANDA 216807 with status AP dated 2023-06-13, and names octreotide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Literature metadata · MOTS-c

Mitochondrial-Encoded Peptide MOTS-c, Diabetes, and Aging-Related Diseases.

PubMed lists PMID 36824008 in Diabetes & metabolism journal as Journal Article, Review, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, with publication-date metadata of 2023-02-24 (day precision). PeptideScanner associated the retained record with the identity slug mots-c. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT04605861

PeptideScanner retained ClinicalTrials.gov record NCT04605861 at 2026-07-30T19:11:49.726Z. Its registry update date was 2023-06-07, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT02333565

PeptideScanner retained ClinicalTrials.gov record NCT02333565 at 2026-07-30T19:13:03.754Z. Its registry update date was 2023-05-25, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT02384122

PeptideScanner retained ClinicalTrials.gov record NCT02384122 at 2026-07-30T19:13:03.754Z. Its registry update date was 2023-05-24, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Setmelanotide

ClinicalTrials.gov record NCT03287960

PeptideScanner retained ClinicalTrials.gov record NCT03287960 at 2026-07-30T19:13:03.752Z. Its registry update date was 2023-05-23, and PeptideScanner's reviewed identity mapping was setmelanotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Lixisenatide

Comprehensive Evaluation of Combination Therapy with Basal Insulin and Either Lixisenatide or Vildagliptin in Japanese Patients with Type 2 Diabetes: A Randomized, Open-Label, Parallel-Group, Multice…

PubMed lists PMID 30206903 in Diabetes therapy : research, treatment and education of diabetes and related disorders as Journal Article, with publication-date metadata of 2018-09-11 (day precision). PeptideScanner associated the retained record with the identity slug lixisenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT03072147

PeptideScanner retained ClinicalTrials.gov record NCT03072147 at 2026-07-30T19:13:03.748Z. Its registry update date was 2023-05-12, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT01779362

PeptideScanner retained ClinicalTrials.gov record NCT01779362 at 2026-07-30T19:13:03.753Z. Its registry update date was 2023-05-11, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Glucagon

ClinicalTrials.gov record NCT04859322

PeptideScanner retained ClinicalTrials.gov record NCT04859322 at 2026-07-30T19:13:03.753Z. Its registry update date was 2023-05-11, and PeptideScanner's reviewed identity mapping was glucagon.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT02058706

PeptideScanner retained ClinicalTrials.gov record NCT02058706 at 2026-07-30T19:13:03.747Z. Its registry update date was 2023-05-10, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Exenatide

ClinicalTrials.gov record NCT01416649

PeptideScanner retained ClinicalTrials.gov record NCT01416649 at 2026-07-30T19:14:02.187Z. Its registry update date was 2023-04-26, and PeptideScanner's reviewed identity mapping was exenatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Afamelanotide

ClinicalTrials.gov record NCT04962503

PeptideScanner retained ClinicalTrials.gov record NCT04962503 at 2026-07-30T19:14:02.188Z. Its registry update date was 2023-04-11, and PeptideScanner's reviewed identity mapping was afamelanotide.

Added August 8, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Abaloparatide

ClinicalTrials.gov record NCT03512262

PeptideScanner retained ClinicalTrials.gov record NCT03512262 at 2026-07-30T19:14:02.186Z. Its registry update date was 2023-04-07, and PeptideScanner's reviewed identity mapping was abaloparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT04172987

PeptideScanner retained ClinicalTrials.gov record NCT04172987 at 2026-07-30T19:15:14.513Z. Its registry update date was 2023-03-27, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT03940742

PeptideScanner retained ClinicalTrials.gov record NCT03940742 at 2026-07-30T19:15:14.510Z. Its registry update date was 2023-03-24, and PeptideScanner's reviewed identity mapping was tirzepatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT00001259

PeptideScanner retained ClinicalTrials.gov record NCT00001259 at 2026-07-30T19:15:14.515Z. Its registry update date was 2023-03-02, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · MOTS-c

Circulating levels of mitochondrial oxidative stress-related peptides MOTS-c and Romo1 in stable COPD: A cross-sectional study.

PubMed lists PMID 36844198 in Frontiers in medicine as Journal Article, with publication-date metadata of 2023-02-08 (day precision). PeptideScanner associated the retained record with the identity slug mots-c. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Regulatory · Afamelanotide + 3 more

Federal Register notice 2023-03364

The Federal Register published notice 2023-03364, attributed to FDA and its parent HHS department, on 2023-02-17. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Afamelanotide, Glucagon, Leuprolide and Vosoritide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT03043807

PeptideScanner retained ClinicalTrials.gov record NCT03043807 at 2026-07-30T19:16:22.177Z. Its registry update date was 2023-02-16, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Abaloparatide

ClinicalTrials.gov record NCT04064411

PeptideScanner retained ClinicalTrials.gov record NCT04064411 at 2026-07-30T19:16:22.171Z. Its registry update date was 2023-02-15, and PeptideScanner's reviewed identity mapping was abaloparatide.

Added August 14, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT04589819

PeptideScanner retained ClinicalTrials.gov record NCT04589819 at 2026-07-30T19:16:22.171Z. Its registry update date was 2023-02-13, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Afamelanotide

ClinicalTrials.gov record NCT05368857

PeptideScanner retained ClinicalTrials.gov record NCT05368857 at 2026-07-30T19:16:22.169Z. Its registry update date was 2023-02-09, and PeptideScanner's reviewed identity mapping was afamelanotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Linaclotide

Drugs@FDA application ANDA209611

The official Drugs@FDA dataset lists original submission 1 for ANDA 209611 with status AP dated 2023-02-07, and names linaclotide among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Literature metadata · Pramlintide

Development and validation of a new robust RP-HPLC method for simultaneous quantitation of insulin and pramlintide in non-invasive and smart glucose-responsive microparticles.

PubMed lists PMID 36704426 in Research in pharmaceutical sciences as Journal Article, with publication-date metadata of 2022-10-29 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT03472846

PeptideScanner retained ClinicalTrials.gov record NCT03472846 at 2026-07-30T19:17:35.707Z. Its registry update date was 2023-01-26, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Abaloparatide

ClinicalTrials.gov record NCT03746041

PeptideScanner retained ClinicalTrials.gov record NCT03746041 at 2026-07-30T19:17:35.680Z. Its registry update date was 2023-01-23, and PeptideScanner's reviewed identity mapping was abaloparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT02967757

PeptideScanner retained ClinicalTrials.gov record NCT02967757 at 2026-07-30T19:17:35.705Z. Its registry update date was 2023-01-20, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Bremelanotide

An evaluation of bremelanotide injection for the treatment of hypoactive sexual desire disorder.

PubMed lists PMID 36242769 in Expert opinion on pharmacotherapy as Journal Article, Review, with publication-date metadata of 2022-10-18 (day precision). PeptideScanner associated the retained record with the identity slug bremelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT02440581

PeptideScanner retained ClinicalTrials.gov record NCT02440581 at 2026-07-30T19:17:35.692Z. Its registry update date was 2023-01-05, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · MOTS-c

The mitochondrial-derived peptide MOTS-c: a player in exceptional longevity?

PubMed lists PMID 26289118 in Aging cell as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2015-08-20 (day precision). PeptideScanner associated the retained record with the identity slug mots-c. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Afamelanotide

Afamelanotide implants and narrow-band ultraviolet B phototherapy for the treatment of nonsegmental vitiligo in Asians.

PubMed lists PMID 31987791 in Journal of the American Academy of Dermatology as Letter, Randomized Controlled Trial, with publication-date metadata of 2020-01-25 (day precision). PeptideScanner associated the retained record with the identity slug afamelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Cagrilintide

PubMed record PMID 36242844

PeptideScanner retained PubMed bibliographic metadata for PMID 36242844 at 2026-07-30T19:34:05.168Z. PubMed recorded a metadata revision date of 2022-11-29 and an Entrez history date of 2022-10-15. PeptideScanner associated this retained record with the identity slug cagrilintide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT01796301

PeptideScanner retained ClinicalTrials.gov record NCT01796301 at 2026-07-30T19:32:59.853Z. Its registry update date was 2022-11-29, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT03479762

PeptideScanner retained ClinicalTrials.gov record NCT03479762 at 2026-07-30T19:32:59.846Z. Its registry update date was 2022-11-25, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT05153590

PeptideScanner retained ClinicalTrials.gov record NCT05153590 at 2026-07-30T19:32:59.847Z. Its registry update date was 2022-11-17, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Glucagon

ClinicalTrials.gov record NCT04042142

PeptideScanner retained ClinicalTrials.gov record NCT04042142 at 2026-07-30T19:32:59.855Z. Its registry update date was 2022-11-04, and PeptideScanner's reviewed identity mapping was glucagon.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Leuprolide

Drugs@FDA application ANDA215336

The official Drugs@FDA dataset lists original submission 1 for ANDA 215336 with status AP dated 2022-10-28, and names leuprolide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Literature metadata · MOTS-c

MOTS-c, the Most Recent Mitochondrial Derived Peptide in Human Aging and Age-Related Diseases.

PubMed lists PMID 36233287 in International journal of molecular sciences as Journal Article, Review, with publication-date metadata of 2022-10-09 (day precision). PeptideScanner associated the retained record with the identity slug mots-c. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT02064036

PeptideScanner retained ClinicalTrials.gov record NCT02064036 at 2026-07-30T19:34:18.792Z. Its registry update date was 2022-10-18, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Lanreotide

ClinicalTrials.gov record NCT00774930

PeptideScanner retained ClinicalTrials.gov record NCT00774930 at 2026-07-30T19:34:18.792Z. Its registry update date was 2022-10-14, and PeptideScanner's reviewed identity mapping was lanreotide.

Added August 14, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Setmelanotide

Structural analysis of setmelanotide binding to MC4R variants in comparison to wild-type receptor.

PubMed lists PMID 35931197 in Life sciences as Journal Article, with publication-date metadata of 2022-08-02 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Tesamorelin

ClinicalTrials.gov record NCT00608023

PeptideScanner retained ClinicalTrials.gov record NCT00608023 at 2026-07-30T19:35:26.307Z. Its registry update date was 2022-09-30, and PeptideScanner's reviewed identity mapping was tesamorelin.

Added August 14, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Exenatide

ClinicalTrials.gov record NCT03456687

PeptideScanner retained ClinicalTrials.gov record NCT03456687 at 2026-07-30T19:35:26.142Z. Its registry update date was 2022-09-16, and PeptideScanner's reviewed identity mapping was exenatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Vosoritide

Federal Register notice 2022-19155

The Federal Register published notice 2022-19155, attributed to FDA and its parent HHS department, on 2022-09-06. Its official title is “Issuance of Priority Review Voucher; Rare Pediatric Disease Product,” and PeptideScanner's exact reviewed identity mapping connects the document to Vosoritide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Clinical trials · Glucagon

ClinicalTrials.gov record NCT03255629

PeptideScanner retained ClinicalTrials.gov record NCT03255629 at 2026-07-30T19:35:26.311Z. Its registry update date was 2022-09-06, and PeptideScanner's reviewed identity mapping was glucagon.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Tirzepatide

Federal Register notice 2022-18523

The Federal Register published notice 2022-18523, attributed to FDA and its parent HHS department, on 2022-08-29. Its official title is “Notice of Approval of Product Under Voucher: Material Threat Medical Countermeasure Priority Review Voucher,” and PeptideScanner's exact reviewed identity mapping connects the document to Tirzepatide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Literature metadata · Pramlintide

Study of forced degradation behavior of pramlintide acetate by HPLC and LC-MS.

PubMed lists PMID 29389581 in Journal of food and drug analysis as Journal Article, with publication-date metadata of 2017-08-24 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 16, 2026 · Source: PubMed ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT01229943

PeptideScanner retained ClinicalTrials.gov record NCT01229943 at 2026-07-30T19:36:31.409Z. Its registry update date was 2022-08-04, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT02716974

PeptideScanner retained ClinicalTrials.gov record NCT02716974 at 2026-07-30T19:36:31.405Z. Its registry update date was 2022-08-04, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Setmelanotide

Federal Register notice 2022-16502

The Federal Register published notice 2022-16502, attributed to FDA and its parent HHS department, on 2022-08-03. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Setmelanotide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Clinical trials · Glucagon

ClinicalTrials.gov record NCT02748369

PeptideScanner retained ClinicalTrials.gov record NCT02748369 at 2026-07-30T19:36:31.410Z. Its registry update date was 2022-08-03, and PeptideScanner's reviewed identity mapping was glucagon.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT04225221

PeptideScanner retained ClinicalTrials.gov record NCT04225221 at 2026-07-30T19:37:37.629Z. Its registry update date was 2022-07-26, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Dulaglutide

Glycaemic variability in patients with type 2 diabetes mellitus treated with dulaglutide, with and without concomitant insulin: Post hoc analyses of randomized clinical trials.

PubMed lists PMID 34866291 in Diabetes, obesity & metabolism as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2021-12-19 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Regulatory · Setmelanotide

Federal Register notice 2022-14134

The Federal Register published notice 2022-14134, attributed to FDA and its parent HHS department, on 2022-07-01. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; IMCIVREE,” and PeptideScanner's exact reviewed identity mapping connects the document to Setmelanotide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Clinical trials · Glucagon

ClinicalTrials.gov record NCT04007809

PeptideScanner retained ClinicalTrials.gov record NCT04007809 at 2026-07-30T19:38:43.098Z. Its registry update date was 2022-06-28, and PeptideScanner's reviewed identity mapping was glucagon.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Bremelanotide

The neurobiology of bremelanotide for the treatment of hypoactive sexual desire disorder in premenopausal women.

PubMed lists PMID 33455598 in CNS spectrums as Journal Article, Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2021-01-18 (day precision). PeptideScanner associated the retained record with the identity slug bremelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT02770391

PeptideScanner retained ClinicalTrials.gov record NCT02770391 at 2026-07-30T19:38:43.103Z. Its registry update date was 2022-06-21, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Exenatide

ClinicalTrials.gov record NCT00775684

PeptideScanner retained ClinicalTrials.gov record NCT00775684 at 2026-07-30T19:38:43.099Z. Its registry update date was 2022-06-07, and PeptideScanner's reviewed identity mapping was exenatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Leuprolide

Drugs@FDA application ANDA212963

The official Drugs@FDA dataset lists original submission 1 for ANDA 212963 with status AP dated 2022-06-06, and names leuprolide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Literature metadata · Plecanatide

Liquid-Phase Total Synthesis of Plecanatide Aided by Diphenylphosphinyloxyl Diphenyl Ketone (DDK) Derivatives.

PubMed lists PMID 32275447 in Organic letters as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2020-04-10 (day precision). PeptideScanner associated the retained record with the identity slug plecanatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT02010385

PeptideScanner retained ClinicalTrials.gov record NCT02010385 at 2026-07-30T19:39:59.677Z. Its registry update date was 2022-05-23, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Exenatide + 1 more

Federal Register notice 2022-10701

The Federal Register published notice 2022-10701, attributed to FDA and its parent HHS department, on 2022-05-20. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Exenatide and Linaclotide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Regulatory · Tirzepatide

Drugs@FDA application NDA215866

The official Drugs@FDA dataset lists original submission 1 for NDA 215866 with status AP dated 2022-05-13, and names tirzepatide among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT03520569

PeptideScanner retained ClinicalTrials.gov record NCT03520569 at 2026-07-30T19:39:59.677Z. Its registry update date was 2022-05-13, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Exenatide

ClinicalTrials.gov record NCT02664441

PeptideScanner retained ClinicalTrials.gov record NCT02664441 at 2026-07-30T19:39:59.673Z. Its registry update date was 2022-05-05, and PeptideScanner's reviewed identity mapping was exenatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT02268175

PeptideScanner retained ClinicalTrials.gov record NCT02268175 at 2026-07-30T19:40:58.917Z. Its registry update date was 2022-04-19, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT02765399

PeptideScanner retained ClinicalTrials.gov record NCT02765399 at 2026-07-30T19:40:58.914Z. Its registry update date was 2022-04-12, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Plecanatide

A Randomized Phase III Clinical Trial of Plecanatide, a Uroguanylin Analog, in Patients With Chronic Idiopathic Constipation.

PubMed lists PMID 28169285 in The American journal of gastroenterology as Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2017-02-07 (day precision). PeptideScanner associated the retained record with the identity slug plecanatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT00754442

PeptideScanner retained ClinicalTrials.gov record NCT00754442 at 2026-07-30T19:40:58.915Z. Its registry update date was 2022-04-01, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Pramlintide

Pramlintide and the treatment of diabetes: a review of the data since its introduction.

PubMed lists PMID 21564002 in Expert opinion on pharmacotherapy as Journal Article, Review, with publication-date metadata of 2011-05-13 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Pramlintide

Activity of pramlintide, rat and human amylin but not Aβ1-42 at human amylin receptors.

PubMed lists PMID 24169554 in Endocrinology as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2013-12-20 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Vosoritide

Vosoritide.

PubMed lists PMID 35180295 in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists as Journal Article, with publication-date metadata of 2022-03-07 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Lanreotide

ClinicalTrials.gov record NCT03158090

PeptideScanner retained ClinicalTrials.gov record NCT03158090 at 2026-07-30T19:42:14.203Z. Its registry update date was 2022-03-16, and PeptideScanner's reviewed identity mapping was lanreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Bremelanotide

Prespecified and Integrated Subgroup Analyses from the RECONNECT Phase 3 Studies of Bremelanotide.

PubMed lists PMID 35230162 in Journal of women's health (2002) as Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2022-02-25 (day precision). PeptideScanner associated the retained record with the identity slug bremelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Abaloparatide

Abaloparatide: a new anabolic therapy on the horizon.

PubMed lists PMID 25987981 in BoneKEy reports as Journal Article, with publication-date metadata of 2015-04-29 (day precision). PeptideScanner associated the retained record with the identity slug abaloparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Regulatory · Leuprolide

Federal Register notice 2022-03248

The Federal Register published notice 2022-03248, attributed to FDA and its parent HHS department, on 2022-02-18. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Leuprolide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Literature metadata · Vosoritide

Vosoritide: First Approval.

PubMed lists PMID 34694597 in Drugs as Journal Article, Review, with publication-date metadata of 2021-11 (month precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Bremelanotide

Bremelanotide for Treatment of Female Hypoactive Sexual Desire.

PubMed lists PMID 35076581 in Neurology international as Journal Article, Review, with publication-date metadata of 2022-01-04 (day precision). PeptideScanner associated the retained record with the identity slug bremelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT03548987

PeptideScanner retained ClinicalTrials.gov record NCT03548987 at 2026-07-30T19:44:52.954Z. Its registry update date was 2022-01-19, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT03085095

PeptideScanner retained ClinicalTrials.gov record NCT03085095 at 2026-07-30T19:44:52.972Z. Its registry update date was 2022-01-18, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT02122198

PeptideScanner retained ClinicalTrials.gov record NCT02122198 at 2026-07-30T19:44:52.962Z. Its registry update date was 2022-01-10, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Setmelanotide

ClinicalTrials.gov record NCT03262610

PeptideScanner retained ClinicalTrials.gov record NCT03262610 at 2026-07-30T19:44:52.963Z. Its registry update date was 2022-01-04, and PeptideScanner's reviewed identity mapping was setmelanotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · KPV

PubMed record PMID 34846053

PeptideScanner retained PubMed bibliographic metadata for PMID 34846053 at 2026-07-30T19:56:20.406Z. PubMed recorded a metadata revision date of 2021-12-23 and an Entrez history date of 2021-11-30. PeptideScanner associated this retained record with the identity slug kpv. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Regulatory · Lanreotide

Drugs@FDA application NDA215395

The official Drugs@FDA dataset lists original submission 1 for NDA 215395 with status AP dated 2021-12-17, and names lanreotide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Literature metadata · Dulaglutide

Acute Kidney Injury Occurring in a Patient Initiated on Dulaglutide.

PubMed lists PMID 34861012 in The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians as Journal Article, with publication-date metadata of 2018-06-25 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT03357380

PeptideScanner retained ClinicalTrials.gov record NCT03357380 at 2026-07-30T19:56:31.568Z. Its registry update date was 2021-11-22, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Vosoritide

Drugs@FDA application NDA214938

The official Drugs@FDA dataset lists original submission 1 for NDA 214938 with status AP dated 2021-11-19, and names vosoritide among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Literature metadata · Abaloparatide

The use of abaloparatide to treat nonunion following dorsal closing wedge osteotomy for Freiberg's disease: A case report.

PubMed lists PMID 34786439 in Bone reports as Case Reports, Journal Article, with publication-date metadata of 2021-10-30 (day precision). PeptideScanner associated the retained record with the identity slug abaloparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT03611582

PeptideScanner retained ClinicalTrials.gov record NCT03611582 at 2026-07-30T19:56:31.576Z. Its registry update date was 2021-11-11, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Glucagon + 1 more

Federal Register notice 2021-24431

The Federal Register published notice 2021-24431, attributed to FDA and its parent HHS department, on 2021-11-09. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Glucagon and Leuprolide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Regulatory · Afamelanotide

Federal Register notice 2021-24074

The Federal Register published notice 2021-24074, attributed to FDA and its parent HHS department, on 2021-11-04. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; SCENESSE,” and PeptideScanner's exact reviewed identity mapping connects the document to Afamelanotide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Clinical trials · Afamelanotide

ClinicalTrials.gov record NCT04943159

PeptideScanner retained ClinicalTrials.gov record NCT04943159 at 2026-07-30T19:57:27.404Z. Its registry update date was 2021-10-26, and PeptideScanner's reviewed identity mapping was afamelanotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Pramlintide

In silico design of optimal ratio for co-administration of pramlintide and insulin in type 1 diabetes.

PubMed lists PMID 23865841 in Diabetes technology & therapeutics as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2013-07-18 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Semax

Stability of Semax acetyl to proteolysis in various biological media.

PubMed lists PMID 23652441 in Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2013-05-08 (day precision). PeptideScanner associated the retained record with the identity slug semax. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Elamipretide

The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin.

PubMed lists PMID 23813215 in Journal of the American Society of Nephrology : JASN as Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, with publication-date metadata of 2013-07-11 (day precision). PeptideScanner associated the retained record with the identity slug elamipretide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Semax

Study of proteolysis of Semax analogues with different N-terminal amino acids by carboxypeptidases.

PubMed lists PMID 23821053 in Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2013-07-03 (day precision). PeptideScanner associated the retained record with the identity slug semax. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Tesamorelin

Population pharmacokinetic analysis of tesamorelin in HIV-infected patients and healthy subjects.

PubMed lists PMID 25358450 in Clinical pharmacokinetics as Clinical Trial, Phase I, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2015-03 (month precision). PeptideScanner associated the retained record with the identity slug tesamorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · KPV

PubMed record PMID 34547895

PeptideScanner retained PubMed bibliographic metadata for PMID 34547895 at 2026-07-30T19:58:34.757Z. PubMed recorded a metadata revision date of 2021-10-21 and an Entrez history date of 2021-09-22. PeptideScanner associated this retained record with the identity slug kpv. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · KPV

PubMed record PMID 22837805

PeptideScanner retained PubMed bibliographic metadata for PMID 22837805 at 2026-07-30T19:58:22.828Z. PubMed recorded a metadata revision date of 2021-10-21 and an Entrez history date of 2012-07-28. PeptideScanner associated this retained record with the identity slug kpv. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Clinical trials · Abaloparatide

ClinicalTrials.gov record NCT03710889

PeptideScanner retained ClinicalTrials.gov record NCT03710889 at 2026-07-30T19:57:27.406Z. Its registry update date was 2021-10-15, and PeptideScanner's reviewed identity mapping was abaloparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Afamelanotide

ClinicalTrials.gov record NCT00979745

PeptideScanner retained ClinicalTrials.gov record NCT00979745 at 2026-07-30T19:57:27.405Z. Its registry update date was 2021-10-12, and PeptideScanner's reviewed identity mapping was afamelanotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Setmelanotide

Setmelanotide: First Approval.

PubMed lists PMID 33638809 in Drugs as Journal Article, Review, with publication-date metadata of 2021-02 (month precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Afamelanotide

ClinicalTrials.gov record NCT04425746

PeptideScanner retained ClinicalTrials.gov record NCT04425746 at 2026-07-30T19:57:27.405Z. Its registry update date was 2021-10-01, and PeptideScanner's reviewed identity mapping was afamelanotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Setmelanotide

Setmelanotide Acetate.

PubMed lists PMID 33787829 in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists as Journal Article, with publication-date metadata of 2021-03-31 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Setmelanotide

Setmelanotide (Imcivree) for rare genetic forms of obesity.

PubMed lists PMID 34544109 in The Medical letter on drugs and therapeutics as Journal Article, Review, with publication-date metadata of 2021-07-26 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Regulatory · Exenatide

Federal Register notice 2021-18928

The Federal Register published notice 2021-18928, attributed to FDA and its parent HHS department, on 2021-09-02. Its official title is “Proposal To Refuse To Approve a New Drug Application for ITCA 650 (Exenatide in DUROS Device); Opportunity for a Hearing,” and PeptideScanner's exact reviewed identity mapping connects the document to Exenatide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Safety · Dulaglutide

FDA enforcement report D-0773-2021

FDA's dated enforcement report D-0773-2021 lists Class II and source status Terminated for Eli Lilly & Company. PeptideScanner connects the report to reviewed application BLA125469 through exact openFDA application-number annotations.

Added August 25, 2026 · Source: FDA enforcement reports via openFDA ↗

Regulatory · Leuprolide + 1 more

Federal Register notice 2021-18072

The Federal Register published notice 2021-18072, attributed to FDA and its parent HHS department, on 2021-08-23. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Leuprolide and Semaglutide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Literature metadata · Dulaglutide

Dulaglutide for erectile dysfunction in type 2 diabetes.

PubMed lists PMID 34153270 in The lancet. Diabetes & endocrinology as Journal Article, Comment, with publication-date metadata of 2021-06-18 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT03734627

PeptideScanner retained ClinicalTrials.gov record NCT03734627 at 2026-07-30T19:59:58.328Z. Its registry update date was 2021-08-16, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Leuprolide

Drugs@FDA application ANDA213829

The official Drugs@FDA dataset lists original submission 1 for ANDA 213829 with status AP dated 2021-08-13, and names leuprolide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Literature metadata · Setmelanotide

Setmelanotide: what does it mean for clinical care of patients with obesity?

PubMed lists PMID 33137294 in The lancet. Diabetes & endocrinology as Journal Article, Comment, with publication-date metadata of 2020-10-30 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT02023411

PeptideScanner retained ClinicalTrials.gov record NCT02023411 at 2026-07-30T20:02:09.392Z. Its registry update date was 2021-06-30, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT00003653

PeptideScanner retained ClinicalTrials.gov record NCT00003653 at 2026-07-30T20:02:09.393Z. Its registry update date was 2021-06-23, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Exenatide

ClinicalTrials.gov record NCT01590433

PeptideScanner retained ClinicalTrials.gov record NCT01590433 at 2026-07-30T20:02:09.394Z. Its registry update date was 2021-06-23, and PeptideScanner's reviewed identity mapping was exenatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Semax

Composition of Colon Microbiota in Rats Treated with ACTH(4-7)-PGP Peptide (Semax) under Conditions of Restraint Stress.

PubMed lists PMID 32737723 in Bulletin of experimental biology and medicine as Journal Article, with publication-date metadata of 2020-08-01 (day precision). PeptideScanner associated the retained record with the identity slug semax. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Regulatory · Semaglutide

Drugs@FDA application NDA215256

The official Drugs@FDA dataset lists original submission 1 for NDA 215256 with status AP dated 2021-06-04, and names semaglutide among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Regulatory · Octreotide

Federal Register notice 2021-11575

The Federal Register published notice 2021-11575, attributed to FDA and its parent HHS department, on 2021-06-02. Its official title is “Determination That SANDOSTATIN (Octreotide Acetate) Injection, Equal to 0.2 Milligrams Base/Milliliter and Equal to 1 Milligrams Base/Milliliter, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness,” and PeptideScanner's exact reviewed identity mapping connects the document to Octreotide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Literature metadata · Abaloparatide

Abaloparatide followed by alendronate in women ≥80 years with osteoporosis: post hoc analysis of ACTIVExtend.

PubMed lists PMID 32665529 in Menopause (New York, N.Y.) as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2020-10 (month precision). PeptideScanner associated the retained record with the identity slug abaloparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Glucagon

ClinicalTrials.gov record NCT04347252

PeptideScanner retained ClinicalTrials.gov record NCT04347252 at 2026-07-30T20:03:05.484Z. Its registry update date was 2021-05-14, and PeptideScanner's reviewed identity mapping was glucagon.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Exenatide

ClinicalTrials.gov record NCT02685852

PeptideScanner retained ClinicalTrials.gov record NCT02685852 at 2026-07-30T20:03:05.483Z. Its registry update date was 2021-05-06, and PeptideScanner's reviewed identity mapping was exenatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT01292252

PeptideScanner retained ClinicalTrials.gov record NCT01292252 at 2026-07-30T20:03:05.485Z. Its registry update date was 2021-05-03, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Abaloparatide

Abaloparatide Real-World Patient Experience Study.

PubMed lists PMID 33778325 in JBMR plus as Journal Article, with publication-date metadata of 2021-02-04 (day precision). PeptideScanner associated the retained record with the identity slug abaloparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Regulatory · Bremelanotide + 1 more

Federal Register notice 2021-06202

The Federal Register published notice 2021-06202, attributed to FDA and its parent HHS department, on 2021-03-25. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Bremelanotide and Octreotide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT02616003

PeptideScanner retained ClinicalTrials.gov record NCT02616003 at 2026-07-30T20:05:17.854Z. Its registry update date was 2021-03-23, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Afamelanotide

ClinicalTrials.gov record NCT04704713

PeptideScanner retained ClinicalTrials.gov record NCT04704713 at 2026-07-30T20:05:17.854Z. Its registry update date was 2021-03-19, and PeptideScanner's reviewed identity mapping was afamelanotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT01338987

PeptideScanner retained ClinicalTrials.gov record NCT01338987 at 2026-07-30T20:05:17.853Z. Its registry update date was 2021-03-18, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT03466021

PeptideScanner retained ClinicalTrials.gov record NCT03466021 at 2026-07-30T20:05:17.854Z. Its registry update date was 2021-03-16, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Dulaglutide

Comparative study of dulaglutide single-use pen Ateos versus insulin degludec FlexTouch on learning and mock administration time in Japanese patients with type 2 diabetes mellitus - a post-hoc analys…

PubMed lists PMID 32141343 in Current medical research and opinion as Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2020-03-19 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Abaloparatide

Erratum for Abaloparatide in Postmenopausal Women With Osteoporosis and Type 2 Diabetes: A Post Hoc Analysis of the ACTIVE Study.

PubMed lists PMID 33615100 in JBMR plus as Published Erratum, with publication-date metadata of 2020-11-03 (day precision). PeptideScanner associated the retained record with the identity slug abaloparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Regulatory · Linaclotide

Drugs@FDA application ANDA209564

The official Drugs@FDA dataset lists original submission 1 for ANDA 209564 with status AP dated 2021-02-09, and names linaclotide among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT02176382

PeptideScanner retained ClinicalTrials.gov record NCT02176382 at 2026-07-30T20:06:10.499Z. Its registry update date was 2021-02-09, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Dulaglutide

Dulaglutide for type 2 diabetes.

PubMed lists PMID 30410215 in Australian prescriber as Journal Article, Review, with publication-date metadata of 2018-09-11 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Lanreotide

ClinicalTrials.gov record NCT03012594

PeptideScanner retained ClinicalTrials.gov record NCT03012594 at 2026-07-30T20:07:13.495Z. Its registry update date was 2021-01-15, and PeptideScanner's reviewed identity mapping was lanreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT04206618

PeptideScanner retained ClinicalTrials.gov record NCT04206618 at 2026-07-30T20:07:13.493Z. Its registry update date was 2021-01-12, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Lixisenatide

Austrian Experience with Lixisenatide Under Real-Life Conditions: A Prospective Observational Study.

PubMed lists PMID 30656523 in Diabetes therapy : research, treatment and education of diabetes and related disorders as Journal Article, with publication-date metadata of 2019-01-17 (day precision). PeptideScanner associated the retained record with the identity slug lixisenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Regulatory · Glucagon

Drugs@FDA application ANDA208086

The official Drugs@FDA dataset lists original submission 1 for ANDA 208086 with status AP dated 2020-12-28, and names glucagon among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT03842202

PeptideScanner retained ClinicalTrials.gov record NCT03842202 at 2026-07-30T20:18:37.981Z. Its registry update date was 2020-12-24, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Linaclotide

ClinicalTrials.gov record NCT02220348

PeptideScanner retained ClinicalTrials.gov record NCT02220348 at 2026-07-30T20:18:37.979Z. Its registry update date was 2020-12-19, and PeptideScanner's reviewed identity mapping was linaclotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Setmelanotide

Federal Register notice 2020-27760

The Federal Register published notice 2020-27760, attributed to FDA and its parent HHS department, on 2020-12-17. Its official title is “Issuance of Priority Review Voucher; Rare Pediatric Disease Product,” and PeptideScanner's exact reviewed identity mapping connects the document to Setmelanotide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Regulatory · Setmelanotide

Drugs@FDA application NDA213793

The official Drugs@FDA dataset lists original submission 1 for NDA 213793 with status AP dated 2020-11-25, and names setmelanotide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Clinical trials · Afamelanotide

ClinicalTrials.gov record NCT04578496

PeptideScanner retained ClinicalTrials.gov record NCT04578496 at 2026-07-30T20:20:00.372Z. Its registry update date was 2020-11-19, and PeptideScanner's reviewed identity mapping was afamelanotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Dulaglutide

A CASE OF MORBILLIFORM DRUG ERUPTION TO DULAGLUTIDE.

PubMed lists PMID 33144906 in The Journal of clinical and aesthetic dermatology as Journal Article, with publication-date metadata of 2020-04-01 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Exenatide

ClinicalTrials.gov record NCT02404376

PeptideScanner retained ClinicalTrials.gov record NCT02404376 at 2026-07-30T20:20:00.368Z. Its registry update date was 2020-11-03, and PeptideScanner's reviewed identity mapping was exenatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT02064582

PeptideScanner retained ClinicalTrials.gov record NCT02064582 at 2026-07-30T20:21:17.072Z. Its registry update date was 2020-10-12, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT02916433

PeptideScanner retained ClinicalTrials.gov record NCT02916433 at 2026-07-30T20:21:17.072Z. Its registry update date was 2020-10-08, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Linaclotide

Linaclotide and Prucalopride for Management of Constipation in Patients with Parkinsonism.

PubMed lists PMID 30746404 in Movement disorders clinical practice as Journal Article, with publication-date metadata of 2018-01-28 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Linaclotide

Engineering of an Anti-Inflammatory Peptide Based on the Disulfide-Rich Linaclotide Scaffold.

PubMed lists PMID 30301200 in Biomedicines as Journal Article, with publication-date metadata of 2018-10-06 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT02563353

PeptideScanner retained ClinicalTrials.gov record NCT02563353 at 2026-07-30T20:22:36.942Z. Its registry update date was 2020-09-18, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT02059213

PeptideScanner retained ClinicalTrials.gov record NCT02059213 at 2026-07-30T20:22:36.939Z. Its registry update date was 2020-09-16, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT04129255

PeptideScanner retained ClinicalTrials.gov record NCT04129255 at 2026-07-30T20:22:36.942Z. Its registry update date was 2020-09-10, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Emideltide

Content of DSIP, enkephalins and ACTH in some tissues of active and hibernating ground squirrels (Citellus suslicus).

PubMed lists PMID 6132770 in Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology as Comparative Study, Journal Article, with publication-date metadata of 1983 (year precision). PeptideScanner associated the retained record with the identity slug emideltide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Regulatory · Bremelanotide

Federal Register notice 2020-18240

The Federal Register published notice 2020-18240, attributed to FDA and its parent HHS department, on 2020-08-20. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; VYLEESI,” and PeptideScanner's exact reviewed identity mapping connects the document to Bremelanotide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Clinical trials · Plecanatide

ClinicalTrials.gov record NCT02706483

PeptideScanner retained ClinicalTrials.gov record NCT02706483 at 2026-07-30T20:24:11.156Z. Its registry update date was 2020-08-18, and PeptideScanner's reviewed identity mapping was plecanatide.

Added August 8, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Exenatide

ClinicalTrials.gov record NCT00551343

PeptideScanner retained ClinicalTrials.gov record NCT00551343 at 2026-07-30T20:25:27.243Z. Its registry update date was 2020-07-07, and PeptideScanner's reviewed identity mapping was exenatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · BPC-157

An endogeous defensive concept, renewed cytoprotection/adaptive cytoprotection: intra(per)-oral/intragastric strong alcohol in rat. Involvement of pentadecapeptide BPC 157 and nitric oxide system.

PubMed lists PMID 30279308 in Journal of physiology and pharmacology : an official journal of the Polish Physiological Society as Journal Article, with publication-date metadata of 2018-09-28 (day precision). PeptideScanner associated the retained record with the identity slug bpc-157. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Bremelanotide

PubMed record PMID 31277966

PeptideScanner retained PubMed bibliographic metadata for PMID 31277966 at 2026-07-30T20:27:29.445Z. PubMed recorded a metadata revision date of 2020-06-29 and an Entrez history date of 2019-07-07. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Regulatory · Octreotide

Drugs@FDA application NDA208232

The official Drugs@FDA dataset lists original submission 1 for NDA 208232 with status AP dated 2020-06-26, and names octreotide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Literature metadata · MOTS-c

A possible role for mitochondrial-derived peptides humanin and MOTS-c in patients with Q fever fatigue syndrome and chronic fatigue syndrome.

PubMed lists PMID 31088495 in Journal of translational medicine as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2019-05-14 (day precision). PeptideScanner associated the retained record with the identity slug mots-c. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Exenatide

ClinicalTrials.gov record NCT04303819

PeptideScanner retained ClinicalTrials.gov record NCT04303819 at 2026-07-30T20:26:41.665Z. Its registry update date was 2020-06-11, and PeptideScanner's reviewed identity mapping was exenatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT02650206

PeptideScanner retained ClinicalTrials.gov record NCT02650206 at 2026-07-30T20:26:41.666Z. Its registry update date was 2020-06-09, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Dulaglutide

Body weight and eGFR during dulaglutide treatment in type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7).

PubMed lists PMID 30762290 in Diabetes, obesity & metabolism as Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2019-03-29 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Afamelanotide

PubMed record PMID 32459219

PeptideScanner retained PubMed bibliographic metadata for PMID 32459219 at 2026-07-30T20:28:46.334Z. PubMed recorded a metadata revision date of 2020-05-29 and an Entrez history date of 2020-05-28. PeptideScanner associated this retained record with the identity slug afamelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Glucagon

ClinicalTrials.gov record NCT03770637

PeptideScanner retained ClinicalTrials.gov record NCT03770637 at 2026-07-30T20:27:50.524Z. Its registry update date was 2020-05-21, and PeptideScanner's reviewed identity mapping was glucagon.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Elamipretide

ClinicalTrials.gov record NCT02788747

PeptideScanner retained ClinicalTrials.gov record NCT02788747 at 2026-07-30T20:27:50.521Z. Its registry update date was 2020-05-14, and PeptideScanner's reviewed identity mapping was elamipretide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Dulaglutide

Dulaglutide-related bullous pemphigoid in a patient with type 2 diabetes: A case report.

PubMed lists PMID 31823494 in Geriatrics & gerontology international as Case Reports, Letter, with publication-date metadata of 2019-12 (month precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Lixisenatide

ClinicalTrials.gov record NCT02640118

PeptideScanner retained ClinicalTrials.gov record NCT02640118 at 2026-07-30T20:27:50.520Z. Its registry update date was 2020-05-07, and PeptideScanner's reviewed identity mapping was lixisenatide.

Added August 8, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Leuprolide

Drugs@FDA application NDA213150

The official Drugs@FDA dataset lists original submission 1 for NDA 213150 with status AP dated 2020-05-01, and names leuprolide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Literature metadata · Plecanatide

PubMed record PMID 30277094

PeptideScanner retained PubMed bibliographic metadata for PMID 30277094 at 2026-07-30T20:30:10.458Z. PubMed recorded a metadata revision date of 2020-04-27 and an Entrez history date of 2018-10-03. PeptideScanner associated this retained record with the identity slug plecanatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT02918279

PeptideScanner retained ClinicalTrials.gov record NCT02918279 at 2026-07-30T20:29:13.572Z. Its registry update date was 2020-04-27, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Linaclotide

ClinicalTrials.gov record NCT02559206

PeptideScanner retained ClinicalTrials.gov record NCT02559206 at 2026-07-30T20:29:13.579Z. Its registry update date was 2020-04-24, and PeptideScanner's reviewed identity mapping was linaclotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Tesamorelin

PubMed record PMID 31237318

PeptideScanner retained PubMed bibliographic metadata for PMID 31237318 at 2026-07-30T20:30:10.504Z. PubMed recorded a metadata revision date of 2020-04-07 and an Entrez history date of 2019-06-26. PeptideScanner associated this retained record with the identity slug tesamorelin. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT00002633

PeptideScanner retained ClinicalTrials.gov record NCT00002633 at 2026-07-30T20:29:13.591Z. Its registry update date was 2020-04-03, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT00002864

PeptideScanner retained ClinicalTrials.gov record NCT00002864 at 2026-07-30T20:29:13.581Z. Its registry update date was 2020-04-01, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Plecanatide

PubMed record PMID 30649746

PeptideScanner retained PubMed bibliographic metadata for PMID 30649746 at 2026-07-30T20:31:47.875Z. PubMed recorded a metadata revision date of 2020-03-09 and an Entrez history date of 2019-01-17. PeptideScanner associated this retained record with the identity slug plecanatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Afamelanotide

PubMed record PMID 28063031

PeptideScanner retained PubMed bibliographic metadata for PMID 28063031 at 2026-07-30T20:31:47.806Z. PubMed recorded a metadata revision date of 2020-03-06 and an Entrez history date of 2017-01-08. PeptideScanner associated this retained record with the identity slug afamelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Regulatory · Liraglutide + 1 more

Federal Register notice 2020-04320

The Federal Register published notice 2020-04320, attributed to FDA and its parent HHS department, on 2020-03-03. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Liraglutide and Semaglutide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Literature metadata · Lixisenatide

PubMed record PMID 31873867

PeptideScanner retained PubMed bibliographic metadata for PMID 31873867 at 2026-07-30T20:33:08.013Z. PubMed recorded a metadata revision date of 2020-02-26 and an Entrez history date of 2019-12-25. PeptideScanner associated this retained record with the identity slug lixisenatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Bremelanotide

PubMed record PMID 31429064

PeptideScanner retained PubMed bibliographic metadata for PMID 31429064 at 2026-07-30T20:33:07.992Z. PubMed recorded a metadata revision date of 2020-02-25 and an Entrez history date of 2019-08-21. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT04281680

PeptideScanner retained ClinicalTrials.gov record NCT04281680 at 2026-07-30T20:32:04.760Z. Its registry update date was 2020-02-24, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT04175665

PeptideScanner retained ClinicalTrials.gov record NCT04175665 at 2026-07-30T20:32:04.760Z. Its registry update date was 2020-02-21, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT02351232

PeptideScanner retained ClinicalTrials.gov record NCT02351232 at 2026-07-30T20:32:04.755Z. Its registry update date was 2020-02-12, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · GHK-Cu

PubMed record PMID 31500015

PeptideScanner retained PubMed bibliographic metadata for PMID 31500015 at 2026-07-30T20:34:13.000Z. PubMed recorded a metadata revision date of 2020-01-28 and an Entrez history date of 2019-09-11. PeptideScanner associated this retained record with the identity slug ghk-cu. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT00226967

PeptideScanner retained ClinicalTrials.gov record NCT00226967 at 2026-07-30T20:33:20.622Z. Its registry update date was 2020-01-27, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tesamorelin

ClinicalTrials.gov record NCT02196831

PeptideScanner retained ClinicalTrials.gov record NCT02196831 at 2026-07-30T20:33:20.623Z. Its registry update date was 2020-01-27, and PeptideScanner's reviewed identity mapping was tesamorelin.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · GHK-Cu

PubMed record PMID 31809714

PeptideScanner retained PubMed bibliographic metadata for PMID 31809714 at 2026-07-30T20:34:13.013Z. PubMed recorded a metadata revision date of 2020-01-23 and an Entrez history date of 2019-12-07. PeptideScanner associated this retained record with the identity slug ghk-cu. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Regulatory · Semaglutide

Drugs@FDA application NDA213182

The official Drugs@FDA dataset lists original submission 1 for NDA 213182 with status AP dated 2020-01-16, and names semaglutide among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Literature metadata · CJC-1295

PubMed record PMID 30938069

PeptideScanner retained PubMed bibliographic metadata for PMID 30938069 at 2026-07-30T20:34:12.987Z. PubMed recorded a metadata revision date of 2020-01-13 and an Entrez history date of 2019-04-03. PeptideScanner associated this retained record with the identity slug cjc-1295. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Plecanatide

PubMed record PMID 30550753

PeptideScanner retained PubMed bibliographic metadata for PMID 30550753 at 2026-07-30T20:34:12.979Z. PubMed recorded a metadata revision date of 2020-01-07 and an Entrez history date of 2018-12-15. PeptideScanner associated this retained record with the identity slug plecanatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT01440803

PeptideScanner retained ClinicalTrials.gov record NCT01440803 at 2026-07-30T20:42:14.438Z. Its registry update date was 2019-12-11, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Pramlintide

Amyloidogenesis of the amylin analogue pramlintide.

PubMed lists PMID 27665170 in Biophysical chemistry as Journal Article, with publication-date metadata of 2016-09-20 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · BPC-157

Detection and in vitro metabolism of the confiscated peptides BPC 157 and MGF R23H.

PubMed lists PMID 28035768 in Drug testing and analysis as Journal Article, Validation Study, with publication-date metadata of 2017-02-10 (day precision). PeptideScanner associated the retained record with the identity slug bpc-157. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Pramlintide

Physico-chemical properties of co-formulated fast-acting insulin with pramlintide.

PubMed lists PMID 29928940 in International journal of pharmaceutics as Journal Article, with publication-date metadata of 2018-06-19 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Epitalon

PubMed record PMID 25535022

PeptideScanner retained PubMed bibliographic metadata for PMID 25535022 at 2026-07-30T20:43:08.960Z. PubMed recorded a metadata revision date of 2019-12-10 and an Entrez history date of 2014-12-24. PeptideScanner associated this retained record with the identity slug epitalon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Ipamorelin

PubMed record PMID 25869809

PeptideScanner retained PubMed bibliographic metadata for PMID 25869809 at 2026-07-30T20:43:08.964Z. PubMed recorded a metadata revision date of 2019-12-10 and an Entrez history date of 2015-04-15. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · KPV

PubMed record PMID 25298219

PeptideScanner retained PubMed bibliographic metadata for PMID 25298219 at 2026-07-30T20:43:08.957Z. PubMed recorded a metadata revision date of 2019-12-10 and an Entrez history date of 2014-10-10. PeptideScanner associated this retained record with the identity slug kpv. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · CJC-1295

PubMed record PMID 30489688

PeptideScanner retained PubMed bibliographic metadata for PMID 30489688 at 2026-07-30T20:43:12.045Z. PubMed recorded a metadata revision date of 2019-12-10 and an Entrez history date of 2018-11-30. PeptideScanner associated this retained record with the identity slug cjc-1295. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Clinical trials · Glucagon

ClinicalTrials.gov record NCT02937558

PeptideScanner retained ClinicalTrials.gov record NCT02937558 at 2026-07-30T20:42:14.438Z. Its registry update date was 2019-12-10, and PeptideScanner's reviewed identity mapping was glucagon.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Semaglutide

Federal Register notice 2019-25850

The Federal Register published notice 2019-25850, attributed to FDA and its parent HHS department, on 2019-11-29. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; OZEMPIC,” and PeptideScanner's exact reviewed identity mapping connects the document to Semaglutide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Literature metadata · Plecanatide

PubMed record PMID 31575291

PeptideScanner retained PubMed bibliographic metadata for PMID 31575291 at 2026-07-30T20:44:20.978Z. PubMed recorded a metadata revision date of 2019-11-22 and an Entrez history date of 2019-10-03. PeptideScanner associated this retained record with the identity slug plecanatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Plecanatide

ClinicalTrials.gov record NCT03551873

PeptideScanner retained ClinicalTrials.gov record NCT03551873 at 2026-07-30T20:43:27.317Z. Its registry update date was 2019-11-22, and PeptideScanner's reviewed identity mapping was plecanatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Plecanatide

PubMed record PMID 29276262

PeptideScanner retained PubMed bibliographic metadata for PMID 29276262 at 2026-07-30T20:44:20.511Z. PubMed recorded a metadata revision date of 2019-11-20 and an Entrez history date of 2017-12-26. PeptideScanner associated this retained record with the identity slug plecanatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Bremelanotide

PubMed record PMID 30290453

PeptideScanner retained PubMed bibliographic metadata for PMID 30290453 at 2026-07-30T20:44:20.566Z. PubMed recorded a metadata revision date of 2019-11-20 and an Entrez history date of 2018-10-07. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Afamelanotide

PubMed record PMID 30517779

PeptideScanner retained PubMed bibliographic metadata for PMID 30517779 at 2026-07-30T20:44:20.583Z. PubMed recorded a metadata revision date of 2019-11-20 and an Entrez history date of 2018-12-06. PeptideScanner associated this retained record with the identity slug afamelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Lixisenatide

PubMed record PMID 30736157

PeptideScanner retained PubMed bibliographic metadata for PMID 30736157 at 2026-07-30T20:44:20.586Z. PubMed recorded a metadata revision date of 2019-11-20 and an Entrez history date of 2019-02-10. PeptideScanner associated this retained record with the identity slug lixisenatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Lixisenatide

PubMed record PMID 30736158

PeptideScanner retained PubMed bibliographic metadata for PMID 30736158 at 2026-07-30T20:44:20.587Z. PubMed recorded a metadata revision date of 2019-11-20 and an Entrez history date of 2019-02-10. PeptideScanner associated this retained record with the identity slug lixisenatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Tesamorelin

PubMed record PMID 30764032

PeptideScanner retained PubMed bibliographic metadata for PMID 30764032 at 2026-07-30T20:44:20.588Z. PubMed recorded a metadata revision date of 2019-11-20 and an Entrez history date of 2019-02-16. PeptideScanner associated this retained record with the identity slug tesamorelin. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Lixisenatide

PubMed record PMID 28420696

PeptideScanner retained PubMed bibliographic metadata for PMID 28420696 at 2026-07-30T20:44:20.465Z. PubMed recorded a metadata revision date of 2019-11-20 and an Entrez history date of 2017-04-20. PeptideScanner associated this retained record with the identity slug lixisenatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Lixisenatide

PubMed record PMID 28428368

PeptideScanner retained PubMed bibliographic metadata for PMID 28428368 at 2026-07-30T20:44:20.465Z. PubMed recorded a metadata revision date of 2019-11-20 and an Entrez history date of 2017-04-22. PeptideScanner associated this retained record with the identity slug lixisenatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · BPC-157

Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications.

PubMed lists PMID 27138887 in Current neuropharmacology as Journal Article, Review, with publication-date metadata of 2016 (year precision). PeptideScanner associated the retained record with the identity slug bpc-157. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Epitalon

PubMed record PMID 14501183

PeptideScanner retained PubMed bibliographic metadata for PMID 14501183 at 2026-07-30T20:44:18.228Z. PubMed recorded a metadata revision date of 2019-11-08 and an Entrez history date of 2003-09-23. PeptideScanner associated this retained record with the identity slug epitalon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Bremelanotide

PubMed record PMID 31381550

PeptideScanner retained PubMed bibliographic metadata for PMID 31381550 at 2026-07-30T20:44:20.977Z. PubMed recorded a metadata revision date of 2019-11-08 and an Entrez history date of 2019-08-06. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Pramlintide

Pramlintide as an adjunct to insulin therapy.

PubMed lists PMID 12685439 in Current diabetes reports as Comment, Journal Article, with publication-date metadata of 2003-02 (month precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Tesamorelin

ClinicalTrials.gov record NCT02553603

PeptideScanner retained ClinicalTrials.gov record NCT02553603 at 2026-07-30T20:43:27.316Z. Its registry update date was 2019-11-04, and PeptideScanner's reviewed identity mapping was tesamorelin.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · BPC-157

Long-lasting cytoprotection after pentadecapeptide BPC 157, ranitidine, sucralfate or cholestyramine application in reflux oesophagitis in rats.

PubMed lists PMID 10672991 in Journal of physiology, Paris as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 1999-12 (month precision). PeptideScanner associated the retained record with the identity slug bpc-157. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Afamelanotide

ClinicalTrials.gov record NCT01097044

PeptideScanner retained ClinicalTrials.gov record NCT01097044 at 2026-07-30T20:44:36.694Z. Its registry update date was 2019-10-28, and PeptideScanner's reviewed identity mapping was afamelanotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT01865760

PeptideScanner retained ClinicalTrials.gov record NCT01865760 at 2026-07-30T20:44:36.695Z. Its registry update date was 2019-10-28, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Semax

[Proteolysis of semax analogues with different N-terminal amino acids by aminopeptidases].

PubMed lists PMID 22096989 in Bioorganicheskaia khimiia as Journal Article, with publication-date metadata of 2011 Jul-Aug (source-text precision). PeptideScanner associated the retained record with the identity slug semax. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Semax

[The binding of Semax, ACTH 4-10 heptapeptide, to plasma membranes of the rat forebrain basal nuclei and its biodegradation].

PubMed lists PMID 15344653 in Bioorganicheskaia khimiia as English Abstract, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2004 May-Jun (source-text precision). PeptideScanner associated the retained record with the identity slug semax. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Semax

[Kinetics of Semax penetration into the brain and blood of rats after its intranasal administration].

PubMed lists PMID 16523722 in Bioorganicheskaia khimiia as English Abstract, Journal Article, with publication-date metadata of 2006 Jan-Feb (source-text precision). PeptideScanner associated the retained record with the identity slug semax. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT02969590

PeptideScanner retained ClinicalTrials.gov record NCT02969590 at 2026-07-30T20:44:36.693Z. Its registry update date was 2019-10-18, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Glucagon

ClinicalTrials.gov record NCT03533179

PeptideScanner retained ClinicalTrials.gov record NCT03533179 at 2026-07-30T20:44:36.691Z. Its registry update date was 2019-10-17, and PeptideScanner's reviewed identity mapping was glucagon.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT00254397

PeptideScanner retained ClinicalTrials.gov record NCT00254397 at 2026-07-30T20:44:36.700Z. Its registry update date was 2019-10-16, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Afamelanotide

ClinicalTrials.gov record NCT04053270

PeptideScanner retained ClinicalTrials.gov record NCT04053270 at 2026-07-30T20:44:36.678Z. Its registry update date was 2019-10-10, and PeptideScanner's reviewed identity mapping was afamelanotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Afamelanotide

Drugs@FDA application NDA210797

The official Drugs@FDA dataset lists original submission 1 for NDA 210797 with status AP dated 2019-10-08, and names afamelanotide among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Clinical trials · Exenatide

ClinicalTrials.gov record NCT01061775

PeptideScanner retained ClinicalTrials.gov record NCT01061775 at 2026-07-30T20:44:36.699Z. Its registry update date was 2019-10-08, and PeptideScanner's reviewed identity mapping was exenatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Teriparatide

Drugs@FDA application NDA211939

The official Drugs@FDA dataset lists original submission 1 for NDA 211939 with status AP dated 2019-10-04, and names teriparatide among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT01709110

PeptideScanner retained ClinicalTrials.gov record NCT01709110 at 2026-07-30T20:45:58.285Z. Its registry update date was 2019-09-23, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Semax

Specific binding of semax in different regions of the rat brain.

PubMed lists PMID 17278839 in Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2006 Sep-Oct (source-text precision). PeptideScanner associated the retained record with the identity slug semax. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Regulatory · Semaglutide

Drugs@FDA application NDA213051

The official Drugs@FDA dataset lists original submission 1 for NDA 213051 with status AP dated 2019-09-20, and names semaglutide among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Literature metadata · Emideltide

Purification and characterization of DSIP-like material from ovine pineal glands: possible peptide-protein interaction.

PubMed lists PMID 3367267 in Journal of pineal research as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 1988 (year precision). PeptideScanner associated the retained record with the identity slug emideltide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Afamelanotide

ClinicalTrials.gov record NCT01605136

PeptideScanner retained ClinicalTrials.gov record NCT01605136 at 2026-07-30T20:45:58.280Z. Its registry update date was 2019-09-19, and PeptideScanner's reviewed identity mapping was afamelanotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Linaclotide

Linaclotide in the treatment of patients with irritable bowel syndrome and constipation - analysis of an opportunity.

PubMed lists PMID 24090017 in Revista espanola de enfermedades digestivas as Journal Article, Review, with publication-date metadata of 2013-07 (month precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Regulatory · Plecanatide

Federal Register notice 2019-20108

The Federal Register published notice 2019-20108, attributed to FDA and its parent HHS department, on 2019-09-17. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Plecanatide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Literature metadata · Tesamorelin

PubMed record PMID 19243281

PeptideScanner retained PubMed bibliographic metadata for PMID 19243281 at 2026-07-30T20:47:02.486Z. PubMed recorded a metadata revision date of 2019-09-17 and an Entrez history date of 2009-02-27. PeptideScanner associated this retained record with the identity slug tesamorelin. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Exenatide

ClinicalTrials.gov record NCT03352869

PeptideScanner retained ClinicalTrials.gov record NCT03352869 at 2026-07-30T20:45:58.274Z. Its registry update date was 2019-09-11, and PeptideScanner's reviewed identity mapping was exenatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Glucagon

Drugs@FDA application NDA212097

The official Drugs@FDA dataset lists original submission 1 for NDA 212097 with status AP dated 2019-09-10, and names glucagon among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Literature metadata · Ipamorelin

PubMed record PMID 9879640

PeptideScanner retained PubMed bibliographic metadata for PMID 9879640 at 2026-07-30T20:46:59.653Z. PubMed recorded a metadata revision date of 2019-09-09 and an Entrez history date of 1999-01-08. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Ipamorelin

PubMed record PMID 9849822

PeptideScanner retained PubMed bibliographic metadata for PMID 9849822 at 2026-07-30T20:46:59.652Z. PubMed recorded a metadata revision date of 2019-09-05 and an Entrez history date of 1998-12-16. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Epitalon

PubMed record PMID 11087911

PeptideScanner retained PubMed bibliographic metadata for PMID 11087911 at 2026-07-30T20:48:24.194Z. PubMed recorded a metadata revision date of 2019-08-31 and an Entrez history date of 2000-11-23. PeptideScanner associated this retained record with the identity slug epitalon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Emideltide

DSIP--a tool for investigating the sleep onset mechanism: a review.

PubMed lists PMID 3286557 in The International journal of neuroscience as Journal Article, Review, with publication-date metadata of 1988-02 (month precision). PeptideScanner associated the retained record with the identity slug emideltide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT02488057

PeptideScanner retained ClinicalTrials.gov record NCT02488057 at 2026-07-30T20:47:16.573Z. Its registry update date was 2019-08-28, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · BPC-157

Focus on ulcerative colitis: stable gastric pentadecapeptide BPC 157.

PubMed lists PMID 22300085 in Current medicinal chemistry as Journal Article, Review, with publication-date metadata of 2012 (year precision). PeptideScanner associated the retained record with the identity slug bpc-157. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Ipamorelin

PubMed record PMID 11459660

PeptideScanner retained PubMed bibliographic metadata for PMID 11459660 at 2026-07-30T20:48:24.201Z. PubMed recorded a metadata revision date of 2019-08-19 and an Entrez history date of 2001-07-19. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Emideltide

Human pheochromocytoma cells studied in culture contain large amounts of DSIP-like material.

PubMed lists PMID 1800948 in Peptides as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 1991 Sep-Oct (source-text precision). PeptideScanner associated the retained record with the identity slug emideltide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Emideltide

DSIP/DSIP-P and circadian motor activity of rats under continuous light.

PubMed lists PMID 6897115 in Peptides as Journal Article, with publication-date metadata of 1982 Jul-Aug (source-text precision). PeptideScanner associated the retained record with the identity slug emideltide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Pramlintide

Isolation and identification of peptide degradation products of heat stressed pramlintide injection drug product.

PubMed lists PMID 9587964 in Pharmaceutical research as Journal Article, with publication-date metadata of 1998-04 (month precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Ipamorelin

PubMed record PMID 10496658

PeptideScanner retained PubMed bibliographic metadata for PMID 10496658 at 2026-07-30T20:48:24.176Z. PubMed recorded a metadata revision date of 2019-08-18 and an Entrez history date of 1999-09-25. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Pramlintide

Isolation and identification of cyclic imide and deamidation products in heat stressed pramlintide injection drug product.

PubMed lists PMID 10701984 in Journal of pharmaceutical and biomedical analysis as Journal Article, with publication-date metadata of 1999-09 (month precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Semax

Comparative study of analgesic potency of ACTH4-10 fragment and its analog semax.

PubMed lists PMID 18018999 in Bulletin of experimental biology and medicine as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2007-01 (month precision). PeptideScanner associated the retained record with the identity slug semax. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Semax

Audiogenic epilepsy in young mice of different strains after neonatal semax treatment.

PubMed lists PMID 19145359 in Bulletin of experimental biology and medicine as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2008-07 (month precision). PeptideScanner associated the retained record with the identity slug semax. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Plecanatide

PubMed record PMID 30014100

PeptideScanner retained PubMed bibliographic metadata for PMID 30014100 at 2026-07-30T20:48:25.280Z. PubMed recorded a metadata revision date of 2019-08-13 and an Entrez history date of 2018-07-18. PeptideScanner associated this retained record with the identity slug plecanatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Plecanatide

PubMed record PMID 29545635

PeptideScanner retained PubMed bibliographic metadata for PMID 29545635 at 2026-07-30T20:48:25.273Z. PubMed recorded a metadata revision date of 2019-08-06 and an Entrez history date of 2018-03-17. PeptideScanner associated this retained record with the identity slug plecanatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · BPC-157

Stable gastric pentadecapeptide BPC 157-NO-system relation.

PubMed lists PMID 23755725 in Current pharmaceutical design as Journal Article, Review, with publication-date metadata of 2014 (year precision). PeptideScanner associated the retained record with the identity slug bpc-157. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · BPC-157

BPC 157 and blood vessels.

PubMed lists PMID 23782145 in Current pharmaceutical design as Journal Article, Review, with publication-date metadata of 2014 (year precision). PeptideScanner associated the retained record with the identity slug bpc-157. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Regulatory · Glucagon

Drugs@FDA application NDA210134

The official Drugs@FDA dataset lists original submission 1 for NDA 210134 with status AP dated 2019-07-24, and names glucagon among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT00669162

PeptideScanner retained ClinicalTrials.gov record NCT00669162 at 2026-07-30T20:48:52.438Z. Its registry update date was 2019-07-24, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Epitalon

PubMed record PMID 12049808

PeptideScanner retained PubMed bibliographic metadata for PMID 12049808 at 2026-07-30T20:50:08.377Z. PubMed recorded a metadata revision date of 2019-07-20 and an Entrez history date of 2002-06-07. PeptideScanner associated this retained record with the identity slug epitalon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Emideltide

Radioimmunoassay of DSIP-like material in rat brain.

PubMed lists PMID 318193 in Brain research bulletin as Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., with publication-date metadata of 1978 Nov-Dec (source-text precision). PeptideScanner associated the retained record with the identity slug emideltide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Emideltide

Entry of DSIP peptides into dog CSF: role of physicochemical and pharmacokinetic parameters.

PubMed lists PMID 3768731 in Brain research bulletin as Comparative Study, Journal Article, Research Support, U.S. Gov't, Non-P.H.S., with publication-date metadata of 1986-08 (month precision). PeptideScanner associated the retained record with the identity slug emideltide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Emideltide

DSIP-like immunoreactivity in the developing rat brain.

PubMed lists PMID 6895711 in Brain research bulletin as Comparative Study, Journal Article, Research Support, U.S. Gov't, Non-P.H.S., with publication-date metadata of 1981-12 (month precision). PeptideScanner associated the retained record with the identity slug emideltide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT01179048

PeptideScanner retained ClinicalTrials.gov record NCT01179048 at 2026-07-30T20:48:52.462Z. Its registry update date was 2019-07-17, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Emideltide

DSIP occurs in free form in mammalian plasma, human CSF and urine.

PubMed lists PMID 6549071 in Pharmacology, biochemistry, and behavior as Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., with publication-date metadata of 1984-11 (month precision). PeptideScanner associated the retained record with the identity slug emideltide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Emideltide

DSIP-like material in brain parts of rats running a complex maze.

PubMed lists PMID 6549074 in Physiology & behavior as Journal Article, Research Support, U.S. Gov't, Non-P.H.S., with publication-date metadata of 1984-09 (month precision). PeptideScanner associated the retained record with the identity slug emideltide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Emideltide

Permeability of blood-brain barrier to DSIP peptides.

PubMed lists PMID 6895670 in Pharmacology, biochemistry, and behavior as Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S., with publication-date metadata of 1981-12 (month precision). PeptideScanner associated the retained record with the identity slug emideltide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Emideltide

Radioimmunoassay of DSIP-like material in human blood: possible protein binding.

PubMed lists PMID 6895671 in Pharmacology, biochemistry, and behavior as Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S., with publication-date metadata of 1981-12 (month precision). PeptideScanner associated the retained record with the identity slug emideltide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Emideltide

Differential penetration of DSIP peptides into rat brain.

PubMed lists PMID 6897680 in Pharmacology, biochemistry, and behavior as Journal Article, Research Support, U.S. Gov't, Non-P.H.S., with publication-date metadata of 1982-12 (month precision). PeptideScanner associated the retained record with the identity slug emideltide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Ipamorelin

PubMed record PMID 10828840

PeptideScanner retained PubMed bibliographic metadata for PMID 10828840 at 2026-07-30T20:50:07.370Z. PubMed recorded a metadata revision date of 2019-07-09 and an Entrez history date of 2000-06-01. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT03846180

PeptideScanner retained ClinicalTrials.gov record NCT03846180 at 2026-07-30T20:48:52.443Z. Its registry update date was 2019-07-05, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Plecanatide

ClinicalTrials.gov record NCT01919697

PeptideScanner retained ClinicalTrials.gov record NCT01919697 at 2026-07-30T20:48:52.437Z. Its registry update date was 2019-07-02, and PeptideScanner's reviewed identity mapping was plecanatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Emideltide

Circadian variation of DSIP-like material in rat plasma.

PubMed lists PMID 6548540 in Life sciences as Journal Article, Research Support, U.S. Gov't, Non-P.H.S., with publication-date metadata of 1984-11-12 (day precision). PeptideScanner associated the retained record with the identity slug emideltide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Emideltide

Transport of the synthetic peptide DSIP through the blood-brain barrier in rabbit.

PubMed lists PMID 590449 in Experientia as Journal Article, with publication-date metadata of 1977-12-15 (day precision). PeptideScanner associated the retained record with the identity slug emideltide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Emideltide

Separation of tryptophan from DSIP, a Trp-nonapeptide, by adsorption to aluminum oxide.

PubMed lists PMID 3777433 in Analytical biochemistry as Journal Article, with publication-date metadata of 1986-09 (month precision). PeptideScanner associated the retained record with the identity slug emideltide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Regulatory · Bremelanotide

Drugs@FDA application NDA210557

The official Drugs@FDA dataset lists original submission 1 for NDA 210557 with status AP dated 2019-06-21, and names bremelanotide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT03466567

PeptideScanner retained ClinicalTrials.gov record NCT03466567 at 2026-07-30T20:50:35.918Z. Its registry update date was 2019-06-19, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Bremelanotide

PubMed record PMID 12851303

PeptideScanner retained PubMed bibliographic metadata for PMID 12851303 at 2026-07-30T20:51:53.921Z. PubMed recorded a metadata revision date of 2019-06-16 and an Entrez history date of 2003-07-10. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Plecanatide

ClinicalTrials.gov record NCT02387359

PeptideScanner retained ClinicalTrials.gov record NCT02387359 at 2026-07-30T20:50:35.893Z. Its registry update date was 2019-06-14, and PeptideScanner's reviewed identity mapping was plecanatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Plecanatide

ClinicalTrials.gov record NCT02493452

PeptideScanner retained ClinicalTrials.gov record NCT02493452 at 2026-07-30T20:50:35.872Z. Its registry update date was 2019-06-14, and PeptideScanner's reviewed identity mapping was plecanatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Linaclotide

Long-term treatment with linaclotide of intestinal pseudo-obstruction secondary to Ehlers-Danlos syndrome.

PubMed lists PMID 30470553 in Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver as Letter, with publication-date metadata of 2018-10-28 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Plecanatide

PubMed record PMID 29343131

PeptideScanner retained PubMed bibliographic metadata for PMID 29343131 at 2026-07-30T20:51:54.923Z. PubMed recorded a metadata revision date of 2019-06-13 and an Entrez history date of 2018-01-19. PeptideScanner associated this retained record with the identity slug plecanatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Semax

N-terminal degradation of ACTH(4-10) and its synthetic analog semax by the rat blood enzymes.

PubMed lists PMID 1851003 in Biochemical and biophysical research communications as Journal Article, with publication-date metadata of 1991-04-30 (day precision). PeptideScanner associated the retained record with the identity slug semax. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Lanreotide

ClinicalTrials.gov record NCT02075606

PeptideScanner retained ClinicalTrials.gov record NCT02075606 at 2026-07-30T20:50:35.870Z. Its registry update date was 2019-06-07, and PeptideScanner's reviewed identity mapping was lanreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · BPC-157

Stable gastric pentadecapeptide BPC 157 in the therapy of the rats with bile duct ligation.

PubMed lists PMID 30690000 in European journal of pharmacology as Journal Article, with publication-date metadata of 2019-01-25 (day precision). PeptideScanner associated the retained record with the identity slug bpc-157. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Regulatory · Leuprolide

Federal Register notice 2019-11243

The Federal Register published notice 2019-11243, attributed to FDA and its parent HHS department, on 2019-05-30. Its official title is “Determination That LUPRON (Leuprolide Acetate) Injection, 1 Milligram/0.2 Milliliter, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness,” and PeptideScanner's exact reviewed identity mapping connects the document to Leuprolide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT02060383

PeptideScanner retained ClinicalTrials.gov record NCT02060383 at 2026-07-30T20:52:10.194Z. Its registry update date was 2019-05-29, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Plecanatide

ClinicalTrials.gov record NCT01429987

PeptideScanner retained ClinicalTrials.gov record NCT01429987 at 2026-07-30T20:52:10.191Z. Its registry update date was 2019-05-28, and PeptideScanner's reviewed identity mapping was plecanatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Plecanatide

ClinicalTrials.gov record NCT01722318

PeptideScanner retained ClinicalTrials.gov record NCT01722318 at 2026-07-30T20:52:10.190Z. Its registry update date was 2019-05-28, and PeptideScanner's reviewed identity mapping was plecanatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Abaloparatide

PubMed record PMID 27859635

PeptideScanner retained PubMed bibliographic metadata for PMID 27859635 at 2026-07-30T20:53:23.986Z. PubMed recorded a metadata revision date of 2019-05-09 and an Entrez history date of 2016-11-19. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT02911818

PeptideScanner retained ClinicalTrials.gov record NCT02911818 at 2026-07-30T20:52:10.188Z. Its registry update date was 2019-05-07, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · GHK-Cu

PubMed record PMID 29986520

PeptideScanner retained PubMed bibliographic metadata for PMID 29986520 at 2026-07-30T20:54:32.100Z. PubMed recorded a metadata revision date of 2019-04-24 and an Entrez history date of 2018-07-11. PeptideScanner associated this retained record with the identity slug ghk-cu. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT02239523

PeptideScanner retained ClinicalTrials.gov record NCT02239523 at 2026-07-30T20:53:39.666Z. Its registry update date was 2019-04-05, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Abaloparatide

PubMed record PMID 29800372

PeptideScanner retained PubMed bibliographic metadata for PMID 29800372 at 2026-07-30T20:55:52.341Z. PubMed recorded a metadata revision date of 2019-03-26 and an Entrez history date of 2018-05-26. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Plecanatide

PubMed record PMID 28506401

PeptideScanner retained PubMed bibliographic metadata for PMID 28506401 at 2026-07-30T20:55:52.312Z. PubMed recorded a metadata revision date of 2019-03-20 and an Entrez history date of 2017-05-17. PeptideScanner associated this retained record with the identity slug plecanatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Linaclotide

Linaclotide for the treatment of chronic constipation.

PubMed lists PMID 29985664 in Expert opinion on pharmacotherapy as Clinical Trial, Phase II, Journal Article, Randomized Controlled Trial, with publication-date metadata of 2018-07-09 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Bremelanotide

PubMed record PMID 28189361

PeptideScanner retained PubMed bibliographic metadata for PMID 28189361 at 2026-07-30T20:55:52.311Z. PubMed recorded a metadata revision date of 2019-03-18 and an Entrez history date of 2017-02-13. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Abaloparatide

PubMed record PMID 29260289

PeptideScanner retained PubMed bibliographic metadata for PMID 29260289 at 2026-07-30T20:57:06.138Z. PubMed recorded a metadata revision date of 2019-02-25 and an Entrez history date of 2017-12-21. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Pramlintide

Properties of pramlintide and insulin upon mixing.

PubMed lists PMID 15821274 in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists as Clinical Trial, Journal Article, Randomized Controlled Trial, with publication-date metadata of 2005-04-15 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Dulaglutide

PubMed record PMID 29910025

PeptideScanner retained PubMed bibliographic metadata for PMID 29910025 at 2026-07-30T20:57:06.150Z. PubMed recorded a metadata revision date of 2019-02-21 and an Entrez history date of 2018-06-19. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Linaclotide

ClinicalTrials.gov record NCT00765999

PeptideScanner retained ClinicalTrials.gov record NCT00765999 at 2026-07-30T20:56:08.251Z. Its registry update date was 2019-02-15, and PeptideScanner's reviewed identity mapping was linaclotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Dulaglutide

ClinicalTrials.gov record NCT03824002

PeptideScanner retained ClinicalTrials.gov record NCT03824002 at 2026-07-30T20:57:18.709Z. Its registry update date was 2019-01-31, and PeptideScanner's reviewed identity mapping was dulaglutide.

Added August 8, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT02472782

PeptideScanner retained ClinicalTrials.gov record NCT02472782 at 2026-07-30T20:57:18.711Z. Its registry update date was 2019-01-10, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Dulaglutide

PubMed record PMID 29852875

PeptideScanner retained PubMed bibliographic metadata for PMID 29852875 at 2026-07-30T20:58:13.922Z. PubMed recorded a metadata revision date of 2019-01-03 and an Entrez history date of 2018-06-02. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Regulatory · Linaclotide

Federal Register notice 2018-28213

The Federal Register published notice 2018-28213, attributed to FDA and its parent HHS department, on 2018-12-28. Its official title is “Product-Specific Guidance for Linaclotide; Draft Guidance for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Linaclotide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Regulatory · Octreotide

Drugs@FDA application ANDA204669

The official Drugs@FDA dataset lists original submission 1 for ANDA 204669 with status AP dated 2018-12-27, and names octreotide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Regulatory · Lixisenatide

Federal Register notice 2018-27805

The Federal Register published notice 2018-27805, attributed to FDA and its parent HHS department, on 2018-12-26. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; ADLYXIN,” and PeptideScanner's exact reviewed identity mapping connects the document to Lixisenatide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Literature metadata · KPV

PubMed record PMID 29953505

PeptideScanner retained PubMed bibliographic metadata for PMID 29953505 at 2026-07-30T21:09:28.939Z. PubMed recorded a metadata revision date of 2018-12-19 and an Entrez history date of 2018-06-29. PeptideScanner associated this retained record with the identity slug kpv. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Ipamorelin

PubMed record PMID 15665799

PeptideScanner retained PubMed bibliographic metadata for PMID 15665799 at 2026-07-30T21:09:05.701Z. PubMed recorded a metadata revision date of 2018-12-17 and an Entrez history date of 2005-01-25. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Dulaglutide

PubMed record PMID 29536610

PeptideScanner retained PubMed bibliographic metadata for PMID 29536610 at 2026-07-30T21:09:28.294Z. PubMed recorded a metadata revision date of 2018-12-11 and an Entrez history date of 2018-03-15. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Regulatory · Plecanatide

Federal Register notice 2018-26289

The Federal Register published notice 2018-26289, attributed to FDA and its parent HHS department, on 2018-12-04. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; TRULANCE,” and PeptideScanner's exact reviewed identity mapping connects the document to Plecanatide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Literature metadata · Dulaglutide

PubMed record PMID 25860029

PeptideScanner retained PubMed bibliographic metadata for PMID 25860029 at 2026-07-30T21:09:16.094Z. PubMed recorded a metadata revision date of 2018-12-03 and an Entrez history date of 2015-04-11. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Ziconotide

Chemical Stability of Morphine, Ropivacaine, and Ziconotide in Combination for Intrathecal Analgesia.

PubMed lists PMID 28719378 in International journal of pharmaceutical compounding as Journal Article, with publication-date metadata of 2017 Jul-Aug (source-text precision). PeptideScanner associated the retained record with the identity slug ziconotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 16, 2026 · Source: PubMed ↗

Literature metadata · Linaclotide

Linaclotide for the treatment of irritable bowel syndrome with constipation: is it time to reshuffle the deck?

PubMed lists PMID 23791794 in Gastroenterology as Journal Article, Comment, with publication-date metadata of 2013-06-20 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Linaclotide

Clarification of linaclotide clinical trial information in a recent review on constipation.

PubMed lists PMID 23810343 in Gastroenterology as Letter, Comment, with publication-date metadata of 2013-06-26 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Ziconotide

Acute rhabdomyolysis in a patient with long-term exposure to intrathecal ziconotide: a case report.

PubMed lists PMID 25565390 in Pain practice : the official journal of World Institute of Pain as Case Reports, Journal Article, with publication-date metadata of 2015-01-07 (day precision). PeptideScanner associated the retained record with the identity slug ziconotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Afamelanotide

PubMed record PMID 25607635

PeptideScanner retained PubMed bibliographic metadata for PMID 25607635 at 2026-07-30T21:09:14.737Z. PubMed recorded a metadata revision date of 2018-12-02 and an Entrez history date of 2015-01-22. PeptideScanner associated this retained record with the identity slug afamelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Afamelanotide

PubMed record PMID 25607828

PeptideScanner retained PubMed bibliographic metadata for PMID 25607828 at 2026-07-30T21:09:14.737Z. PubMed recorded a metadata revision date of 2018-12-02 and an Entrez history date of 2015-01-22. PeptideScanner associated this retained record with the identity slug afamelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Bremelanotide

PubMed record PMID 27977473

PeptideScanner retained PubMed bibliographic metadata for PMID 27977473 at 2026-07-30T21:09:23.592Z. PubMed recorded a metadata revision date of 2018-12-02 and an Entrez history date of 2016-12-16. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Abaloparatide

PubMed record PMID 28389324

PeptideScanner retained PubMed bibliographic metadata for PMID 28389324 at 2026-07-30T21:09:25.134Z. PubMed recorded a metadata revision date of 2018-12-02 and an Entrez history date of 2017-04-09. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Abaloparatide

PubMed record PMID 29251010

PeptideScanner retained PubMed bibliographic metadata for PMID 29251010 at 2026-07-30T21:09:28.247Z. PubMed recorded a metadata revision date of 2018-12-02 and an Entrez history date of 2017-12-19. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Bremelanotide

PubMed record PMID 27751477

PeptideScanner retained PubMed bibliographic metadata for PMID 27751477 at 2026-07-30T21:09:23.546Z. PubMed recorded a metadata revision date of 2018-12-02 and an Entrez history date of 2016-10-19. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Exenatide

Clinical observations of exenatide treatment.

PubMed lists PMID 16873820 in Diabetes care as Letter, with publication-date metadata of 2006-08 (month precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 16, 2026 · Source: PubMed ↗

Literature metadata · Exenatide

Pharmacokinetics of an oral drug (acetaminophen) administered at various times in relation to subcutaneous injection of exenatide (exendin-4) in healthy subjects.

PubMed lists PMID 15831781 in Journal of clinical pharmacology as Clinical Trial, Clinical Trial, Phase II, Journal Article, Randomized Controlled Trial, with publication-date metadata of 2005-05 (month precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Exenatide

Exenatide (Byetta) for type 2 diabetes.

PubMed lists PMID 15933616 in The Medical letter on drugs and therapeutics as Journal Article, with publication-date metadata of 2005-06-06 (day precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Exenatide

[Exenatide--an incretin mimetic for treatment of diabetes mellitus type 2].

PubMed lists PMID 16550880 in Medizinische Monatsschrift fur Pharmazeuten as Journal Article, Review, with publication-date metadata of 2006-03 (month precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Exenatide

Byetta (exenatide): what's your gut feeling?

PubMed lists PMID 16610466 in South Dakota medicine : the journal of the South Dakota State Medical Association as Journal Article, with publication-date metadata of 2006-01 (month precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · BPC-157

Ibuprofen hepatic encephalopathy, hepatomegaly, gastric lesion and gastric pentadecapeptide BPC 157 in rats.

PubMed lists PMID 21645505 in European journal of pharmacology as Journal Article, with publication-date metadata of 2011-05-30 (day precision). PeptideScanner associated the retained record with the identity slug bpc-157. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Linaclotide

Clarification of trial end points presented in a recent review of linaclotide.

PubMed lists PMID 22149576 in Expert review of gastroenterology & hepatology as Letter, Comment, with publication-date metadata of 2012-02 (month precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Tesamorelin

PubMed record PMID 21695284

PeptideScanner retained PubMed bibliographic metadata for PMID 21695284 at 2026-07-30T21:09:11.482Z. PubMed recorded a metadata revision date of 2018-12-01 and an Entrez history date of 2011-06-23. PeptideScanner associated this retained record with the identity slug tesamorelin. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · CJC-1295

PubMed record PMID 17018654

PeptideScanner retained PubMed bibliographic metadata for PMID 17018654 at 2026-07-30T21:09:06.872Z. PubMed recorded a metadata revision date of 2018-12-01 and an Entrez history date of 2006-10-05. PeptideScanner associated this retained record with the identity slug cjc-1295. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · CJC-1295

PubMed record PMID 16352683

PeptideScanner retained PubMed bibliographic metadata for PMID 16352683 at 2026-07-30T21:09:05.761Z. PubMed recorded a metadata revision date of 2018-12-01 and an Entrez history date of 2005-12-15. PeptideScanner associated this retained record with the identity slug cjc-1295. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Ipamorelin

PubMed record PMID 9733495

PeptideScanner retained PubMed bibliographic metadata for PMID 9733495 at 2026-07-30T21:08:59.367Z. PubMed recorded a metadata revision date of 2018-12-01 and an Entrez history date of 1998-09-11. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Semax

[New regulatory peptides in rat stomach secretion (amylin, PGP, semax)].

PubMed lists PMID 12875006 in Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology as Journal Article, with publication-date metadata of 2003 (year precision). PeptideScanner associated the retained record with the identity slug semax. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Exenatide

Molecule of the month. Exenatide.

PubMed lists PMID 14702143 in Drug news & perspectives as Journal Article, with publication-date metadata of 2003-11 (month precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Regulatory · Plecanatide

Federal Register notice 2018-25950

The Federal Register published notice 2018-25950, attributed to FDA and its parent HHS department, on 2018-11-29. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Plecanatide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Clinical trials · Pramlintide

ClinicalTrials.gov record NCT00690235

PeptideScanner retained ClinicalTrials.gov record NCT00690235 at 2026-07-30T21:07:45.452Z. Its registry update date was 2018-11-16, and PeptideScanner's reviewed identity mapping was pramlintide.

Added August 8, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Pramlintide

Kinetics of pramlintide degradation in aqueous solution as a function of temperature and pH.

PubMed lists PMID 14727840 in AAPS PharmSciTech as Comparative Study, Journal Article, with publication-date metadata of 2000-03-18 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Pramlintide

Pramlintide injection drug product robustness studies.

PubMed lists PMID 14727841 in AAPS PharmSciTech as Journal Article, with publication-date metadata of 2000-03-18 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Pramlintide

Orthogonal HPLC methods for quantitating related substances and degradation products of pramlintide.

PubMed lists PMID 14727855 in AAPS PharmSciTech as Journal Article, with publication-date metadata of 2000-03-24 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Ziconotide

Delivery of ziconotide to cerebrospinal fluid via intranasal pathway for the treatment of chronic pain.

PubMed lists PMID 26732557 in Journal of controlled release : official journal of the Controlled Release Society as Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S., with publication-date metadata of 2015-12-28 (day precision). PeptideScanner associated the retained record with the identity slug ziconotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Tesamorelin

PubMed record PMID 25895899

PeptideScanner retained PubMed bibliographic metadata for PMID 25895899 at 2026-07-30T21:09:16.102Z. PubMed recorded a metadata revision date of 2018-11-13 and an Entrez history date of 2015-04-22. PeptideScanner associated this retained record with the identity slug tesamorelin. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Afamelanotide

PubMed record PMID 26132941

PeptideScanner retained PubMed bibliographic metadata for PMID 26132941 at 2026-07-30T21:09:16.183Z. PubMed recorded a metadata revision date of 2018-11-13 and an Entrez history date of 2015-07-02. PeptideScanner associated this retained record with the identity slug afamelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Abaloparatide

PubMed record PMID 26562265

PeptideScanner retained PubMed bibliographic metadata for PMID 26562265 at 2026-07-30T21:09:17.736Z. PubMed recorded a metadata revision date of 2018-11-13 and an Entrez history date of 2015-11-13. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Abaloparatide

PubMed record PMID 27395059

PeptideScanner retained PubMed bibliographic metadata for PMID 27395059 at 2026-07-30T21:09:22.204Z. PubMed recorded a metadata revision date of 2018-11-13 and an Entrez history date of 2016-07-11. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Tesamorelin

PubMed record PMID 28832410

PeptideScanner retained PubMed bibliographic metadata for PMID 28832410 at 2026-07-30T21:09:26.816Z. PubMed recorded a metadata revision date of 2018-11-13 and an Entrez history date of 2017-08-24. PeptideScanner associated this retained record with the identity slug tesamorelin. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Abaloparatide

PubMed record PMID 28609423

PeptideScanner retained PubMed bibliographic metadata for PMID 28609423 at 2026-07-30T21:09:26.729Z. PubMed recorded a metadata revision date of 2018-11-05 and an Entrez history date of 2017-06-14. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Ziconotide

Ziconotide. CI 1009, SNX 111.

PubMed lists PMID 10565986 in Drugs in R&D as Journal Article, with publication-date metadata of 1999-01 (month precision). PeptideScanner associated the retained record with the identity slug ziconotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Pramlintide

Pramlintide. AC 137, ACO 137, Normylin, Symlin, Tripro-amylin.

PubMed lists PMID 10820656 in Drugs in R&D as Journal Article, with publication-date metadata of 1999-08 (month precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Pramlintide

Pramlintide: (AC 137, AC 0137, Symlin, Tripro-Amylin).

PubMed lists PMID 12534323 in BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy as Journal Article, Review, with publication-date metadata of 2003 (year precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Dulaglutide

PubMed record PMID 29525225

PeptideScanner retained PubMed bibliographic metadata for PMID 29525225 at 2026-07-30T21:09:28.294Z. PubMed recorded a metadata revision date of 2018-10-24 and an Entrez history date of 2018-03-12. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Regulatory · Abaloparatide

Federal Register notice 2018-22956

The Federal Register published notice 2018-22956, attributed to FDA and its parent HHS department, on 2018-10-22. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; TYMLOS,” and PeptideScanner's exact reviewed identity mapping connects the document to Abaloparatide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Literature metadata · BPC-157

Rat inferior caval vein (ICV) ligature and particular new insights with the stable gastric pentadecapeptide BPC 157.

PubMed lists PMID 29510201 in Vascular pharmacology as Journal Article, with publication-date metadata of 2018-03-03 (day precision). PeptideScanner associated the retained record with the identity slug bpc-157. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Abaloparatide

PubMed record PMID 27612281

PeptideScanner retained PubMed bibliographic metadata for PMID 27612281 at 2026-07-30T21:09:23.525Z. PubMed recorded a metadata revision date of 2018-10-15 and an Entrez history date of 2016-09-10. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Abaloparatide

PubMed record PMID 27748532

PeptideScanner retained PubMed bibliographic metadata for PMID 27748532 at 2026-07-30T21:09:23.546Z. PubMed recorded a metadata revision date of 2018-10-15 and an Entrez history date of 2016-10-18. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · BPC-157

Stress in Gastrointestinal Tract and Stable Gastric Pentadecapeptide BPC 157. Finally, do we have a Solution?

PubMed lists PMID 28228068 in Current pharmaceutical design as Journal Article, Review, with publication-date metadata of 2017 (year precision). PeptideScanner associated the retained record with the identity slug bpc-157. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT02473809

PeptideScanner retained ClinicalTrials.gov record NCT02473809 at 2026-07-30T21:10:03.006Z. Its registry update date was 2018-09-26, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT00455689

PeptideScanner retained ClinicalTrials.gov record NCT00455689 at 2026-07-30T21:10:02.989Z. Its registry update date was 2018-09-18, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · KPV

PubMed record PMID 18092346

PeptideScanner retained PubMed bibliographic metadata for PMID 18092346 at 2026-07-30T21:10:56.892Z. PubMed recorded a metadata revision date of 2018-09-13 and an Entrez history date of 2007-12-20. PeptideScanner associated this retained record with the identity slug kpv. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Regulatory · Octreotide

Drugs@FDA application ANDA203765

The official Drugs@FDA dataset lists original submission 1 for ANDA 203765 with status AP dated 2018-09-07, and names octreotide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Regulatory · Leuprolide

Drugs@FDA application NDA205054

The official Drugs@FDA dataset lists original submission 1 for NDA 205054 with status AP dated 2018-08-28, and names leuprolide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Literature metadata · Abaloparatide

PubMed record PMID 29911694

PeptideScanner retained PubMed bibliographic metadata for PMID 29911694 at 2026-07-30T21:10:57.556Z. PubMed recorded a metadata revision date of 2018-08-23 and an Entrez history date of 2018-06-19. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Afamelanotide

ClinicalTrials.gov record NCT03634137

PeptideScanner retained ClinicalTrials.gov record NCT03634137 at 2026-07-30T21:10:03.005Z. Its registry update date was 2018-08-16, and PeptideScanner's reviewed identity mapping was afamelanotide.

Added August 14, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT00223665

PeptideScanner retained ClinicalTrials.gov record NCT00223665 at 2026-07-30T21:10:02.996Z. Its registry update date was 2018-08-07, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT03619330

PeptideScanner retained ClinicalTrials.gov record NCT03619330 at 2026-07-30T21:10:02.994Z. Its registry update date was 2018-08-07, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Linaclotide

ClinicalTrials.gov record NCT02078323

PeptideScanner retained ClinicalTrials.gov record NCT02078323 at 2026-07-30T21:10:02.997Z. Its registry update date was 2018-07-23, and PeptideScanner's reviewed identity mapping was linaclotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Exenatide

ClinicalTrials.gov record NCT02104739

PeptideScanner retained ClinicalTrials.gov record NCT02104739 at 2026-07-30T21:10:03.007Z. Its registry update date was 2018-07-03, and PeptideScanner's reviewed identity mapping was exenatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT00926380

PeptideScanner retained ClinicalTrials.gov record NCT00926380 at 2026-07-30T21:11:31.043Z. Its registry update date was 2018-06-29, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT02717858

PeptideScanner retained ClinicalTrials.gov record NCT02717858 at 2026-07-30T21:11:31.043Z. Its registry update date was 2018-06-28, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · GHK-Cu

PubMed record PMID 28370978

PeptideScanner retained PubMed bibliographic metadata for PMID 28370978 at 2026-07-30T21:12:28.721Z. PubMed recorded a metadata revision date of 2018-06-25 and an Entrez history date of 2017-04-04. PeptideScanner associated this retained record with the identity slug ghk-cu. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT00002597

PeptideScanner retained ClinicalTrials.gov record NCT00002597 at 2026-07-30T21:11:31.042Z. Its registry update date was 2018-06-14, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT02064348

PeptideScanner retained ClinicalTrials.gov record NCT02064348 at 2026-07-30T21:11:31.040Z. Its registry update date was 2018-06-13, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT00004635

PeptideScanner retained ClinicalTrials.gov record NCT00004635 at 2026-07-30T21:11:31.039Z. Its registry update date was 2018-05-22, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Exenatide

ClinicalTrials.gov record NCT00845507

PeptideScanner retained ClinicalTrials.gov record NCT00845507 at 2026-07-30T21:11:31.043Z. Its registry update date was 2018-04-20, and PeptideScanner's reviewed identity mapping was exenatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT02146079

PeptideScanner retained ClinicalTrials.gov record NCT02146079 at 2026-07-30T21:11:31.042Z. Its registry update date was 2018-04-18, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Lixisenatide

Federal Register notice 2018-07256

The Federal Register published notice 2018-07256, attributed to FDA and its parent HHS department, on 2018-04-10. Its official title is “Notice of Approval of Products Under Voucher: Rare Pediatric Disease Priority Review Vouchers,” and PeptideScanner's exact reviewed identity mapping connects the document to Lixisenatide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Literature metadata · KPV

PubMed record PMID 28343991

PeptideScanner retained PubMed bibliographic metadata for PMID 28343991 at 2026-07-30T21:12:28.720Z. PubMed recorded a metadata revision date of 2018-04-05 and an Entrez history date of 2017-03-28. PeptideScanner associated this retained record with the identity slug kpv. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Semax

Influence of ACTG4-7-PGP (Semax) on Morphofunctional State of Hepatocytes in Chronic Emotional and Painful Stress.

PubMed lists PMID 28577097 in Bulletin of experimental biology and medicine as Journal Article, with publication-date metadata of 2017-06-03 (day precision). PeptideScanner associated the retained record with the identity slug semax. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT00966355

PeptideScanner retained ClinicalTrials.gov record NCT00966355 at 2026-07-30T21:12:47.407Z. Its registry update date was 2018-03-19, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Pramlintide

Zn(II) - pramlintide: Stability, binding sites and unexpected aggregation.

PubMed lists PMID 28672144 in Journal of inorganic biochemistry as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2017-06-23 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Semax

Influence of the N-terminus acetylation of Semax, a synthetic analog of ACTH(4-10), on copper(II) and zinc(II) coordination and biological properties.

PubMed lists PMID 27586814 in Journal of inorganic biochemistry as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2016-08-27 (day precision). PeptideScanner associated the retained record with the identity slug semax. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Exenatide

ClinicalTrials.gov record NCT01046721

PeptideScanner retained ClinicalTrials.gov record NCT01046721 at 2026-07-30T21:12:47.415Z. Its registry update date was 2018-03-06, and PeptideScanner's reviewed identity mapping was exenatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Glucagon

ClinicalTrials.gov record NCT01680653

PeptideScanner retained ClinicalTrials.gov record NCT01680653 at 2026-07-30T21:12:47.409Z. Its registry update date was 2018-03-05, and PeptideScanner's reviewed identity mapping was glucagon.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT01120236

PeptideScanner retained ClinicalTrials.gov record NCT01120236 at 2026-07-30T21:12:47.407Z. Its registry update date was 2018-02-26, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Linaclotide

ClinicalTrials.gov record NCT00730171

PeptideScanner retained ClinicalTrials.gov record NCT00730171 at 2026-07-30T21:12:47.419Z. Its registry update date was 2018-02-19, and PeptideScanner's reviewed identity mapping was linaclotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Emideltide

PubMed record PMID 3758119

PeptideScanner retained PubMed bibliographic metadata for PMID 3758119 at 2026-07-30T21:13:34.042Z. PubMed recorded a metadata revision date of 2018-02-14 and an Entrez history date of 1986-01-01. PeptideScanner associated this retained record with the identity slug emideltide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Regulatory · Leuprolide

Federal Register notice 2018-02667

The Federal Register published notice 2018-02667, attributed to FDA and its parent HHS department, on 2018-02-09. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Leuprolide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Literature metadata · TB-500

PubMed record PMID 28887173

PeptideScanner retained PubMed bibliographic metadata for PMID 28887173 at 2026-07-30T21:13:36.164Z. PubMed recorded a metadata revision date of 2018-02-08 and an Entrez history date of 2017-09-10. PeptideScanner associated this retained record with the identity slug tb-500. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Clinical trials · Exenatide

ClinicalTrials.gov record NCT02092597

PeptideScanner retained ClinicalTrials.gov record NCT02092597 at 2026-07-30T21:12:47.409Z. Its registry update date was 2018-02-07, and PeptideScanner's reviewed identity mapping was exenatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT02140983

PeptideScanner retained ClinicalTrials.gov record NCT02140983 at 2026-07-30T21:12:47.414Z. Its registry update date was 2018-01-25, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT01116401

PeptideScanner retained ClinicalTrials.gov record NCT01116401 at 2026-07-30T21:12:47.405Z. Its registry update date was 2018-01-23, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT01272219

PeptideScanner retained ClinicalTrials.gov record NCT01272219 at 2026-07-30T21:12:47.414Z. Its registry update date was 2018-01-19, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Exenatide

ClinicalTrials.gov record NCT00845182

PeptideScanner retained ClinicalTrials.gov record NCT00845182 at 2026-07-30T21:12:47.410Z. Its registry update date was 2018-01-18, and PeptideScanner's reviewed identity mapping was exenatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Abaloparatide

PubMed record PMID 27894941

PeptideScanner retained PubMed bibliographic metadata for PMID 27894941 at 2026-07-30T21:22:58.009Z. PubMed recorded a metadata revision date of 2017-12-23 and an Entrez history date of 2016-11-30. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT01705587

PeptideScanner retained ClinicalTrials.gov record NCT01705587 at 2026-07-30T21:22:00.252Z. Its registry update date was 2017-12-12, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Semaglutide

Drugs@FDA application NDA209637

The official Drugs@FDA dataset lists original submission 1 for NDA 209637 with status AP dated 2017-12-05, and names semaglutide among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT02079870

PeptideScanner retained ClinicalTrials.gov record NCT02079870 at 2026-07-30T21:22:00.245Z. Its registry update date was 2017-12-02, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Octreotide

Federal Register notice 2017-25920

The Federal Register published notice 2017-25920, attributed to FDA and its parent HHS department, on 2017-12-01. Its official title is “Barr Laboratories, Inc. et al.; Withdrawal of Approval of 68 Abbreviated New Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Octreotide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Clinical trials · Exenatide

ClinicalTrials.gov record NCT01588418

PeptideScanner retained ClinicalTrials.gov record NCT01588418 at 2026-07-30T21:22:00.248Z. Its registry update date was 2017-11-24, and PeptideScanner's reviewed identity mapping was exenatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT01762943

PeptideScanner retained ClinicalTrials.gov record NCT01762943 at 2026-07-30T21:22:00.263Z. Its registry update date was 2017-11-20, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Linaclotide

Constella™(EU)-Linzess™(USA): the last milestone in the long journey of the peptide linaclotide and its implications for the future of peptide drugs.

PubMed lists PMID 23464519 in Future medicinal chemistry as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2013-03 (month precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Linaclotide

Linaclotide for constipation-predominant IBS.

PubMed lists PMID 24227771 in Drug and therapeutics bulletin as Journal Article, with publication-date metadata of 2013-11 (month precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · BPC-157

Pentadecapeptide BPC 157 and anaphylactoid reaction in rats and mice after intravenous dextran and white egg administration.

PubMed lists PMID 24486708 in European journal of pharmacology as Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2014-01-31 (day precision). PeptideScanner associated the retained record with the identity slug bpc-157. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Linaclotide

Economic evaluation of linaclotide for the treatment of adult patients with irritable bowel syndrome with constipation in the United States.

PubMed lists PMID 25333331 in Journal of medical economics as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2015-04 (month precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · BPC-157

Perforating corneal injury in rat and pentadecapeptide BPC 157.

PubMed lists PMID 25912999 in Experimental eye research as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2015-04-24 (day precision). PeptideScanner associated the retained record with the identity slug bpc-157. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · BPC-157

BPC 157: The counteraction of succinylcholine, hyperkalemia, and arrhythmias.

PubMed lists PMID 27060013 in European journal of pharmacology as Journal Article, with publication-date metadata of 2016-04-06 (day precision). PeptideScanner associated the retained record with the identity slug bpc-157. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · BPC-157

Stable gastric pentadecapeptide BPC 157 and bupivacaine.

PubMed lists PMID 27815173 in European journal of pharmacology as Journal Article, with publication-date metadata of 2016-11-01 (day precision). PeptideScanner associated the retained record with the identity slug bpc-157. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Epitalon

PubMed record PMID 12101568

PeptideScanner retained PubMed bibliographic metadata for PMID 12101568 at 2026-07-30T21:22:56.967Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2002-07-10. PeptideScanner associated this retained record with the identity slug epitalon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · BPC-157

PubMed record PMID 15381050

PeptideScanner retained PubMed bibliographic metadata for PMID 15381050 at 2026-07-30T21:22:56.969Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2004-09-24. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · BPC-157

PubMed record PMID 15774286

PeptideScanner retained PubMed bibliographic metadata for PMID 15774286 at 2026-07-30T21:22:56.970Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2005-03-19. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · BPC-157

PubMed record PMID 15840402

PeptideScanner retained PubMed bibliographic metadata for PMID 15840402 at 2026-07-30T21:22:56.970Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2005-04-21. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · BPC-157

PubMed record PMID 16117343

PeptideScanner retained PubMed bibliographic metadata for PMID 16117343 at 2026-07-30T21:22:56.971Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2005-08-25. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · BPC-157

PubMed record PMID 16369461

PeptideScanner retained PubMed bibliographic metadata for PMID 16369461 at 2026-07-30T21:22:56.972Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2005-12-22. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · BPC-157

PubMed record PMID 16583442

PeptideScanner retained PubMed bibliographic metadata for PMID 16583442 at 2026-07-30T21:22:56.973Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2006-04-04. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · BPC-157

PubMed record PMID 16609979

PeptideScanner retained PubMed bibliographic metadata for PMID 16609979 at 2026-07-30T21:22:56.973Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2006-04-13. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Linaclotide

PubMed record PMID 17694454

PeptideScanner retained PubMed bibliographic metadata for PMID 17694454 at 2026-07-30T21:22:56.977Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2007-08-19. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · BPC-157

PubMed record PMID 18594781

PeptideScanner retained PubMed bibliographic metadata for PMID 18594781 at 2026-07-30T21:22:56.978Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2008-07-03. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Linaclotide

PubMed record PMID 19098860

PeptideScanner retained PubMed bibliographic metadata for PMID 19098860 at 2026-07-30T21:22:56.979Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2008-12-23. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · BPC-157

PubMed record PMID 19465062

PeptideScanner retained PubMed bibliographic metadata for PMID 19465062 at 2026-07-30T21:22:56.982Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2009-05-26. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Linaclotide

PubMed record PMID 19706070

PeptideScanner retained PubMed bibliographic metadata for PMID 19706070 at 2026-07-30T21:22:57.963Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2009-08-27. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · BPC-157

PubMed record PMID 19903499

PeptideScanner retained PubMed bibliographic metadata for PMID 19903499 at 2026-07-30T21:22:57.965Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2009-11-12. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · BPC-157

PubMed record PMID 19931318

PeptideScanner retained PubMed bibliographic metadata for PMID 19931318 at 2026-07-30T21:22:57.965Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2009-11-26. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · BPC-157

PubMed record PMID 20190676

PeptideScanner retained PubMed bibliographic metadata for PMID 20190676 at 2026-07-30T21:22:57.967Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2010-03-02. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Linaclotide

PubMed record PMID 20560145

PeptideScanner retained PubMed bibliographic metadata for PMID 20560145 at 2026-07-30T21:22:57.971Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2010-06-19. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Tesamorelin

PubMed record PMID 22050344

PeptideScanner retained PubMed bibliographic metadata for PMID 22050344 at 2026-07-30T21:22:57.978Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2011-11-05. PeptideScanner associated this retained record with the identity slug tesamorelin. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Afamelanotide

PubMed record PMID 25402764

PeptideScanner retained PubMed bibliographic metadata for PMID 25402764 at 2026-07-30T21:22:57.992Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2014-11-18. PeptideScanner associated this retained record with the identity slug afamelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Afamelanotide

PubMed record PMID 26979527

PeptideScanner retained PubMed bibliographic metadata for PMID 26979527 at 2026-07-30T21:22:57.999Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2016-03-17. PeptideScanner associated this retained record with the identity slug afamelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · BPC-157

PubMed record PMID 11742568

PeptideScanner retained PubMed bibliographic metadata for PMID 11742568 at 2026-07-30T21:22:56.965Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2001-12-18. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · BPC-157

PubMed record PMID 11978191

PeptideScanner retained PubMed bibliographic metadata for PMID 11978191 at 2026-07-30T21:22:56.966Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2002-04-30. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · BPC-157

PubMed record PMID 14554208

PeptideScanner retained PubMed bibliographic metadata for PMID 14554208 at 2026-07-30T21:22:56.968Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2003-10-14. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Tesamorelin

PubMed record PMID 17575575

PeptideScanner retained PubMed bibliographic metadata for PMID 17575575 at 2026-07-30T21:22:56.977Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2007-06-19. PeptideScanner associated this retained record with the identity slug tesamorelin. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Tesamorelin

PubMed record PMID 18690162

PeptideScanner retained PubMed bibliographic metadata for PMID 18690162 at 2026-07-30T21:22:56.979Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2008-08-12. PeptideScanner associated this retained record with the identity slug tesamorelin. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Tesamorelin

PubMed record PMID 18724445

PeptideScanner retained PubMed bibliographic metadata for PMID 18724445 at 2026-07-30T21:22:56.979Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2008-08-30. PeptideScanner associated this retained record with the identity slug tesamorelin. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Tesamorelin

PubMed record PMID 18828236

PeptideScanner retained PubMed bibliographic metadata for PMID 18828236 at 2026-07-30T21:22:56.979Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2008-10-03. PeptideScanner associated this retained record with the identity slug tesamorelin. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Afamelanotide

PubMed record PMID 23407924

PeptideScanner retained PubMed bibliographic metadata for PMID 23407924 at 2026-07-30T21:22:57.984Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2013-02-15. PeptideScanner associated this retained record with the identity slug afamelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Afamelanotide

PubMed record PMID 23884489

PeptideScanner retained PubMed bibliographic metadata for PMID 23884489 at 2026-07-30T21:22:57.985Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2013-07-26. PeptideScanner associated this retained record with the identity slug afamelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Afamelanotide

PubMed record PMID 25230094

PeptideScanner retained PubMed bibliographic metadata for PMID 25230094 at 2026-07-30T21:22:57.990Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2014-09-18. PeptideScanner associated this retained record with the identity slug afamelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Afamelanotide

PubMed record PMID 25470471

PeptideScanner retained PubMed bibliographic metadata for PMID 25470471 at 2026-07-30T21:22:57.992Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2014-12-04. PeptideScanner associated this retained record with the identity slug afamelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Afamelanotide

PubMed record PMID 21073357

PeptideScanner retained PubMed bibliographic metadata for PMID 21073357 at 2026-07-30T21:22:57.974Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2010-11-16. PeptideScanner associated this retained record with the identity slug afamelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Afamelanotide

PubMed record PMID 21597671

PeptideScanner retained PubMed bibliographic metadata for PMID 21597671 at 2026-07-30T21:22:57.976Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2011-05-21. PeptideScanner associated this retained record with the identity slug afamelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Afamelanotide

PubMed record PMID 23277150

PeptideScanner retained PubMed bibliographic metadata for PMID 23277150 at 2026-07-30T21:22:57.983Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2013-01-02. PeptideScanner associated this retained record with the identity slug afamelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT03061604

PeptideScanner retained ClinicalTrials.gov record NCT03061604 at 2026-07-30T21:22:00.250Z. Its registry update date was 2017-11-14, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT00422058

PeptideScanner retained ClinicalTrials.gov record NCT00422058 at 2026-07-30T21:22:00.247Z. Its registry update date was 2017-11-01, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT00781937

PeptideScanner retained ClinicalTrials.gov record NCT00781937 at 2026-07-30T21:22:00.250Z. Its registry update date was 2017-11-01, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT01557166

PeptideScanner retained ClinicalTrials.gov record NCT01557166 at 2026-07-30T21:22:00.252Z. Its registry update date was 2017-11-01, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tesamorelin

ClinicalTrials.gov record NCT01263717

PeptideScanner retained ClinicalTrials.gov record NCT01263717 at 2026-07-30T21:22:00.255Z. Its registry update date was 2017-10-30, and PeptideScanner's reviewed identity mapping was tesamorelin.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT02647944

PeptideScanner retained ClinicalTrials.gov record NCT02647944 at 2026-07-30T21:22:00.265Z. Its registry update date was 2017-10-27, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Exenatide

Drugs@FDA application NDA209210

The official Drugs@FDA dataset lists original submission 1 for NDA 209210 with status AP dated 2017-10-20, and names exenatide synthetic among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Clinical trials · Lanreotide

ClinicalTrials.gov record NCT02351128

PeptideScanner retained ClinicalTrials.gov record NCT02351128 at 2026-07-30T21:22:00.252Z. Its registry update date was 2017-10-18, and PeptideScanner's reviewed identity mapping was lanreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Bremelanotide

PubMed record PMID 16839319

PeptideScanner retained PubMed bibliographic metadata for PMID 16839319 at 2026-07-30T21:22:56.974Z. PubMed recorded a metadata revision date of 2017-10-16 and an Entrez history date of 2006-07-15. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT00589472

PeptideScanner retained ClinicalTrials.gov record NCT00589472 at 2026-07-30T21:22:00.251Z. Its registry update date was 2017-10-06, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Exenatide

ClinicalTrials.gov record NCT01969149

PeptideScanner retained ClinicalTrials.gov record NCT01969149 at 2026-07-30T21:22:00.262Z. Its registry update date was 2017-10-06, and PeptideScanner's reviewed identity mapping was exenatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Semaglutide

Federal Register notice 2017-21176

The Federal Register published notice 2017-21176, attributed to FDA and its parent HHS department, on 2017-10-03. Its official title is “Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments,” and PeptideScanner's exact reviewed identity mapping connects the document to Semaglutide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Regulatory · Glucagon + 2 more

Federal Register notice 2017-21202

The Federal Register published notice 2017-21202, attributed to FDA and its parent HHS department, on 2017-10-03. Its official title is “Abbreviated New Drug Applications for Certain Highly Purified Synthetic Peptide Drug Products That Refer to Listed Drugs of Recombinant Deoxyribonucleic Acid Origin; Draft Guidance for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Glucagon, Liraglutide and Teriparatide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Clinical trials · Exenatide

ClinicalTrials.gov record NCT00456885

PeptideScanner retained ClinicalTrials.gov record NCT00456885 at 2026-07-30T21:23:14.762Z. Its registry update date was 2017-09-11, and PeptideScanner's reviewed identity mapping was exenatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT02321878

PeptideScanner retained ClinicalTrials.gov record NCT02321878 at 2026-07-30T21:23:14.758Z. Its registry update date was 2017-09-01, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Glucagon

ClinicalTrials.gov record NCT02516150

PeptideScanner retained ClinicalTrials.gov record NCT02516150 at 2026-07-30T21:23:14.758Z. Its registry update date was 2017-08-31, and PeptideScanner's reviewed identity mapping was glucagon.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT02474914

PeptideScanner retained ClinicalTrials.gov record NCT02474914 at 2026-07-30T21:23:14.756Z. Its registry update date was 2017-08-22, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT01153425

PeptideScanner retained ClinicalTrials.gov record NCT01153425 at 2026-07-30T21:23:14.757Z. Its registry update date was 2017-08-04, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT00978393

PeptideScanner retained ClinicalTrials.gov record NCT00978393 at 2026-07-30T21:23:14.756Z. Its registry update date was 2017-07-27, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT00600886

PeptideScanner retained ClinicalTrials.gov record NCT00600886 at 2026-07-30T21:23:14.761Z. Its registry update date was 2017-07-02, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Leuprolide + 1 more

Federal Register notice 2017-12908

The Federal Register published notice 2017-12908, attributed to FDA and its parent HHS department, on 2017-06-21. Its official title is “Wyeth Pharmaceuticals Inc. et al.; Withdrawal of Approval of 121 New Drug Applications and 161 Abbreviated New Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Leuprolide and Octreotide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Clinical trials · Linaclotide

ClinicalTrials.gov record NCT02291679

PeptideScanner retained ClinicalTrials.gov record NCT02291679 at 2026-07-30T21:24:24.231Z. Its registry update date was 2017-06-15, and PeptideScanner's reviewed identity mapping was linaclotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT01023061

PeptideScanner retained ClinicalTrials.gov record NCT01023061 at 2026-07-30T21:24:24.232Z. Its registry update date was 2017-06-06, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT00225420

PeptideScanner retained ClinicalTrials.gov record NCT00225420 at 2026-07-30T21:24:24.228Z. Its registry update date was 2017-06-01, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Abaloparatide

PubMed record PMID 28160873

PeptideScanner retained PubMed bibliographic metadata for PMID 28160873 at 2026-07-30T21:25:18.679Z. PubMed recorded a metadata revision date of 2017-05-31 and an Entrez history date of 2017-02-06. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT01562678

PeptideScanner retained ClinicalTrials.gov record NCT01562678 at 2026-07-30T21:24:24.231Z. Its registry update date was 2017-05-31, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT01431391

PeptideScanner retained ClinicalTrials.gov record NCT01431391 at 2026-07-30T21:24:24.227Z. Its registry update date was 2017-05-30, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Ipamorelin

PubMed record PMID 12168778

PeptideScanner retained PubMed bibliographic metadata for PMID 12168778 at 2026-07-30T21:25:18.666Z. PubMed recorded a metadata revision date of 2017-05-29 and an Entrez history date of 2002-08-10. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT02107391

PeptideScanner retained ClinicalTrials.gov record NCT02107391 at 2026-07-30T21:24:24.227Z. Its registry update date was 2017-05-24, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Liraglutide

Federal Register notice 2017-10326

The Federal Register published notice 2017-10326, attributed to FDA and its parent HHS department, on 2017-05-22. Its official title is “Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments,” and PeptideScanner's exact reviewed identity mapping connects the document to Liraglutide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT00170157

PeptideScanner retained ClinicalTrials.gov record NCT00170157 at 2026-07-30T21:24:24.228Z. Its registry update date was 2017-05-15, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT00759772

PeptideScanner retained ClinicalTrials.gov record NCT00759772 at 2026-07-30T21:24:24.229Z. Its registry update date was 2017-05-11, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT01739049

PeptideScanner retained ClinicalTrials.gov record NCT01739049 at 2026-07-30T21:24:24.225Z. Its registry update date was 2017-05-04, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Abaloparatide

Drugs@FDA application NDA208743

The official Drugs@FDA dataset lists original submission 1 for NDA 208743 with status AP dated 2017-04-28, and names abaloparatide among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Literature metadata · Ziconotide

Ziconotide: a new option for refractory pain.

PubMed lists PMID 16845440 in Drugs of today (Barcelona, Spain : 1998) as Journal Article, Review, with publication-date metadata of 2006-06 (month precision). PeptideScanner associated the retained record with the identity slug ziconotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Ipamorelin

ClinicalTrials.gov record NCT00672074

PeptideScanner retained ClinicalTrials.gov record NCT00672074 at 2026-07-30T21:24:24.228Z. Its registry update date was 2017-04-14, and PeptideScanner's reviewed identity mapping was ipamorelin.

Added August 8, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Ipamorelin

ClinicalTrials.gov record NCT01280344

PeptideScanner retained ClinicalTrials.gov record NCT01280344 at 2026-07-30T21:24:24.229Z. Its registry update date was 2017-04-13, and PeptideScanner's reviewed identity mapping was ipamorelin.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT00182754

PeptideScanner retained ClinicalTrials.gov record NCT00182754 at 2026-07-30T21:24:24.234Z. Its registry update date was 2017-04-11, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Exenatide

ClinicalTrials.gov record NCT00650546

PeptideScanner retained ClinicalTrials.gov record NCT00650546 at 2026-07-30T21:24:24.230Z. Its registry update date was 2017-04-11, and PeptideScanner's reviewed identity mapping was exenatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT01400516

PeptideScanner retained ClinicalTrials.gov record NCT01400516 at 2026-07-30T21:24:24.225Z. Its registry update date was 2017-04-11, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT00380406

PeptideScanner retained ClinicalTrials.gov record NCT00380406 at 2026-07-30T21:24:24.229Z. Its registry update date was 2017-04-05, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT02022254

PeptideScanner retained ClinicalTrials.gov record NCT02022254 at 2026-07-30T21:24:24.232Z. Its registry update date was 2017-04-04, and PeptideScanner's reviewed identity mapping was semaglutide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT00332969

PeptideScanner retained ClinicalTrials.gov record NCT00332969 at 2026-07-30T21:25:36.783Z. Its registry update date was 2017-03-31, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Dulaglutide

PubMed record PMID 25715416

PeptideScanner retained PubMed bibliographic metadata for PMID 25715416 at 2026-07-30T21:26:46.054Z. PubMed recorded a metadata revision date of 2017-03-08 and an Entrez history date of 2015-02-26. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT00318461

PeptideScanner retained ClinicalTrials.gov record NCT00318461 at 2026-07-30T21:25:37.025Z. Its registry update date was 2017-03-07, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Exenatide

ClinicalTrials.gov record NCT01484873

PeptideScanner retained ClinicalTrials.gov record NCT01484873 at 2026-07-30T21:25:36.820Z. Its registry update date was 2017-03-03, and PeptideScanner's reviewed identity mapping was exenatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Exenatide

ClinicalTrials.gov record NCT00855439

PeptideScanner retained ClinicalTrials.gov record NCT00855439 at 2026-07-30T21:25:36.764Z. Its registry update date was 2017-03-01, and PeptideScanner's reviewed identity mapping was exenatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT03068065

PeptideScanner retained ClinicalTrials.gov record NCT03068065 at 2026-07-30T21:25:36.832Z. Its registry update date was 2017-03-01, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT01518101

PeptideScanner retained ClinicalTrials.gov record NCT01518101 at 2026-07-30T21:25:36.782Z. Its registry update date was 2017-02-27, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT00171886

PeptideScanner retained ClinicalTrials.gov record NCT00171886 at 2026-07-30T21:25:36.764Z. Its registry update date was 2017-02-24, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT01128894

PeptideScanner retained ClinicalTrials.gov record NCT01128894 at 2026-07-30T21:25:36.852Z. Its registry update date was 2017-02-23, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Exenatide

ClinicalTrials.gov record NCT02325960

PeptideScanner retained ClinicalTrials.gov record NCT02325960 at 2026-07-30T21:25:37.027Z. Its registry update date was 2017-02-23, and PeptideScanner's reviewed identity mapping was exenatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Ziconotide

Perioperative Management of a Patient With an Intrathecal Drug Delivery Device Infusing Ziconotide: A Case Report.

PubMed lists PMID 28195861 in A & A case reports as Case Reports, Journal Article, with publication-date metadata of 2017-02-15 (day precision). PeptideScanner associated the retained record with the identity slug ziconotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT00873223

PeptideScanner retained ClinicalTrials.gov record NCT00873223 at 2026-07-30T21:25:36.788Z. Its registry update date was 2017-01-26, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT01515592

PeptideScanner retained ClinicalTrials.gov record NCT01515592 at 2026-07-30T21:25:36.784Z. Its registry update date was 2017-01-25, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT01516255

PeptideScanner retained ClinicalTrials.gov record NCT01516255 at 2026-07-30T21:25:36.817Z. Its registry update date was 2017-01-25, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT01518166

PeptideScanner retained ClinicalTrials.gov record NCT01518166 at 2026-07-30T21:25:36.824Z. Its registry update date was 2017-01-25, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT01620476

PeptideScanner retained ClinicalTrials.gov record NCT01620476 at 2026-07-30T21:25:37.025Z. Its registry update date was 2017-01-25, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT01507272

PeptideScanner retained ClinicalTrials.gov record NCT01507272 at 2026-07-30T21:25:36.818Z. Its registry update date was 2017-01-24, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT01507337

PeptideScanner retained ClinicalTrials.gov record NCT01507337 at 2026-07-30T21:25:36.779Z. Its registry update date was 2017-01-24, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT01508806

PeptideScanner retained ClinicalTrials.gov record NCT01508806 at 2026-07-30T21:25:36.763Z. Its registry update date was 2017-01-24, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT01620463

PeptideScanner retained ClinicalTrials.gov record NCT01620463 at 2026-07-30T21:25:36.783Z. Its registry update date was 2017-01-24, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Plecanatide

Drugs@FDA application NDA208745

The official Drugs@FDA dataset lists original submission 1 for NDA 208745 with status AP dated 2017-01-19, and names plecanatide among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT00223691

PeptideScanner retained ClinicalTrials.gov record NCT00223691 at 2026-07-30T21:25:36.812Z. Its registry update date was 2017-01-18, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Dulaglutide

PubMed record PMID 26179454

PeptideScanner retained PubMed bibliographic metadata for PMID 26179454 at 2026-07-30T21:35:57.004Z. PubMed recorded a metadata revision date of 2016-12-30 and an Entrez history date of 2015-07-17. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · CJC-1295

PubMed record PMID 26771670

PeptideScanner retained PubMed bibliographic metadata for PMID 26771670 at 2026-07-30T21:35:57.020Z. PubMed recorded a metadata revision date of 2016-12-30 and an Entrez history date of 2016-01-16. PeptideScanner associated this retained record with the identity slug cjc-1295. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Regulatory · Dulaglutide

Federal Register notice 2016-30399

The Federal Register published notice 2016-30399, attributed to FDA and its parent HHS department, on 2016-12-19. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; TRULICITY,” and PeptideScanner's exact reviewed identity mapping connects the document to Dulaglutide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT00002779

PeptideScanner retained ClinicalTrials.gov record NCT00002779 at 2026-07-30T21:34:56.506Z. Its registry update date was 2016-12-15, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT00928434

PeptideScanner retained ClinicalTrials.gov record NCT00928434 at 2026-07-30T21:34:56.510Z. Its registry update date was 2016-12-13, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Lanreotide

[Treatment of acromegaly with sustained-release lanreotide. A new somatostatin analog].

PubMed lists PMID 8099735 in Presse medicale (Paris, France : 1983) as Journal Article, with publication-date metadata of 1993-03-27 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT01750398

PeptideScanner retained ClinicalTrials.gov record NCT01750398 at 2026-07-30T21:34:56.506Z. Its registry update date was 2016-12-05, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Lanreotide

Combinative treatment of transarterial chemoembolization, celecoxib and lanreotide in unresectable hepatocellular carcinoma.

PubMed lists PMID 25746137 in Clinics and research in hepatology and gastroenterology as Case Reports, Letter, Research Support, Non-U.S. Gov't, with publication-date metadata of 2015-03-04 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Lanreotide

Long-acting lanreotide in adolescent girls with constitutional tall stature.

PubMed lists PMID 19258715 in Hormone research as Clinical Trial, Journal Article, Multicenter Study, with publication-date metadata of 2009-03-04 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Lanreotide

Preliminary experience with (68)Ga-DOTA-lanreotide positron emission tomography.

PubMed lists PMID 20168286 in The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of... as Clinical Trial, Journal Article, with publication-date metadata of 2010-02 (month precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Lanreotide

Elucidation of the self-assembly pathway of lanreotide octapeptide into beta-sheet nanotubes: role of two stable intermediates.

PubMed lists PMID 20199027 in Journal of the American Chemical Society as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2010-03-31 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Lanreotide

Therapeutic 188Re-lanreotide: determination of radiopharmacokinetic parameters in rats.

PubMed lists PMID 20604834 in The Journal of pharmacy and pharmacology as Journal Article, with publication-date metadata of 2010-04 (month precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Lanreotide

Use of lanreotide for the treatment of gastrointestinal fistulae.

PubMed lists PMID 21135689 in Annals of surgery as Letter, Comment, with publication-date metadata of 2011-01 (month precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Lanreotide

Resolving bile reflux by lanreotide in patients with Roux-en-Y gastrojejunostomy.

PubMed lists PMID 25682623 in Acta gastro-enterologica Belgica as Case Reports, Journal Article, with publication-date metadata of 2014-12 (month precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Ziconotide

Influence of pH and temperature on ziconotide stability in intrathecal analgesic admixtures in implantable pumps and syringes.

PubMed lists PMID 25891257 in International journal of pharmaceutics as Journal Article, with publication-date metadata of 2015-04-16 (day precision). PeptideScanner associated the retained record with the identity slug ziconotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Semax

Study on the neurotropic activity of the products of Semax enzymatic degradation.

PubMed lists PMID 10944712 in Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2000 May-Jun (source-text precision). PeptideScanner associated the retained record with the identity slug semax. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Lanreotide

[Somatuline(R) Autogel(R), a new formulation of lanreotide for the treatment of acromegalic patients].

PubMed lists PMID 12037499 in Annales d'endocrinologie as Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2002-04 (month precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Lanreotide

[Lanreotide in the treatment of thyroid orbitopathy].

PubMed lists PMID 15789913 in Przeglad lekarski as Journal Article, with publication-date metadata of 2004 (year precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Lanreotide

Pharmacokinetics and population pharmacodynamic analysis of lanreotide Autogel.

PubMed lists PMID 16154424 in Metabolism: clinical and experimental as Clinical Trial, Clinical Trial, Phase III, Journal Article, Multicenter Study, with publication-date metadata of 2005-10 (month precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Semax

Degradation of the ACTH(4-10) analog Semax in the presence of rat basal forebrain cell cultures and plasma membranes.

PubMed lists PMID 16773243 in Amino acids as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2006-05-26 (day precision). PeptideScanner associated the retained record with the identity slug semax. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Lanreotide

Radiation recall dermatitis in a patient affected with pheochromocytoma after treatment with lanreotide.

PubMed lists PMID 17854356 in The British journal of dermatology as Case Reports, Letter, with publication-date metadata of 2007-09-13 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Lanreotide

Self-assembly of the octapeptide lanreotide and lanreotide-based derivatives: the role of the aromatic residues.

PubMed lists PMID 17929329 in Journal of peptide science : an official publication of the European Peptide Society as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2008-01 (month precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Lanreotide

Optimalization and cost management of lanreotide-Autogel therapy in acromegaly.

PubMed lists PMID 17984236 in European journal of endocrinology as Comparative Study, Journal Article, Multicenter Study, with publication-date metadata of 2007-11 (month precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Lanreotide

Lanreotide autogel and insulin sensitivity markers: report of 5 acromegalic patients and literature review.

PubMed lists PMID 18063933 in Neuro endocrinology letters as Clinical Trial, Journal Article, Review, with publication-date metadata of 2007-12 (month precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Lanreotide

Lanreotide Autogel for persistent diabetic macular edema.

PubMed lists PMID 18367285 in Diabetes research and clinical practice as Case Reports, Journal Article, with publication-date metadata of 2008-03-26 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Lanreotide

Para-aortic lymphocele treated with an injection of somatostatine analog (lanreotide).

PubMed lists PMID 18684551 in European journal of obstetrics, gynecology, and reproductive biology as Case Reports, Letter, with publication-date metadata of 2008-08-05 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Lanreotide

PubMed record PMID 10199803

PeptideScanner retained PubMed bibliographic metadata for PMID 10199803 at 2026-07-30T21:35:52.336Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 1999-04-13. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Lanreotide

PubMed record PMID 10231313

PeptideScanner retained PubMed bibliographic metadata for PMID 10231313 at 2026-07-30T21:35:52.337Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 1999-05-07. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Lanreotide

PubMed record PMID 10480146

PeptideScanner retained PubMed bibliographic metadata for PMID 10480146 at 2026-07-30T21:35:52.338Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 1999-09-10. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Lanreotide

PubMed record PMID 10579475

PeptideScanner retained PubMed bibliographic metadata for PMID 10579475 at 2026-07-30T21:35:52.340Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 1999-12-01. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Lanreotide

PubMed record PMID 10748802

PeptideScanner retained PubMed bibliographic metadata for PMID 10748802 at 2026-07-30T21:35:52.342Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 2000-04-05. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Ziconotide

PubMed record PMID 11059665

PeptideScanner retained PubMed bibliographic metadata for PMID 11059665 at 2026-07-30T21:35:52.345Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 2000-11-04. PeptideScanner associated this retained record with the identity slug ziconotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Lanreotide

PubMed record PMID 11095353

PeptideScanner retained PubMed bibliographic metadata for PMID 11095353 at 2026-07-30T21:35:52.345Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 2000-11-30. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Lanreotide

PubMed record PMID 11128563

PeptideScanner retained PubMed bibliographic metadata for PMID 11128563 at 2026-07-30T21:35:52.346Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 2000-12-29. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Ziconotide

PubMed record PMID 11927761

PeptideScanner retained PubMed bibliographic metadata for PMID 11927761 at 2026-07-30T21:35:53.267Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 2002-04-03. PeptideScanner associated this retained record with the identity slug ziconotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Ziconotide

PubMed record PMID 12817525

PeptideScanner retained PubMed bibliographic metadata for PMID 12817525 at 2026-07-30T21:35:53.272Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 2003-06-24. PeptideScanner associated this retained record with the identity slug ziconotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Ziconotide

PubMed record PMID 16207099

PeptideScanner retained PubMed bibliographic metadata for PMID 16207099 at 2026-07-30T21:35:54.205Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 2005-10-07. PeptideScanner associated this retained record with the identity slug ziconotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Ziconotide

PubMed record PMID 16331245

PeptideScanner retained PubMed bibliographic metadata for PMID 16331245 at 2026-07-30T21:35:54.206Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 2005-12-07. PeptideScanner associated this retained record with the identity slug ziconotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Ziconotide

PubMed record PMID 16503720

PeptideScanner retained PubMed bibliographic metadata for PMID 16503720 at 2026-07-30T21:35:54.208Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 2006-03-01. PeptideScanner associated this retained record with the identity slug ziconotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Ziconotide

PubMed record PMID 17078783

PeptideScanner retained PubMed bibliographic metadata for PMID 17078783 at 2026-07-30T21:35:54.213Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 2006-11-03. PeptideScanner associated this retained record with the identity slug ziconotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Ziconotide

PubMed record PMID 17131701

PeptideScanner retained PubMed bibliographic metadata for PMID 17131701 at 2026-07-30T21:35:54.213Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 2006-11-30. PeptideScanner associated this retained record with the identity slug ziconotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Ziconotide

PubMed record PMID 17157748

PeptideScanner retained PubMed bibliographic metadata for PMID 17157748 at 2026-07-30T21:35:54.214Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 2006-12-13. PeptideScanner associated this retained record with the identity slug ziconotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Ziconotide

PubMed record PMID 17310258

PeptideScanner retained PubMed bibliographic metadata for PMID 17310258 at 2026-07-30T21:35:54.215Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 2007-02-21. PeptideScanner associated this retained record with the identity slug ziconotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Ziconotide

PubMed record PMID 17963128

PeptideScanner retained PubMed bibliographic metadata for PMID 17963128 at 2026-07-30T21:35:54.219Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 2007-10-27. PeptideScanner associated this retained record with the identity slug ziconotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Ziconotide

PubMed record PMID 18366507

PeptideScanner retained PubMed bibliographic metadata for PMID 18366507 at 2026-07-30T21:35:54.222Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 2008-03-28. PeptideScanner associated this retained record with the identity slug ziconotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Ziconotide

PubMed record PMID 18366508

PeptideScanner retained PubMed bibliographic metadata for PMID 18366508 at 2026-07-30T21:35:54.222Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 2008-03-28. PeptideScanner associated this retained record with the identity slug ziconotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Lanreotide

PubMed record PMID 8954072

PeptideScanner retained PubMed bibliographic metadata for PMID 8954072 at 2026-07-30T21:35:51.206Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 1996-12-01. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Lanreotide

PubMed record PMID 9119171

PeptideScanner retained PubMed bibliographic metadata for PMID 9119171 at 2026-07-30T21:35:52.319Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 1996-01-01. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Lanreotide

PubMed record PMID 9537429

PeptideScanner retained PubMed bibliographic metadata for PMID 9537429 at 2026-07-30T21:35:52.324Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 1998-04-16. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Lanreotide

PubMed record PMID 9867148

PeptideScanner retained PubMed bibliographic metadata for PMID 9867148 at 2026-07-30T21:35:52.335Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 1998-12-29. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Lanreotide

PubMed record PMID 9934776

PeptideScanner retained PubMed bibliographic metadata for PMID 9934776 at 2026-07-30T21:35:52.335Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 1999-02-06. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Ziconotide

PubMed record PMID 10547097

PeptideScanner retained PubMed bibliographic metadata for PMID 10547097 at 2026-07-30T21:35:52.339Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 1999-11-05. PeptideScanner associated this retained record with the identity slug ziconotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Ziconotide

PubMed record PMID 10610271

PeptideScanner retained PubMed bibliographic metadata for PMID 10610271 at 2026-07-30T21:35:52.341Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 1999-12-28. PeptideScanner associated this retained record with the identity slug ziconotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Ziconotide

PubMed record PMID 11059664

PeptideScanner retained PubMed bibliographic metadata for PMID 11059664 at 2026-07-30T21:35:52.345Z. PubMed recorded a metadata revision date of 2016-11-24 and an Entrez history date of 2000-11-04. PeptideScanner associated this retained record with the identity slug ziconotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Emideltide

PubMed record PMID 8728103

PeptideScanner retained PubMed bibliographic metadata for PMID 8728103 at 2026-07-30T21:35:51.202Z. PubMed recorded a metadata revision date of 2016-11-23 and an Entrez history date of 1996-04-01. PeptideScanner associated this retained record with the identity slug emideltide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Lanreotide

PubMed record PMID 8975096

PeptideScanner retained PubMed bibliographic metadata for PMID 8975096 at 2026-07-30T21:35:51.206Z. PubMed recorded a metadata revision date of 2016-11-23 and an Entrez history date of 1996-09-07. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Lanreotide

PubMed record PMID 7864583

PeptideScanner retained PubMed bibliographic metadata for PMID 7864583 at 2026-07-30T21:35:51.193Z. PubMed recorded a metadata revision date of 2016-11-23 and an Entrez history date of 1994-01-01. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Lanreotide

PubMed record PMID 8646723

PeptideScanner retained PubMed bibliographic metadata for PMID 8646723 at 2026-07-30T21:35:51.201Z. PubMed recorded a metadata revision date of 2016-11-23 and an Entrez history date of 1996-07-01. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Lanreotide

PubMed record PMID 8786564

PeptideScanner retained PubMed bibliographic metadata for PMID 8786564 at 2026-07-30T21:35:51.203Z. PubMed recorded a metadata revision date of 2016-11-23 and an Entrez history date of 1996-03-01. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Lanreotide

PubMed record PMID 8931985

PeptideScanner retained PubMed bibliographic metadata for PMID 8931985 at 2026-07-30T21:35:51.205Z. PubMed recorded a metadata revision date of 2016-11-23 and an Entrez history date of 1996-09-01. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Lanreotide

PubMed record PMID 7540120

PeptideScanner retained PubMed bibliographic metadata for PMID 7540120 at 2026-07-30T21:35:51.187Z. PubMed recorded a metadata revision date of 2016-11-23 and an Entrez history date of 1995-01-01. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT01309399

PeptideScanner retained ClinicalTrials.gov record NCT01309399 at 2026-07-30T21:34:56.507Z. Its registry update date was 2016-11-23, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Exenatide

ClinicalTrials.gov record NCT01971242

PeptideScanner retained ClinicalTrials.gov record NCT01971242 at 2026-07-30T21:34:56.502Z. Its registry update date was 2016-11-17, and PeptideScanner's reviewed identity mapping was exenatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Exenatide

ClinicalTrials.gov record NCT02313220

PeptideScanner retained ClinicalTrials.gov record NCT02313220 at 2026-07-30T21:34:56.513Z. Its registry update date was 2016-11-17, and PeptideScanner's reviewed identity mapping was exenatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Ziconotide

PubMed record PMID 23969873

PeptideScanner retained PubMed bibliographic metadata for PMID 23969873 at 2026-07-30T21:35:56.437Z. PubMed recorded a metadata revision date of 2016-10-24 and an Entrez history date of 2013-08-24. PeptideScanner associated this retained record with the identity slug ziconotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Ziconotide

PubMed record PMID 23969707

PeptideScanner retained PubMed bibliographic metadata for PMID 23969707 at 2026-07-30T21:35:56.437Z. PubMed recorded a metadata revision date of 2016-10-24 and an Entrez history date of 2013-08-24. PeptideScanner associated this retained record with the identity slug ziconotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Ziconotide

PubMed record PMID 23969933

PeptideScanner retained PubMed bibliographic metadata for PMID 23969933 at 2026-07-30T21:35:56.437Z. PubMed recorded a metadata revision date of 2016-10-24 and an Entrez history date of 2013-08-24. PeptideScanner associated this retained record with the identity slug ziconotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Epitalon

PubMed record PMID 15490730

PeptideScanner retained PubMed bibliographic metadata for PMID 15490730 at 2026-07-30T21:35:53.278Z. PubMed recorded a metadata revision date of 2016-10-21 and an Entrez history date of 2004-10-20. PeptideScanner associated this retained record with the identity slug epitalon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Epitalon

PubMed record PMID 17152723

PeptideScanner retained PubMed bibliographic metadata for PMID 17152723 at 2026-07-30T21:35:54.214Z. PubMed recorded a metadata revision date of 2016-10-21 and an Entrez history date of 2006-12-13. PeptideScanner associated this retained record with the identity slug epitalon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Epitalon

PubMed record PMID 17152724

PeptideScanner retained PubMed bibliographic metadata for PMID 17152724 at 2026-07-30T21:35:54.214Z. PubMed recorded a metadata revision date of 2016-10-21 and an Entrez history date of 2006-12-13. PeptideScanner associated this retained record with the identity slug epitalon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Epitalon

PubMed record PMID 20405731

PeptideScanner retained PubMed bibliographic metadata for PMID 20405731 at 2026-07-30T21:35:55.360Z. PubMed recorded a metadata revision date of 2016-10-21 and an Entrez history date of 2010-04-22. PeptideScanner associated this retained record with the identity slug epitalon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Emideltide

PubMed record PMID 6857232

PeptideScanner retained PubMed bibliographic metadata for PMID 6857232 at 2026-07-30T21:35:51.184Z. PubMed recorded a metadata revision date of 2016-10-21 and an Entrez history date of 1983-02-01. PeptideScanner associated this retained record with the identity slug emideltide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Emideltide

PubMed record PMID 11525128

PeptideScanner retained PubMed bibliographic metadata for PMID 11525128 at 2026-07-30T21:35:53.265Z. PubMed recorded a metadata revision date of 2016-10-20 and an Entrez history date of 2001-08-30. PeptideScanner associated this retained record with the identity slug emideltide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Epitalon

PubMed record PMID 12942748

PeptideScanner retained PubMed bibliographic metadata for PMID 12942748 at 2026-07-30T21:35:53.272Z. PubMed recorded a metadata revision date of 2016-10-20 and an Entrez history date of 2003-08-29. PeptideScanner associated this retained record with the identity slug epitalon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Epitalon

PubMed record PMID 17217245

PeptideScanner retained PubMed bibliographic metadata for PMID 17217245 at 2026-07-30T21:35:54.214Z. PubMed recorded a metadata revision date of 2016-10-20 and an Entrez history date of 2007-01-16. PeptideScanner associated this retained record with the identity slug epitalon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT01782261

PeptideScanner retained ClinicalTrials.gov record NCT01782261 at 2026-07-30T21:34:56.513Z. Its registry update date was 2016-10-11, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Exenatide

ClinicalTrials.gov record NCT01444898

PeptideScanner retained ClinicalTrials.gov record NCT01444898 at 2026-07-30T21:36:16.906Z. Its registry update date was 2016-09-29, and PeptideScanner's reviewed identity mapping was exenatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT01076335

PeptideScanner retained ClinicalTrials.gov record NCT01076335 at 2026-07-30T21:36:16.908Z. Its registry update date was 2016-09-19, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT02478879

PeptideScanner retained ClinicalTrials.gov record NCT02478879 at 2026-07-30T21:36:16.907Z. Its registry update date was 2016-08-23, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT02545738

PeptideScanner retained ClinicalTrials.gov record NCT02545738 at 2026-07-30T21:36:16.908Z. Its registry update date was 2016-08-10, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Exenatide

ClinicalTrials.gov record NCT02160990

PeptideScanner retained ClinicalTrials.gov record NCT02160990 at 2026-07-30T21:36:16.909Z. Its registry update date was 2016-08-09, and PeptideScanner's reviewed identity mapping was exenatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Lixisenatide

Drugs@FDA application BLA208471

The official Drugs@FDA dataset lists original submission 1 for BLA 208471 with status AP dated 2016-07-27, and names lixisenatide among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT01204476

PeptideScanner retained ClinicalTrials.gov record NCT01204476 at 2026-07-30T21:36:16.909Z. Its registry update date was 2016-07-15, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT00033605

PeptideScanner retained ClinicalTrials.gov record NCT00033605 at 2026-07-30T21:36:16.907Z. Its registry update date was 2016-07-13, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT00943956

PeptideScanner retained ClinicalTrials.gov record NCT00943956 at 2026-07-30T21:37:20.823Z. Its registry update date was 2016-05-25, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Exenatide

PubMed record PMID 27200638

PeptideScanner retained PubMed bibliographic metadata for PMID 27200638 at 2026-07-30T21:38:23.144Z. PubMed recorded a metadata revision date of 2016-05-21 and an Entrez history date of 2016-05-21. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Exenatide

PubMed record PMID 27200644

PeptideScanner retained PubMed bibliographic metadata for PMID 27200644 at 2026-07-30T21:38:23.144Z. PubMed recorded a metadata revision date of 2016-05-21 and an Entrez history date of 2016-05-21. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Exenatide

PubMed record PMID 27200645

PeptideScanner retained PubMed bibliographic metadata for PMID 27200645 at 2026-07-30T21:38:23.144Z. PubMed recorded a metadata revision date of 2016-05-21 and an Entrez history date of 2016-05-21. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Exenatide

PubMed record PMID 27200672

PeptideScanner retained PubMed bibliographic metadata for PMID 27200672 at 2026-07-30T21:38:23.145Z. PubMed recorded a metadata revision date of 2016-05-21 and an Entrez history date of 2016-05-21. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Exenatide

PubMed record PMID 27200673

PeptideScanner retained PubMed bibliographic metadata for PMID 27200673 at 2026-07-30T21:38:23.145Z. PubMed recorded a metadata revision date of 2016-05-21 and an Entrez history date of 2016-05-21. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Linaclotide

PubMed record PMID 27200765

PeptideScanner retained PubMed bibliographic metadata for PMID 27200765 at 2026-07-30T21:38:23.145Z. PubMed recorded a metadata revision date of 2016-05-21 and an Entrez history date of 2016-05-21. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Dulaglutide

PubMed record PMID 27200592

PeptideScanner retained PubMed bibliographic metadata for PMID 27200592 at 2026-07-30T21:38:23.144Z. PubMed recorded a metadata revision date of 2016-05-21 and an Entrez history date of 2016-05-21. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Lixisenatide

PubMed record PMID 27200667

PeptideScanner retained PubMed bibliographic metadata for PMID 27200667 at 2026-07-30T21:38:23.145Z. PubMed recorded a metadata revision date of 2016-05-21 and an Entrez history date of 2016-05-21. PeptideScanner associated this retained record with the identity slug lixisenatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Lanreotide

PubMed record PMID 27200668

PeptideScanner retained PubMed bibliographic metadata for PMID 27200668 at 2026-07-30T21:38:23.145Z. PubMed recorded a metadata revision date of 2016-05-21 and an Entrez history date of 2016-05-21. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Dulaglutide

PubMed record PMID 27200698

PeptideScanner retained PubMed bibliographic metadata for PMID 27200698 at 2026-07-30T21:38:23.145Z. PubMed recorded a metadata revision date of 2016-05-21 and an Entrez history date of 2016-05-21. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Clinical trials · Exenatide

ClinicalTrials.gov record NCT01951651

PeptideScanner retained ClinicalTrials.gov record NCT01951651 at 2026-07-30T21:37:20.824Z. Its registry update date was 2016-05-16, and PeptideScanner's reviewed identity mapping was exenatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · CJC-1295

PubMed record PMID 21204297

PeptideScanner retained PubMed bibliographic metadata for PMID 21204297 at 2026-07-30T21:38:23.138Z. PubMed recorded a metadata revision date of 2016-05-11 and an Entrez history date of 2011-01-05. PeptideScanner associated this retained record with the identity slug cjc-1295. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Clinical trials · Lixisenatide

ClinicalTrials.gov record NCT02276196

PeptideScanner retained ClinicalTrials.gov record NCT02276196 at 2026-07-30T21:37:20.821Z. Its registry update date was 2016-04-29, and PeptideScanner's reviewed identity mapping was lixisenatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Tesamorelin

PubMed record PMID 27121785

PeptideScanner retained PubMed bibliographic metadata for PMID 27121785 at 2026-07-30T21:38:23.144Z. PubMed recorded a metadata revision date of 2016-04-28 and an Entrez history date of 2016-04-29. PeptideScanner associated this retained record with the identity slug tesamorelin. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT00903162

PeptideScanner retained ClinicalTrials.gov record NCT00903162 at 2026-07-30T21:37:20.822Z. Its registry update date was 2016-04-18, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT00241020

PeptideScanner retained ClinicalTrials.gov record NCT00241020 at 2026-07-30T21:37:20.823Z. Its registry update date was 2016-04-12, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Exenatide

ClinicalTrials.gov record NCT01432405

PeptideScanner retained ClinicalTrials.gov record NCT01432405 at 2026-07-30T21:37:20.822Z. Its registry update date was 2016-04-12, and PeptideScanner's reviewed identity mapping was exenatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Glucagon

ClinicalTrials.gov record NCT01483651

PeptideScanner retained ClinicalTrials.gov record NCT01483651 at 2026-07-30T21:38:42.855Z. Its registry update date was 2016-03-29, and PeptideScanner's reviewed identity mapping was glucagon.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT01237119

PeptideScanner retained ClinicalTrials.gov record NCT01237119 at 2026-07-30T21:38:42.856Z. Its registry update date was 2016-03-23, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Liraglutide

Federal Register notice 2016-05959

The Federal Register published notice 2016-05959, attributed to FDA and its parent HHS department, on 2016-03-17. Its official title is “Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Liraglutide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Regulatory · Lixisenatide

Federal Register notice 2016-05931

The Federal Register published notice 2016-05931, attributed to FDA and its parent HHS department, on 2016-03-16. Its official title is “Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Lixisenatide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Clinical trials · Dulaglutide

ClinicalTrials.gov record NCT01667900

PeptideScanner retained ClinicalTrials.gov record NCT01667900 at 2026-07-30T21:38:42.858Z. Its registry update date was 2016-03-07, and PeptideScanner's reviewed identity mapping was dulaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT00454571

PeptideScanner retained ClinicalTrials.gov record NCT00454571 at 2026-07-30T21:38:42.855Z. Its registry update date was 2016-02-10, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT01121939

PeptideScanner retained ClinicalTrials.gov record NCT01121939 at 2026-07-30T21:38:42.856Z. Its registry update date was 2016-02-05, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT01917773

PeptideScanner retained ClinicalTrials.gov record NCT01917773 at 2026-07-30T21:39:57.679Z. Its registry update date was 2015-12-21, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Lixisenatide

ClinicalTrials.gov record NCT02020629

PeptideScanner retained ClinicalTrials.gov record NCT02020629 at 2026-07-30T21:39:57.678Z. Its registry update date was 2015-12-15, and PeptideScanner's reviewed identity mapping was lixisenatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Ziconotide

ClinicalTrials.gov record NCT00076544

PeptideScanner retained ClinicalTrials.gov record NCT00076544 at 2026-07-30T21:39:57.683Z. Its registry update date was 2015-12-14, and PeptideScanner's reviewed identity mapping was ziconotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Glucagon

ClinicalTrials.gov record NCT01155206

PeptideScanner retained ClinicalTrials.gov record NCT01155206 at 2026-07-30T21:39:57.683Z. Its registry update date was 2015-12-02, and PeptideScanner's reviewed identity mapping was glucagon.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Liraglutide

[Basal insulin and liraglutide combined in a pen].

PubMed lists PMID 26364391 in Medizinische Monatsschrift fur Pharmazeuten as Journal Article, with publication-date metadata of 2015-04 (month precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Liraglutide

New drugs: Liraglutide, dalfampridine, and abobotulinumtoxinA.

PubMed lists PMID 20452924 in Journal of the American Pharmacists Association : JAPhA as Journal Article, with publication-date metadata of 2010 May-Jun (source-text precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Liraglutide

Liraglutide in islet transplantation: from bench to bedside.

PubMed lists PMID 20456108 in Transplant international : official journal of the European Society for Organ Transplantation as Comment, Journal Article, with publication-date metadata of 2010-03-01 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Liraglutide

Liraglutide therapy in Prader-Willi syndrome.

PubMed lists PMID 21388446 in Diabetic medicine : a journal of the British Diabetic Association as Case Reports, Letter, Research Support, Non-U.S. Gov't, with publication-date metadata of 2011-06 (month precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Liraglutide

[Liraglutide].

PubMed lists PMID 21595276 in Nihon rinsho. Japanese journal of clinical medicine as English Abstract, Journal Article, Review, with publication-date metadata of 2011-05 (month precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Liraglutide

[Liraglutide in the treatment of diabetes type 2].

PubMed lists PMID 22165195 in Lijecnicki vjesnik as English Abstract, Journal Article, Review, with publication-date metadata of 2011 Jul-Aug (source-text precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Liraglutide

Combination therapy with liraglutide and sulfonylurea for a type 2 diabetic patient with high titer of anti-insulin antibodies produced by insulin therapy.

PubMed lists PMID 22257418 in Diabetes research and clinical practice as Case Reports, Letter, with publication-date metadata of 2012-01-16 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Liraglutide

[Acute pancreatitis in a patient treated with liraglutide].

PubMed lists PMID 23507272 in Medicina clinica as Case Reports, Letter, with publication-date metadata of 2013-03-15 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Liraglutide

Liraglutide in combination with acitretin for severe recalcitrant psoriasis.

PubMed lists PMID 23834125 in The British journal of dermatology as Case Reports, Letter, with publication-date metadata of 2013-07 (month precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Liraglutide

Acute interstitial nephritis after treatment with liraglutide.

PubMed lists PMID 24315766 in American journal of kidney diseases : the official journal of the National Kidney Foundation as Case Reports, Letter, with publication-date metadata of 2013-12-04 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Liraglutide

Liraglutide treatment in a patient with HIV, type 2 diabetes and sleep apnoea-hypopnoea syndrome.

PubMed lists PMID 25455831 in Diabetes & metabolism as Case Reports, Letter, with publication-date metadata of 2014-11-06 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Exenatide

PubMed record PMID 22997980

PeptideScanner retained PubMed bibliographic metadata for PMID 22997980 at 2026-07-30T21:41:09.514Z. PubMed recorded a metadata revision date of 2015-11-19 and an Entrez history date of 2012-09-25. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Bremelanotide

PubMed record PMID 14999221

PeptideScanner retained PubMed bibliographic metadata for PMID 14999221 at 2026-07-30T21:41:07.288Z. PubMed recorded a metadata revision date of 2015-11-19 and an Entrez history date of 2004-03-05. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Bremelanotide

PubMed record PMID 15833522

PeptideScanner retained PubMed bibliographic metadata for PMID 15833522 at 2026-07-30T21:41:07.293Z. PubMed recorded a metadata revision date of 2015-11-19 and an Entrez history date of 2005-04-19. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT01753856

PeptideScanner retained ClinicalTrials.gov record NCT01753856 at 2026-07-30T21:39:57.682Z. Its registry update date was 2015-10-08, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT01360424

PeptideScanner retained ClinicalTrials.gov record NCT01360424 at 2026-07-30T21:41:27.767Z. Its registry update date was 2015-09-29, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT01785043

PeptideScanner retained ClinicalTrials.gov record NCT01785043 at 2026-07-30T21:41:27.766Z. Its registry update date was 2015-09-15, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Glucagon

Federal Register notice 2015-22673

The Federal Register published notice 2015-22673, attributed to FDA and its parent HHS department, on 2015-09-09. Its official title is “Determination That GLUCAGON (Glucagon Hydrochloride) for Injection, Equivalent to 1 Milligram Base/Vial and Equivalent to 10 Milligram Base/Vial, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness,” and PeptideScanner's exact reviewed identity mapping connects the document to Glucagon.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT00005006

PeptideScanner retained ClinicalTrials.gov record NCT00005006 at 2026-07-30T21:41:27.764Z. Its registry update date was 2015-08-19, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT00473265

PeptideScanner retained ClinicalTrials.gov record NCT00473265 at 2026-07-30T21:41:27.762Z. Its registry update date was 2015-07-16, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · GHK-Cu

PubMed record PMID 25731775

PeptideScanner retained PubMed bibliographic metadata for PMID 25731775 at 2026-07-30T21:43:30.952Z. PubMed recorded a metadata revision date of 2015-06-02 and an Entrez history date of 2015-03-04. PeptideScanner associated this retained record with the identity slug ghk-cu. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Exenatide

PubMed record PMID 25998595

PeptideScanner retained PubMed bibliographic metadata for PMID 25998595 at 2026-07-30T21:43:30.962Z. PubMed recorded a metadata revision date of 2015-05-22 and an Entrez history date of 2015-05-23. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT02315001

PeptideScanner retained ClinicalTrials.gov record NCT02315001 at 2026-07-30T21:42:40.790Z. Its registry update date was 2015-05-20, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Glucagon

Drugs@FDA application NDA201849

The official Drugs@FDA dataset lists original submission 1 for NDA 201849 with status AP dated 2015-05-08, and names glucagon hydrochloride among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Clinical trials · Exenatide

ClinicalTrials.gov record NCT00835848

PeptideScanner retained ClinicalTrials.gov record NCT00835848 at 2026-07-30T21:42:40.790Z. Its registry update date was 2015-05-05, and PeptideScanner's reviewed identity mapping was exenatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT00500110

PeptideScanner retained ClinicalTrials.gov record NCT00500110 at 2026-07-30T21:42:40.792Z. Its registry update date was 2015-04-28, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT01473589

PeptideScanner retained ClinicalTrials.gov record NCT01473589 at 2026-07-30T21:42:40.788Z. Its registry update date was 2015-04-16, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT01473602

PeptideScanner retained ClinicalTrials.gov record NCT01473602 at 2026-07-30T21:42:40.804Z. Its registry update date was 2015-04-16, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Exenatide

ClinicalTrials.gov record NCT01077323

PeptideScanner retained ClinicalTrials.gov record NCT01077323 at 2026-07-30T21:42:40.803Z. Its registry update date was 2015-04-15, and PeptideScanner's reviewed identity mapping was exenatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Exenatide

ClinicalTrials.gov record NCT01297062

PeptideScanner retained ClinicalTrials.gov record NCT01297062 at 2026-07-30T21:42:40.803Z. Its registry update date was 2015-04-14, and PeptideScanner's reviewed identity mapping was exenatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT02416271

PeptideScanner retained ClinicalTrials.gov record NCT02416271 at 2026-07-30T21:42:40.803Z. Its registry update date was 2015-04-14, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Exenatide

ClinicalTrials.gov record NCT00375492

PeptideScanner retained ClinicalTrials.gov record NCT00375492 at 2026-07-30T21:42:40.801Z. Its registry update date was 2015-04-07, and PeptideScanner's reviewed identity mapping was exenatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Exenatide

ClinicalTrials.gov record NCT00500370

PeptideScanner retained ClinicalTrials.gov record NCT00500370 at 2026-07-30T21:42:40.804Z. Its registry update date was 2015-04-07, and PeptideScanner's reviewed identity mapping was exenatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT00004426

PeptideScanner retained ClinicalTrials.gov record NCT00004426 at 2026-07-30T21:43:54.469Z. Its registry update date was 2015-03-26, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT00004436

PeptideScanner retained ClinicalTrials.gov record NCT00004436 at 2026-07-30T21:43:54.456Z. Its registry update date was 2015-03-25, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT00004438

PeptideScanner retained ClinicalTrials.gov record NCT00004438 at 2026-07-30T21:43:54.452Z. Its registry update date was 2015-03-25, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT01755572

PeptideScanner retained ClinicalTrials.gov record NCT01755572 at 2026-07-30T21:43:54.457Z. Its registry update date was 2015-03-25, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Exenatide

ClinicalTrials.gov record NCT00381342

PeptideScanner retained ClinicalTrials.gov record NCT00381342 at 2026-07-30T21:43:54.470Z. Its registry update date was 2015-02-23, and PeptideScanner's reviewed identity mapping was exenatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT00631527

PeptideScanner retained ClinicalTrials.gov record NCT00631527 at 2026-07-30T21:43:54.453Z. Its registry update date was 2015-01-29, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Dulaglutide

PubMed record PMID 25575154

PeptideScanner retained PubMed bibliographic metadata for PMID 25575154 at 2026-07-30T21:44:40.387Z. PubMed recorded a metadata revision date of 2015-01-10 and an Entrez history date of 2015-01-10. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Regulatory · Liraglutide

Drugs@FDA application NDA206321

The official Drugs@FDA dataset lists original submission 1 for NDA 206321 with status AP dated 2014-12-23, and names liraglutide among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Clinical trials · Bremelanotide

ClinicalTrials.gov record NCT01382719

PeptideScanner retained ClinicalTrials.gov record NCT01382719 at 2026-07-30T21:54:46.551Z. Its registry update date was 2014-12-18, and PeptideScanner's reviewed identity mapping was bremelanotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT01507389

PeptideScanner retained ClinicalTrials.gov record NCT01507389 at 2026-07-30T21:54:46.547Z. Its registry update date was 2014-12-09, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT02305069

PeptideScanner retained ClinicalTrials.gov record NCT02305069 at 2026-07-30T21:54:46.552Z. Its registry update date was 2014-12-02, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT00412061

PeptideScanner retained ClinicalTrials.gov record NCT00412061 at 2026-07-30T21:54:46.554Z. Its registry update date was 2014-11-21, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Bremelanotide

PubMed record PMID 14963471

PeptideScanner retained PubMed bibliographic metadata for PMID 14963471 at 2026-07-30T21:55:37.950Z. PubMed recorded a metadata revision date of 2014-11-20 and an Entrez history date of 2004-02-14. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Bremelanotide

PubMed record PMID 15134289

PeptideScanner retained PubMed bibliographic metadata for PMID 15134289 at 2026-07-30T21:55:37.950Z. PubMed recorded a metadata revision date of 2014-11-20 and an Entrez history date of 2004-05-12. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Elamipretide

PubMed record PMID 17151329

PeptideScanner retained PubMed bibliographic metadata for PMID 17151329 at 2026-07-30T21:55:37.962Z. PubMed recorded a metadata revision date of 2014-11-20 and an Entrez history date of 2006-12-08. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Clinical trials · Dulaglutide

ClinicalTrials.gov record NCT01524770

PeptideScanner retained ClinicalTrials.gov record NCT01524770 at 2026-07-30T21:54:46.539Z. Its registry update date was 2014-10-22, and PeptideScanner's reviewed identity mapping was dulaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Leuprolide

Federal Register notice 2014-23961

The Federal Register published notice 2014-23961, attributed to FDA and its parent HHS department, on 2014-10-08. Its official title is “Determination That LUPRON DEPOT (Leuprolide Acetate for Depot Suspension), Injectable 3.75 Milligrams/Vial Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness,” and PeptideScanner's exact reviewed identity mapping connects the document to Leuprolide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Clinical trials · Dulaglutide

ClinicalTrials.gov record NCT01432938

PeptideScanner retained ClinicalTrials.gov record NCT01432938 at 2026-07-30T21:54:46.558Z. Its registry update date was 2014-10-07, and PeptideScanner's reviewed identity mapping was dulaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Dulaglutide

ClinicalTrials.gov record NCT01436201

PeptideScanner retained ClinicalTrials.gov record NCT01436201 at 2026-07-30T21:54:46.550Z. Its registry update date was 2014-10-07, and PeptideScanner's reviewed identity mapping was dulaglutide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT01166958

PeptideScanner retained ClinicalTrials.gov record NCT01166958 at 2026-07-30T21:54:46.558Z. Its registry update date was 2014-09-22, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Dulaglutide

Drugs@FDA application BLA125469

The official Drugs@FDA dataset lists original submission 1 for BLA 125469 with status AP dated 2014-09-18, and names dulaglutide among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT01270789

PeptideScanner retained ClinicalTrials.gov record NCT01270789 at 2026-07-30T21:54:46.538Z. Its registry update date was 2014-09-12, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Exenatide

ClinicalTrials.gov record NCT01237197

PeptideScanner retained ClinicalTrials.gov record NCT01237197 at 2026-07-30T21:54:46.554Z. Its registry update date was 2014-09-12, and PeptideScanner's reviewed identity mapping was exenatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Leuprolide

Federal Register notice 2014-19713

The Federal Register published notice 2014-19713, attributed to FDA and its parent HHS department, on 2014-08-20. Its official title is “Determination That LUPRON DEPOT-PED (Leuprolide Acetate for Depot Suspension), Injectable 3.75 Milligrams/Vial and 7.5 Milligrams/Vial; and LUPRON DEPOT-PED (Leuprolide Acetate for Depot Suspension), Injectable 7.5 Milligrams/Vial and 7.5 Milligrams/Vial, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness,” and PeptideScanner's exact reviewed identity mapping connects the document to Leuprolide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Literature metadata · Lanreotide

PubMed record PMID 15003204

PeptideScanner retained PubMed bibliographic metadata for PMID 15003204 at 2026-07-30T21:55:37.950Z. PubMed recorded a metadata revision date of 2014-08-18 and an Entrez history date of 2004-03-09. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Regulatory · Liraglutide

Federal Register notice 2014-18304

The Federal Register published notice 2014-18304, attributed to FDA and its parent HHS department, on 2014-08-04. Its official title is “Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Liraglutide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Regulatory · Lanreotide

Federal Register notice 2014-17293

The Federal Register published notice 2014-17293, attributed to FDA and its parent HHS department, on 2014-07-23. Its official title is “Draft and Revised Draft Guidances for Industry Describing Product-Specific Bioequivalence Recommendations; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Lanreotide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Clinical trials · Lanreotide

ClinicalTrials.gov record NCT01354405

PeptideScanner retained ClinicalTrials.gov record NCT01354405 at 2026-07-30T21:54:46.540Z. Its registry update date was 2014-07-09, and PeptideScanner's reviewed identity mapping was lanreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT01669291

PeptideScanner retained ClinicalTrials.gov record NCT01669291 at 2026-07-30T21:54:46.557Z. Its registry update date was 2014-06-04, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT00521300

PeptideScanner retained ClinicalTrials.gov record NCT00521300 at 2026-07-30T21:54:46.544Z. Its registry update date was 2014-06-02, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Linaclotide

Federal Register notice 2014-11926

The Federal Register published notice 2014-11926, attributed to FDA and its parent HHS department, on 2014-05-23. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; LINZESS,” and PeptideScanner's exact reviewed identity mapping connects the document to Linaclotide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT01088529

PeptideScanner retained ClinicalTrials.gov record NCT01088529 at 2026-07-30T21:54:46.544Z. Its registry update date was 2014-05-15, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT01160328

PeptideScanner retained ClinicalTrials.gov record NCT01160328 at 2026-07-30T21:54:46.559Z. Its registry update date was 2014-05-14, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Leuprolide + 1 more

Federal Register notice 2014-07330

The Federal Register published notice 2014-07330, attributed to FDA and its parent HHS department, on 2014-04-02. Its official title is “Draft and Revised Draft Guidances for Industry Describing Product-Specific Bioequivalence Recommendations; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Leuprolide and Octreotide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT01611571

PeptideScanner retained ClinicalTrials.gov record NCT01611571 at 2026-07-30T21:54:46.552Z. Its registry update date was 2014-03-04, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT01550653

PeptideScanner retained ClinicalTrials.gov record NCT01550653 at 2026-07-30T21:54:46.545Z. Its registry update date was 2014-02-27, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Glucagon

ClinicalTrials.gov record NCT01916265

PeptideScanner retained ClinicalTrials.gov record NCT01916265 at 2026-07-30T21:54:46.545Z. Its registry update date was 2014-02-05, and PeptideScanner's reviewed identity mapping was glucagon.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT00003124

PeptideScanner retained ClinicalTrials.gov record NCT00003124 at 2026-07-30T21:54:46.538Z. Its registry update date was 2014-01-06, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT00008073

PeptideScanner retained ClinicalTrials.gov record NCT00008073 at 2026-07-30T21:55:56.626Z. Its registry update date was 2013-12-19, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT00000400

PeptideScanner retained ClinicalTrials.gov record NCT00000400 at 2026-07-30T21:55:56.630Z. Its registry update date was 2013-12-09, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Pramlintide

PubMed record PMID 10576958

PeptideScanner retained PubMed bibliographic metadata for PMID 10576958 at 2026-07-30T21:56:55.038Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 1999-11-30. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Pramlintide

PubMed record PMID 11710342

PeptideScanner retained PubMed bibliographic metadata for PMID 11710342 at 2026-07-30T21:56:55.058Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 2001-11-17. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Pramlintide

PubMed record PMID 11763160

PeptideScanner retained PubMed bibliographic metadata for PMID 11763160 at 2026-07-30T21:56:55.060Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 2002-01-05. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Pramlintide

PubMed record PMID 12017422

PeptideScanner retained PubMed bibliographic metadata for PMID 12017422 at 2026-07-30T21:56:55.064Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 2002-05-23. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Pramlintide

PubMed record PMID 12079622

PeptideScanner retained PubMed bibliographic metadata for PMID 12079622 at 2026-07-30T21:56:55.908Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 2002-06-25. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Pramlintide

PubMed record PMID 14737746

PeptideScanner retained PubMed bibliographic metadata for PMID 14737746 at 2026-07-30T21:56:55.928Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 2004-01-23. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Pramlintide

PubMed record PMID 15912124

PeptideScanner retained PubMed bibliographic metadata for PMID 15912124 at 2026-07-30T21:56:56.704Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 2005-05-25. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Pramlintide

PubMed record PMID 16050943

PeptideScanner retained PubMed bibliographic metadata for PMID 16050943 at 2026-07-30T21:56:56.707Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 2005-07-30. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Pramlintide

PubMed record PMID 17879973

PeptideScanner retained PubMed bibliographic metadata for PMID 17879973 at 2026-07-30T21:56:58.631Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 2007-09-21. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Pramlintide

PubMed record PMID 19732574

PeptideScanner retained PubMed bibliographic metadata for PMID 19732574 at 2026-07-30T21:56:59.483Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 2009-09-08. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Pramlintide

PubMed record PMID 20094043

PeptideScanner retained PubMed bibliographic metadata for PMID 20094043 at 2026-07-30T21:56:59.487Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 2010-01-23. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Pramlintide

PubMed record PMID 20105039

PeptideScanner retained PubMed bibliographic metadata for PMID 20105039 at 2026-07-30T21:56:59.487Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 2010-01-29. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Pramlintide

PubMed record PMID 20164472

PeptideScanner retained PubMed bibliographic metadata for PMID 20164472 at 2026-07-30T21:56:59.488Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 2010-02-19. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Pramlintide

PubMed record PMID 9147903

PeptideScanner retained PubMed bibliographic metadata for PMID 9147903 at 2026-07-30T21:56:53.319Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 1997-04-01. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Pramlintide

PubMed record PMID 9223392

PeptideScanner retained PubMed bibliographic metadata for PMID 9223392 at 2026-07-30T21:56:54.170Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 1997-07-01. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Pramlintide

PubMed record PMID 9628276

PeptideScanner retained PubMed bibliographic metadata for PMID 9628276 at 2026-07-30T21:56:54.177Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 1998-06-17. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Pramlintide

PubMed record PMID 9761382

PeptideScanner retained PubMed bibliographic metadata for PMID 9761382 at 2026-07-30T21:56:54.179Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 1998-10-07. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Pramlintide

PubMed record PMID 9028722

PeptideScanner retained PubMed bibliographic metadata for PMID 9028722 at 2026-07-30T21:56:53.316Z. PubMed recorded a metadata revision date of 2013-11-25 and an Entrez history date of 1997-01-01. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Leuprolide

Treatment of prostatic cancer with TAP-144-SR, a depot preparation of LH-RH agonist (leuprolide).

PubMed lists PMID 16312848 in Journal of chemotherapy (Florence, Italy) as Journal Article, with publication-date metadata of 1989-07 (month precision). PeptideScanner associated the retained record with the identity slug leuprolide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 16, 2026 · Source: PubMed ↗

Literature metadata · Octreotide

The orthostatic tachycardia syndrome: evaluation of autonomic function and treatment with octreotide and ergot alkaloids.

PubMed lists PMID 2045464 in The Journal of clinical endocrinology and metabolism as Journal Article, Research Support, U.S. Gov't, P.H.S., with publication-date metadata of 1991-07 (month precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 16, 2026 · Source: PubMed ↗

Literature metadata · Leuprolide

Leuprolide acetate therapy in LH-dependent Cushing's syndrome: in vivo and in vitro observations.

PubMed lists PMID 15685898 in The Netherlands journal of medicine as Case Reports, Journal Article, with publication-date metadata of 2004-12 (month precision). PeptideScanner associated the retained record with the identity slug leuprolide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Leuprolide

The role of leuprolide acetate therapy in triggering auto-immune thyroiditis.

PubMed lists PMID 15689930 in The Journal of pediatrics as Comment, Letter, with publication-date metadata of 2005-02 (month precision). PeptideScanner associated the retained record with the identity slug leuprolide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Leuprolide

LC determination of leuprolide component amino acids in injectable solution by phanquinone pre-column derivatization labelling procedure.

PubMed lists PMID 15862697 in Journal of pharmaceutical and biomedical analysis as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2005-04-29 (day precision). PeptideScanner associated the retained record with the identity slug leuprolide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Leuprolide

Leuprolide acetate given by a subcutaneous extended-release injection: less of a pain?

PubMed lists PMID 16111462 in Expert review of anticancer therapy as Journal Article, Review, with publication-date metadata of 2005-08 (month precision). PeptideScanner associated the retained record with the identity slug leuprolide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Teriparatide

Actual versus predicted first-year utilization patterns of teriparatide in patients with employer-sponsored health insurance.

PubMed lists PMID 18021497 in Current medical research and opinion as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2007-12 (month precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Teriparatide

Teriparatide and orthopedic surgery.

PubMed lists PMID 18182888 in Aging clinical and experimental research as Journal Article, with publication-date metadata of 2007-08 (month precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Octreotide

[Modification of the motility of stomach, intestine and gallbladder by octreotide].

PubMed lists PMID 1980772 in Zeitschrift fur Gastroenterologie as Journal Article, with publication-date metadata of 1990-09 (month precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Octreotide

[Clinical applications of octreotide in gastro-entero-pancreatic (GEP) tumors].

PubMed lists PMID 1980774 in Zeitschrift fur Gastroenterologie as Journal Article, Review, with publication-date metadata of 1990-09 (month precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Leuprolide

Endocrinological and clinical evaluation of two depot formulations of leuprolide acetate in pre- and perimenopausal breast cancer patients.

PubMed lists PMID 10321505 in Cancer chemotherapy and pharmacology as Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 1999 (year precision). PeptideScanner associated the retained record with the identity slug leuprolide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Leuprolide

Managing advanced prostate cancer with Viadur (leuprolide acetate implant).

PubMed lists PMID 11998504 in Urologic nursing as Journal Article, Review, with publication-date metadata of 2001-12 (month precision). PeptideScanner associated the retained record with the identity slug leuprolide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Teriparatide

Teriparatide (forteo) for osteoporsis.

PubMed lists PMID 12571538 in The Medical letter on drugs and therapeutics as Clinical Trial, Journal Article, Randomized Controlled Trial, with publication-date metadata of 2003-02-03 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Octreotide

[Treatment of pseudocyst in chronic pancreatitis by puncture-drainage and octreotide combination].

PubMed lists PMID 1397864 in Gastroenterologie clinique et biologique as Case Reports, Letter, with publication-date metadata of 1992 (year precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Teriparatide

Treating osteoporosis with teriparatide: many unknowns?

PubMed lists PMID 14610756 in Issues in emerging health technologies as Comparative Study, Journal Article, with publication-date metadata of 2003-11 (month precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Teriparatide

Teriparatide (rhPTH 1-34) for the treatment of osteoporosis.

PubMed lists PMID 14627183 in International journal of clinical practice as Journal Article, Review, with publication-date metadata of 2003-10 (month precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Teriparatide

[Therapy of osteoporosis: bisphosphonates, SERM's, teriparatide and strontium].

PubMed lists PMID 14685711 in Zeitschrift fur Rheumatologie as Comparative Study, English Abstract, Journal Article, Review, with publication-date metadata of 2003-12 (month precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Teriparatide

Teriparatide for severe osteoporosis.

PubMed lists PMID 14742769 in The Annals of pharmacotherapy as Journal Article, Review, with publication-date metadata of 2003-12-30 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Teriparatide

Teriparatide (Forteo) for osteoporosis.

PubMed lists PMID 15117021 in American family physician as Journal Article, with publication-date metadata of 2004-04-15 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Octreotide

Octreotide in the management of postoperative enterocutaneous fistulas and stress ulcer bleeding.

PubMed lists PMID 1519586 in The American journal of gastroenterology as Case Reports, Journal Article, with publication-date metadata of 1992-09 (month precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Teriparatide

Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis.

PubMed lists PMID 15228497 in Basic & clinical pharmacology & toxicology as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2004-06 (month precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Octreotide

[Octreotide and vascular headache].

PubMed lists PMID 1523600 in Therapie as Letter, with publication-date metadata of 1992 Jan-Feb (source-text precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Leuprolide

In vitro transdermal iontophoretic delivery of leuprolide under constant current application.

PubMed lists PMID 15245886 in Journal of controlled release : official journal of the Controlled Release Society as Journal Article, with publication-date metadata of 2004-07-23 (day precision). PeptideScanner associated the retained record with the identity slug leuprolide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Teriparatide

[Teriparatide (human recombinant 1-34 parathyroid hormone)--a new treatment regimen for severe osteoporosis].

PubMed lists PMID 15347166 in Ugeskrift for laeger as Journal Article, Review, with publication-date metadata of 2004-08-02 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Teriparatide

Teriparatide for postmenopausal osteoporosis.

PubMed lists PMID 15587764 in Drug and therapeutics bulletin as Journal Article, Review, with publication-date metadata of 2004-12 (month precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Teriparatide

Teriparatide: new preparation. Osteoporosis: less well evaluated than alendronic acid.

PubMed lists PMID 15747448 in Prescrire international as Comparative Study, Journal Article, with publication-date metadata of 2005-02 (month precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Octreotide

[Possible use of octreotide in gastrointestinal pathology and in diabetes mellitus].

PubMed lists PMID 1603422 in Minerva chirurgica as Journal Article, Review, with publication-date metadata of 1992-04-30 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Octreotide

[Insulinoma and octreotide].

PubMed lists PMID 1614574 in Nederlands tijdschrift voor geneeskunde as Comment, Letter, with publication-date metadata of 1992-06-20 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Octreotide

A randomized comparison of intranasal and injectable octreotide administration in patients with acromegaly.

PubMed lists PMID 1619006 in The Journal of clinical endocrinology and metabolism as Clinical Trial, Journal Article, Randomized Controlled Trial, with publication-date metadata of 1992-07 (month precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Octreotide

[Octreotide: clinical experience].

PubMed lists PMID 1620938 in Revista clinica espanola as Journal Article, Review, with publication-date metadata of 1992-05 (month precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Octreotide

Assessment of gall bladder dynamics, cholecystokinin release and the development of gallstones during octreotide therapy for acromegaly.

PubMed lists PMID 1631261 in The Quarterly journal of medicine as Journal Article, with publication-date metadata of 1992-04 (month precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Octreotide

[Octreotide in intestinal pseudo-obstruction?].

PubMed lists PMID 1632118 in Zeitschrift fur Gastroenterologie as Journal Article, with publication-date metadata of 1992-05 (month precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Teriparatide

Initial experience with teriparatide in the United States.

PubMed lists PMID 16684431 in Current medical research and opinion as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2006-04 (month precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Octreotide

Evaluation of somatostatin and the somatostatin analogue octreotide as therapeutic agents in gastrointestinal disorders.

PubMed lists PMID 1687076 in The Netherlands journal of medicine as Journal Article, Review, with publication-date metadata of 1991-12 (month precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Octreotide

Treatment of gastrointestinal endocrine tumours with interferon-alpha and octreotide.

PubMed lists PMID 1713038 in Acta oncologica (Stockholm, Sweden) as Clinical Trial, Comparative Study, Journal Article, with publication-date metadata of 1991 (year precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Octreotide

[Somatostatin and octreotide in therapy of gastrointestinal diseases].

PubMed lists PMID 1714136 in Zeitschrift fur Gastroenterologie. Verhandlungsband as Journal Article, Review, with publication-date metadata of 1991-03 (month precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Octreotide

[Drug treatment of acute esophageal varices hemorrhage using vasoactive substances (somatostatin and octreotide)].

PubMed lists PMID 1980776 in Zeitschrift fur Gastroenterologie as Journal Article, Review, with publication-date metadata of 1990-09 (month precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Leuprolide

Leuprolide acetate treatment and myoma arterial size.

PubMed lists PMID 7651647 in Obstetrics and gynecology as Clinical Trial, Journal Article, Randomized Controlled Trial, with publication-date metadata of 1995-09 (month precision). PeptideScanner associated the retained record with the identity slug leuprolide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Leuprolide

[Short-term treatment with leuprolide acetate depot before surgical intervention for uterine leiomyomatosis].

PubMed lists PMID 7936386 in Minerva ginecologica as Clinical Trial, English Abstract, Journal Article, Randomized Controlled Trial, with publication-date metadata of 1994-06 (month precision). PeptideScanner associated the retained record with the identity slug leuprolide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Leuprolide

[Advanced endometriosis treatment with leuprolide acetate].

PubMed lists PMID 7991863 in Revista chilena de obstetricia y ginecologia as Case Reports, English Abstract, Journal Article, with publication-date metadata of 1993 (year precision). PeptideScanner associated the retained record with the identity slug leuprolide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Leuprolide

Leuprolide acetate for exhibitionism in Huntington's disease.

PubMed lists PMID 8041380 in Movement disorders : official journal of the Movement Disorder Society as Case Reports, Journal Article, with publication-date metadata of 1994-05 (month precision). PeptideScanner associated the retained record with the identity slug leuprolide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Leuprolide

Cyclophosphamide, cisplatin, and leuprolide acetate in patients with debulked stage III or IV ovarian carcinoma.

PubMed lists PMID 8063245 in Gynecologic oncology as Clinical Trial, Clinical Trial, Phase II, Journal Article, Multicenter Study, Research Support, U.S. Gov't, P.H.S., with publication-date metadata of 1994-08 (month precision). PeptideScanner associated the retained record with the identity slug leuprolide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Leuprolide

[Clinical use of a GnRH analogue in a depot preparation (leuprolide acetate) in patients with surgical indication for uterine fibromyoma].

PubMed lists PMID 8065589 in Minerva ginecologica as English Abstract, Journal Article, with publication-date metadata of 1994-04 (month precision). PeptideScanner associated the retained record with the identity slug leuprolide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Leuprolide

[Medical treatment of endometriosis: comparative study of leuprolide acetate and danazol].

PubMed lists PMID 8065590 in Minerva ginecologica as Clinical Trial, Comparative Study, English Abstract, Journal Article, Randomized Controlled Trial, with publication-date metadata of 1994-04 (month precision). PeptideScanner associated the retained record with the identity slug leuprolide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Leuprolide

Obesity affects circulating estradiol levels of premenopausal hirsute women receiving leuprolide acetate depot.

PubMed lists PMID 8348161 in International journal of fertility and menopausal studies as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 1993 May-Jun (source-text precision). PeptideScanner associated the retained record with the identity slug leuprolide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Leuprolide

Leuprolide and estrogen versus oral contraceptive pills for the treatment of hirsutism: a prospective randomized study.

PubMed lists PMID 8530573 in The Journal of clinical endocrinology and metabolism as Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S., with publication-date metadata of 1995-12 (month precision). PeptideScanner associated the retained record with the identity slug leuprolide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Leuprolide

A phase II study of leuprolide in advanced/recurrent endometrial cancer.

PubMed lists PMID 8995560 in Gynecologic oncology as Clinical Trial, Clinical Trial, Phase II, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 1997-01 (month precision). PeptideScanner associated the retained record with the identity slug leuprolide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Leuprolide

Can androgen deprivation with leuprolide be predicted from histology alone? If not, why not?

PubMed lists PMID 9146615 in The Journal of urology as Journal Article, with publication-date metadata of 1997-06 (month precision). PeptideScanner associated the retained record with the identity slug leuprolide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Leuprolide

Pituitary apoplexy after leuprolide administration for carcinoma of the prostate: what's new?

PubMed lists PMID 9156052 in Clinical endocrinology as Comment, Letter, with publication-date metadata of 1997-03 (month precision). PeptideScanner associated the retained record with the identity slug leuprolide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Leuprolide

Leuprolide in the treatment of endometrial cancer.

PubMed lists PMID 9299275 in Gynecologic oncology as Letter, with publication-date metadata of 1997-09 (month precision). PeptideScanner associated the retained record with the identity slug leuprolide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Semax

PubMed record PMID 11548444

PeptideScanner retained PubMed bibliographic metadata for PMID 11548444 at 2026-07-30T21:56:55.056Z. PubMed recorded a metadata revision date of 2013-11-21 and an Entrez history date of 2001-09-11. PeptideScanner associated this retained record with the identity slug semax. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Leuprolide

PubMed record PMID 1407643

PeptideScanner retained PubMed bibliographic metadata for PMID 1407643 at 2026-07-30T21:56:46.929Z. PubMed recorded a metadata revision date of 2013-11-21 and an Entrez history date of 1992-07-01. PeptideScanner associated this retained record with the identity slug leuprolide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Semax

PubMed record PMID 14653248

PeptideScanner retained PubMed bibliographic metadata for PMID 14653248 at 2026-07-30T21:56:55.927Z. PubMed recorded a metadata revision date of 2013-11-21 and an Entrez history date of 2003-12-05. PeptideScanner associated this retained record with the identity slug semax. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Semax

PubMed record PMID 15188751

PeptideScanner retained PubMed bibliographic metadata for PMID 15188751 at 2026-07-30T21:56:56.690Z. PubMed recorded a metadata revision date of 2013-11-21 and an Entrez history date of 2004-06-11. PeptideScanner associated this retained record with the identity slug semax. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Leuprolide

PubMed record PMID 1533022

PeptideScanner retained PubMed bibliographic metadata for PMID 1533022 at 2026-07-30T21:56:46.935Z. PubMed recorded a metadata revision date of 2013-11-21 and an Entrez history date of 1992-05-01. PeptideScanner associated this retained record with the identity slug leuprolide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Leuprolide

PubMed record PMID 1621201

PeptideScanner retained PubMed bibliographic metadata for PMID 1621201 at 2026-07-30T21:56:46.937Z. PubMed recorded a metadata revision date of 2013-11-21 and an Entrez history date of 1992-07-11. PeptideScanner associated this retained record with the identity slug leuprolide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Semax

PubMed record PMID 16635254

PeptideScanner retained PubMed bibliographic metadata for PMID 16635254 at 2026-07-30T21:56:57.667Z. PubMed recorded a metadata revision date of 2013-11-21 and an Entrez history date of 2006-04-26. PeptideScanner associated this retained record with the identity slug semax. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Leuprolide

PubMed record PMID 1666142

PeptideScanner retained PubMed bibliographic metadata for PMID 1666142 at 2026-07-30T21:56:47.772Z. PubMed recorded a metadata revision date of 2013-11-21 and an Entrez history date of 1991-10-01. PeptideScanner associated this retained record with the identity slug leuprolide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Epitalon

PubMed record PMID 17209456

PeptideScanner retained PubMed bibliographic metadata for PMID 17209456 at 2026-07-30T21:56:57.679Z. PubMed recorded a metadata revision date of 2013-11-21 and an Entrez history date of 2007-01-11. PeptideScanner associated this retained record with the identity slug epitalon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Leuprolide

PubMed record PMID 1748007

PeptideScanner retained PubMed bibliographic metadata for PMID 1748007 at 2026-07-30T21:56:47.777Z. PubMed recorded a metadata revision date of 2013-11-21 and an Entrez history date of 1991-09-01. PeptideScanner associated this retained record with the identity slug leuprolide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Leuprolide

PubMed record PMID 1835275

PeptideScanner retained PubMed bibliographic metadata for PMID 1835275 at 2026-07-30T21:56:47.778Z. PubMed recorded a metadata revision date of 2013-11-21 and an Entrez history date of 1991-11-01. PeptideScanner associated this retained record with the identity slug leuprolide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Leuprolide

PubMed record PMID 1941784

PeptideScanner retained PubMed bibliographic metadata for PMID 1941784 at 2026-07-30T21:56:47.780Z. PubMed recorded a metadata revision date of 2013-11-21 and an Entrez history date of 1991-07-01. PeptideScanner associated this retained record with the identity slug leuprolide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Leuprolide

PubMed record PMID 1981209

PeptideScanner retained PubMed bibliographic metadata for PMID 1981209 at 2026-07-30T21:56:47.782Z. PubMed recorded a metadata revision date of 2013-11-21 and an Entrez history date of 1990-11-01. PeptideScanner associated this retained record with the identity slug leuprolide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Leuprolide

PubMed record PMID 2106145

PeptideScanner retained PubMed bibliographic metadata for PMID 2106145 at 2026-07-30T21:56:47.795Z. PubMed recorded a metadata revision date of 2013-11-21 and an Entrez history date of 1990-01-01. PeptideScanner associated this retained record with the identity slug leuprolide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Leuprolide

PubMed record PMID 2115128

PeptideScanner retained PubMed bibliographic metadata for PMID 2115128 at 2026-07-30T21:56:47.795Z. PubMed recorded a metadata revision date of 2013-11-21 and an Entrez history date of 1990-05-01. PeptideScanner associated this retained record with the identity slug leuprolide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Leuprolide

PubMed record PMID 2119048

PeptideScanner retained PubMed bibliographic metadata for PMID 2119048 at 2026-07-30T21:56:47.795Z. PubMed recorded a metadata revision date of 2013-11-21 and an Entrez history date of 1990-08-01. PeptideScanner associated this retained record with the identity slug leuprolide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Leuprolide

PubMed record PMID 2120646

PeptideScanner retained PubMed bibliographic metadata for PMID 2120646 at 2026-07-30T21:56:47.795Z. PubMed recorded a metadata revision date of 2013-11-21 and an Entrez history date of 1990-11-01. PeptideScanner associated this retained record with the identity slug leuprolide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Semax

PubMed record PMID 22295573

PeptideScanner retained PubMed bibliographic metadata for PMID 22295573 at 2026-07-30T21:57:00.518Z. PubMed recorded a metadata revision date of 2013-11-21 and an Entrez history date of 2012-02-03. PeptideScanner associated this retained record with the identity slug semax. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Semax

PubMed record PMID 23072114

PeptideScanner retained PubMed bibliographic metadata for PMID 23072114 at 2026-07-30T21:57:01.392Z. PubMed recorded a metadata revision date of 2013-11-21 and an Entrez history date of 2012-10-18. PeptideScanner associated this retained record with the identity slug semax. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Leuprolide

PubMed record PMID 2410765

PeptideScanner retained PubMed bibliographic metadata for PMID 2410765 at 2026-07-30T21:56:47.801Z. PubMed recorded a metadata revision date of 2013-11-21 and an Entrez history date of 1985-08-16. PeptideScanner associated this retained record with the identity slug leuprolide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Leuprolide

PubMed record PMID 2474565

PeptideScanner retained PubMed bibliographic metadata for PMID 2474565 at 2026-07-30T21:56:47.803Z. PubMed recorded a metadata revision date of 2013-11-21 and an Entrez history date of 1989-09-01. PeptideScanner associated this retained record with the identity slug leuprolide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Emideltide

PubMed record PMID 3582201

PeptideScanner retained PubMed bibliographic metadata for PMID 3582201 at 2026-07-30T21:56:49.550Z. PubMed recorded a metadata revision date of 2013-11-21 and an Entrez history date of 1987-06-05. PeptideScanner associated this retained record with the identity slug emideltide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Emideltide

PubMed record PMID 3839701

PeptideScanner retained PubMed bibliographic metadata for PMID 3839701 at 2026-07-30T21:56:49.552Z. PubMed recorded a metadata revision date of 2013-11-21 and an Entrez history date of 1985-08-01. PeptideScanner associated this retained record with the identity slug emideltide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Emideltide

PubMed record PMID 6897366

PeptideScanner retained PubMed bibliographic metadata for PMID 6897366 at 2026-07-30T21:56:51.318Z. PubMed recorded a metadata revision date of 2013-11-21 and an Entrez history date of 1982-09-01. PeptideScanner associated this retained record with the identity slug emideltide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Emideltide

PubMed record PMID 7405185

PeptideScanner retained PubMed bibliographic metadata for PMID 7405185 at 2026-07-30T21:56:52.343Z. PubMed recorded a metadata revision date of 2013-11-21 and an Entrez history date of 1980-04-01. PeptideScanner associated this retained record with the identity slug emideltide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Emideltide

PubMed record PMID 891716

PeptideScanner retained PubMed bibliographic metadata for PMID 891716 at 2026-07-30T21:56:46.919Z. PubMed recorded a metadata revision date of 2013-11-21 and an Entrez history date of 1977-01-01. PeptideScanner associated this retained record with the identity slug emideltide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Epitalon

PubMed record PMID 11524632

PeptideScanner retained PubMed bibliographic metadata for PMID 11524632 at 2026-07-30T21:56:55.056Z. PubMed recorded a metadata revision date of 2013-11-21 and an Entrez history date of 2001-08-29. PeptideScanner associated this retained record with the identity slug epitalon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Epitalon

PubMed record PMID 12964022

PeptideScanner retained PubMed bibliographic metadata for PMID 12964022 at 2026-07-30T21:56:55.922Z. PubMed recorded a metadata revision date of 2013-11-21 and an Entrez history date of 2003-09-10. PeptideScanner associated this retained record with the identity slug epitalon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Leuprolide

PubMed record PMID 1349596

PeptideScanner retained PubMed bibliographic metadata for PMID 1349596 at 2026-07-30T21:56:46.926Z. PubMed recorded a metadata revision date of 2013-11-21 and an Entrez history date of 1992-03-01. PeptideScanner associated this retained record with the identity slug leuprolide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Leuprolide

PubMed record PMID 1407904

PeptideScanner retained PubMed bibliographic metadata for PMID 1407904 at 2026-07-30T21:56:46.929Z. PubMed recorded a metadata revision date of 2013-11-21 and an Entrez history date of 1992-10-01. PeptideScanner associated this retained record with the identity slug leuprolide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Epitalon

PubMed record PMID 15909815

PeptideScanner retained PubMed bibliographic metadata for PMID 15909815 at 2026-07-30T21:56:56.704Z. PubMed recorded a metadata revision date of 2013-11-21 and an Entrez history date of 2005-05-25. PeptideScanner associated this retained record with the identity slug epitalon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Ipamorelin

PubMed record PMID 11735244

PeptideScanner retained PubMed bibliographic metadata for PMID 11735244 at 2026-07-30T21:56:55.059Z. PubMed recorded a metadata revision date of 2013-11-21 and an Entrez history date of 2001-12-12. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · KPV

PubMed record PMID 15102092

PeptideScanner retained PubMed bibliographic metadata for PMID 15102092 at 2026-07-30T21:56:55.933Z. PubMed recorded a metadata revision date of 2013-11-21 and an Entrez history date of 2004-04-23. PeptideScanner associated this retained record with the identity slug kpv. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Ziconotide

PubMed record PMID 19530373

PeptideScanner retained PubMed bibliographic metadata for PMID 19530373 at 2026-07-30T21:56:59.480Z. PubMed recorded a metadata revision date of 2013-11-21 and an Entrez history date of 2009-06-18. PeptideScanner associated this retained record with the identity slug ziconotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Elamipretide

PubMed record PMID 21697135

PeptideScanner retained PubMed bibliographic metadata for PMID 21697135 at 2026-07-30T21:57:00.496Z. PubMed recorded a metadata revision date of 2013-11-21 and an Entrez history date of 2011-06-24. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Regulatory · Octreotide

Drugs@FDA application ANDA090834

The official Drugs@FDA dataset lists original submission 1 for ANDA 090834 with status AP dated 2013-11-12, and names octreotide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Regulatory · Octreotide

Drugs@FDA application ANDA091041

The official Drugs@FDA dataset lists original submission 1 for ANDA 091041 with status AP dated 2013-11-12, and names octreotide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Clinical trials · Exenatide

ClinicalTrials.gov record NCT00546728

PeptideScanner retained ClinicalTrials.gov record NCT00546728 at 2026-07-30T21:55:56.615Z. Its registry update date was 2013-11-08, and PeptideScanner's reviewed identity mapping was exenatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT00002580

PeptideScanner retained ClinicalTrials.gov record NCT00002580 at 2026-07-30T21:55:56.626Z. Its registry update date was 2013-11-06, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Pramlintide

PubMed record PMID 24123422

PeptideScanner retained PubMed bibliographic metadata for PMID 24123422 at 2026-07-30T21:57:02.024Z. PubMed recorded a metadata revision date of 2013-10-23 and an Entrez history date of 2013-10-15. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT01394341

PeptideScanner retained ClinicalTrials.gov record NCT01394341 at 2026-07-30T21:55:56.622Z. Its registry update date was 2013-10-09, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Teriparatide

PubMed record PMID 24076523

PeptideScanner retained PubMed bibliographic metadata for PMID 24076523 at 2026-07-30T21:57:02.024Z. PubMed recorded a metadata revision date of 2013-10-04 and an Entrez history date of 2013-10-01. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Teriparatide

PubMed record PMID 24026625

PeptideScanner retained PubMed bibliographic metadata for PMID 24026625 at 2026-07-30T21:57:02.022Z. PubMed recorded a metadata revision date of 2013-09-26 and an Entrez history date of 2013-09-13. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Teriparatide

PubMed record PMID 23982227

PeptideScanner retained PubMed bibliographic metadata for PMID 23982227 at 2026-07-30T21:57:02.020Z. PubMed recorded a metadata revision date of 2013-09-16 and an Entrez history date of 2013-08-29. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Octreotide

PubMed record PMID 23925288

PeptideScanner retained PubMed bibliographic metadata for PMID 23925288 at 2026-07-30T21:57:02.018Z. PubMed recorded a metadata revision date of 2013-08-08 and an Entrez history date of 2013-08-09. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT00002582

PeptideScanner retained ClinicalTrials.gov record NCT00002582 at 2026-07-30T21:55:56.631Z. Its registry update date was 2013-08-02, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT01911468

PeptideScanner retained ClinicalTrials.gov record NCT01911468 at 2026-07-30T21:55:56.619Z. Its registry update date was 2013-07-30, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Teriparatide

PubMed record PMID 23897194

PeptideScanner retained PubMed bibliographic metadata for PMID 23897194 at 2026-07-30T21:57:02.018Z. PubMed recorded a metadata revision date of 2013-07-30 and an Entrez history date of 2013-07-31. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT00690430

PeptideScanner retained ClinicalTrials.gov record NCT00690430 at 2026-07-30T21:55:56.629Z. Its registry update date was 2013-07-30, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT01899430

PeptideScanner retained ClinicalTrials.gov record NCT01899430 at 2026-07-30T21:55:56.626Z. Its registry update date was 2013-07-15, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT00826228

PeptideScanner retained ClinicalTrials.gov record NCT00826228 at 2026-07-30T21:55:56.618Z. Its registry update date was 2013-07-11, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT00429494

PeptideScanner retained ClinicalTrials.gov record NCT00429494 at 2026-07-30T21:55:56.622Z. Its registry update date was 2013-07-09, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT00003394

PeptideScanner retained ClinicalTrials.gov record NCT00003394 at 2026-07-30T21:55:56.623Z. Its registry update date was 2013-06-24, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Octreotide

PubMed record PMID 23789763

PeptideScanner retained PubMed bibliographic metadata for PMID 23789763 at 2026-07-30T21:57:02.014Z. PubMed recorded a metadata revision date of 2013-06-24 and an Entrez history date of 2013-06-25. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Octreotide

PubMed record PMID 23780564

PeptideScanner retained PubMed bibliographic metadata for PMID 23780564 at 2026-07-30T21:57:02.013Z. PubMed recorded a metadata revision date of 2013-06-21 and an Entrez history date of 2013-06-20. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT01063504

PeptideScanner retained ClinicalTrials.gov record NCT01063504 at 2026-07-30T21:55:56.620Z. Its registry update date was 2013-06-19, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Epitalon

PubMed record PMID 14647006

PeptideScanner retained PubMed bibliographic metadata for PMID 14647006 at 2026-07-30T21:56:55.927Z. PubMed recorded a metadata revision date of 2013-05-20 and an Entrez history date of 2003-12-04. PeptideScanner associated this retained record with the identity slug epitalon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Octreotide

PubMed record PMID 22874886

PeptideScanner retained PubMed bibliographic metadata for PMID 22874886 at 2026-07-30T21:57:01.388Z. PubMed recorded a metadata revision date of 2013-05-13 and an Entrez history date of 2012-08-10. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Octreotide

PubMed record PMID 23275042

PeptideScanner retained PubMed bibliographic metadata for PMID 23275042 at 2026-07-30T21:57:01.399Z. PubMed recorded a metadata revision date of 2013-05-06 and an Entrez history date of 2013-01-01. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Pramlintide

PubMed record PMID 23452312

PeptideScanner retained PubMed bibliographic metadata for PMID 23452312 at 2026-07-30T21:57:01.406Z. PubMed recorded a metadata revision date of 2013-04-29 and an Entrez history date of 2013-03-05. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT01469351

PeptideScanner retained ClinicalTrials.gov record NCT01469351 at 2026-07-30T21:55:56.623Z. Its registry update date was 2013-04-19, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Leuprolide

PubMed record PMID 23594627

PeptideScanner retained PubMed bibliographic metadata for PMID 23594627 at 2026-07-30T21:57:01.413Z. PubMed recorded a metadata revision date of 2013-04-18 and an Entrez history date of 2013-04-19. PeptideScanner associated this retained record with the identity slug leuprolide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Octreotide

PubMed record PMID 23591434

PeptideScanner retained PubMed bibliographic metadata for PMID 23591434 at 2026-07-30T21:57:01.412Z. PubMed recorded a metadata revision date of 2013-04-17 and an Entrez history date of 2013-04-18. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT00927186

PeptideScanner retained ClinicalTrials.gov record NCT00927186 at 2026-07-30T21:55:56.626Z. Its registry update date was 2013-04-04, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Octreotide

PubMed record PMID 23228417

PeptideScanner retained PubMed bibliographic metadata for PMID 23228417 at 2026-07-30T21:57:01.397Z. PubMed recorded a metadata revision date of 2013-03-29 and an Entrez history date of 2012-12-12. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Afamelanotide

ClinicalTrials.gov record NCT01382589

PeptideScanner retained ClinicalTrials.gov record NCT01382589 at 2026-07-30T21:55:56.622Z. Its registry update date was 2013-03-22, and PeptideScanner's reviewed identity mapping was afamelanotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Afamelanotide

ClinicalTrials.gov record NCT01430195

PeptideScanner retained ClinicalTrials.gov record NCT01430195 at 2026-07-30T21:55:56.618Z. Its registry update date was 2013-03-22, and PeptideScanner's reviewed identity mapping was afamelanotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT01561066

PeptideScanner retained ClinicalTrials.gov record NCT01561066 at 2026-07-30T21:55:56.621Z. Its registry update date was 2013-02-26, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Teriparatide

PubMed record PMID 22840755

PeptideScanner retained PubMed bibliographic metadata for PMID 22840755 at 2026-07-30T21:57:01.388Z. PubMed recorded a metadata revision date of 2013-02-01 and an Entrez history date of 2012-07-31. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Linaclotide

ClinicalTrials.gov record NCT00730015

PeptideScanner retained ClinicalTrials.gov record NCT00730015 at 2026-07-30T21:55:56.622Z. Its registry update date was 2013-01-30, and PeptideScanner's reviewed identity mapping was linaclotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Leuprolide

PubMed record PMID 23078121

PeptideScanner retained PubMed bibliographic metadata for PMID 23078121 at 2026-07-30T21:57:01.393Z. PubMed recorded a metadata revision date of 2013-01-16 and an Entrez history date of 2012-10-20. PeptideScanner associated this retained record with the identity slug leuprolide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT01430104

PeptideScanner retained ClinicalTrials.gov record NCT01430104 at 2026-07-30T21:55:56.620Z. Its registry update date was 2013-01-14, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Octreotide

PubMed record PMID 23140265

PeptideScanner retained PubMed bibliographic metadata for PMID 23140265 at 2026-07-30T21:57:01.395Z. PubMed recorded a metadata revision date of 2013-01-01 and an Entrez history date of 2012-11-13. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT00426153

PeptideScanner retained ClinicalTrials.gov record NCT00426153 at 2026-07-30T22:14:20.912Z. Its registry update date was 2012-11-21, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Ipamorelin

PubMed record PMID 10373343

PeptideScanner retained PubMed bibliographic metadata for PMID 10373343 at 2026-07-30T22:15:26.481Z. PubMed recorded a metadata revision date of 2012-11-15 and an Entrez history date of 1999-06-22. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Epitalon

PubMed record PMID 12195242

PeptideScanner retained PubMed bibliographic metadata for PMID 12195242 at 2026-07-30T22:15:26.486Z. PubMed recorded a metadata revision date of 2012-11-15 and an Entrez history date of 2002-08-27. PeptideScanner associated this retained record with the identity slug epitalon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Epitalon

PubMed record PMID 12500162

PeptideScanner retained PubMed bibliographic metadata for PMID 12500162 at 2026-07-30T22:15:26.487Z. PubMed recorded a metadata revision date of 2012-11-15 and an Entrez history date of 2002-12-25. PeptideScanner associated this retained record with the identity slug epitalon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Epitalon

PubMed record PMID 12500171

PeptideScanner retained PubMed bibliographic metadata for PMID 12500171 at 2026-07-30T22:15:26.487Z. PubMed recorded a metadata revision date of 2012-11-15 and an Entrez history date of 2002-12-25. PeptideScanner associated this retained record with the identity slug epitalon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Epitalon

PubMed record PMID 16634527

PeptideScanner retained PubMed bibliographic metadata for PMID 16634527 at 2026-07-30T22:15:26.490Z. PubMed recorded a metadata revision date of 2012-11-15 and an Entrez history date of 2006-04-26. PeptideScanner associated this retained record with the identity slug epitalon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT01695109

PeptideScanner retained ClinicalTrials.gov record NCT01695109 at 2026-07-30T22:14:20.912Z. Its registry update date was 2012-09-27, and PeptideScanner's reviewed identity mapping was liraglutide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Teriparatide

PubMed record PMID 22986396

PeptideScanner retained PubMed bibliographic metadata for PMID 22986396 at 2026-07-30T22:15:26.556Z. PubMed recorded a metadata revision date of 2012-09-18 and an Entrez history date of 2012-09-19. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Regulatory · Linaclotide

Drugs@FDA application NDA202811

The official Drugs@FDA dataset lists original submission 1 for NDA 202811 with status AP dated 2012-08-30, and names linaclotide among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Literature metadata · Exenatide

PubMed record PMID 22753275

PeptideScanner retained PubMed bibliographic metadata for PMID 22753275 at 2026-07-30T22:15:26.545Z. PubMed recorded a metadata revision date of 2012-08-23 and an Entrez history date of 2012-07-04. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT01078805

PeptideScanner retained ClinicalTrials.gov record NCT01078805 at 2026-07-30T22:14:20.917Z. Its registry update date was 2012-06-26, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Exenatide

ClinicalTrials.gov record NCT01056549

PeptideScanner retained ClinicalTrials.gov record NCT01056549 at 2026-07-30T22:14:20.917Z. Its registry update date was 2012-06-22, and PeptideScanner's reviewed identity mapping was exenatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT00004895

PeptideScanner retained ClinicalTrials.gov record NCT00004895 at 2026-07-30T22:14:20.917Z. Its registry update date was 2012-06-06, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Tesamorelin

Federal Register notice 2012-10808

The Federal Register published notice 2012-10808, attributed to FDA and its parent HHS department, on 2012-05-04. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; EGRIFTA,” and PeptideScanner's exact reviewed identity mapping connects the document to Tesamorelin.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Regulatory · Liraglutide

Federal Register notice 2012-10517

The Federal Register published notice 2012-10517, attributed to FDA and its parent HHS department, on 2012-05-02. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; Victoza,” and PeptideScanner's exact reviewed identity mapping connects the document to Liraglutide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT00171613

PeptideScanner retained ClinicalTrials.gov record NCT00171613 at 2026-07-30T22:14:20.909Z. Its registry update date was 2012-04-30, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Exenatide

ClinicalTrials.gov record NCT01580514

PeptideScanner retained ClinicalTrials.gov record NCT01580514 at 2026-07-30T22:14:20.913Z. Its registry update date was 2012-04-19, and PeptideScanner's reviewed identity mapping was exenatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT00653757

PeptideScanner retained ClinicalTrials.gov record NCT00653757 at 2026-07-30T22:14:20.913Z. Its registry update date was 2012-03-19, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT00257426

PeptideScanner retained ClinicalTrials.gov record NCT00257426 at 2026-07-30T22:14:20.913Z. Its registry update date was 2012-02-14, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Liraglutide

PubMed record PMID 20610447

PeptideScanner retained PubMed bibliographic metadata for PMID 20610447 at 2026-07-30T22:15:26.499Z. PubMed recorded a metadata revision date of 2012-02-09 and an Entrez history date of 2010-07-09. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Exenatide

PubMed record PMID 20436114

PeptideScanner retained PubMed bibliographic metadata for PMID 20436114 at 2026-07-30T22:15:26.497Z. PubMed recorded a metadata revision date of 2012-02-09 and an Entrez history date of 2010-05-04. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Regulatory · Exenatide

Drugs@FDA application NDA022200

The official Drugs@FDA dataset lists original submission 1 for NDA 022200 with status AP dated 2012-01-27, and names exenatide synthetic among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT00805935

PeptideScanner retained ClinicalTrials.gov record NCT00805935 at 2026-07-30T22:14:20.915Z. Its registry update date was 2012-01-27, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Leuprolide + 1 more

Federal Register notice 2012-1433

The Federal Register published notice 2012-1433, attributed to FDA and its parent HHS department, on 2012-01-25. Its official title is “Draft and Revised Draft Guidances for Industry Describing Product-Specific Bioequivalence Recommendations; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Leuprolide and Octreotide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT00557310

PeptideScanner retained ClinicalTrials.gov record NCT00557310 at 2026-07-30T22:15:58.883Z. Its registry update date was 2011-11-11, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Glucagon

ClinicalTrials.gov record NCT00797823

PeptideScanner retained ClinicalTrials.gov record NCT00797823 at 2026-07-30T22:15:58.887Z. Its registry update date was 2011-10-07, and PeptideScanner's reviewed identity mapping was glucagon.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT00761332

PeptideScanner retained ClinicalTrials.gov record NCT00761332 at 2026-07-30T22:15:58.887Z. Its registry update date was 2011-06-21, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Leuprolide

Federal Register notice 2011-14164

The Federal Register published notice 2011-14164, attributed to FDA and its parent HHS department, on 2011-06-08. Its official title is “Bristol-Myers Squibb Co. et al.; Withdrawal of Approval of 70 New Drug Applications and 97 Abbreviated New Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Leuprolide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT00343252

PeptideScanner retained ClinicalTrials.gov record NCT00343252 at 2026-07-30T22:15:58.895Z. Its registry update date was 2011-05-26, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Lanreotide

PubMed record PMID 21607321

PeptideScanner retained PubMed bibliographic metadata for PMID 21607321 at 2026-07-30T22:17:00.088Z. PubMed recorded a metadata revision date of 2011-05-24 and an Entrez history date of 2011-05-25. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Regulatory · Octreotide

Drugs@FDA application ANDA090985

The official Drugs@FDA dataset lists original submission 1 for ANDA 090985 with status AP dated 2011-05-11, and names octreotide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Regulatory · Octreotide

Drugs@FDA application ANDA090986

The official Drugs@FDA dataset lists original submission 1 for ANDA 090986 with status AP dated 2011-05-11, and names octreotide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT00696644

PeptideScanner retained ClinicalTrials.gov record NCT00696644 at 2026-07-30T22:15:58.886Z. Its registry update date was 2011-05-09, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT00439244

PeptideScanner retained ClinicalTrials.gov record NCT00439244 at 2026-07-30T22:15:58.884Z. Its registry update date was 2011-04-20, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Tesamorelin

ClinicalTrials.gov record NCT00850564

PeptideScanner retained ClinicalTrials.gov record NCT00850564 at 2026-07-30T22:15:58.888Z. Its registry update date was 2011-04-19, and PeptideScanner's reviewed identity mapping was tesamorelin.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Emideltide

PubMed record PMID 21262293

PeptideScanner retained PubMed bibliographic metadata for PMID 21262293 at 2026-07-30T22:17:00.064Z. PubMed recorded a metadata revision date of 2011-03-18 and an Entrez history date of 2011-01-26. PeptideScanner associated this retained record with the identity slug emideltide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Bremelanotide

ClinicalTrials.gov record NCT00425256

PeptideScanner retained ClinicalTrials.gov record NCT00425256 at 2026-07-30T22:15:58.882Z. Its registry update date was 2011-02-23, and PeptideScanner's reviewed identity mapping was bremelanotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Octreotide

Drugs@FDA application ANDA079198

The official Drugs@FDA dataset lists original submission 1 for ANDA 079198 with status AP dated 2011-02-10, and names octreotide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Literature metadata · Semax

PubMed record PMID 11569188

PeptideScanner retained PubMed bibliographic metadata for PMID 11569188 at 2026-07-30T22:26:16.761Z. PubMed recorded a metadata revision date of 2010-11-18 and an Entrez history date of 2001-09-25. PeptideScanner associated this retained record with the identity slug semax. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · CJC-1295

PubMed record PMID 15817669

PeptideScanner retained PubMed bibliographic metadata for PMID 15817669 at 2026-07-30T22:26:16.765Z. PubMed recorded a metadata revision date of 2010-11-18 and an Entrez history date of 2005-04-09. PeptideScanner associated this retained record with the identity slug cjc-1295. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Regulatory · Tesamorelin

Drugs@FDA application BLA022505

The official Drugs@FDA dataset lists original submission 1 for BLA 022505 with status AP dated 2010-11-10, and names tesamorelin acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT00002881

PeptideScanner retained ClinicalTrials.gov record NCT00002881 at 2026-07-30T22:25:23.114Z. Its registry update date was 2010-11-09, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Exenatide

ClinicalTrials.gov record NCT01208649

PeptideScanner retained ClinicalTrials.gov record NCT01208649 at 2026-07-30T22:25:23.111Z. Its registry update date was 2010-09-24, and PeptideScanner's reviewed identity mapping was exenatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Liraglutide

PubMed record PMID 20861602

PeptideScanner retained PubMed bibliographic metadata for PMID 20861602 at 2026-07-30T22:26:16.803Z. PubMed recorded a metadata revision date of 2010-09-23 and an Entrez history date of 2010-09-24. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT00259298

PeptideScanner retained ClinicalTrials.gov record NCT00259298 at 2026-07-30T22:25:23.113Z. Its registry update date was 2010-08-11, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT00005906

PeptideScanner retained ClinicalTrials.gov record NCT00005906 at 2026-07-30T22:25:23.111Z. Its registry update date was 2010-04-30, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Tesamorelin

Federal Register notice 2010-6169

The Federal Register published notice 2010-6169, attributed to FDA and its parent HHS department, on 2010-03-22. Its official title is “Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Tesamorelin.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Regulatory · Liraglutide

Drugs@FDA application NDA022341

The official Drugs@FDA dataset lists original submission 1 for NDA 022341 with status AP dated 2010-01-25, and names liraglutide among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Regulatory · Tesamorelin

Federal Register notice 2010-785

The Federal Register published notice 2010-785, attributed to FDA and its parent HHS department, on 2010-01-19. Its official title is “Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Tesamorelin.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT00063310

PeptideScanner retained ClinicalTrials.gov record NCT00063310 at 2026-07-30T22:26:45.017Z. Its registry update date was 2009-12-11, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Exenatide

Drugs@FDA application NDA021919

The official Drugs@FDA dataset lists original submission 1 for NDA 021919 with status AP dated 2009-10-30, and names exenatide synthetic among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Literature metadata · Octreotide

PubMed record PMID 19864727

PeptideScanner retained PubMed bibliographic metadata for PMID 19864727 at 2026-07-30T22:27:39.979Z. PubMed recorded a metadata revision date of 2009-10-29 and an Entrez history date of 2009-10-30. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Octreotide

PubMed record PMID 19864763

PeptideScanner retained PubMed bibliographic metadata for PMID 19864763 at 2026-07-30T22:27:39.979Z. PubMed recorded a metadata revision date of 2009-10-29 and an Entrez history date of 2009-10-30. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT00414973

PeptideScanner retained ClinicalTrials.gov record NCT00414973 at 2026-07-30T22:26:45.016Z. Its registry update date was 2009-10-28, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Afamelanotide

ClinicalTrials.gov record NCT00859534

PeptideScanner retained ClinicalTrials.gov record NCT00859534 at 2026-07-30T22:26:45.018Z. Its registry update date was 2009-09-15, and PeptideScanner's reviewed identity mapping was afamelanotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Exenatide

ClinicalTrials.gov record NCT00974272

PeptideScanner retained ClinicalTrials.gov record NCT00974272 at 2026-07-30T22:26:45.013Z. Its registry update date was 2009-09-10, and PeptideScanner's reviewed identity mapping was exenatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Exenatide

PubMed record PMID 19588557

PeptideScanner retained PubMed bibliographic metadata for PMID 19588557 at 2026-07-30T22:27:39.924Z. PubMed recorded a metadata revision date of 2009-08-04 and an Entrez history date of 2009-07-10. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Regulatory · Leuprolide

Federal Register notice E9-13272

The Federal Register published notice E9-13272, attributed to FDA and its parent HHS department, on 2009-06-08. Its official title is “Draft and Revised Draft Guidances for Industry Describing Product-Specific Bioequivalence Recommendations; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Leuprolide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Literature metadata · Octreotide

PubMed record PMID 20641226

PeptideScanner retained PubMed bibliographic metadata for PMID 20641226 at 2026-07-30T22:27:39.988Z. PubMed recorded a metadata revision date of 2009-06-05 and an Entrez history date of 2009-06-05. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Glucagon

ClinicalTrials.gov record NCT00434772

PeptideScanner retained ClinicalTrials.gov record NCT00434772 at 2026-07-30T22:26:45.006Z. Its registry update date was 2009-05-28, and PeptideScanner's reviewed identity mapping was glucagon.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Semax

PubMed record PMID 19441725

PeptideScanner retained PubMed bibliographic metadata for PMID 19441725 at 2026-07-30T22:27:39.905Z. PubMed recorded a metadata revision date of 2009-05-15 and an Entrez history date of 2009-05-16. PeptideScanner associated this retained record with the identity slug semax. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Glucagon

ClinicalTrials.gov record NCT00817271

PeptideScanner retained ClinicalTrials.gov record NCT00817271 at 2026-07-30T22:26:45.011Z. Its registry update date was 2009-05-07, and PeptideScanner's reviewed identity mapping was glucagon.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT00051558

PeptideScanner retained ClinicalTrials.gov record NCT00051558 at 2026-07-30T22:26:45.005Z. Its registry update date was 2009-03-12, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Liraglutide

Federal Register notice E9-5024

The Federal Register published notice E9-5024, attributed to FDA and its parent HHS department, on 2009-03-10. Its official title is “Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Liraglutide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Regulatory · Leuprolide

Drugs@FDA application ANDA078885

The official Drugs@FDA dataset lists original submission 1 for ANDA 078885 with status AP dated 2009-03-09, and names leuprolide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Clinical trials · Lanreotide

ClinicalTrials.gov record NCT00565097

PeptideScanner retained ClinicalTrials.gov record NCT00565097 at 2026-07-30T22:26:45.013Z. Its registry update date was 2009-02-17, and PeptideScanner's reviewed identity mapping was lanreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Lanreotide

Federal Register notice E8-27179

The Federal Register published notice E8-27179, attributed to FDA and its parent HHS department, on 2008-11-17. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; SOMATULINE DEPOT,” and PeptideScanner's exact reviewed identity mapping connects the document to Lanreotide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Regulatory · Octreotide

Federal Register notice E8-24356

The Federal Register published notice E8-24356, attributed to FDA and its parent HHS department, on 2008-10-15. Its official title is “Pediatric Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Octreotide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Literature metadata · Semax

PubMed record PMID 11188738

PeptideScanner retained PubMed bibliographic metadata for PMID 11188738 at 2026-07-30T22:38:13.871Z. PubMed recorded a metadata revision date of 2008-10-08 and an Entrez history date of 2001-02-24. PeptideScanner associated this retained record with the identity slug semax. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Emideltide

PubMed record PMID 8193332

PeptideScanner retained PubMed bibliographic metadata for PMID 8193332 at 2026-07-30T22:38:13.861Z. PubMed recorded a metadata revision date of 2008-10-08 and an Entrez history date of 1994-01-01. PeptideScanner associated this retained record with the identity slug emideltide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Semax

PubMed record PMID 8679991

PeptideScanner retained PubMed bibliographic metadata for PMID 8679991 at 2026-07-30T22:38:13.862Z. PubMed recorded a metadata revision date of 2008-10-08 and an Entrez history date of 1996-01-01. PeptideScanner associated this retained record with the identity slug semax. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Semax

PubMed record PMID 8998343

PeptideScanner retained PubMed bibliographic metadata for PMID 8998343 at 2026-07-30T22:38:13.864Z. PubMed recorded a metadata revision date of 2008-10-08 and an Entrez history date of 1996-11-01. PeptideScanner associated this retained record with the identity slug semax. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Semax

PubMed record PMID 9303728

PeptideScanner retained PubMed bibliographic metadata for PMID 9303728 at 2026-07-30T22:38:13.866Z. PubMed recorded a metadata revision date of 2008-10-08 and an Entrez history date of 1997-07-01. PeptideScanner associated this retained record with the identity slug semax. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Semax

PubMed record PMID 9606550

PeptideScanner retained PubMed bibliographic metadata for PMID 9606550 at 2026-07-30T22:38:13.868Z. PubMed recorded a metadata revision date of 2008-10-08 and an Entrez history date of 1998-06-02. PeptideScanner associated this retained record with the identity slug semax. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Semax

PubMed record PMID 18756821

PeptideScanner retained PubMed bibliographic metadata for PMID 18756821 at 2026-07-30T22:38:13.932Z. PubMed recorded a metadata revision date of 2008-09-01 and an Entrez history date of 2008-09-02. PeptideScanner associated this retained record with the identity slug semax. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Exenatide

PubMed record PMID 18630353

PeptideScanner retained PubMed bibliographic metadata for PMID 18630353 at 2026-07-30T22:38:13.928Z. PubMed recorded a metadata revision date of 2008-07-15 and an Entrez history date of 2008-07-17. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Teriparatide

PubMed record PMID 18623910

PeptideScanner retained PubMed bibliographic metadata for PMID 18623910 at 2026-07-30T22:38:13.927Z. PubMed recorded a metadata revision date of 2008-07-14 and an Entrez history date of 2008-07-16. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Teriparatide

PubMed record PMID 18477986

PeptideScanner retained PubMed bibliographic metadata for PMID 18477986 at 2026-07-30T22:38:13.910Z. PubMed recorded a metadata revision date of 2008-06-23 and an Entrez history date of 2008-05-15. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Semax

PubMed record PMID 18488900

PeptideScanner retained PubMed bibliographic metadata for PMID 18488900 at 2026-07-30T22:38:13.911Z. PubMed recorded a metadata revision date of 2008-05-20 and an Entrez history date of 2008-05-21. PeptideScanner associated this retained record with the identity slug semax. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT00670501

PeptideScanner retained ClinicalTrials.gov record NCT00670501 at 2026-07-30T22:36:49.601Z. Its registry update date was 2008-05-01, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Teriparatide

PubMed record PMID 18334980

PeptideScanner retained PubMed bibliographic metadata for PMID 18334980 at 2026-07-30T22:38:13.898Z. PubMed recorded a metadata revision date of 2008-04-28 and an Entrez history date of 2008-03-13. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Semax

PubMed record PMID 18431004

PeptideScanner retained PubMed bibliographic metadata for PMID 18431004 at 2026-07-30T22:38:13.909Z. PubMed recorded a metadata revision date of 2008-04-23 and an Entrez history date of 2008-04-24. PeptideScanner associated this retained record with the identity slug semax. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Pramlintide

PubMed record PMID 18283327

PeptideScanner retained PubMed bibliographic metadata for PMID 18283327 at 2026-07-30T22:38:13.895Z. PubMed recorded a metadata revision date of 2008-03-21 and an Entrez history date of 2008-02-20. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Regulatory · Octreotide

Drugs@FDA application ANDA077329

The official Drugs@FDA dataset lists original submission 1 for ANDA 077329 with status AP dated 2008-03-04, and names octreotide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Regulatory · Octreotide

Drugs@FDA application ANDA077330

The official Drugs@FDA dataset lists original submission 1 for ANDA 077330 with status AP dated 2008-03-04, and names octreotide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Regulatory · Octreotide

Drugs@FDA application ANDA077331

The official Drugs@FDA dataset lists original submission 1 for ANDA 077331 with status AP dated 2008-03-04, and names octreotide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Clinical trials · Pramlintide

ClinicalTrials.gov record NCT00489645

PeptideScanner retained ClinicalTrials.gov record NCT00489645 at 2026-07-30T22:36:49.602Z. Its registry update date was 2008-01-16, and PeptideScanner's reviewed identity mapping was pramlintide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Octreotide

PubMed record PMID 17955038

PeptideScanner retained PubMed bibliographic metadata for PMID 17955038 at 2026-07-30T22:40:22.998Z. PubMed recorded a metadata revision date of 2007-12-17 and an Entrez history date of 2007-10-24. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT00534677

PeptideScanner retained ClinicalTrials.gov record NCT00534677 at 2026-07-30T22:39:13.109Z. Its registry update date was 2007-12-05, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Octreotide

PubMed record PMID 20641749

PeptideScanner retained PubMed bibliographic metadata for PMID 20641749 at 2026-07-30T22:40:23.016Z. PubMed recorded a metadata revision date of 2007-11-07 and an Entrez history date of 2007-11-07. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT00191867

PeptideScanner retained ClinicalTrials.gov record NCT00191867 at 2026-07-30T22:39:13.109Z. Its registry update date was 2007-11-06, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT00190944

PeptideScanner retained ClinicalTrials.gov record NCT00190944 at 2026-07-30T22:39:13.107Z. Its registry update date was 2007-10-12, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT00532207

PeptideScanner retained ClinicalTrials.gov record NCT00532207 at 2026-07-30T22:39:13.109Z. Its registry update date was 2007-09-20, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT00532545

PeptideScanner retained ClinicalTrials.gov record NCT00532545 at 2026-07-30T22:39:13.108Z. Its registry update date was 2007-09-20, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Lanreotide

Drugs@FDA application NDA022074

The official Drugs@FDA dataset lists original submission 1 for NDA 022074 with status AP dated 2007-08-30, and names lanreotide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Regulatory · Octreotide

Drugs@FDA application ANDA077372

The official Drugs@FDA dataset lists original submission 1 for ANDA 077372 with status AP dated 2007-08-14, and names octreotide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Regulatory · Octreotide

Drugs@FDA application ANDA077373

The official Drugs@FDA dataset lists original submission 1 for ANDA 077373 with status AP dated 2007-08-14, and names octreotide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Literature metadata · Octreotide

PubMed record PMID 15299336

PeptideScanner retained PubMed bibliographic metadata for PMID 15299336 at 2026-07-30T22:40:22.107Z. PubMed recorded a metadata revision date of 2007-07-24 and an Entrez history date of 1995-01-01. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Octreotide

PubMed record PMID 15299335

PeptideScanner retained PubMed bibliographic metadata for PMID 15299335 at 2026-07-30T22:40:22.107Z. PubMed recorded a metadata revision date of 2007-07-24 and an Entrez history date of 1995-01-01. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT00239629

PeptideScanner retained ClinicalTrials.gov record NCT00239629 at 2026-07-30T22:39:13.108Z. Its registry update date was 2007-06-12, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT00079924

PeptideScanner retained ClinicalTrials.gov record NCT00079924 at 2026-07-30T22:39:13.107Z. Its registry update date was 2007-05-25, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT00035256

PeptideScanner retained ClinicalTrials.gov record NCT00035256 at 2026-07-30T22:39:13.109Z. Its registry update date was 2007-05-15, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Octreotide

Federal Register notice E7-4877

The Federal Register published notice E7-4877, attributed to FDA and its parent HHS department, on 2007-03-19. Its official title is “Pediatric Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Octreotide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Literature metadata · Octreotide

PubMed record PMID 17357189

PeptideScanner retained PubMed bibliographic metadata for PMID 17357189 at 2026-07-30T22:40:22.974Z. PubMed recorded a metadata revision date of 2007-03-14 and an Entrez history date of 2007-03-16. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Octreotide

PubMed record PMID 17335137

PeptideScanner retained PubMed bibliographic metadata for PMID 17335137 at 2026-07-30T22:40:22.973Z. PubMed recorded a metadata revision date of 2007-03-05 and an Entrez history date of 2007-03-06. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Semax

PubMed record PMID 16996699

PeptideScanner retained PubMed bibliographic metadata for PMID 16996699 at 2026-07-30T22:40:22.965Z. PubMed recorded a metadata revision date of 2007-02-23 and an Entrez history date of 2006-09-26. PeptideScanner associated this retained record with the identity slug semax. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Emideltide

PubMed record PMID 2440061

PeptideScanner retained PubMed bibliographic metadata for PMID 2440061 at 2026-07-30T22:40:22.011Z. PubMed recorded a metadata revision date of 2007-01-29 and an Entrez history date of 1987-03-01. PeptideScanner associated this retained record with the identity slug emideltide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT00191321

PeptideScanner retained ClinicalTrials.gov record NCT00191321 at 2026-07-30T22:39:13.108Z. Its registry update date was 2007-01-26, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT00191893

PeptideScanner retained ClinicalTrials.gov record NCT00191893 at 2026-07-30T22:39:13.108Z. Its registry update date was 2007-01-26, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Literature metadata · Glucagon

[A-cell-hyperplasia of islets of Langerhans on rabbits after immunisation with glucagon (author's transl)].

PubMed lists PMID 6791449 in Acta histochemica as English Abstract, Journal Article, with publication-date metadata of 1981 (year precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 16, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

Immunoreactive glucagon in neurons of various parts of the human brain. Demonstration by immunofluorescence technique.

PubMed lists PMID 6805223 in Acta histochemica as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 1981 (year precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 16, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

Behavior of amphipathic helices on analysis via matrix methods, with application to glucagon, secretin, and vasoactive intestinal peptide.

PubMed lists PMID 6850049 in Biopolymers as Journal Article, Research Support, U.S. Gov't, Non-P.H.S., with publication-date metadata of 1983-03 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 16, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

[Glucagon-producing carcinoid of the rectum--report of a case].

PubMed lists PMID 6854972 in Gan no rinsho. Japan journal of cancer clinics as Case Reports, English Abstract, Journal Article, with publication-date metadata of 1983-04 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 16, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

Glucagon-like immunoreactants in extracts of the rat hypothalamus.

PubMed lists PMID 6896489 in Endocrinology as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 1982-08 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 16, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

[McArdle's disease: therapeutic use of depot-glucagon].

PubMed lists PMID 6958445 in Deutsche medizinische Wochenschrift (1946) as Case Reports, English Abstract, Journal Article, with publication-date metadata of 1982-11-26 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 16, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

Normal vibrations of proteins: glucagon.

PubMed lists PMID 7066480 in Biopolymers as Journal Article, Research Support, U.S. Gov't, Non-P.H.S., with publication-date metadata of 1982-03 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 16, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

Glomerulopressin activity in peripheral blood of newly diagnosed type I (insulin-dependent) diabetic patients and in normal subjects treated with glucagon.

PubMed lists PMID 3111173 in Acta physiologica et pharmacologica latinoamericana : organo de la Asociacion Latinoamericana de Ciencias Fisiologicas y de la Asociacion Latinoamericana de Farmacologia as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 1986 (year precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

[Overcoming uterine tube spasm during hysterosalpingography with glucagon].

PubMed lists PMID 3245554 in Akusherstvo i ginekologiia as English Abstract, Journal Article, with publication-date metadata of 1988 (year precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

[Intraoperative spasmolysis with glucagon in an irreducible invagination].

PubMed lists PMID 3414204 in Zeitschrift fur Kinderchirurgie : organ der Deutschen, der Schweizerischen und der Osterreichischen Gesellschaft fur Kinderchirurgie = Surgery in infancy and childhood as English Abstract, Journal Article, with publication-date metadata of 1988-06 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

Distribution of oxyntomodulin and glucagon in the gastrointestinal tract and the plasma of the rat.

PubMed lists PMID 3595539 in Endocrinology as Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 1987-08 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

[Glucagon-related polypeptides in health and disease].

PubMed lists PMID 3903285 in Rinsho byori. The Japanese journal of clinical pathology as Journal Article, Review, with publication-date metadata of 1985-05 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

Identification of cells immunoreactive to antisera against porcine pancreatic glucagon in the gastro-intestinal tract of Xenopus laevis.

PubMed lists PMID 3909679 in Zeitschrift fur mikroskopisch-anatomische Forschung as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 1985 (year precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

[Glucagon and impacted food in the esophagus].

PubMed lists PMID 4024335 in Ugeskrift for laeger as Case Reports, English Abstract, Journal Article, with publication-date metadata of 1985-06-03 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

[Procedure-reliability studies on radioimmunologic pancreatic glucagon determination].

PubMed lists PMID 4024688 in Zeitschrift fur medizinische Laboratoriumsdiagnostik as English Abstract, Journal Article, with publication-date metadata of 1985 (year precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

Glucagon and VIP in the retina.

PubMed lists PMID 4044167 in Investigative ophthalmology & visual science as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 1985-10 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

[Immunoreactive insulin and glucagon levels in chronic alcoholism patients].

PubMed lists PMID 4082014 in Terapevticheskii arkhiv as Comparative Study, English Abstract, Journal Article, with publication-date metadata of 1985 (year precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

Observations on glucagon treatment in pancreatitis.

PubMed lists PMID 4853407 in Scandinavian journal of gastroenterology as Comparative Study, Journal Article, with publication-date metadata of 1974 (year precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

[Demonstration of a specific receptor site for glucagon-37 (oxyntomodulin/bioactive enteroglucagon) in rat oxyntic glands].

PubMed lists PMID 6097350 in Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie as English Abstract, Journal Article, with publication-date metadata of 1984 (year precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

Gut glucagon, enteroglucagon, gut glucagonlike immunoreactivity, glicentin--current status.

PubMed lists PMID 6188645 in Gastroenterology as Journal Article, Review, with publication-date metadata of 1983-06 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

[The glucagon syndrome].

PubMed lists PMID 6254912 in Helvetica chirurgica acta as Case Reports, English Abstract, Journal Article, with publication-date metadata of 1980-06 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

Excessive circulating large molecular weight immunoreactive glucagon components in subjects with the idiopathic postprandial syndrome.

PubMed lists PMID 6265488 in The Journal of clinical endocrinology and metabolism as Journal Article, with publication-date metadata of 1981-08 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

Glucagon antibodies alter Langerhans' islets.

PubMed lists PMID 6383371 in Biomedica biochimica acta as Comparative Study, Journal Article, with publication-date metadata of 1984 (year precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

[Nasal administration of glucagon in the treatment of neonatal hypoglycemia].

PubMed lists PMID 6482853 in Minerva pediatrica as Comparative Study, English Abstract, Journal Article, with publication-date metadata of 1984-05-31 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

Presence of immunoreactive glucagon in healthy and diseased human thyroid. Evidence of glucagon synthesis by this gland.

PubMed lists PMID 6484280 in Revista espanola de fisiologia as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 1984-06 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

[Possible intervention of glucagon in the genesis of various primary hyperlipemias].

PubMed lists PMID 6515072 in Revista clinica espanola as English Abstract, Journal Article, with publication-date metadata of 1984 Aug 15-31 (source-text precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

[Concentration of gastrin in serum, gastric and duodenal tissues and gastric argentaffin cells following administration of pancreozymin and glucagon].

PubMed lists PMID 6628748 in Fiziologicheskii zhurnal SSSR imeni I. M. Sechenova as Comparative Study, English Abstract, Journal Article, with publication-date metadata of 1983-08 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

[Glucagon and water overload as medical therapy for the spontaneous expulsion of ureteral calculi].

PubMed lists PMID 6633478 in Minerva urologica as English Abstract, Journal Article, with publication-date metadata of 1983 Apr-Jun (source-text precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

The glucagon/glucagon-like immunoreactivities in neurons of the human brain.

PubMed lists PMID 6682782 in Experimental and clinical endocrinology as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 1983-01 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

Content and gel filtration profiles of glucagon-like and somatostatin-like immunoreactivity in human fundic mucosa.

PubMed lists PMID 6687598 in The Journal of clinical endocrinology and metabolism as Journal Article, with publication-date metadata of 1983-04 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

[Immunogenic properties of glucagon: the interaction of glucagon from the hen with specific antisera to glucagon from mammals].

PubMed lists PMID 6730803 in Zhurnal evoliutsionnoi biokhimii i fiziologii as Comparative Study, English Abstract, Journal Article, with publication-date metadata of 1984 Mar-Apr (source-text precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

Molecular forms of glucagon-like immunoreactivity in porcine intestine and pancreas.

PubMed lists PMID 6822217 in Endocrinology as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 1983-03 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 14, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

[Glucagon treatment and plasma kininogenesis in acute experimental pancreatitis (author's transl)].

PubMed lists PMID 1257513 in Przeglad lekarski as English Abstract, Journal Article, with publication-date metadata of 1976 (year precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

Glucagon and related peptides (an overview).

PubMed lists PMID 2200048 in Progress in clinical and biological research as Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Review, with publication-date metadata of 1990 (year precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

Glucagon gene 3'-flanking sequences direct formation of proglucagon messenger RNA 3'-ends in islet and nonislet cells lines.

PubMed lists PMID 2233738 in Molecular endocrinology (Baltimore, Md.) as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 1990-06 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

Chronic pancreatitis and diabetes mellitus: plasma and gastroduodenal mucosal profiles of regulatory peptides (gastrin, motilin, secretin, cholecystokinin, gastric inhibitory polypeptide, somatostati…

PubMed lists PMID 2465985 in Hepato-gastroenterology as Journal Article, with publication-date metadata of 1988-10 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

[Glucagon is processed to the (19-29) fragment at the level of the hepatocyte membrane].

PubMed lists PMID 2499405 in Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie as English Abstract, Journal Article, with publication-date metadata of 1989 (year precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

[Glucagon: therapeutic uses and nursing implications].

PubMed lists PMID 250868 in Revista enfermagem em novas dimensoes as English Abstract, Journal Article, with publication-date metadata of 1978 Nov-Dec (source-text precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

[Circulating types of human glucagon (author's transl)].

PubMed lists PMID 306029 in MMW, Munchener medizinische Wochenschrift as English Abstract, Journal Article, with publication-date metadata of 1978-03-24 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

Distribution and ontogeny of glucagon-like cells in the gastrointestinal tract of the cartilaginous fish Scyliorhinus stellaris (L.).

PubMed lists PMID 3132018 in Acta histochemica as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 1988 (year precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

[Role of glucagon in pathophysiology (author's transl)].

PubMed lists PMID 389458 in Ceskoslovenska gastroenterologie a vyziva as English Abstract, Journal Article, Review, with publication-date metadata of 1979-09 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

[Blood level of glucagon in peptic ulcer].

PubMed lists PMID 441940 in Terapevticheskii arkhiv as English Abstract, Journal Article, with publication-date metadata of 1979 (year precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

[Role of glucagon in the treatment of acute pancreatitis].

PubMed lists PMID 693411 in Polski przeglad chirurgiczny as English Abstract, Journal Article, with publication-date metadata of 1978-05 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Emideltide

PubMed record PMID 16539679

PeptideScanner retained PubMed bibliographic metadata for PMID 16539679 at 2026-07-30T22:50:21.668Z. PubMed recorded a metadata revision date of 2006-11-15 and an Entrez history date of 2006-03-17. PeptideScanner associated this retained record with the identity slug emideltide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Emideltide

PubMed record PMID 3841224

PeptideScanner retained PubMed bibliographic metadata for PMID 3841224 at 2026-07-30T22:50:19.151Z. PubMed recorded a metadata revision date of 2006-11-15 and an Entrez history date of 1985-11-19. PeptideScanner associated this retained record with the identity slug emideltide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Emideltide

PubMed record PMID 6896947

PeptideScanner retained PubMed bibliographic metadata for PMID 6896947 at 2026-07-30T22:50:20.539Z. PubMed recorded a metadata revision date of 2006-11-15 and an Entrez history date of 1982-07-01. PeptideScanner associated this retained record with the identity slug emideltide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Emideltide

PubMed record PMID 6897693

PeptideScanner retained PubMed bibliographic metadata for PMID 6897693 at 2026-07-30T22:50:20.540Z. PubMed recorded a metadata revision date of 2006-11-15 and an Entrez history date of 1982-11-01. PeptideScanner associated this retained record with the identity slug emideltide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Semax

PubMed record PMID 11548604

PeptideScanner retained PubMed bibliographic metadata for PMID 11548604 at 2026-07-30T22:50:21.632Z. PubMed recorded a metadata revision date of 2006-11-15 and an Entrez history date of 2001-09-11. PeptideScanner associated this retained record with the identity slug semax. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Semax

PubMed record PMID 15678666

PeptideScanner retained PubMed bibliographic metadata for PMID 15678666 at 2026-07-30T22:50:21.662Z. PubMed recorded a metadata revision date of 2006-11-15 and an Entrez history date of 2005-02-01. PeptideScanner associated this retained record with the identity slug semax. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Semax

PubMed record PMID 15895862

PeptideScanner retained PubMed bibliographic metadata for PMID 15895862 at 2026-07-30T22:50:21.664Z. PubMed recorded a metadata revision date of 2006-11-15 and an Entrez history date of 2005-05-18. PeptideScanner associated this retained record with the identity slug semax. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Emideltide

PubMed record PMID 3506231

PeptideScanner retained PubMed bibliographic metadata for PMID 3506231 at 2026-07-30T22:50:19.146Z. PubMed recorded a metadata revision date of 2006-11-15 and an Entrez history date of 1986-01-01. PeptideScanner associated this retained record with the identity slug emideltide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Emideltide

PubMed record PMID 3776352

PeptideScanner retained PubMed bibliographic metadata for PMID 3776352 at 2026-07-30T22:50:19.149Z. PubMed recorded a metadata revision date of 2006-11-15 and an Entrez history date of 1986-06-01. PeptideScanner associated this retained record with the identity slug emideltide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Emideltide

PubMed record PMID 3788358

PeptideScanner retained PubMed bibliographic metadata for PMID 3788358 at 2026-07-30T22:50:19.149Z. PubMed recorded a metadata revision date of 2006-11-15 and an Entrez history date of 1986-09-01. PeptideScanner associated this retained record with the identity slug emideltide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Emideltide

PubMed record PMID 3840534

PeptideScanner retained PubMed bibliographic metadata for PMID 3840534 at 2026-07-30T22:50:19.151Z. PubMed recorded a metadata revision date of 2006-11-15 and an Entrez history date of 1985-01-01. PeptideScanner associated this retained record with the identity slug emideltide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Semax

PubMed record PMID 10498989

PeptideScanner retained PubMed bibliographic metadata for PMID 10498989 at 2026-07-30T22:50:21.627Z. PubMed recorded a metadata revision date of 2006-11-15 and an Entrez history date of 1999-09-28. PeptideScanner associated this retained record with the identity slug semax. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Semax

PubMed record PMID 10741256

PeptideScanner retained PubMed bibliographic metadata for PMID 10741256 at 2026-07-30T22:50:21.628Z. PubMed recorded a metadata revision date of 2006-11-15 and an Entrez history date of 2000-03-31. PeptideScanner associated this retained record with the identity slug semax. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Semax

PubMed record PMID 11177268

PeptideScanner retained PubMed bibliographic metadata for PMID 11177268 at 2026-07-30T22:50:21.630Z. PubMed recorded a metadata revision date of 2006-11-15 and an Entrez history date of 2001-02-15. PeptideScanner associated this retained record with the identity slug semax. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Semax

PubMed record PMID 11202510

PeptideScanner retained PubMed bibliographic metadata for PMID 11202510 at 2026-07-30T22:50:21.630Z. PubMed recorded a metadata revision date of 2006-11-15 and an Entrez history date of 2001-02-24. PeptideScanner associated this retained record with the identity slug semax. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Emideltide

PubMed record PMID 1455954

PeptideScanner retained PubMed bibliographic metadata for PMID 1455954 at 2026-07-30T22:50:19.089Z. PubMed recorded a metadata revision date of 2006-11-15 and an Entrez history date of 1992-07-11. PeptideScanner associated this retained record with the identity slug emideltide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Emideltide

PubMed record PMID 2562040

PeptideScanner retained PubMed bibliographic metadata for PMID 2562040 at 2026-07-30T22:50:19.118Z. PubMed recorded a metadata revision date of 2006-11-15 and an Entrez history date of 1989-07-01. PeptideScanner associated this retained record with the identity slug emideltide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Regulatory · Octreotide

Federal Register notice E6-17284

The Federal Register published notice E6-17284, attributed to FDA and its parent HHS department, on 2006-10-18. Its official title is “Summaries of Medical and Clinical Pharmacology Reviews of Pediatric Studies; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Octreotide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Regulatory · Exenatide

Federal Register notice E6-16086

The Federal Register published notice E6-16086, attributed to FDA and its parent HHS department, on 2006-10-02. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; BYETTA,” and PeptideScanner's exact reviewed identity mapping connects the document to Exenatide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Literature metadata · Octreotide

PubMed record PMID 16957757

PeptideScanner retained PubMed bibliographic metadata for PMID 16957757 at 2026-07-30T22:50:21.672Z. PubMed recorded a metadata revision date of 2006-09-07 and an Entrez history date of 2006-09-08. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Exenatide

PubMed record PMID 16929370

PeptideScanner retained PubMed bibliographic metadata for PMID 16929370 at 2026-07-30T22:50:21.672Z. PubMed recorded a metadata revision date of 2006-08-24 and an Entrez history date of 2006-08-25. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT00046137

PeptideScanner retained ClinicalTrials.gov record NCT00046137 at 2026-07-30T22:49:18.183Z. Its registry update date was 2006-07-20, and PeptideScanner's reviewed identity mapping was teriparatide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT00349258

PeptideScanner retained ClinicalTrials.gov record NCT00349258 at 2026-07-30T22:49:18.182Z. Its registry update date was 2006-07-06, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Pramlintide

Federal Register notice E6-9414

The Federal Register published notice E6-9414, attributed to FDA and its parent HHS department, on 2006-06-16. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; SYMLIN,” and PeptideScanner's exact reviewed identity mapping connects the document to Pramlintide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Regulatory · Glucagon

Federal Register notice E6-9440

The Federal Register published notice E6-9440, attributed to FDA and its parent HHS department, on 2006-06-16. Its official title is “Merck & Co., Inc., et al.; Withdrawal of Approval of 65 New Drug Applications and 52 Abbreviated New Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Glucagon.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Literature metadata · Leuprolide

PubMed record PMID 16727932

PeptideScanner retained PubMed bibliographic metadata for PMID 16727932 at 2026-07-30T22:50:21.669Z. PubMed recorded a metadata revision date of 2006-05-26 and an Entrez history date of 1996-09-01. PeptideScanner associated this retained record with the identity slug leuprolide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

[Immunoreactive glucagon content of the pancreas of chick embryos and chicks].

PubMed lists PMID 7102172 in Zhurnal evoliutsionnoi biokhimii i fiziologii as Journal Article, with publication-date metadata of 1982 May-Jun (source-text precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

[Isolation of glucagon from the chick pancreas using a macroporous ion exchanger].

PubMed lists PMID 7158155 in Zhurnal evoliutsionnoi biokhimii i fiziologii as Journal Article, with publication-date metadata of 1982 Nov-Dec (source-text precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Emideltide

PubMed record PMID 7817664

PeptideScanner retained PubMed bibliographic metadata for PMID 7817664 at 2026-07-30T22:50:20.563Z. PubMed recorded a metadata revision date of 2006-04-12 and an Entrez history date of 1994-03-01. PeptideScanner associated this retained record with the identity slug emideltide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

[Case of type I glycogenosis. Considerations on its treatment with glucagon].

PubMed lists PMID 5273686 in Minerva pediatrica as Case Reports, Journal Article, with publication-date metadata of 1970-09-15 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

[Cardiogenic shock and severe hypotension in acute myocardial infarct treated with glucagon. Preliminary experience from a coronary unit].

PubMed lists PMID 5577747 in Ugeskrift for laeger as Journal Article, with publication-date metadata of 1971-05-07 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

[Behavior of glycemic answer to glucagon in the premature infant in the first months of life].

PubMed lists PMID 5629311 in Minerva pediatrica as Journal Article, with publication-date metadata of 1967-08-04 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Regulatory · Ziconotide

Federal Register notice E6-3712

The Federal Register published notice E6-3712, attributed to FDA and its parent HHS department, on 2006-03-15. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; PRIALT,” and PeptideScanner's exact reviewed identity mapping connects the document to Ziconotide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Regulatory · Octreotide

Drugs@FDA application ANDA077450

The official Drugs@FDA dataset lists original submission 1 for ANDA 077450 with status AP dated 2006-02-10, and names octreotide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Regulatory · Octreotide

Drugs@FDA application ANDA077457

The official Drugs@FDA dataset lists original submission 1 for ANDA 077457 with status AP dated 2006-02-10, and names octreotide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Regulatory · Octreotide

Drugs@FDA application ANDA075959

The official Drugs@FDA dataset lists original submission 1 for ANDA 075959 with status AP dated 2005-11-21, and names octreotide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Literature metadata · Glucagon

[Glucagon in pediatrics. Exploration of carbohydrate metabolism in healthy children].

PubMed lists PMID 5323091 in Prensa medica argentina as Journal Article, Review, with publication-date metadata of 1965-07-16 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

[On the physiological significance of glucagon in lipid metabolism].

PubMed lists PMID 5527114 in Acta isotopica as Journal Article, with publication-date metadata of 1970 (year precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

[Glucagon in pediatrics. Exploration of glucide metabolism in sick children].

PubMed lists PMID 5861621 in Prensa medica argentina as Journal Article, with publication-date metadata of 1965-08-06 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

[Research on carbohydrate metabolism in thymectomized rats. VI. Behavior of sensitivity to glucagon].

PubMed lists PMID 5876758 in Bollettino della Societa italiana di biologia sperimentale as Journal Article, with publication-date metadata of 1965-02-28 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

[Exploration of glucide metabolism with the glucagon "test". Evaluation of the various methods of administration].

PubMed lists PMID 5995206 in Prensa medica argentina as Journal Article, with publication-date metadata of 1966-09-02 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

Regional distribution of glucagon-like immunoreactive material in the brain of rats and sand rats. An immunohistochemical investigation.

PubMed lists PMID 6774586 in Acta histochemica as Journal Article, with publication-date metadata of 1980 (year precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

Glucagon, glucagon-like peptide-1 and their receptors: an introduction.

PubMed lists PMID 8830884 in Acta physiologica Scandinavica as Journal Article, Review, with publication-date metadata of 1996-07 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

Glucagon and GLP-1 receptors: lessons from chimeric ligands and receptors.

PubMed lists PMID 8830889 in Acta physiologica Scandinavica as Journal Article, Review, with publication-date metadata of 1996-07 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Regulatory · Leuprolide

Federal Register notice 05-20301

The Federal Register published notice 05-20301, attributed to FDA and its parent HHS department, on 2005-10-07. Its official title is “Solicitation of Public Review and Comment on Research Protocol: Gonadotropin-releasing Hormone Agonist Test in Disorders of Puberty,” and PeptideScanner's exact reviewed identity mapping connects the document to Leuprolide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Regulatory · Leuprolide

Federal Register notice 05-20302

The Federal Register published notice 05-20302, attributed to FDA and its parent HHS department, on 2005-10-07. Its official title is “Pediatric Ethics Subcommittee of the Pediatric Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Leuprolide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Regulatory · Octreotide

Drugs@FDA application ANDA075957

The official Drugs@FDA dataset lists original submission 1 for ANDA 075957 with status AP dated 2005-10-03, and names octreotide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT00004311

PeptideScanner retained ClinicalTrials.gov record NCT00004311 at 2026-07-30T22:50:58.187Z. Its registry update date was 2005-06-24, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT00004344

PeptideScanner retained ClinicalTrials.gov record NCT00004344 at 2026-07-30T22:50:58.186Z. Its registry update date was 2005-06-24, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT00004771

PeptideScanner retained ClinicalTrials.gov record NCT00004771 at 2026-07-30T22:50:58.183Z. Its registry update date was 2005-06-24, and PeptideScanner's reviewed identity mapping was leuprolide.

Added August 13, 2026 · Source: ClinicalTrials.gov ↗

Clinical trials · Octreotide

ClinicalTrials.gov record NCT00004327

PeptideScanner retained ClinicalTrials.gov record NCT00004327 at 2026-07-30T22:50:58.187Z. Its registry update date was 2005-06-24, and PeptideScanner's reviewed identity mapping was octreotide.

Added August 9, 2026 · Source: ClinicalTrials.gov ↗

Regulatory · Exenatide

Drugs@FDA application NDA021773

The official Drugs@FDA dataset lists original submission 1 for NDA 021773 with status AP dated 2005-04-28, and names exenatide synthetic among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Literature metadata · Glucagon

[Glucagon].

PubMed lists PMID 4495145 in Revue de l'infirmiere as Journal Article, with publication-date metadata of 1974-02 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Regulatory · Octreotide

Drugs@FDA application ANDA076330

The official Drugs@FDA dataset lists original submission 1 for ANDA 076330 with status AP dated 2005-04-08, and names octreotide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Regulatory · Octreotide

Drugs@FDA application ANDA076313

The official Drugs@FDA dataset lists original submission 1 for ANDA 076313 with status AP dated 2005-03-28, and names octreotide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Regulatory · Pramlintide

Drugs@FDA application NDA021332

The official Drugs@FDA dataset lists original submission 1 for NDA 021332 with status AP dated 2005-03-16, and names pramlintide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Regulatory · Ziconotide

Drugs@FDA application NDA021060

The official Drugs@FDA dataset lists original submission 1 for NDA 021060 with status AP dated 2004-12-28, and names ziconotide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Regulatory · Leuprolide

Drugs@FDA application NDA021731

The official Drugs@FDA dataset lists original submission 1 for NDA 021731 with status AP dated 2004-12-14, and names leuprolide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Literature metadata · Glucagon

Upper endoscopy and glucagon: a new technique in the management of acute esophageal food impaction.

PubMed lists PMID 11280577 in The American journal of gastroenterology as Case Reports, Journal Article, with publication-date metadata of 2001-03 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

Laparoscopic resection for nonfunctioning small glucagon-producing tumor: report of a case and review of the literature.

PubMed lists PMID 14598140 in Journal of hepato-biliary-pancreatic surgery as Case Reports, Journal Article, with publication-date metadata of 2003 (year precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

Glucagon, physiological and pharmacological aspects.

PubMed lists PMID 4640881 in Folia medica Neerlandica as Journal Article, with publication-date metadata of 1972 (year precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

[Myocardial contractility and metabolism under glucagon].

PubMed lists PMID 4663551 in Verhandlungen der Deutschen Gesellschaft fur Kreislaufforschung as Journal Article, with publication-date metadata of 1972 (year precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

Glucagon and obesity.

PubMed lists PMID 4681911 in The New England journal of medicine as Journal Article, with publication-date metadata of 1973-01-04 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

[Digestive fistula therapy with glucagon].

PubMed lists PMID 4721994 in Anesthesie, analgesie, reanimation as Journal Article, with publication-date metadata of 1973 Jan-Feb (source-text precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

Glucagon in the treatment of cardiogenic shock following acute myocardial infarction.

PubMed lists PMID 4727938 in Journal of the Irish Medical Association as Journal Article, with publication-date metadata of 1973-08-11 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

[New findings on pancreatic glucagon in diabetes].

PubMed lists PMID 4731157 in Vnitrni lekarstvi as Journal Article, with publication-date metadata of 1973-08 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

[Has glucagon a value in the treatment of acute pancreatitis?].

PubMed lists PMID 4760683 in La Nouvelle presse medicale as Journal Article, with publication-date metadata of 1973-11-10 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

[Glucagon therapy of pancreatitis].

PubMed lists PMID 4790028 in Verhandlungen der Deutschen Gesellschaft fur Innere Medizin as Journal Article, with publication-date metadata of 1973 (year precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

[The role of glucagon in child's body].

PubMed lists PMID 4804852 in Pediatria polska as Journal Article, with publication-date metadata of 1973-02 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

Site of glucagon in the islets of Langerhans of man as studied by the immunofluorescent technic.

PubMed lists PMID 4893298 in Sbornik vedeckych praci Lekarske fakulty Karlovy university v Hradci Kralove as Journal Article, with publication-date metadata of 1968 (year precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

Hyperglycemia and insulin resistance during glucagon infusion.

PubMed lists PMID 5020833 in Connecticut medicine as Journal Article, with publication-date metadata of 1972-04 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

Detection of glucagon in urine by radioimmunoassay studies in normal and diabetic subjects.

PubMed lists PMID 5039244 in The Journal of endocrinology as Journal Article, with publication-date metadata of 1972-06 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

The early rise of plasma growth hormone (HGH) and immunoreactive insulin (IRI) in children following intravenous glucagon.

PubMed lists PMID 5059769 in The Journal of clinical endocrinology and metabolism as Journal Article, with publication-date metadata of 1972-02 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

[Glucagon in cardiac insufficiency].

PubMed lists PMID 5118400 in Nordisk medicin as Journal Article, with publication-date metadata of 1971-11-08 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

[Recent advances in studies on glucagon].

PubMed lists PMID 5338042 in Saishin igaku. Modern medicine as Journal Article, Review, with publication-date metadata of 1966-01 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

[Reactive hypoglycemia and intestinal glucagon].

PubMed lists PMID 5480274 in Deutsche medizinische Wochenschrift (1946) as Journal Article, with publication-date metadata of 1970-11-27 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

[Glucagon and cardiogenic shock].

PubMed lists PMID 5526158 in Schweizerische medizinische Wochenschrift as Journal Article, with publication-date metadata of 1970-12-12 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

Intervention of kidney and liver in glucagon catabolism and clearance from plasma.

PubMed lists PMID 5527115 in Acta isotopica as Journal Article, with publication-date metadata of 1970 (year precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

The glucagon content in tissues of the human intestinal tract.

PubMed lists PMID 5582726 in Acta physiologica et pharmacologica Neerlandica as Journal Article, with publication-date metadata of 1967-12 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

[Glucagon and the gastrointestinal tract].

PubMed lists PMID 5597579 in Lakartidningen as Journal Article, with publication-date metadata of 1967-07-05 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

[Glucagon].

PubMed lists PMID 5622181 in Les Cahiers du College de medecine des hopitaux de Paris as Journal Article, with publication-date metadata of 1967-12 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

[On the mathematical analysis of hyperglycemia caused by glucagon evaluated as a liver function in the aged].

PubMed lists PMID 5732585 in Giornale di gerontologia as Journal Article, with publication-date metadata of 1968-12 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

[Glucagon, the specific glycogenolytic hormone].

PubMed lists PMID 5966095 in Studii si cercetari de endocrinologie as Journal Article, with publication-date metadata of 1966 (year precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

[Recent studies on the physiology of glucagon].

PubMed lists PMID 6058576 in Journees annuelles de diabetologie de l'Hotel-Dieu as Journal Article, with publication-date metadata of 1967 (year precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

Glucagon: hormone or therapeutic agent?

PubMed lists PMID 6375966 in Critical care medicine as Journal Article, Review, with publication-date metadata of 1984-07 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

Glucagon administration for the treatment of postoperative cholangitis after Kasai's operation--a preliminary report.

PubMed lists PMID 6637110 in Zeitschrift fur Kinderchirurgie : organ der Deutschen, der Schweizerischen und der Osterreichischen Gesellschaft fur Kinderchirurgie = Surgery in infancy and childhood as Case Reports, Journal Article, with publication-date metadata of 1983-04 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

Plasma glucagon levels during spinal anesthesia and surgery in a glucagon-deficient patient.

PubMed lists PMID 6881572 in Anesthesia and analgesia as Case Reports, Journal Article, with publication-date metadata of 1983-09 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

Hypothesis: a role for glucagon as a mineralocorticoid antagonist during the first postnatal week.

PubMed lists PMID 6955682 in The New Zealand medical journal as Letter, with publication-date metadata of 1982-07-14 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

[Role of glucagon in diabetes].

PubMed lists PMID 7233044 in La Revue du praticien as Journal Article, with publication-date metadata of 1981-05-21 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

Glucagon receptor gene mutation in essential hypertension.

PubMed lists PMID 8563746 in Nature genetics as Letter, with publication-date metadata of 1996-02 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

Glucagon treatment in NICTH.

PubMed lists PMID 8636389 in The Journal of clinical endocrinology and metabolism as Case Reports, Letter, with publication-date metadata of 1996-04 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

Glucagon facilitates end-to-end pancreaticojejunostomy.

PubMed lists PMID 9100688 in Journal of the American College of Surgeons as Journal Article, with publication-date metadata of 1997-04 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Added August 13, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 1027323

PeptideScanner retained PubMed bibliographic metadata for PMID 1027323 at 2026-07-30T23:02:28.584Z. PubMed recorded a metadata revision date of 2004-11-17 and an Entrez history date of 1976-01-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 1122835

PeptideScanner retained PubMed bibliographic metadata for PMID 1122835 at 2026-07-30T23:02:28.584Z. PubMed recorded a metadata revision date of 2004-11-17 and an Entrez history date of 1975-04-11. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 2103273

PeptideScanner retained PubMed bibliographic metadata for PMID 2103273 at 2026-07-30T23:02:28.589Z. PubMed recorded a metadata revision date of 2004-11-17 and an Entrez history date of 1990-08-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 2153998

PeptideScanner retained PubMed bibliographic metadata for PMID 2153998 at 2026-07-30T23:02:28.589Z. PubMed recorded a metadata revision date of 2004-11-17 and an Entrez history date of 1990-01-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 2503306

PeptideScanner retained PubMed bibliographic metadata for PMID 2503306 at 2026-07-30T23:02:28.591Z. PubMed recorded a metadata revision date of 2004-11-17 and an Entrez history date of 1989-03-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 2952663

PeptideScanner retained PubMed bibliographic metadata for PMID 2952663 at 2026-07-30T23:02:28.595Z. PubMed recorded a metadata revision date of 2004-11-17 and an Entrez history date of 1987-06-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 2972904

PeptideScanner retained PubMed bibliographic metadata for PMID 2972904 at 2026-07-30T23:02:28.595Z. PubMed recorded a metadata revision date of 2004-11-17 and an Entrez history date of 1988-01-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 2985414

PeptideScanner retained PubMed bibliographic metadata for PMID 2985414 at 2026-07-30T23:02:28.596Z. PubMed recorded a metadata revision date of 2004-11-17 and an Entrez history date of 1985-02-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 3321166

PeptideScanner retained PubMed bibliographic metadata for PMID 3321166 at 2026-07-30T23:02:28.599Z. PubMed recorded a metadata revision date of 2004-11-17 and an Entrez history date of 1987-09-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 3608818

PeptideScanner retained PubMed bibliographic metadata for PMID 3608818 at 2026-07-30T23:02:28.600Z. PubMed recorded a metadata revision date of 2004-11-17 and an Entrez history date of 1987-07-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 3843858

PeptideScanner retained PubMed bibliographic metadata for PMID 3843858 at 2026-07-30T23:02:28.603Z. PubMed recorded a metadata revision date of 2004-11-17 and an Entrez history date of 1985-01-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 3869441

PeptideScanner retained PubMed bibliographic metadata for PMID 3869441 at 2026-07-30T23:02:28.603Z. PubMed recorded a metadata revision date of 2004-11-17 and an Entrez history date of 1985-12-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 3974692

PeptideScanner retained PubMed bibliographic metadata for PMID 3974692 at 2026-07-30T23:02:28.604Z. PubMed recorded a metadata revision date of 2004-11-17 and an Entrez history date of 1985-04-11. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 43509

PeptideScanner retained PubMed bibliographic metadata for PMID 43509 at 2026-07-30T23:02:28.571Z. PubMed recorded a metadata revision date of 2004-11-17 and an Entrez history date of 1979-11-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 636737

PeptideScanner retained PubMed bibliographic metadata for PMID 636737 at 2026-07-30T23:02:28.581Z. PubMed recorded a metadata revision date of 2004-11-17 and an Entrez history date of 1978-02-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 663336

PeptideScanner retained PubMed bibliographic metadata for PMID 663336 at 2026-07-30T23:02:28.581Z. PubMed recorded a metadata revision date of 2004-11-17 and an Entrez history date of 1978-03-31. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 692941

PeptideScanner retained PubMed bibliographic metadata for PMID 692941 at 2026-07-30T23:02:28.581Z. PubMed recorded a metadata revision date of 2004-11-17 and an Entrez history date of 1978-09-15. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 729983

PeptideScanner retained PubMed bibliographic metadata for PMID 729983 at 2026-07-30T23:02:28.582Z. PubMed recorded a metadata revision date of 2004-11-17 and an Entrez history date of 1978-10-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 760430

PeptideScanner retained PubMed bibliographic metadata for PMID 760430 at 2026-07-30T23:02:28.582Z. PubMed recorded a metadata revision date of 2004-11-17 and an Entrez history date of 1979-01-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 78626

PeptideScanner retained PubMed bibliographic metadata for PMID 78626 at 2026-07-30T23:02:28.576Z. PubMed recorded a metadata revision date of 2004-11-17 and an Entrez history date of 1976-01-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 830592

PeptideScanner retained PubMed bibliographic metadata for PMID 830592 at 2026-07-30T23:02:28.582Z. PubMed recorded a metadata revision date of 2004-11-17 and an Entrez history date of 1977-02-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 846663

PeptideScanner retained PubMed bibliographic metadata for PMID 846663 at 2026-07-30T23:02:28.583Z. PubMed recorded a metadata revision date of 2004-11-17 and an Entrez history date of 1977-01-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 932613

PeptideScanner retained PubMed bibliographic metadata for PMID 932613 at 2026-07-30T23:02:28.583Z. PubMed recorded a metadata revision date of 2004-11-17 and an Entrez history date of 1976-07-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 934252

PeptideScanner retained PubMed bibliographic metadata for PMID 934252 at 2026-07-30T23:02:28.583Z. PubMed recorded a metadata revision date of 2004-11-17 and an Entrez history date of 1976-08-19. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 935388

PeptideScanner retained PubMed bibliographic metadata for PMID 935388 at 2026-07-30T23:02:28.583Z. PubMed recorded a metadata revision date of 2004-11-17 and an Entrez history date of 1976-06-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 935416

PeptideScanner retained PubMed bibliographic metadata for PMID 935416 at 2026-07-30T23:02:28.583Z. PubMed recorded a metadata revision date of 2004-11-17 and an Entrez history date of 1976-06-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Emideltide

PubMed record PMID 6895513

PeptideScanner retained PubMed bibliographic metadata for PMID 6895513 at 2026-07-30T23:02:28.621Z. PubMed recorded a metadata revision date of 2004-11-17 and an Entrez history date of 1981-08-01. PeptideScanner associated this retained record with the identity slug emideltide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Octreotide

PubMed record PMID 8302723

PeptideScanner retained PubMed bibliographic metadata for PMID 8302723 at 2026-07-30T23:02:28.626Z. PubMed recorded a metadata revision date of 2004-11-17 and an Entrez history date of 1993-11-01. PeptideScanner associated this retained record with the identity slug octreotide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 15080976

PeptideScanner retained PubMed bibliographic metadata for PMID 15080976 at 2026-07-30T23:02:28.644Z. PubMed recorded a metadata revision date of 2004-04-14 and an Entrez history date of 2004-04-15. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 15016242

PeptideScanner retained PubMed bibliographic metadata for PMID 15016242 at 2026-07-30T23:02:28.643Z. PubMed recorded a metadata revision date of 2004-03-12 and an Entrez history date of 2004-03-16. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 10416065

PeptideScanner retained PubMed bibliographic metadata for PMID 10416065 at 2026-07-30T23:04:35.986Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1999-07-23. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 10667403

PeptideScanner retained PubMed bibliographic metadata for PMID 10667403 at 2026-07-30T23:04:35.986Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 2000-02-10. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 7246228

PeptideScanner retained PubMed bibliographic metadata for PMID 7246228 at 2026-07-30T23:04:35.984Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1980-01-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 7390563

PeptideScanner retained PubMed bibliographic metadata for PMID 7390563 at 2026-07-30T23:04:35.984Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1980-03-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 7461809

PeptideScanner retained PubMed bibliographic metadata for PMID 7461809 at 2026-07-30T23:04:35.985Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1980-07-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 9798264

PeptideScanner retained PubMed bibliographic metadata for PMID 9798264 at 2026-07-30T23:04:35.986Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1998-11-03. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 12, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 3743642

PeptideScanner retained PubMed bibliographic metadata for PMID 3743642 at 2026-07-30T23:04:35.979Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1986-06-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 3836025

PeptideScanner retained PubMed bibliographic metadata for PMID 3836025 at 2026-07-30T23:04:35.979Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1985-01-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 3904523

PeptideScanner retained PubMed bibliographic metadata for PMID 3904523 at 2026-07-30T23:04:35.979Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1985-07-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 4115811

PeptideScanner retained PubMed bibliographic metadata for PMID 4115811 at 2026-07-30T23:04:35.979Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1972-09-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 4248015

PeptideScanner retained PubMed bibliographic metadata for PMID 4248015 at 2026-07-30T23:04:35.980Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1970-01-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 4447694

PeptideScanner retained PubMed bibliographic metadata for PMID 4447694 at 2026-07-30T23:04:35.980Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1974-06-15. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 4671016

PeptideScanner retained PubMed bibliographic metadata for PMID 4671016 at 2026-07-30T23:04:35.980Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1972-01-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 4752892

PeptideScanner retained PubMed bibliographic metadata for PMID 4752892 at 2026-07-30T23:04:35.980Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1973-12-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 4817825

PeptideScanner retained PubMed bibliographic metadata for PMID 4817825 at 2026-07-30T23:04:35.980Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1974-03-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 4832640

PeptideScanner retained PubMed bibliographic metadata for PMID 4832640 at 2026-07-30T23:04:35.980Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1974-04-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 4890146

PeptideScanner retained PubMed bibliographic metadata for PMID 4890146 at 2026-07-30T23:04:35.980Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1967-01-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 4907910

PeptideScanner retained PubMed bibliographic metadata for PMID 4907910 at 2026-07-30T23:04:35.981Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1969-08-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 4911709

PeptideScanner retained PubMed bibliographic metadata for PMID 4911709 at 2026-07-30T23:04:35.981Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1968-09-11. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 4946157

PeptideScanner retained PubMed bibliographic metadata for PMID 4946157 at 2026-07-30T23:04:35.981Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1971-09-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 5069033

PeptideScanner retained PubMed bibliographic metadata for PMID 5069033 at 2026-07-30T23:04:35.981Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1972-09-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 5149146

PeptideScanner retained PubMed bibliographic metadata for PMID 5149146 at 2026-07-30T23:04:35.981Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1971-01-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 5163974

PeptideScanner retained PubMed bibliographic metadata for PMID 5163974 at 2026-07-30T23:04:35.981Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1971-10-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 5383156

PeptideScanner retained PubMed bibliographic metadata for PMID 5383156 at 2026-07-30T23:04:35.981Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1969-01-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 5384820

PeptideScanner retained PubMed bibliographic metadata for PMID 5384820 at 2026-07-30T23:04:35.981Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1969-01-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 5434173

PeptideScanner retained PubMed bibliographic metadata for PMID 5434173 at 2026-07-30T23:04:35.981Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1970-07-23. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 5434174

PeptideScanner retained PubMed bibliographic metadata for PMID 5434174 at 2026-07-30T23:04:35.981Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1970-07-23. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 5450717

PeptideScanner retained PubMed bibliographic metadata for PMID 5450717 at 2026-07-30T23:04:35.981Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1970-08-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 5490892

PeptideScanner retained PubMed bibliographic metadata for PMID 5490892 at 2026-07-30T23:04:35.982Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1970-01-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 5544573

PeptideScanner retained PubMed bibliographic metadata for PMID 5544573 at 2026-07-30T23:04:35.982Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1971-03-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 5559638

PeptideScanner retained PubMed bibliographic metadata for PMID 5559638 at 2026-07-30T23:04:35.982Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1971-07-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 5568529

PeptideScanner retained PubMed bibliographic metadata for PMID 5568529 at 2026-07-30T23:04:35.982Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1971-09-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 5601973

PeptideScanner retained PubMed bibliographic metadata for PMID 5601973 at 2026-07-30T23:04:35.982Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1967-12-31. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 5628913

PeptideScanner retained PubMed bibliographic metadata for PMID 5628913 at 2026-07-30T23:04:35.982Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1967-04-15. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 5629731

PeptideScanner retained PubMed bibliographic metadata for PMID 5629731 at 2026-07-30T23:04:35.982Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1967-01-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 5759567

PeptideScanner retained PubMed bibliographic metadata for PMID 5759567 at 2026-07-30T23:04:35.982Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1968-10-30. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 5902039

PeptideScanner retained PubMed bibliographic metadata for PMID 5902039 at 2026-07-30T23:04:35.982Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1966-01-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 5981929

PeptideScanner retained PubMed bibliographic metadata for PMID 5981929 at 2026-07-30T23:04:35.982Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1966-07-15. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 5986526

PeptideScanner retained PubMed bibliographic metadata for PMID 5986526 at 2026-07-30T23:04:35.982Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1966-01-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 6009003

PeptideScanner retained PubMed bibliographic metadata for PMID 6009003 at 2026-07-30T23:04:35.983Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1966-08-15. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 6058557

PeptideScanner retained PubMed bibliographic metadata for PMID 6058557 at 2026-07-30T23:04:35.983Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1967-01-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 6399004

PeptideScanner retained PubMed bibliographic metadata for PMID 6399004 at 2026-07-30T23:04:35.983Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1984-06-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 6725442

PeptideScanner retained PubMed bibliographic metadata for PMID 6725442 at 2026-07-30T23:04:35.983Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1984-06-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 6872939

PeptideScanner retained PubMed bibliographic metadata for PMID 6872939 at 2026-07-30T23:04:35.983Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1983-08-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 7380185

PeptideScanner retained PubMed bibliographic metadata for PMID 7380185 at 2026-07-30T23:04:35.984Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1980-05-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 11, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 1010636

PeptideScanner retained PubMed bibliographic metadata for PMID 1010636 at 2026-07-30T23:04:35.974Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1976-10-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 1025663

PeptideScanner retained PubMed bibliographic metadata for PMID 1025663 at 2026-07-30T23:04:35.974Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1976-01-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 1027956

PeptideScanner retained PubMed bibliographic metadata for PMID 1027956 at 2026-07-30T23:04:35.974Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1976-01-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 1073226

PeptideScanner retained PubMed bibliographic metadata for PMID 1073226 at 2026-07-30T23:04:35.974Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1975-01-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 1140469

PeptideScanner retained PubMed bibliographic metadata for PMID 1140469 at 2026-07-30T23:04:35.975Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1975-05-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 1205518

PeptideScanner retained PubMed bibliographic metadata for PMID 1205518 at 2026-07-30T23:04:35.975Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1975-05-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 1224198

PeptideScanner retained PubMed bibliographic metadata for PMID 1224198 at 2026-07-30T23:04:35.975Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1975-11-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 128016

PeptideScanner retained PubMed bibliographic metadata for PMID 128016 at 2026-07-30T23:04:35.968Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1975-01-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 1646577

PeptideScanner retained PubMed bibliographic metadata for PMID 1646577 at 2026-07-30T23:04:35.976Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1991-01-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 1980056

PeptideScanner retained PubMed bibliographic metadata for PMID 1980056 at 2026-07-30T23:04:35.976Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1990-01-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 2276959

PeptideScanner retained PubMed bibliographic metadata for PMID 2276959 at 2026-07-30T23:04:35.976Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1990-12-15. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Emideltide

PubMed record PMID 2361467

PeptideScanner retained PubMed bibliographic metadata for PMID 2361467 at 2026-07-30T23:04:35.977Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1990-03-01. PeptideScanner associated this retained record with the identity slug emideltide. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 2737241

PeptideScanner retained PubMed bibliographic metadata for PMID 2737241 at 2026-07-30T23:04:35.978Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1989-04-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 4055913

PeptideScanner retained PubMed bibliographic metadata for PMID 4055913 at 2026-07-30T23:04:35.979Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1985-11-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 4224451

PeptideScanner retained PubMed bibliographic metadata for PMID 4224451 at 2026-07-30T23:04:35.979Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1966-01-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 42957

PeptideScanner retained PubMed bibliographic metadata for PMID 42957 at 2026-07-30T23:04:35.967Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1979-11-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 430390

PeptideScanner retained PubMed bibliographic metadata for PMID 430390 at 2026-07-30T23:04:35.969Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1979-02-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 463488

PeptideScanner retained PubMed bibliographic metadata for PMID 463488 at 2026-07-30T23:04:35.970Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1979-04-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 480374

PeptideScanner retained PubMed bibliographic metadata for PMID 480374 at 2026-07-30T23:04:35.970Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1979-10-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 506756

PeptideScanner retained PubMed bibliographic metadata for PMID 506756 at 2026-07-30T23:04:35.971Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1979-07-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 549425

PeptideScanner retained PubMed bibliographic metadata for PMID 549425 at 2026-07-30T23:04:35.971Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1979-12-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 575700

PeptideScanner retained PubMed bibliographic metadata for PMID 575700 at 2026-07-30T23:04:35.971Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1979-01-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 671287

PeptideScanner retained PubMed bibliographic metadata for PMID 671287 at 2026-07-30T23:04:35.971Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1978-05-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · KPV

PubMed record PMID 6785126

PeptideScanner retained PubMed bibliographic metadata for PMID 6785126 at 2026-07-30T23:04:35.983Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1981-01-01. PeptideScanner associated this retained record with the identity slug kpv. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 731450

PeptideScanner retained PubMed bibliographic metadata for PMID 731450 at 2026-07-30T23:04:35.971Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1978-11-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 791855

PeptideScanner retained PubMed bibliographic metadata for PMID 791855 at 2026-07-30T23:04:35.971Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1976-03-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 801307

PeptideScanner retained PubMed bibliographic metadata for PMID 801307 at 2026-07-30T23:04:35.972Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1976-01-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 881068

PeptideScanner retained PubMed bibliographic metadata for PMID 881068 at 2026-07-30T23:04:35.973Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1977-06-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 885598

PeptideScanner retained PubMed bibliographic metadata for PMID 885598 at 2026-07-30T23:04:35.973Z. PubMed recorded a metadata revision date of 2003-11-14 and an Entrez history date of 1977-04-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Regulatory · Leuprolide

Drugs@FDA application NDA021488

The official Drugs@FDA dataset lists original submission 1 for NDA 021488 with status AP dated 2003-02-13, and names leuprolide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Literature metadata · Glucagon

PubMed record PMID 4141391

PeptideScanner retained PubMed bibliographic metadata for PMID 4141391 at 2026-07-30T23:15:36.432Z. PubMed recorded a metadata revision date of 2002-12-10 and an Entrez history date of 1974-10-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Regulatory · Teriparatide

Drugs@FDA application NDA021318

The official Drugs@FDA dataset lists original submission 1 for NDA 021318 with status AP dated 2002-11-26, and names teriparatide among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Regulatory · Leuprolide

Drugs@FDA application NDA021379

The official Drugs@FDA dataset lists original submission 1 for NDA 021379 with status AP dated 2002-07-24, and names leuprolide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Regulatory · Leuprolide

Drugs@FDA application NDA021343

The official Drugs@FDA dataset lists original submission 1 for NDA 021343 with status AP dated 2002-01-23, and names leuprolide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Regulatory · Leuprolide

Drugs@FDA application ANDA075721

The official Drugs@FDA dataset lists original submission 1 for ANDA 075721 with status AP dated 2001-11-29, and names leuprolide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Regulatory · Pramlintide + 1 more

Federal Register notice 01-14410

The Federal Register published notice 01-14410, attributed to FDA and its parent HHS department, on 2001-06-08. Its official title is “Endocrinologic and Metabolic Drugs Advisory Committe; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Pramlintide and Teriparatide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Literature metadata · Glucagon

PubMed record PMID 5198467

PeptideScanner retained PubMed bibliographic metadata for PMID 5198467 at 2026-07-30T23:27:29.856Z. PubMed recorded a metadata revision date of 2000-12-18 and an Entrez history date of 1970-02-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 5501122

PeptideScanner retained PubMed bibliographic metadata for PMID 5501122 at 2026-07-30T23:27:29.856Z. PubMed recorded a metadata revision date of 2000-12-18 and an Entrez history date of 1970-01-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Literature metadata · Glucagon

PubMed record PMID 801696

PeptideScanner retained PubMed bibliographic metadata for PMID 801696 at 2026-07-30T23:27:29.851Z. PubMed recorded a metadata revision date of 2000-12-18 and an Entrez history date of 1976-01-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.

Added August 10, 2026 · Source: PubMed ↗

Regulatory · Leuprolide

Drugs@FDA application ANDA075471

The official Drugs@FDA dataset lists original submission 1 for ANDA 075471 with status AP dated 2000-10-25, and names leuprolide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Regulatory · Leuprolide

Drugs@FDA application NDA021088

The official Drugs@FDA dataset lists original submission 1 for NDA 021088 with status AP dated 2000-03-03, and names leuprolide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Regulatory · Glucagon

Federal Register notice 00-1872

The Federal Register published notice 00-1872, attributed to FDA and its parent HHS department, on 2000-01-27. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; GlucaGen®,” and PeptideScanner's exact reviewed identity mapping connects the document to Glucagon.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Regulatory · Teriparatide

Federal Register notice 99-24595

The Federal Register published notice 99-24595, attributed to FDA and its parent HHS department, on 1999-09-22. Its official title is “Wallace Laboratories et al.; Withdrawal of Approval of 18 New Drug Applications and 44 Abbreviated New Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Teriparatide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Regulatory · Octreotide

Drugs@FDA application NDA021008

The official Drugs@FDA dataset lists original submission 1 for NDA 021008 with status AP dated 1998-11-25, and names octreotide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Regulatory · Glucagon

Federal Register proposed rule 98-29855

The Federal Register published proposed rule 98-29855, attributed to FDA and its parent HHS department, on 1998-11-12. Its official title is “Medical Devices; Exemption From Premarket Notification and Reserved Devices; Class I,” and PeptideScanner's exact reviewed identity mapping connects the document to Glucagon.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Regulatory · Glucagon

Drugs@FDA application NDA020928

The official Drugs@FDA dataset lists original submission 1 for NDA 020928 with status AP dated 1998-09-11, and names glucagon among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Regulatory · Leuprolide

Drugs@FDA application ANDA074728

The official Drugs@FDA dataset lists original submission 1 for ANDA 074728 with status AP dated 1998-08-04, and names leuprolide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Regulatory · Glucagon

Drugs@FDA application NDA020918

The official Drugs@FDA dataset lists original submission 1 for NDA 020918 with status AP dated 1998-06-22, and names glucagon hydrochloride among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Regulatory · Leuprolide

Federal Register notice 98-13045

The Federal Register published notice 98-13045, attributed to FDA and its parent HHS department, on 1998-05-18. Its official title is “Environmental Assessments and Findings of No Significant Impact,” and PeptideScanner's exact reviewed identity mapping connects the document to Leuprolide.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Regulatory · Glucagon

Federal Register notice 98-2498

The Federal Register published notice 98-2498, attributed to FDA and its parent HHS department, on 1998-02-02. Its official title is “Medical Devices; Exemptions From Premarket Notification and Reserved Devices; Class I,” and PeptideScanner's exact reviewed identity mapping connects the document to Glucagon.

Added August 21, 2026 · Source: Federal Register via GovInfo ↗

Regulatory · Leuprolide

Drugs@FDA application NDA020708

The official Drugs@FDA dataset lists original submission 1 for NDA 020708 with status AP dated 1997-03-07, and names leuprolide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Regulatory · Leuprolide

Drugs@FDA application NDA020517

The official Drugs@FDA dataset lists original submission 1 for NDA 020517 with status AP dated 1995-12-22, and names leuprolide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Regulatory · Leuprolide

Drugs@FDA application NDA019943

The official Drugs@FDA dataset lists original submission 1 for NDA 019943 with status AP dated 1995-03-30, and names leuprolide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Regulatory · Leuprolide

Drugs@FDA application NDA020263

The official Drugs@FDA dataset lists original submission 1 for NDA 020263 with status AP dated 1993-04-16, and names leuprolide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Regulatory · Leuprolide

Drugs@FDA application NDA020011

The official Drugs@FDA dataset lists original submission 1 for NDA 020011 with status AP dated 1990-10-22, and names leuprolide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Regulatory · Leuprolide

Drugs@FDA application NDA019732

The official Drugs@FDA dataset lists original submission 1 for NDA 019732 with status AP dated 1989-01-26, and names leuprolide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Regulatory · Octreotide

Drugs@FDA application NDA019667

The official Drugs@FDA dataset lists original submission 1 for NDA 019667 with status AP dated 1988-10-21, and names octreotide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Regulatory · Leuprolide

Drugs@FDA application NDA019010

The official Drugs@FDA dataset lists original submission 1 for NDA 019010 with status AP dated 1985-04-09, and names leuprolide acetate among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗

Regulatory · Glucagon

Drugs@FDA application NDA012122

The official Drugs@FDA dataset lists original submission 1 for NDA 012122 with status AP dated 1960-11-14, and names glucagon hydrochloride among the application record's active ingredients.

Added August 14, 2026 · Source: Drugs@FDA via openFDA ↗